<div id="page0" style="width:595.3pt;height:793.7pt">
<p style="top:52.6pt;left:115.2pt;line-height:25.2pt"><b><i><span style="font-family:Times New Roman,serif;font-size:25.2pt;color:#255dab">cells</span></i></b></p>
<img style="position:absolute;transform:matrix(.15624357,0,-0,.1565575,485.88453,-25.217606)" src="data:image/png;base64,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">
<img style="position:absolute;transform:matrix(.15624357,0,-0,.1565575,485.88453,-25.217606)" src="data:image/png;base64,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">
<img style="position:absolute;transform:matrix(.15624357,0,-0,.1565575,485.88453,-25.217606)" src="data:image/png;base64,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">
<img style="position:absolute;transform:matrix(.15624357,0,-0,.1565575,485.88453,-25.217606)" src="data:image/png;base64,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">
<p style="top:100.5pt;left:76.2pt;line-height:10.0pt"><i><span style="font-family:URWPalladioL,serif;font-size:10.0pt">Review</span></i></p>
<p style="top:113.4pt;left:76.5pt;line-height:17.9pt"><b><span style="font-family:URWPalladioL,serif;font-size:17.9pt">Systematic Review of Stem-Cell-Based Therapy of</span></b></p>
<p style="top:133.6pt;left:76.5pt;line-height:17.9pt"><b><span style="font-family:URWPalladioL,serif;font-size:17.9pt">Burn Wounds: Lessons Learned from Animal and</span></b></p>
<p style="top:153.9pt;left:76.5pt;line-height:17.9pt"><b><span style="font-family:URWPalladioL,serif;font-size:17.9pt">Clinical Studies</span></b></p>
<p style="top:188.7pt;left:76.3pt;line-height:10.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:10.0pt">Jose&#xfb01;ne Lin Henriksen</span></b><b><span style="font-family:URWPalladioL,serif;font-size:7.6pt"> </span></b><sup><b><span style="font-family:URWPalladioL,serif;font-size:7.6pt">1</span></b></sup><b><span style="font-family:URWPalladioL,serif;font-size:10.0pt">, Nana Brandborg S&#xf8;rensen</span></b><b><span style="font-family:URWPalladioL,serif;font-size:7.6pt"> </span></b><sup><b><span style="font-family:URWPalladioL,serif;font-size:7.6pt">1</span></b></sup><b><span style="font-family:URWPalladioL,serif;font-size:10.0pt">, Trine Fink</span></b><b><span style="font-family:URWPalladioL,serif;font-size:7.6pt"> </span></b><sup><b><span style="font-family:URWPalladioL,serif;font-size:7.6pt">2</span></b></sup></p>
<p style="top:188.7pt;left:387.7pt;line-height:10.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:10.0pt">, Vladimir Zachar</span></b><b><span style="font-family:URWPalladioL,serif;font-size:7.6pt"> </span></b><sup><b><span style="font-family:URWPalladioL,serif;font-size:7.6pt">2</span></b></sup></p>
<p style="top:202.2pt;left:76.5pt;line-height:10.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:10.0pt">and Simone Riis Porsborg</span></b><b><span style="font-family:URWPalladioL,serif;font-size:7.6pt"> </span></b><sup><b><span style="font-family:URWPalladioL,serif;font-size:7.6pt">2,</span></b></sup><b><span style="font-family:URWPalladioL,serif;font-size:10.0pt">*</span></b></p>
<p style="top:219.5pt;left:82.2pt;line-height:7.0pt"><span style="font-family:URWPalladioL,serif;font-size:7.0pt">1</span></p>
<p style="top:221.1pt;left:97.4pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Department of Health Science and Technology, Aalborg University, Fredrik Bajers Vej 7,</span></p>
<p style="top:233.2pt;left:97.4pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">9220 Aalborg, Denmark; lin.henriksen@rn.dk (J.L.H.); nana.s@rn.dk (N.B.S.)</span></p>
<p style="top:243.7pt;left:82.2pt;line-height:7.0pt"><span style="font-family:URWPalladioL,serif;font-size:7.0pt">2</span></p>
<p style="top:245.3pt;left:97.4pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Regenerative Medicine Group, Department of Health Science and Technology, Aalborg University,</span></p>
<p style="top:257.4pt;left:97.4pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Fredrik Bajers Vej 3B, 9220 Aalborg, Denmark; trinef@hst.aau.dk (T.F.); vlaz@hst.aau.dk (V.Z.)</span></p>
<p style="top:269.5pt;left:81.4pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">*</span></b></p>
<p style="top:269.5pt;left:97.4pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Correspondence: sriis@hst.aau.dk; Tel.:</span><span style="font-family:Rpxr,serif;font-size:9.0pt"> +</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">45-99407567</span></p>
<p style="top:290.8pt;left:82.2pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Received: 22 October 2020; Accepted: 24 November 2020; Published: 26 November 2020</span></p>
<p style="top:287.5pt;left:487.1pt;line-height:7.9pt"><span style="font-family:SourceSansRoman,serif;font-size:7.9pt">&#xfffd;&#xfffd;&#xfffd;&#xfffd;&#xfffd;&#xfffd;&#xfffd;&#xfffd;&#xfffd;</span><span style="font-family:SourceSansRoman.613wght,serif;font-size:7.0pt">&#xfffd;</span></p>
<p style="top:294.7pt;left:487.1pt;line-height:7.9pt"><b><span style="font-family:SourceSansRoman,serif;font-size:7.9pt">&#xfffd;&#xfffd;&#xfffd;&#xfffd;&#xfffd;&#xfffd;&#xfffd;</span></b></p>
<p style="top:320.4pt;left:81.8pt;line-height:10.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:10.0pt">Abstract:</span></b><span style="font-family:URWPalladioL,serif;font-size:10.1pt"> Treatment of severe burn wounds presents a daunting medical challenge, and novel</span></p>
<p style="top:333.8pt;left:82.2pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">approaches promoting healing and reducing scarring are highly desirable. The application of</span></p>
<p style="top:347.3pt;left:82.2pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">mesenchymal stem</span><span style="font-family:Rpxr,serif;font-size:10.1pt">/</span><span style="font-family:URWPalladioL,serif;font-size:10.1pt">stromal cells (MSCs) has been suggested as a novel treatment. In this paper,</span></p>
<p style="top:360.8pt;left:81.8pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">we present systematic reviews of pre-clinical and clinical studies of MSC therapy for second-</span></p>
<p style="top:374.3pt;left:82.2pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">or third-degree thermal burn wounds. Following the Preferred Reporting Items for Systematic</span></p>
<p style="top:388.0pt;left:82.2pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">Reviews and Meta-Analysis (PRISMA) guidelines, the PubMed and Embase databases were searched,</span></p>
<p style="top:401.5pt;left:82.2pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">and interventional studies of MSC therapy using rodent models (21 studies) or human burn patients</span></p>
<p style="top:415.0pt;left:81.9pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">(three studies) were included in the pre-clinical and clinical reviews, respectively, where both overall</span></p>
<p style="top:428.5pt;left:82.2pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">outcome and wound-healing-phase-speci&#xfb01;c methodologies and e</span><span style="font-family:Rpxr,serif;font-size:9.9pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:9.9pt">ects were assessed. The pre-clinical</span></p>
<p style="top:441.9pt;left:82.2pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">studies demonstrated a promising e</span><span style="font-family:Rpxr,serif;font-size:10.1pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:10.1pt">ect of the application of MSCs on several wound healing</span></p>
<p style="top:455.4pt;left:81.9pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">phases. The clinical studies also suggested that the MSC treatment was bene&#xfb01;cial, particularly in</span></p>
<p style="top:468.9pt;left:82.2pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">the remodeling phase. However, the limited number of studies, their lack of homogeneity in study</span></p>
<p style="top:482.5pt;left:82.2pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">design, relatively high risk of bias, lack of reporting on mode of action (MOA), and discontinuity of</span></p>
<p style="top:496.0pt;left:82.2pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">evidence restrict the strength of these &#xfb01;ndings. This comprehensive review presents an overview of</span></p>
<p style="top:509.4pt;left:82.2pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">available methodologies to assess the MOA of MSC treatment for distinct wound healing phases.</span></p>
<p style="top:523.1pt;left:82.2pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">Furthermore, it includes a set of recommendations for the design of high-quality clinical studies that</span></p>
<p style="top:536.5pt;left:82.2pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">can determine the e</span><span style="font-family:Rpxr,serif;font-size:10.0pt">&#xfb03;</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">cacy of MSCs as a therapy for burn wounds.</span></p>
<p style="top:562.0pt;left:82.2pt;line-height:10.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:10.0pt">Keywords:</span></b><span style="font-family:URWPalladioL,serif;font-size:10.0pt"> burn wound; mesenchymal stem cell; stem-cell-based treatment; adipose-derived stem</span></p>
<p style="top:575.5pt;left:82.2pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">cells; ASC; MSC</span></p>
<p style="top:625.3pt;left:76.5pt;line-height:10.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:10.0pt">1. Introduction</span></b></p>
<p style="top:644.9pt;left:97.8pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">Since the destruction of 15% of the total body skin surface is su</span><span style="font-family:Rpxr,serif;font-size:9.9pt">&#xfb03;</span><span style="font-family:URWPalladioL,serif;font-size:9.9pt">cient to result in a life-threatening</span></p>
<p style="top:658.4pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">condition, the treatment of severe burn wounds presents a serious medical challenge. Most signi&#xfb01;cantly,</span></p>
<p style="top:671.8pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">burn wounds are associated with hypovolemic shock, but they can also lead to other dysregulations,</span></p>
<p style="top:685.2pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">such as hypermetabolism or immunosuppression [</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt;color:#0774b7">1</span><span style="font-family:URWPalladioL,serif;font-size:10.1pt">]. Long-term consequences may then involve</span></p>
<p style="top:698.7pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">scarring, soft-tissue deformities, and &#xfb01;brosis. These are frequently associated with overall loss of</span></p>
<p style="top:712.3pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">mobility and pain [</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt;color:#0774b7">2</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">].</span></p>
<p style="top:725.8pt;left:97.8pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">The burn wounds are distinctive by a high degree of vascular permeability, but their healing</span></p>
<p style="top:739.3pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">follows a general paradigm common to all wounds. The reparative processes are initiated with an</span></p>
<p style="top:752.8pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">in&#xfb02;ammatory response, which is histologically marked by neutrophil and macrophage in&#xfb01;ltration.</span></p>
<p style="top:793.0pt;left:76.3pt;line-height:8.0pt"><i><span style="font-family:URWPalladioL,serif;font-size:8.0pt">Cells</span></i><b><span style="font-family:URWPalladioL,serif;font-size:8.0pt"> 2020</span></b><span style="font-family:URWPalladioL,serif;font-size:8.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:8.0pt"> 9</span></i><span style="font-family:URWPalladioL,serif;font-size:8.0pt">, 2545; doi:10.3390</span><span style="font-family:Rpxr,serif;font-size:8.0pt">/</span><span style="font-family:URWPalladioL,serif;font-size:8.0pt">cells9122545</span></p>
<p style="top:793.0pt;left:416.5pt;line-height:8.0pt"><span style="font-family:URWPalladioL,serif;font-size:8.0pt">www.mdpi.com</span><span style="font-family:Rpxr,serif;font-size:8.0pt">/</span><span style="font-family:URWPalladioL,serif;font-size:8.0pt">journal</span><span style="font-family:Rpxr,serif;font-size:8.0pt">/</span><span style="font-family:URWPalladioL,serif;font-size:8.0pt">cells</span></p>


<p style="top:56.6pt;left:76.3pt;line-height:8.0pt"><i><span style="font-family:URWPalladioL,serif;font-size:8.0pt">Cells</span></i><b><span style="font-family:URWPalladioL,serif;font-size:8.0pt"> 2020</span></b><span style="font-family:URWPalladioL,serif;font-size:8.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:8.0pt"> 9</span></i><span style="font-family:URWPalladioL,serif;font-size:8.0pt">, 2545</span></p>
<p style="top:56.6pt;left:495.8pt;line-height:8.0pt"><span style="font-family:URWPalladioL,serif;font-size:8.0pt">2 of 21</span></p>
<p style="top:90.0pt;left:76.2pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">This phase is followed by a proliferative phase, where new granulation tissue is formed along with new</span></p>
<p style="top:103.3pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">blood vessels, and the surface is re-epithelialized. During the &#xfb01;nal phase of maturation</span><span style="font-family:Rpxr,serif;font-size:10.0pt">/</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">remodeling,</span></p>
<p style="top:116.8pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">the extracellular matrix (ECM) is remodeled and collagen type III is replaced with collagen type I.</span></p>
<p style="top:130.5pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">It should be noted that the proliferative phase is impaired with increasing depth of injury, and this has</span></p>
<p style="top:144.0pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">adverse consequences for the re-epithelialization and remodeling processes. Consequently, the scarring</span></p>
<p style="top:157.4pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">after severe burns evolves over the years and has a tendency towards hypertrophy [</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt;color:#0774b7">3</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">].</span></p>
<p style="top:171.0pt;left:97.8pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">Thus, there is a need for developing approaches that promote healing, reduce scarring, and restore</span></p>
<p style="top:184.4pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">normal skin function. The application of MSCs has been suggested as a novel therapy for burn</span></p>
<p style="top:197.9pt;left:76.1pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">wounds [</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt;color:#0774b7">4</span><span style="font-family:URWPalladioL,serif;font-size:10.1pt">], as these cells have been shown to in&#xfb02;uence a number of factors associated with the</span></p>
<p style="top:211.5pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">di</span><span style="font-family:Rpxr,serif;font-size:9.9pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:9.9pt">erent phases of wound healing. In terms of the e</span><span style="font-family:Rpxr,serif;font-size:9.9pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:9.9pt">ect on the in&#xfb02;ammatory phase, MSCs can interact</span></p>
<p style="top:225.0pt;left:76.1pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">with cells of the immune system either through secretion of soluble factors or through direct cell&#x2013;cell</span></p>
<p style="top:238.5pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">contact. This immunomodulatory interaction with T and B cells, natural killer (NK) cells, neutrophils,</span></p>
<p style="top:252.1pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">macrophages, and dendritic cells supports a more anti-in&#xfb02;ammatory environment [</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt;color:#0774b7">5</span><span style="font-family:URWPalladioL,serif;font-size:9.9pt">,</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt;color:#0774b7">6</span><span style="font-family:URWPalladioL,serif;font-size:9.9pt">]. The MSCs may</span></p>
<p style="top:265.6pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">also have an impact on the proliferative phase, as we and others have shown that these cells secrete the</span></p>
<p style="top:279.0pt;left:76.2pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">pro-angiogenic vascular endothelial growth factor (VEGF) [</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt;color:#0774b7">7</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">&#x2013;</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt;color:#0774b7">10</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">], but other factors with pro-trophic</span></p>
<p style="top:292.4pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">and anti-apoptotic e</span><span style="font-family:Rpxr,serif;font-size:10.1pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:10.1pt">ects appear to play a role as well [</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt;color:#0774b7">11</span><span style="font-family:URWPalladioL,serif;font-size:10.1pt">]. The functional signi&#xfb01;cance of the MSC</span></p>
<p style="top:305.9pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">secretome for wound healing has been demonstrated</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt"> in vitro</span><span style="font-family:URWPalladioL,serif;font-size:10.1pt"> in dermal &#xfb01;broblast-, keratinocyte-,</span></p>
<p style="top:319.5pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">and endothelial-cell-based scratch assays [</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt;color:#0774b7">12</span><span style="font-family:URWPalladioL,serif;font-size:10.1pt">&#x2013;</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt;color:#0774b7">14</span><span style="font-family:URWPalladioL,serif;font-size:10.1pt">]. Finally, regarding the impact on the remodeling</span></p>
<p style="top:333.1pt;left:76.2pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">phase,</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt"> in vitro</span><span style="font-family:URWPalladioL,serif;font-size:9.9pt"> studies indicate that MSCs produce a number of factors relevant to the composition and</span></p>
<p style="top:346.6pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">regulation of the ECM [</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt;color:#0774b7">15</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">,</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt;color:#0774b7">16</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">].</span></p>
<p style="top:360.0pt;left:97.8pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">The MSCs are found in several tissues, such as the adipose tissue, bone marrow, amniotic</span></p>
<p style="top:373.6pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">membrane, umbilical cord, and dental pulp. For MSCs derived from adipose tissue (ASCs) and bone</span></p>
<p style="top:387.2pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">marrow (BM-MSCs), protocols for isolation and expansion of the clinical-grade stem cells have already</span></p>
<p style="top:400.5pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">been developed, and the clinical utility in at least the selected indications, such as perianal &#xfb01;stulas</span></p>
<p style="top:414.1pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">or ischemic heart disease, has been con&#xfb01;rmed [</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt;color:#0774b7">17</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">&#x2013;</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt;color:#0774b7">21</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">]. Additionally, clinical studies on diabetic foot</span></p>
<p style="top:427.7pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">ulcers [</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt;color:#0774b7">22</span><span style="font-family:URWPalladioL,serif;font-size:9.9pt">] and venous ulcers [</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt;color:#0774b7">23</span><span style="font-family:URWPalladioL,serif;font-size:9.9pt">] are suggestive that MSCs might also be bene&#xfb01;cial in the case of burn</span></p>
<p style="top:441.1pt;left:76.1pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">wounds; nevertheless, a comprehensive understanding of MSCs&#x2019; signi&#xfb01;cance in this scenario is yet to</span></p>
<p style="top:454.6pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">be obtained.</span></p>
<p style="top:468.2pt;left:97.8pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">The aim of this article is to critically access the clinical potential of MSCs for burn wounds. This is</span></p>
<p style="top:481.6pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">done through two systematic reviews analyzing the current state of knowledge. The &#xfb01;rst review is</span></p>
<p style="top:495.2pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">centered on stem cell treatment of burn wounds in rodent models. It attempts to clarify the molecular</span></p>
<p style="top:508.6pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">and cellular e</span><span style="font-family:Rpxr,serif;font-size:10.0pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">ects of stem cell treatment on the di</span><span style="font-family:Rpxr,serif;font-size:10.0pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">erent phases of wound healing. It also strives to</span></p>
<p style="top:522.1pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">identify methodologies that would be easy to translate into the clinical studies. The second review</span></p>
<p style="top:535.6pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">deals with clinical studies in order to evaluate the e</span><span style="font-family:Rpxr,serif;font-size:10.1pt">&#xfb03;</span><span style="font-family:URWPalladioL,serif;font-size:10.1pt">cacy of MSCs for treatment of severe burn</span></p>
<p style="top:549.3pt;left:76.1pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">wounds and to clarify the advancement in the process of clinical translation of the use of stem cells for</span></p>
<p style="top:562.7pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">burn wounds. The animal-based review is methodologically heavy, but it might be bene&#xfb01;cial for the</span></p>
<p style="top:576.2pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">translation. Furthermore, it might aid the design and increase the quality of future resource-intensive</span></p>
<p style="top:589.7pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">clinical trials. These are factors that the current literature lacks.</span></p>
<p style="top:612.9pt;left:76.5pt;line-height:10.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:10.0pt">2. Methods</span></b></p>
<p style="top:632.3pt;left:97.8pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">We conducted two systematic reviews&#x2014;a pre-clinical and a clinical systematic review.</span></p>
<p style="top:645.9pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">Both systematic reviews were performed according to the Preferred Reporting Items for Systematic</span></p>
<p style="top:659.4pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">Reviews and Meta-Analysis (PRISMA) guidelines [</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt;color:#0774b7">24</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">].</span></p>
<p style="top:682.7pt;left:76.5pt;line-height:10.0pt"><i><span style="font-family:URWPalladioL,serif;font-size:10.0pt">2.1. Search Strategies</span></i></p>
<p style="top:702.2pt;left:97.8pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">An a priori protocol based on the PRISMA-P checklist to perform a systematic literature search was</span></p>
<p style="top:715.7pt;left:76.2pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">prepared for both animal and clinical studies and uploaded to the International Prospective Register of</span></p>
<p style="top:729.2pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">Systematic Reviews (PROPSPERO; protocol ID: CRD42018091050 and CRD42018091793, respectively).</span></p>
<p style="top:742.7pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">PubMed and Embase were then searched with regards to their individual thesauruses. The following</span></p>


<p style="top:56.6pt;left:76.3pt;line-height:8.0pt"><i><span style="font-family:URWPalladioL,serif;font-size:8.0pt">Cells</span></i><b><span style="font-family:URWPalladioL,serif;font-size:8.0pt"> 2020</span></b><span style="font-family:URWPalladioL,serif;font-size:8.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:8.0pt"> 9</span></i><span style="font-family:URWPalladioL,serif;font-size:8.0pt">, 2545</span></p>
<p style="top:56.6pt;left:495.8pt;line-height:8.0pt"><span style="font-family:URWPalladioL,serif;font-size:8.0pt">3 of 21</span></p>
<p style="top:89.8pt;left:76.2pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">primary keyword query was applied: &#x201c;Burns&#x201d; AND (&#x201c;MSC&#x201d; OR &#x201c;ASC&#x201d;). For the complete search</span></p>
<p style="top:103.4pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">strategies for each database, please refer to Table</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt;color:#0774b7"> 1</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">.</span></p>
<p style="top:128.9pt;left:230.6pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Table 1.</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> Database search strategy.</span></p>
<p style="top:150.0pt;left:107.0pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Database</span></b></p>
<p style="top:150.0pt;left:315.2pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Search Strategy</span></b></p>
<p style="top:204.4pt;left:108.2pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">PubMed</span></b></p>
<p style="top:166.0pt;left:188.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">(Burn [MeSH] OR &#x201c;Thermal injury&#x201d; OR &#x201c;second degree burn&#x201d; OR &#x201c;third degree</span></p>
<p style="top:177.0pt;left:181.2pt;line-height:8.9pt"><span style="font-family:URWPalladioL,serif;font-size:8.9pt">burn&#x201d; OR &#x201c;skin burn&#x201d; OR &#x201c;burn trauma&#x201d; OR &#x201c;burn damage&#x201d; OR &#x201c;burn wound&#x201d; OR</span></p>
<p style="top:187.9pt;left:186.3pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">&#x201c;burn injur *&#x201d;OR &#x201c;burn patient *&#x201d; OR &#x201c;burn lesion&#x201d; OR &#x201c;burn complication&#x201d; OR</span></p>
<p style="top:198.9pt;left:184.7pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">&#x201c;deep burn&#x201d; OR &#x201c;thermal burn&#x201d; OR &#x201c;deep partial thickness&#x201d; OR &#x201c;full thickness&#x201d;)</span></p>
<p style="top:209.8pt;left:184.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">AND (Mesenchymal stromal cells [MeSH] OR &#x201c;Adipose mesenchymal stem cell *&#x201d;</span></p>
<p style="top:220.8pt;left:192.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">OR &#x201c;adipose derived mesenchymal cell *&#x201d;) AND (&#x201c;Adipose stromal cell *&#x201d; OR</span></p>
<p style="top:231.8pt;left:188.2pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">&#x201c;Adipose tissue-derived stem cell *&#x201d; OR &#x201c;adipose-derived adult stem cell *&#x201d; OR</span></p>
<p style="top:242.7pt;left:271.8pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">&#x201c;adipose derived regenerative cell *&#x201d;)</span></p>
<p style="top:280.4pt;left:109.9pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Embase</span></b></p>
<p style="top:258.5pt;left:202.2pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">(Exp</span><span style="font-family:Rpxr,serif;font-size:9.0pt">/</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">burn OR Exp</span><span style="font-family:Rpxr,serif;font-size:9.0pt">/</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">thermal injury) AND (Exp</span><span style="font-family:Rpxr,serif;font-size:9.0pt">/</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">mesenchymal stem cell OR</span></p>
<p style="top:269.4pt;left:186.9pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Exp</span><span style="font-family:Rpxr,serif;font-size:9.0pt">/</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">mesenchymal stromal cell OR &#x201c;Adipose mesenchymal stem cell *&#x201d;, &#x201c;adipose</span></p>
<p style="top:280.4pt;left:191.0pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">derived mesenchymal cell *&#x201d;) OR (Exp</span><span style="font-family:Rpxr,serif;font-size:9.0pt">/</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">adipose derived stem cell OR (&#x201c;adipose</span></p>
<p style="top:291.4pt;left:181.2pt;line-height:8.9pt"><span style="font-family:URWPalladioL,serif;font-size:8.9pt">derived stem cell&#x201d; OR &#x201c;adipose stromal cell *&#x201d; OR adipose tissue-derived stem cell *&#x201d;</span></p>
<p style="top:302.3pt;left:186.4pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">OR &#x201c;adipose-derived adult stem cell *&#x201d; OR &#x201c;adipose derived regenerative cell *&#x201d;)</span></p>
<p style="top:317.6pt;left:255.4pt;line-height:8.0pt"><span style="font-family:URWPalladioL,serif;font-size:8.0pt">* Unlimited truncation.</span></p>
<p style="top:340.0pt;left:76.5pt;line-height:10.0pt"><i><span style="font-family:URWPalladioL,serif;font-size:10.0pt">2.2. Eligibility Criteria</span></i></p>
<p style="top:359.4pt;left:97.8pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">To be valid for inclusion in the review, the studies were required to be either randomized or</span></p>
<p style="top:373.0pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">non-randomized controlled studies with full-text availability in English published between 2010 and</span></p>
<p style="top:386.4pt;left:76.4pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">January 2020. Moreover, the study populations were stipulated to be either rat</span><span style="font-family:Rpxr,serif;font-size:10.1pt">/</span><span style="font-family:URWPalladioL,serif;font-size:10.1pt">mouse dermal burn</span></p>
<p style="top:400.1pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">models or humans, all with thermal burn or scalding resulting in second- or third-degree burn wounds</span></p>
<p style="top:413.5pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">of partial or full thickness, or post-burn-wound excisional wounds. The intervention was primarily</span></p>
<p style="top:427.1pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">stem cell treatment using MSCs derived from the bone marrow, umbilical cord, dental pulp, or adipose</span></p>
<p style="top:440.5pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">tissue delivered as puri&#xfb01;ed cells or fat grafts.</span></p>
<p style="top:463.7pt;left:76.5pt;line-height:10.0pt"><i><span style="font-family:URWPalladioL,serif;font-size:10.0pt">2.3. Study Selection and Data Extraction</span></i></p>
<p style="top:483.2pt;left:97.8pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">For both reviews, the articles were imported into the Cochrane-partnered software Covidence</span></p>
<p style="top:496.7pt;left:76.2pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">(</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt;color:#0774b7">https:</span><span style="font-family:Rpxr,serif;font-size:10.0pt;color:#0774b7">//</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt;color:#0774b7">www.covidence.org</span><span style="font-family:Rpxr,serif;font-size:10.0pt;color:#0774b7">/</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">). Each study was screened by two independent reviewers based on title</span></p>
<p style="top:510.3pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">and abstract, after which a full-text screening was performed. Studies that did not meet the criteria were</span></p>
<p style="top:523.8pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">excluded. A bias assessment was performed using the Cochrane risk of bias (RoB) Tool SYRCLE [</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt;color:#0774b7">25</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">]</span></p>
<p style="top:537.2pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">for the pre-clinical studies or the National Heart, Lung, and Blood Institute (NHLBI) study quality</span></p>
<p style="top:550.8pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">assessment tools [</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt;color:#0774b7">26</span><span style="font-family:URWPalladioL,serif;font-size:9.9pt">] for the human studies. The data extracted from the full papers were population</span></p>
<p style="top:564.2pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">size and species, intervention type, origin, delivery and dose, comparison, and global outcome.</span></p>
<p style="top:577.7pt;left:76.1pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">Additionally, secondary outcome parameters&#x2014;which included visual appearance, investigations,</span></p>
<p style="top:591.4pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">or measures of in&#xfb02;ammation, proliferation or neovascularization, granulation and re-epithelialization,</span></p>
<p style="top:604.8pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">and remodeling</span><span style="font-family:Rpxr,serif;font-size:10.0pt">/</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">scarring&#x2014;were extracted.</span></p>
<p style="top:628.0pt;left:76.5pt;line-height:10.0pt"><i><span style="font-family:URWPalladioL,serif;font-size:10.0pt">2.4. Assessment of Continuity of Evidence</span></i></p>
<p style="top:647.6pt;left:97.8pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">To assess the continuity of evidence between pre-clinical and clinical studies, as well as among the</span></p>
<p style="top:661.0pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">clinical studies to justify the clinical translation, a cross-citation analysis was performed. To this end,</span></p>
<p style="top:674.5pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">the bibliographies of the included clinical studies were examined to identify which of the included</span></p>
<p style="top:688.0pt;left:76.2pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">pre-clinical and clinical studies had been cited.</span></p>
<p style="top:711.3pt;left:76.5pt;line-height:10.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:10.0pt">3. Results</span></b></p>
<p style="top:730.7pt;left:97.8pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">The literature searches in Embase and Pubmed resulted initially in 374 and 504 publications,</span></p>
<p style="top:744.2pt;left:76.1pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">which, after removal of 73 duplicates, resulted in 805 unique records (Figure</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt;color:#0774b7"> 1</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">). These records were</span></p>
<p style="top:757.8pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">screened for eligibility for inclusion into either the pre-clinical review or the clinical review, &#xfb01;rst through</span></p>


<p style="top:56.6pt;left:76.3pt;line-height:8.0pt"><i><span style="font-family:URWPalladioL,serif;font-size:8.0pt">Cells</span></i><b><span style="font-family:URWPalladioL,serif;font-size:8.0pt"> 2020</span></b><span style="font-family:URWPalladioL,serif;font-size:8.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:8.0pt"> 9</span></i><span style="font-family:URWPalladioL,serif;font-size:8.0pt">, 2545</span></p>
<p style="top:56.6pt;left:495.8pt;line-height:8.0pt"><span style="font-family:URWPalladioL,serif;font-size:8.0pt">4 of 21</span></p>
<p style="top:89.8pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">screenings based on title and abstract, then through screening of full texts. The exclusion criteria</span></p>
<p style="top:103.3pt;left:76.1pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">were related to the publication, study type, and study setup (for details, please refer to Figure</span><span style="font-family:URWPalladioL,serif;font-size:10.1pt;color:#0774b7"> 1</span><span style="font-family:URWPalladioL,serif;font-size:10.1pt">).</span></p>
<p style="top:117.0pt;left:76.2pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">The exclusion process resulted in a total of 21 pre-clinical and three clinical studies, respectively, which</span></p>
<p style="top:130.4pt;left:76.1pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">were included in the subsequent analyses (Figure</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt;color:#0774b7"> 1</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">).</span></p>
<p style="top:71.6pt;left:70.9pt;line-height:8.0pt"><i><span style="font-family:PalatinoLinotype,Italic,serif;font-size:8.0pt">Cells </span></i><b><span style="font-family:PalatinoLinotype,Bold,serif;font-size:8.0pt">2020</span></b><span style="font-family:PalatinoLinotype,serif;font-size:8.0pt">, </span><i><span style="font-family:PalatinoLinotype,Italic,serif;font-size:8.0pt">9</span></i><span style="font-family:PalatinoLinotype,serif;font-size:8.0pt">, x  </span></p>
<p style="top:71.6pt;left:490.1pt;line-height:8.0pt"><span style="font-family:PalatinoLinotype,serif;font-size:8.0pt">4 of 22 </span></p>
<p style="top:808.6pt;left:70.9pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt"> </span></p>
<p style="top:94.9pt;left:70.9pt;line-height:10.0pt"><span style="font-family:PalatinoLinotype,serif;font-size:10.0pt">through screenings based on title and abstract, then through screening of full texts. The exclusion </span></p>
<p style="top:108.4pt;left:70.9pt;line-height:10.0pt"><span style="font-family:PalatinoLinotype,serif;font-size:10.0pt">criteria were related to the publication, study type, and study setup (for details, please refer to Figure </span></p>
<p style="top:121.9pt;left:70.9pt;line-height:10.0pt"><span style="font-family:PalatinoLinotype,serif;font-size:10.0pt">1). The exclusion process resulted in a total of 21 pre-clinical and three clinical studies, respectively, </span></p>
<p style="top:135.3pt;left:70.9pt;line-height:10.0pt"><span style="font-family:PalatinoLinotype,serif;font-size:10.0pt">which were included in the subsequent analyses (Figure 1). </span></p>
<p style="top:390.5pt;left:511.8pt;line-height:10.0pt"><span style="font-family:PalatinoLinotype,serif;font-size:10.0pt"> </span></p>
<p style="top:407.7pt;left:92.2pt;line-height:9.0pt"><b><span style="font-family:PalatinoLinotype,Bold,serif;font-size:9.0pt">Figure 1. </span></b><span style="font-family:PalatinoLinotype,serif;font-size:9.0pt">Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) flow </span></p>
<p style="top:420.7pt;left:92.2pt;line-height:9.0pt"><span style="font-family:PalatinoLinotype,serif;font-size:9.0pt">diagram of the literature search and selection process. n, number. </span></p>
<p style="top:445.1pt;left:70.9pt;line-height:10.0pt"><i><span style="font-family:PalatinoLinotype,Italic,serif;font-size:10.0pt">3.1. Bias Assessment </span></i></p>
<p style="top:464.6pt;left:92.2pt;line-height:10.0pt"><span style="font-family:PalatinoLinotype,serif;font-size:10.0pt">For the pre-clinical studies, the bias assessment revealed that none of the studies reported any </span></p>
<p style="top:478.1pt;left:70.9pt;line-height:10.0pt"><span style="font-family:PalatinoLinotype,serif;font-size:10.0pt">blinding of personnel or allocation concealment, and only 8 out of the 21 studies reported blinding </span></p>
<p style="top:502.3pt;left:70.9pt;line-height:12.0pt"><b><span style="font-family:PalatinoLinotype,Bold,serif;font-size:12.0pt"> </span></b><sup><span style="font-family:PalatinoLinotype,serif;font-size:10.0pt">of the outcome assessors (Table 2). </span></sup></p>
<p style="top:504.7pt;left:214.9pt;line-height:9.0pt"><b><span style="font-family:PalatinoLinotype,Bold,serif;font-size:9.0pt"> </span></b></p>
<img style="position:absolute;transform:matrix(.32,0,-0,.3196813,-526.688,39.972017)" src="data:image/png;base64,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">
<img style="position:absolute;transform:matrix(.32,0,-0,.32031936,-526.688,201.452)" src="data:image/png;base64,
iVBORw0KGgoAAAANSUhEUgAABygAAAH1CAIAAAAicD78AAAACXBIWXMAAA7EAAAO
xAGVKw4bAAGY80lEQVR4nOydCXRNV/v/bwS1CIs2lqGW2TKmSxHDoogalqnR0lrm
qdWivK8hamjNsxah5jFmap5KUTMVaop5ipkgiYjI8Ib7/7rPr/t/es7NzcW9bnLv
97OyspJz9tln733O2c/zfM8+e5vMaZv//e9/H374oclk+uqrr/D3uzlpVFRUUFBQ
3rx5TRaqVq06YMCAXbt26ZJ9/fXXZcuWTU5O1m68ffv28OHDu3btmjlzZhzbvn17
44EkXRAVHTVp0qS+fft27949W7Zs586dc3WJiIPBI4yHNEeOHJGRka4uCyGEkHfN
06dPP/nkExiCMWPGuLoshBBCXMCSJUtgBTJkyLBlyxZXl4UQ4j6cOnUqa9as6F4G
DhyIf02uLk8quER4FdatW4suGKdesGCBcW9UVFTx4sW9vLxOnz5t3JuUlFSsWLEv
v/zS+cV0Ac+fP3/27JmrS+FcUMdevXrNmTNH/r106VJcXJyN9PHx8TjknRTtNXjx
4kVMTIyrS/HmICRGwzovfwqvhBDiyVB4JYQQD4fCKyHEGVB4tZfIyEhfX1+ceuTI
kca96zesl/GwY8eONe69fPkydi1evNj5xXynvHjxYuvWrQ0aNPjpp59cXRbnMmTI
EB8fHzwtqaZMTExcsXIF2mTmzJnvoGD2c+zYsU6dOrVp0yYhIcHVZXlt4uLi5s2b
5+/vv3btGuedhcIrIYR4MhReCSHEw6HwSghxBhReX4P69evj1M2aNdOd+sWLF506
dRLhtWHDhsZBeUuXLvX19b1w4cI7LOy7ICEhwd/fH7UeMGCAq8viRJ48eVKgQIFM
mTKdOXMm1cSRkZEFCxZEm0yfPv0dlM1+unXrhlLVqVPn3T84b8+1a9dkso5169Y6
7ywUXgkhxJOh8EoIIR4OhVdCiDOg8PoaDBs2DKcuUKBAVHSUdvulS5ew8bPPPvP2
9kY3feTIEd2BnTp1atKkycuXL99hYd8FCQkJtWrVQpuktdGdjuX06dPZsmXz8fGx
Oo+EjqioqDJlyqBNNm3e9A7KZj99+vRBqdq0aePqgrwJ4eHhOXPm9PLyOnjwoPPO
QuGVEEI8GQqvhBDi4VB4JYQ4Awqvr8G2bdtkWOvff/+t3T548OBPP/306tWr+fPn
x97Ro0dr98bHx5ctW3bEiBFW84yJibly5cru3bsfPnxotmi4ixYt2rxls26RLvx7
6NChWbNmBQcHh4SEHDt27MWLF7qssOXx48fYtW/fPtmyd+/euXPnzps3b+fOnTYm
x4yIiNi6dStynjFjBuoYFRWVUkojqDiqvGz5MrXl7NmzkydPxnkXLlyIU0+ZMmX9
hvWy6+LFi7JrwYIF06ZN++uvv2T78+fP79+/j2IfP35ctuzfvx9pcPjGjRtu3bpl
9dSRkZHIGfn/+uuvqsqvBc6Llpk5c+bUqVMXL16ckq6KYmfLli1Hjhw3btxINc/E
xEQ/Pz+0Caqg2/Xs2bM7d+78+eefMvb50aNHK1auWP3bal2D4zriwqFSKNW6dWtT
vRxHjhzBPYO22rR504MHD1JKhiccpfr666+NBUbjo1Qynhc5rF69CrmtXbtGe2qk
wRY5S2xsrI3y4HqhXrguc+bMOXr0qNU0CQkJyBBNdOLECbMl1kW2cs+EhoYa06Ot
3n//fS8vL9xdNk79llB4JYQQT4bCKyGEeDgUXgkhzoDC62sQHh6ePXt2nH3hwoVq
47Nnz/z8/KZOnYq/v/nmG+wtXbq0duWlo0ePFi9eXAQmLVeuXEH6gICAIkWK+Pj4
HD58eOfOnTlz5kQO77//vna5qr179zZo0KBhw4a9evXq0qVL4cKFs2XL9tlnnx07
dkyl2bhxQ7Nmzfz9/ZFD7dq1L1261Lt3b2Rr+gfkYCxDVHTU6NGj27RpgxijT58+
xYoVQ0pk0rp168DAwKZNmw4aNCglle3GjRuodY4cOXBImTJlmlro3r37vn37+vbt
KyeF0erXr58a+4lS/fTTT3IISovyJyYmjhs3DmX76KOPMmXKhMRouv79+0s7CKVK
ldKNqE1OTp4yZQruAaRHmyBMwrHI8LVUuXXr1taqVat58+bIAfXNmzdvrly52rVr
d+3aNW0yXPT//vc/XhZq1qwp1Vy9epUxwxcvXuCaojryUXylSpUkMQoZERGBiter
V69cuXLe3t7BwcHXr19HlaWC2uu4Y8cOFOn7778PCgrCH7iCH3/88br166xW4cCB
A8g/d+7cqq3Kly9vHGkbGRm5+rfVIgcjsZQK9w/uh19//bVJkyY4CqXCVTt48GCN
GjVUblWrVj158iRywDVFddR2VAQ1NZYHt9Pw4cNbtGiB3gStigriRsVNLi8VhISE
hMmTJzdu3BjlQUPhrjt9+nSjRo1k5Trw3nvvde3aVR2CVj1z5gxuCbQ/9larVk3K
P2rUKIf3ABReCSHEk6HwSgghHg6FV0KIM6Dw+hrExsbWqVMHZ//uu+/UxlWrVhYt
WvTevXv4e+fOnSIe/fHHHyrBpEmTKlWqZBygitzCwsJmz56N9BkzZvzxxx/h7pco
UcLb2xvp1QpIISEh6Pq7det2//592fL48ePOnTvjqPz58x84cEA2ogC4lm3btsX2
ggULBgQE/Pe//zl+/PiNGze2bt0qolvFihVVJmbLKMLatWsXKFBAjZ99+PBh3bp1
pQrvv/8+8h87dmxK7Yz8kaHoZdmyZctv4Ysvvnj+/Dn2oolEM42OjtYdiJOiPJIM
5718+fKhQ4fKli0rauwPP/wwYsSIkydPXr9+ffHixeXLl5fyzJkzRw6Pio5q2bJl
7ty5t2/fLmVDW40cOVIqaGPIp5bJkyejzYcNG6YGdd65cycwMBCZVKhQAUWSjcgf
FSlevLiUwdfXV6q5dOlSY56oae/evT/66CORCHPmzCmJW7RogRJeuHBh27ZtuXLl
kvsHVcC19vHxQWIp88uXL3/++Wc8jWhzxH6S544dO9DCmTJl0t5Rwu7du1EeZHXu
3Dlc5bVr16DkyDxz5sw6hX3evHk1atTANZI7TUpVpkwZ3DDh4eGnT5/GPSCibdeu
XVf/thotj9NVqVJFWmPhwoU9evRA/tiO3yVLlpS5YuUKKlAG3HWlS5dW48FRi44d
OyJx8+bN1f2MK37t2jWkkSuOOwG33KhRo65cuYIcUFTpj7799luZmgMXCHcFbiTt
bQlwnzh87g4Kr4QQ4slQeCWEEA+HwishxBlQeH09+vXrJwKfCEnJycmBgYHq8+3o
6GgZGNihQwfZggTNmjXr06dPShleuHBBxLiqVavK5LCzZs2qW7eujDM9c+ZMlixZ
ypQpox1Ca7Ys8i4S8Mcff6xEOrB8xXJs9PLyCg4O1qbHZc6YMSN27dixQ20cN24c
tkybNk2bMiwsTEZ3nj9/3nZTvHz5MikpKSAgAJnMmzdPtzc0NNTb2xu7tm7dqt1+
5cqV/PnzG9PLYOECBQooKVm4f/++NGnJkiVFoBw0aBD+nThxojbZs2fP0IDG6lhl
+/btJssyaDo1/NGjRyLw4ZKpmRlQzdOnT+MhyZ49uz1tgntAJEWcRbf3+fPnMp4U
1ZRBrAcPHkRr3L5922wZVYpdjRo10pUqKCgI2z///HPdZBFwC3APaMXHq1evvv/+
+ybDZBeSRm5ddWdqadKkCXZVrlxZq8ufOHFCxndXq1bt5s2bavvu3bszZcqEOwR/
qI14GNu0aaN75WC2TFwg/cvOnTt1J+3du7cIqXv27NFunz9/vkj5atAryn/r1i08
Jjip1YkIHAWFV0II8WQovBJCiIdD4ZUQ4gwovL4e0hfnzp370qVLZos4lS9fPq0Y
NGLECBlzKhrWzZs3ixcvbtTgFLdu3SpRooR2RGdycvLFixeTkpLM/8iRVueHXbd+
nYwB1K7zvmLlClFjjfMDyCpYM2bMkH/j4+Pr1atnFEbRqjLIVPv9e0qgkLVr19YW
XvHy5cv69etjV79+/bTbJ02aZLV4Xbt2ReKePXsaz7J+w3oZV3vo0KEnT54ULlzY
y8vr3LlzumSimjVu3Nh2mRMTE5HGlMKCYCieKNdq/lmzZXEtPCQ+Pj5hYWG2Mzdb
xHdZXEvXsGbLlW3atCl2devWTZu5TCvRvn177EIBdEet/m21DLbVzTD7+PFj3awI
QIY8IytjwWT+B6u7unfvjl1IoCtttWrVjDIurp0MrdVOuHH27Fk0Wvbs2WNiYnSZ
y8jZoUOH6raLEKxtCiE8PFwmo9A+VniOZHEt48p1DoTCKyGEeDIUXgkhxMOh8EoI
cQaeK7xevHhxp4E7d+7YPurYsWPyyfbatWvwb//+/WvXrp2YmKgSHD9+XBLIoM71
G9YXK1ZMO5BQx61bt2RmVd24P7NlFKd85K5VuBRXrlzJly8f9v73v/9RG2XEK8KG
J0+e6NI3a9ZMq+vFxsZWrlwZW2bNmqVNFh8fX7hwYW9vb6uTeOpISEiQEGXjxg3G
vatWrRSROiIiQqWvU6fOuHHjjIlFYpa7UEd0dLRM+QpD+Ndff4kwipZH/tofUQNR
Tdtlvnr1ap48eZDy999/N+7F8yBy9vTp09XGkydPivCa0upbWqKiokR4NY7NTE5O
lrGlRnUVwZ4Mtm3UqJGuXl26dJFBsuHh4SmdFHfRkSNHVq9eVb16dflO35gG9wl2
DRgwwLjr+++/191IgkjnuvgTd4gIstrbcvHixTJMdfjw4drCh4SEyBS02K7LXITg
oKAg3XY8g/KMa1cnQ93R/rly5Up10PHbQOGVEEI8GQqvhBDi4VB4JYQ4Aw8VXmNi
YtTkoVpSWoRdERsbW7FiRRmFGhcXV6xYsdmzZ+tK2KBBAyRo3bo1/g4KCvryyy+T
k5NTylAJr9oPt9Wu/PnzY1dISIjxwIiICClJmzZt1EYRXqtXr26cWVXGWk6ZMkX+
ffny5YABA7ClZs2aWuF4165dcjfY07wJCQmi9Gk1MsWDBw/kYq1YuUK27N27t1Kl
SjIfrg4RXvv372/clZSU5OvrKx/vy/f43t7eXbt2HfhvRo0atXDhwuPHj9suc2ho
KEypl5eXcdZUKbPM0KodZfy6wmvp0qWRw/Xr13W7lPD6yy+/6Hbdv3+/aNGiJssa
aLp6DRkyBPcYrotuTlWz5Q6ZOHFiq1at0HpIiZtN1Ftj/qBXr17Y9fPPPxt39ejR
A7uQQLddhFfdiFfc9jKIddGiRWpjcHAwtmTPnr1379668o8fP37Z8mVq2lyFCK/G
WThQKXmjcPDgQbUxPDwcl6Bw4cLYayy/o6DwSgghngyFV0II8XAovBJCnIGHCq/x
8fHHjh079G9kAfdUadmypckyV+bs2bP9/PyMMuKMGTNEhAoNDa1UqZLtWUeV8Lpr
1y7drjt37ojwqtRSLQ8ePJAxntqVvuwXXuXUNWvW9Pb27tSp04EDB86dOzdv3jwU
eMiQIbopZVNCCa979+61mgB3FfbWq1dP/u3Vq5du5gGFDeEVFwuNCfuHAu/fvx/J
smTJovvu3n5w3TNlyoRMVq1aadyLqynC6+TJk9XGNxNer169qtulhFej+onzivBq
nLQhJVavXlWwYMESJUosXLjw4sWLMgOsrLqmmwBXEOF1woQJxl2OEl5xu2pFfNu8
gfBaqFAh7WyzDofCKyGEeDIUXgkhxMOh8EoIcQYeKry+DTINaIkSJQoUKNC7d29j
gjt37vj4+JgsCyLlz5//8OHDNnJDYpnj1Si8Pn/+XCS8rl27Ghdwf/DgQbly5XTj
YV9LeDVbBpNOnDgxS5YsKGrHjh3HjRt34sSJVFtAoYTXffv2WU3w119/ZbJw8uTJ
qOgoJDbOzSqI8PrDDz8Ydx05csRkWQvLbFnZScYmz58/3/5yarlx40ahQoVSOtfd
u3dFeNVKyW8mvBonYH3x4sVnn31mVXhF4xQpUgS7OnXqZE8tIiIiRKjVziSLm6Rd
u3a2hVcbu95GeJ01a5ZcF9t3uxaOeCWEEJKmoPBKCCEeDoVXQogzoPD62uzZs0e0
Ofy2OjWB0r9AlSpVZOmklDh//vwHH3yArIzCKxg+fLjJMk2qcfLZCxcuZMyYMV++
fFqRSKZVtV94DQ0NDQwMtPpluj0o4dU4Qa2Aa/Tpp5+aLFN8woxZnXtUsDHH65df
foldO3bsMGtk07p161ptWKNCbSySnMvf39+4xtfhw4exq1q1atrM8ZBky5btdYVX
WX5NC04nS5xZ/d5fRlJnz57dnpHXf/75JxLj6j969EhtjI+Pr1Onjm111WowKS1s
nONVJs1ISXjVKv5oGXkoOnfubLXAxusSFBT0usJr/vz5OeKVEEKIk6DwSgghHg6F
V0KIM6Dw+tqotZ6qV6+eUhlEAAXdu3e3ndvRo0czWLA6aPTBgwcyEYFRn+rfvz+2
r1nzm3bjvHnzsLF27dpGUVKEV+2aUXfu3ElpNlI7SUxMrFGjBnKYMWOGbImMjNRN
aDtnzhwkKFy4cNmyZW0sSd+1a1ckq1y5slZ2jI+PnzJlSvbs2bUf/o8dO1batkeP
HlrZEadGMQ4cOJBqscPCwmR9LeMyXy1atDBei7/++itjxow5cuRIabiuFhSjZMmS
Js2CY6qQDx8+9PPzw67g4GDjgWgcnAV7K1SooB13nJSUtGLlipCQEK12+ccffyBl
5syZ1dTAOMvIkSPRVrp5EhQ9e/Y0aWYExm2sJo0V9dw4CwRuJOPsBEp41S6uhbLJ
FQTDhg3T6v737t3DFuNabd9++63J2mJfSnjVvtXALerj44NLo9TYqKgoYx3fEgqv
hBDiyVB4JYQQD4fCKyHEGVB4fW2Sk5Nr1qyJMsyaNSulNHfu3JGBmctXLLedmyho
phSmHDVb9DgR8jp16nTs2LEnT56cO3euf//+OXPmVHKnQsS1woUL3759W7dLZhcd
NGiQ2nLx4kWZEuGLL76Y+W/mzp2b6jpjZovchguBHAoWLDh16tQhQ4aEhITo1oCK
iIgQlbNOnTpJSUkpZSUynNi5Ll26oAw///xzCwt//fWXNiXy79atmyQuVqwYaoR2
GDVqlJ+f36effmp15S4jaHZR99CS58+fj4mJCQ0Nbd++fYECBZYuXapLvHjxYhng
vG3btlRzRvFkoGiZMmWCg4MHDBiwbPky2RUeHo5Lg11BQUFWj0XKLFmyIEHGjBm/
+eYbNMLkyZMbNWqEau7cuVObEjdY8eLFkbJUqVLTpk1DW6EBUU4Zu2p1FgWZIiNz
5sxosV9++WX06NG4NGbLRZQ5K1B9bfqo6CiZzaBHjx7a7Up47du3r3b7w4cPP//8
c7kulSpVGjFixPTp03GuIkWKdO3aFfetNjEeosqVK8u9pxsMe+vWLblhNm7aqDbi
cHkDUaNGDWSLVsUVTHV08+tC4ZUQQjwZCq+EEOLhUHglhDgDCq9vwoABA3LmzGl7
/OPXX3+NLtvGGlBXrlzp3r17pUqVvCyUKlWqbdu2I0eONKZEJsOGDStWrFjBggU/
/fTTZs2affvtt8eOHdOmWbd+HQ5H40hutWrV+vHHH9XAw+Tk5GrVqmF7vnz5kGzz
ls2yfdeuXSIQG/Hx8TEOCDUSFhbWsGFDOaRly5ai5ekQnVQ3OFeHjJesWrVqYGCg
5JY/f/7JkyfrZFwhISEBRrFx48YiU8qB06ZNM06wYIMLFy7gOqJJ0fJo1ebNm/fs
2fPixYvaNMePH+/cubOfn5+0arly5dq3b2/Uu3XgKBkrCnClnjx5glgOD1idOnUy
Z86MfPLkydO6det+/foZh20eOHAAzSWiMChSpEhQUJCuVCqlKLwy+Do0NBQbv/vu
O7nKeED+/vtvbfrHjx8jZ1lY7OOPP8aFw8YJEybgdkIz4qgPPvjgiy++kHGsffv2
RfNKaXPlyoXcFi9eLPnExcUFBARgO262Dh06HDp0SJ0C7R8cHFy3bl3c+VKwpk2b
IkPto4prh8uKk6LfQSY4Bf6ePXv2ixcvJMGlS5dw76nWvnz5smzfunVr+fLlJdsh
Q4bIYmKOhcIrIYR4MhReCSHEw6HwSghxBhRe3wS45vfv37c94O7JkyfGYadanj17
FhYWduHChVsWLl26hIuhZCYj0dHR2Hv27Fmr6wuhPDj86tWr2Hvz5s1z585dvHhR
jTBFUe/evYtdSIBkIo8+fvz4hx9+qFWr1vbt229pCA0NFQUqc+bM9qy1FRcXh6NQ
Wd0kA4pVq1aWKVMGp7ORiZrjNTExEVkhw6joVL4lf/78+YMHD5Dy3r17VvVZe0Cp
0FBoVWRl3Is2P336NBJIy+CPkydP2hDTFbGxsUivZubFvYoLjbPgWHUVzp8/j8pa
PfzRo0fSpLqBojrQ8jgFUioVMioqSvJHsY3H4gLJbaBmorh27dqZM2fCw8OxEX/j
KLlpUTbcnFJa2a7qgnsJ94+qhVE7RqnkLLgnjbfEixcvrl+/rk6K3/gbd6x6mtAm
cl5pbe2kGbgckq2NNnkbKLwSQognQ+GVEEI8HAqvhBBnQOHVQ3n06JG/v/97770n
Ix91xMfHy+fn2pXr35hRo0YZp/LUIcKr1W/kCXk3UHglhBBPhsIrIYR4OBReCSHO
gMKrh7J27RpTymvQg9atWyPBps2b3vJEd+/erV279pkzZ2wnE+G1f//+b3k6Qt4Y
Cq+EEOLJUHglhBAPh8IrIcQZUHj1UKZPn25D6Hzx4oWfn1++fPnu3r37licaOXJk
ixYtUk0mc7xSeCUuhMIrIYR4MhReCSHEw6HwSghxBhRePZT9+/ejGRFgWJ1mdM2a
37B30qRJb3mWq1evFi9efO/evamm7Ny5M86Y6owEhDgPCq+EEOLJUHglhBAPh8Ir
IcQZUHj1UJKSkjp27IiW7N27d2xsrNoeExOzZs1v+fLlGzx4sFqb63VZvmL5rFmz
wsLCqlev3rZtW3sOadCgAQrTp0+fNzsjIW8PhVdCCPFkKLwSQoiHQ+GVEOIMKLx6
Lk+ePAkKCipWrFiTJk1Gjx49c+bM2bNnY0vLli1XrFzxxtkmJSXVqVMH18jLy6tx
48a3bt2ykRgXcePGDTgpEuOQzJkz//zzz/aMkCXE4VB4JYQQT4bCKyGEeDgUXgkh
zoDCq6cTHh6+bPmy8ePHjxs3bu7cuYcOHXrLhk1OTv79999nzpy5bt3auLg424mT
kpJw9okTJ86YMWP27NnTp09HSXD42xSAkDeDwishhHgyFF4JIcTDofBKCHEG6VV4
bd++vavLQghxK3r06EHhlRBCPBYKr4QQ4uGI8Ort7b1v3z5Xl4UQ4j5cv349W7Zs
6U94rVChwrLly1avXrVq1Ur+8Ic//HnLH3QmAQEBFF4JIcRjofBKCCEejgivXl5e
/fv3p9TAH/7wxyE/6EwmTJiQKVOm9CS85smTx0QIIc4hW7ZsFF4JIcQtefny5bZt
2yZPnmx1b6rC671793Cs7cnrCSGEpF9CQkJcHYsQQtyZH374wZwuhNdChQq5uq0I
IW6Lr69vVFSUq7s6QgghjufMmTM+Pj7o6ocPH27ca1t4ffLkyZdffom9HTp0SE5O
dn5hCSGEvGuWLV/m4lCEEOLWDBgwwJz2hdcXL15s2rxpyZIly1cs5w9/+MMfx/4s
Xbp048YNiYmJru7qCCGEOJ579+4FBgaK4zty5EjdXhvCa1RUVMuWLbErY8aMixYt
elflJYQQ8k65efNmSEiIy0MS/vCHP275g+7l2LFj5rQvvBJCCCGEEPJmPHnypEWL
Fla115SE16joqNatW4vqumz5sndbXkIIIYQQ4lZQeCWEEEIIIW5LdHS0TBoARowY
obZbFV6fPHmixrouX7HcFeUlhBBCCCHuA4VXQgghhBDizkRFRTVv3lw37tUovKoZ
BjJnzrxi5QrXlZcQQgghhLgJFF4JIYQQQoibExMTo8a9ivYaHx9fo0YNJbw+efJE
Zhjw9vbmDAOEEEIIIcQhUHglhBBCCCHuT0xMTPv27UV7HTdu3P/+97+AgAD8PWnS
JOxq06YN/s6UKRNnGCCEEEIIIY6CwishhBBCCPEIYmJi2rVrJ9pr//7969Spgz8G
DhzYqVMnmWGAqishhBBCCHEgFF4JIYQQQoin8OzZMzXuNWvWrPidL18+/M6QIQNn
GCCEEEIIIY6FwishhBBCCPEgtHMOCJxhgBBCCCGEOAMKr4QQQgghxLPQzjmQOXPm
pUuXurpEhBBCCCHEDaHwSgghhBBCPI5nz561atXKx8dnyZIlri4LIYQQQghxTyi8
EkIIIYQQT+Thw4eHDh1ydSkIIYQQQojbQuGVEEIIIYQQQgghhBBCHAyFV0IIIYQQ
QgghhBBCCHEwFF4JIYQQQgghhBBCCCHEwVB4JYQQQgghhBBCCCGEEAdD4ZUQQggh
hBBCCCGEEEIcDIVXQgghhBBCCCGEEEIIcTAUXgkhhBBCCCGEEEIIIcTBpAPh9f79
+6dOnTpNCCGO5uTJk7du3XJ1J0cIcRgvX768efMmHm1X9y6EEPckMjLS1f0cIcRh
JCQkXLx4kWoDIcThoGM5d+5cfHy8OV0Ir+PGjcudO7ePj0/mzJnfI4QQR4D+BL2K
r6/voEGDXN3JEUIcxvPnzzt27IhHO2vWrHQbCCGOAv1Jjhw58uTJs3zFclf3c4QQ
hxEeHl6tWrUPPvhAHnNX9zSEEHdAOpNcuXKVKlXq1KlT5nQhvPbt29dkMuXOnbt8
+fJlCCHEEfj5+eXLlw99y9dff+3qTo4Q4jCePXtWu3ZtPNpFihTBY+7qnoYQ4g6U
LVsW/Um2bNnQt8yYMcPV/RwhxGFcvnz5/fffx6NdunRpPOmu7mwIIe4AOhN0KRky
ZEDfcvjwYXO6EF5/+OEHFHfNmt9cXRBCiFvxxx9/oG/59ttvXV0QQojDePbs2aef
fopH+9q1a64uCyHErRg9ejT6ljlz5ri6IIQQh3HlypX333+/QIECycnJri4LIcR9
ePnyZdOmTeE2/PXXX+Z0JLyuXbvG1QUhhLgVu3btovBKiJuhhNfr16+7uiyEELdi
7NixFF4JcTOU8Pry5UtXl4UQ4lYEBgamP+F19W+rXV0QQohbwRGvhLgfSni9evWq
q8tCCHErOOKVEPdDCa//+9//XF0WQoj78OLFi88++4zCKyHE06HwSoj7QeGVEOIk
KLwS4n5QeCWEOAMKr4QQ8goKr4S4HxReCSFOgsIrIe4HhVdCiDOg8EoIIa+g8EqI
+0HhlRDiJCi8EuJ+UHglhDgDCq+EEPIKCq+EuB8UXgkhToLCKyHuB4VXQogzoPBK
CCGvoPBKiPtB4ZUQ4iQovBLiflB4JYQ4AwqvhBDyCgqvhLgfFF4JIU6Cwish7geF
V0KIM6DwSgghr6DwSoj7QeGVEOIkKLwS4n5QeCWEOAMKr4QQ8goKr4S4HxReCSFO
gsIrIe4HhVdCiDOg8EoIIa+g8EqI+0HhlRDiJCi8EuJ+UHglhDgDCq+EEPIKCq+E
uB8UXgkhToLCKyHuB4VXQogzoPBKCCGvoPBKiPtB4ZUQ4iQovBLiflB4JYQ4Awqv
hBDyCgqvhLgfFF4JIU6Cwish7geFV0KIM6DwSgghr6DwSoj7QeGVEOIkKLwS4n5Q
eCWEOAMKr4QQ8goKr4S4HxReCSFOgsIrIe4HhVdCiDOg8EoIIa+g8EqI+0HhlRDi
JCi8EuJ+UHglhDgDCq+EEPIKCq+EuB8UXgkhToLCKyHuB4VXQogzoPBKCCGvoPBK
iPtB4ZUQ4iQovBLiflB4JYQ4AwqvhBDyCgqvhLgfFF4JIU6Cwish7geFV0KIM6Dw
Sgghr6DwSoj7QeGVEOIkKLwS4n5QeCWEOAMKr4QQ8goKr4S4HxReCSFOgsIrIe4H
hVdCiDOg8ErSKE+ePImNjXV1KRzD8+fPIyIi8LA5POeEhIRHjx4lJyc7PGez5RIA
Z+ScNqHwSoj7kTaF16dPn0ZFRznDKLxj4uPjIyMjHWuDkFtUVFRiYqID8yTETuCw
4faz89mk8EqI+0Hh1aOIseDqUjiGhISEiIgIZ9y3SUlJjx49ctITAZc4OjraGTmn
NSi8pmnCwsLgzy1atGjdurXr1q9DrRcsWDDHwrx585YuXbp///67d++6upgOAyHc
2rVrBg8e3KNHj3Llyo0fP97VJXorjh8/PmbMmD59+tSrV69GjRpxcXGOyvnChQtj
x47Fs4Cnt3Dhwoh7HZUzutTNWzbjEvz3v//x8/MLCgpyVM5pHwqvhLgfryu83r59
G9Z2+Yrli/8BphZb8LNi5Yp/bVy3NjQ09LUKs2fPnhEjRsDA+fv7d+vWLf1qi+fO
nYMNgoFo2rQp6nLr1q23z/P+/ftTp07t379/u3btSpcuffDgwbfPkxA7OXny5OjR
o/v161e/fv1atWo9fvzYnqMovBLifnig8Hr58uW5c+cuXLgQYTi8nTVrfsPfIjhg
+5IlS+C9OMTQpxGSkpK2bNny008/9erVq0KFCgMHDnR1id6Ks2fPjh8/HvYLLln5
8uUjIiIclfONGzcmTJgwYMCAL7/8Mk+ePNeuXXNUzi9fvty5cycuQZ8+feBGdunS
xVE5p2UovKZpENQhSJMrBDJlytSpU6eRI0fC1UNw4ufn5+XlVa5cuV9++cUNBs6A
uLi4kJCQvn37Sn2Dg4NdXaK3Yv/+/WPGjClbtizqEhAQ4ED7feLECeRcvXp15PzB
Bx88ffrUUTmjkEuXLsVT5u3tjczRIToq57QPhVdC3I/XFV7nz5+PxPny5atZs2aN
GjVq1ar10UcfiUny9fXFv7JROvaGDRvikAcPHgwZMgRGGR6q7cw3bd6ErtvHxwfH
9ujRwwHVcxHyWrFatWqoSMGCBR3y8g9B3bhx4wIDA5FnxowZjx49+vZ5EmInhw4d
wi2NkBW3H/xqO9+UU3glxP3wQOE1LCwMvdlXX30l3o6Xl1ebNm1GjBiBjQMHDqxS
pUqGDBlKliw5fPjwhIQEVxfWASQmJq5evWrw4MES7cKFc3WJ3opjx47BfuEyoS5w
WR34ueqlS5eQc/369ZEz2sqBo/1evny5bt1atLy4xN26dXNUzmkZCq/pgNjYWASB
qHX79u2126OjoydOnChdJP5wVfEcDh5FeL2oFB5IV5fFAcyePRt1QeTvcPu9dOlS
5PzJJ584wwoGBAQg8/nz5zs85zQLhVdC3I/XFV5nzZoFt/X27dtxFp4/f37q1Cmx
s7/88gv+lY2wv506dWrevDkOmTdvniRYtGiRNqv4+PiIiAhYNN0punfvjsTff/+9
o+roKhYvXoyKfPzxx8Y6vjFwRhHyIeK9fv26o/JU4KpFRUc5PNs35tWME1FpqDwE
zzhu6Tp16tiZnsIrIe6HBwqvwosXL8qUKYM+rUmTJtq6x8bGzp07V/ycgQMHOtDi
u5xatWq5TR++bv06cckcPk/g9u3bkXPp0qWd4bGI3D9hwgSH55wGofCaPihSpAhq
/c033+i2JyUlyVuIPHny3L9/3yVlczgxMTEy6GDjxg2uLosDkJjcGcIrgnzkXLt2
bYcLrzCxdevWNeoI7g2FV0Lcj9cVXn/99VeEHNot169fl3hjxowZupQivN69exee
Sa9evbRa4f79+7/44otmzZrFx8frTiFfdbiB8LpgwQJUpGLFig7Mc9++fV5eXoUK
FUp1+PBrgasAW1y9evU0MoURAtc1a37DnTlgwAB3CmLTO4j9cEvD/7EzPYVXQtwP
jxVegb+/P/o0+DZJSUm6Xa1atcKuzJkzX7p0ySVlczi4vnXq1HGbYUbrN6x3kvC6
ectm+RbE4a+ucZvJffXLL784Nue0CYXXdACc8sKFC6PWXbp0MU4pMGzYMOzKkiWL
20yIhv5CPu1ED+LqsjgAeOROEl4XLlyInGvVquVw4fXp06ciVeAUjs05LUPhlRD3
43WF16VLl/br10+7BTGGCK/Tpk3Tbl+3bq3uMxQt3bp1k6FzxoWn/vvf/7iH8CrT
MlSoUMGBee7du9fLy6tgwYLh4eEOzDYiIqJ48eIo7dSpUx2Y7RsDX65GjRooD3xa
V5eF/H/Gjx8vDpud6Sm8EuJ+eLLwWqlSJfRpn3/+ufGd8a+//iqzEGzavMklZXM4
SUlJ8n3nvHnzXF0WBwCn1EnCK644ci5btqwzhNeWLVsi859//tmxOadNKLymA2wL
r0OGDMGunDlzOnDCY9eCOJnCqz3IiFdnCK8wtxReCSFuwOsKr3FxcTqfNSXhFTnb
WIGnX79+OKR169bGXW4jvMqI13QhvD569AjRSNrxK+DLNWzY0HhTEdciI14pvBLi
yVB4tSq8Tp06VSb6/Pvvv11SNmdA4dUeZMSrM4RXQOE1TUPhVbdLrl9gYKDVr9UO
HTr0yy+/DBs2bNKkSadOnUr1XBcvXpw1a9aYMWPgff7+++9WH93IyMiNGzeMGjUK
2SJmOHjwoNWlvZAM8SqCnLCwMPx78+bNGTNmoNe2ugrH4cOHcUacd+vWrffv35d+
Xxcgwf798ccf48aNGzp06Pjx49ELXLt2zTiYKCUQJG/ctHHkyJEoNsLFe/fuGdPM
nTt3xIgRKIlx+DCi8V9//RVOtnGtQDRscHAwCj9lypQdO3Y8f/5cu1cnvKKt7t69
i/yXr1h+584dbcqoqCi0GLbv2rXLahVw6pCQEJQBLXn16tVly5elJLziwqH/RUMN
Hz58yZIl9szJEhoaipsEtdi0eRMap1GjRhReCSHpndcVXo2kJLwK6NLRM8MKrFq1
EmZObR80aBAO6dSpk/GQlITX2NhYGCmxrSkZKduEh4ej0xYLDmNkNWhMTEyE6YFv
sG79OjSO2dL1waTiqMWLFz948MBG/tgLgwIbBGt469YtmePVTuEVxvrPP/+EQzJ2
7FiY2pS+VVTC6+3bt82Wxp8/fz7KhsY/ceKE1UOePn0KnwSlQrvBd4cBlWO1oKbi
V6BZdLtgHy9cuLBi5QrxVXAsagdH6OHDh9pkuLioO0oyceJEOCr2LL4ExwaJccj0
6dMPHDigc1eaNm2aUryXlJQEBwwHwojD54FRxtntXEMV1Vm9ehVMP1pj8uTJaHNd
RbTAXUHmYy3glkM7/Cur6KgrV67gnjx+/LjZ4oHgwsFP0C2voXwznHHmzJk4xHYJ
z549i2RSNRTPei2io/DA4tRHjhzBv3ALcRvgEqM9cYeklDPu7W3btsmdANfLntkq
cLnxyOAQXHHc3qgdhVdCPBwKr1aF1y5dumBX9erVrQ73gZlALIyOHb20iEq2gbsC
84cuVGyc1dfYMO6wtjBPYs727NmDTt6YzE5TJfz999/wQ2Be4QJFRkbKhI1GQwxD
g4qgOpISroj9N4Oy4Cj27Nmzrb5FRggvgsPOnTuNh6M8OFbrUgpw3mCppdFg6HXG
3Si8wnQePXoU59INzkMCWNi1a9ds2bLFahXQpMtXLMeJcE3Pnz+P6qQkvMIX2rxl
M+qCAsNM2/YhBSWbrFnzG9J36NCBwmvaxcOFV90uhArYnjt3buPbp5MnT3755Zc4
BI9Nnz59SpQoASvy448/ohezehb0C/369cNDlSFDBtM/IIfo6GhtspCQkIoVK2I7
OqMePXqgYO+99x7uodOnT6s0eCxxmWrXrl2oUCFEUHBnURiZphZIt6hAyVu2bIko
S/YifZkyZbJnz64TXhHjtW7dunv37iNHjkQtGjRokC1btipVqtjzhAN0Tzikd+/e
eM47duyI/FEeBFG6ZOhZUGycOn/+/LqwcMqUKSbLuofaBjl37ly3bt3QtqrFUH5s
0c6Mo4RXXEfUHU2HBvTx8cmZMyf6MpUMOSNNsWLFkLhVq1a6giE6gskpX758pkyZ
5ER58uTx8/MzWZvjFfamSZMmAwYMQOjVtm1bXKDSpUvDbKTUOGfOnEGbyD0mID3u
FgqvrwvMBqyOTnknhLgQpwqvly9fbtOmTbVq1T744AMkgAUxWzxddMJiF9DVV7ZQ
tWrV0NBQOcqq8Aoft1GjRjDWiDHghsLAFS1aFCbezkLCjYZlhFFQNgLGqFmzZjrt
CXFL06ZNYUpQMBhBFAlH+fr6qs6/VKlSVpe1RAyGWAUHZs6cWVIiKJVVOFIVXuFo
7t+/H7WDYVUn+vDDD3Vz5goivMIUwieZOXMmTiGLDpssX/bAS9FFg7CqCBFh3OHq
YG+tWrVg3xFKac8OLz8oKChjxozIBK0qVwTuxKNHj/A7ICAAvgp2/frrrxcuXEC9
5HQqdITXNGrUqI8++gjGVJUfp7BxRx0+fBiOjdaqot1k3WR4AjgQUZOs5Is2kfKg
feS1LsoAPwH+FWoEVwquC1LC0Btf+hrZsWMHrH///v3hKfXq1Qt3Jo6FUTO+mEez
4O7CoyG2XsiXLx9iV7MllEIO2IvmwuVA9XGry5BhdZ+rMwYGBqIZUSM4P7iXkElK
w3hv376NerVo0QJV++mnn1BrNAueIK0jJ6euU6cOWg+nhiezb98+hPpy+UyW8Vbt
2rUz+n6I/Ro3bozHCk9Q165dRTfBLZRSW6FnQL20jwwqK48thVdC0jXXr18fNGgQ
+uE3O5zCK6yqbo5XdPXYnjVrVuPbMlgH9Mnt27dHfwjrg04VVhh+jtWBVmaLj4T+
HyZVGXcxqbqXzXBFEObDjUFi5AbnBPYCpuHQoUMqjf2mCiDo7ty5s5IjxOER/0cr
vKLYX1tAbrDacJly5cqFuNjOD4u3bt2qLBGML5xDeDvTp0/XJYMzJgIcmlQnjCxZ
sgTbYcG1umpUVNSYMWNQNWUKAbwX7dICSnhNTEy8ePEiLgqMbI4cOXCIvMIU4MvV
q1evZMmSkoOuYDgWHmzFihWVw4PqS5PiyuqEV3gRqCz8qxEjRnTp0gX+Bpy3kJCQ
lBoHTxa8BdE6hOLFi4tnSOE1jeLJwit6AQRXeA4fP378999/oykQm9WoUUPbBwnr
N6zH3d+pUyf1hKA7kwnF0H8ZT7Fq1Ur4yogTEPMg/5s3b8JbxbOKZ0y9NklOTh48
eDByCA4Ojo2NlY2IWxAhYCOeIjUaBYbqzp07iOgkroAHjJsMYSdOgQKjT5RkCQkJ
KEzu3LnRMeH+Q6XOnDmDSqmOWAmvCHvQ1SKmkuE5coqNGzegnzW+kdMByzF06FDk
iRhPCZQIAtF9Z8iQYfv27br0aChZ2qthw4ZKQTt69Chs8OLFi1UytMasWbPy5s2L
Rkbh0Q6oF/oy9G4I/LRBjhJecQjKjy5SZsnJkyeP9l0c/kYviZ7OeI2OHTsGQwgT
tWDBAjQsGgr3PwIqaSWt8AoLhMgHVcMFVSZzy5YtsEbo2Y1vING9jh8/HtEs7CXu
IuQMszRs2DDV21J4tR/cVHLrwug6tmCEkDfGqcIrDNCNGzfQx0oCCUjgdMKpFSkW
He9HFj755BMZUGk2CK8wZwgR0evCWKjOfPfu3ehPYFCMIzSNwOK0adMG/uvmLZvF
gsOFFYW0efPm2tAxJiYGNgiBCnbBxMMu9+zZE+4EOv+TJ08i1sJ2GDv8rc1fbFC5
cuVkOANOARskS3CY7BBekVumTJlQa9g4nGjfvn1NmjQRBc04VRycEJhmBCponx49
euzatQung2+Af+V0sFBq7CcaH0ZzypQpqt3wB/5F+6s0cFf69OkDiyn9M2JpuSKo
OBKjrRCQSOgFa96qVSvUC9YZjaCiLJwath4uR0REBEwwboMsWbKYLOs+K59EgVsC
Fhzl79u3L664ODa4vrDCCPnMFp9kwoQJiHbEzuJcUh64HCgPPC7YdMSuakQtLh98
D6S3MXBVwIkQSuH2U1ccPsyAAQNQL91oWVQE/h7iT/hF4eHhiDNxUXCroDzyQhrp
4QudPXtWZGh4CPD0EAPDF0UzwiOSfODM4DaDi6Xa4dSpUxJEGZ0HtAaqiVtONSyK
B/8QiRFaq3FMcmrcKmXLlpXAGAE5PFJxfZcuXYr7VhxL5WjBuZo0aRJuGwS6ym3D
XS2X1Wq8gNusTJkyuNbLli9DzjKUW85I4ZWQdA16BjGyMLv2fJpghMIrnAHYBfSN
+A3LMmLECISKiI6NDgncHgTygYGB6mVYVHQU/kUm3bt3N36o8fvvv8OONG7cGFkh
fwS/MBawGjCaWuFVPj6AuVcqBLwXBGgmy2izPXv2yEY7TRVsBKJd2PF27drB2MGU
wMSgUupFshJeYYVRdxhrnE6d4sCBA4UKFUp1pBfOEhwcjPOOGjVK3Xjwf2DlcQrj
e/To6GgZ7FW5cmUlUsPhRGug+tqUKABMYa1ateDjoRiw4MitWLFiuEutCq9Pnz6F
KYRxFw0XDpj2c5b79+/jKBnq+91332lPhGaBs1GiRAkYd/ENcEZJCWDBlawEkz14
8GBUdvbs2coBO3jwYErqCppx1qxZcIy/+OIL3DMim+CiqFe/FF7TKJ4svCIIwbNX
s2ZNOIu4d9EvrN+w3jjqHn1Qrly5cCvr3h1t27ZNYirdS5s//vgDDwkCFZ2BWbRo
EbpO5U9v3LRR+mLd6aKiouRNSN26dbUyKP6GzcP2ggUL4tRmix+MXgM9uCT48ccf
sRcRkS5DBFrZsmXTCq/oOvGv8dUlAqFUpxpYt34djkUXr9suZ0etjSNBYAxk2K8s
sYdeBp04ohdtmuUrlpusfUaKgBZ9inaLcY5XhHliOYyfQ8oH/ui41RaYf3TBiDS0
w2PNlmCybdu2pn9PNSCzviIg0WUry7xI1KdFDJtxJDW6znz58lF4tR+YT1wIk2Ut
HRvTPhJC3jHOnmoA4JFHzIAEu3fvVhsHDhyILR06dDCm1wmvshBtixYtdMlgHE2W
eYSsflunJSkpqXnz5kuXLtVulOnYfHx8jB/1w5GQUX7Dhw/XboexK1q0qK6maDfU
TvvSVEBYIjYoVeEVNr1atWraTwHQYcpM7kartHfvXomF+vXrp6u4uH/Zs2dX398t
XrwYfr/OpUHIgchK5xvAYko8qRsCY7YES/LKE5GVSOcnTpyoWrUqIhBJ0KpVK91w
FTHrXl5eKq5ToEmxa+zYsbrtuNyDBg3SbhH1WafZwVmC/7Z//37tRoRwcBuMIq+O
0aNHw1fUGSAEacePH9dGv8gHHhEKr5vUCD4bPCIZ8aqQ+NnX11eCRtwMCBTRvGbL
9ETIBNdRNzBKXi1juwpczRaNFZlj+7Fjx7SJEXXLrah9dgQEhOJAKqdRkCXdcubM
qeZQwlVDSeCn6XIQDwfXXfdV0KlTp+AJw4vWOcloOrkoFF4JSdfAxokdmTJlyhsc
TuG1ZcuW6OHr169fuXJldJUwgjABRhsUGRlZokQJWGFlLgVYRsTR2K57iYs84Ut8
/PHHuqy2bNlSt25dJT7i8uHwTz75RKfbqgVIjNOY2jBVYPLkydgLj0UX8sMeIRjX
Cq+49Ph37do1uppu2rwpVREfp4Ml8vf3120XZwxlNo4VQ4PIe1xxD2CqGjRo8PXX
X2srDhcOl6BYsWK6EcRoZFws7acwxqkGzp8/jwcBRvbcuXO6U3fq1AmJhw4dqrbA
IJYqVQqJdXoLTHzPnj2RuFy5ckp4lQEHzZo102UrKw81bdpU5xiEhIRg+2effabz
68LCwmThUwqvaRRPFl67du0KR1aW7DBZPouzmn7GjBnYi0dXt/3GjRtwVbFL+yEh
egHprTZu3KBLj44PXZVEL7A98lpGF9oJiEmwK2PGjNq5t/BoIZI0WUbLq41wsmW0
LPoCpEdXoovl5EAZc6qE14MHD+Lfvn372jNXqRYUu02bNjjW+EmjzNKAAlh9hTVi
xAjsfe+99+Cg//jjj1999ZW2p0DnK5/5o4l0ByIA0PUdRuEVXbNV4RUJcNWwC82u
NkrsYXXhY6mCEl4R2MhbKeOllFsib9682q781q1bsH+4CmoclgLdpWRF4dVOpk2b
ZrKMbjMOPyeEuJB3ILzev39fPl7TikdiqeHoG9NrhVfYd3iuVjNH94vtsP7GV3Q6
ZNCHbpITGFnEAIhejJOG79+/H9sRosAK6HbB48dJe/furbbAgmML7KDxvPAH7BFe
4bcYqyCmrXHjxjqFVEa85siRwxgnoJ1llKjyDWR1L1hM3ZxIRh4/fixviI32Echr
M+1rYPhLKspCK+nmaEJJ5PXw5i2btdvv3Lkj8wgZ5zmF17pmzW/qX1x3WVxL58jJ
G27cIW+whMXIkSNxxefOnau+SbLK1q1bTdYW/ESRxowZo/MH5DLBj1Jb4DJJa8uL
ARRVl/+ePXtMlqkVtHPyyvvmPHnyGCcHlOuCU+u2d+/e3arzg+cRjY+ayroFKLbE
hKNHj9al3Llzp8ky2Ef77CN9u3btUgrzZFIpCq+EpHf69++PZxN9xRssPU3htXnz
5vCdxo4dK87PsGHDrCaGUcNexOy67bBf4hTNnj1bbYSjIg6GcULV06dP41xKlxT1
QBsL685oMiwDY8NU3bx5E8E+TJKa7kmL+IeqSBcuXJBX5g8fPrS6dk5KIDEcJxwL
Q6zbJTbR29vbqHiY/4nQ4fYcPHgQVW7QoIFOU5ZsJ0yYoDsQJUTEqtU3jcIrrGRK
wmv79u1N//7EVjRTqysTiDFVc7zCbRN1Bf6GLuXatWvE7Gp9mMjISBmSrKRwLTYs
svtB4TUdoJvjFWagVatWIgsax3Kb/wmccIsHBwfP0jB48GC4qrqP+8LDwyWSMU7a
gudK6XQIPCSZ1WUNDh8+nDVrVt1jk5iYKF+uWQ1WZUyEcX5Ss2WuOp3wihBIxqIX
K1YMwer8+fMRN6Y0d4yWiIgImYQOHRmKoW0NmSGhVKlSVhcwkckNTJbJRxo1aqSb
Jg99t7zKM06tixbT9dRvI7yiKWQSllWrVhoLKeNblfCKish7M1gs9OPayiK4xXY0
hTbEFd22YsWKxgAP1a9bty6FVzs5c+ZMrly5cOzAgQOdUTBCyBvzboRXsdFa4VVk
Kd2nEoJWeIXrLEaqXr16s/6NCLKwhqkKr1rQnx8/fhw+EpwlWHz43Nq5vQQZl1Gw
YEHj6kPi4qvRuM+fP5f5T63qlaJ72rm4loAQaNeuXQhyqlatimO/+uor3ZAWmeMV
JzWKwnAq5FKqaX/geyCxyTIQIygoCEYtpZGhjx49Er/C2Brmf4TXVMdGoW3R2yO2
GTFiBOIK46BRNLu4DcZLptOXUWsRXrVqrNkS8MscTXBOevXqBRN84MABO1coFkUV
VKtWbdCgQctXLIeLoht1YraMvTVZBjQZczCqDBLNGqPuuLg4eTvr7+8/depU7X37
zTffmCzTxWoXdJXYElXDE6FNDG8nR44caEn5wEiLfKkjE+NquXbtmjiEEkXDXZGZ
l3ARcQW1mctSMB9++KFWB4+KipIhCFa9WQS3FF4JcQMeP34s31UgZH4tBc1M4dXy
eauY5h49eogsaDUOlRkIEQFNnDhR2/eOHDlSPjnXRpHoe/PmzWuyNp4U51ImEnZW
5quxKvWcP39evtzv37+/dntKpspsmU1RREPjC1rYRwn2lfAKV0G++8HV79q1K/r2
P//8057lZGJjY+Uz35o1a+oskcyoA5todU1R3GOiSBQpUqR27dq6d5/wwcRF1ErY
Au5q3f35NsJrQkKCzEhpnI7WbJlCXSu8orJyjRo1aiSLkSpEocKF1ra2TBBsdRgB
LoEcQuE1jeLhwqv0g/fu3ZMxAqVLlzYGJ61btxaVDR7kOA3oFhGuoAfRjhvFoyie
ekprywpw3+VzMKsvK9R6FNo3J0p4tRrMyCAaBB5Gq4b+Qoyl9nXW77//jujOpKFi
xYqolO2RHWgc6RrQqY0fP17bGnD3EfDgvjeGJapS8vWodsSusG3bNpGwjcKrkbcR
XmFgZKJA3Zs9QcZDKeEVIbS0TOfOnXWVxSVAd6z7xA/2SSyEMahDJCPxLYVXe5Ax
4zBIb7AKOSHEqbhKeE1pkIL538Ir+m0ZGNKiRYtx/0aMFPrtVKcaMFucudWrV8H6
w+zCTRo7dqzoVrAgxoVxRXiFgdPODibI4EH8ln+VDmh1qln56Nse4fXatWuwOHA3
v/nmmyFDhsDDFoOuTqQQ4bVgwYLGhYDhC0kAg5rKFoRqy5YvU8thmSyf/8Oowezq
9FxEU/ArsFc3aY8gwqtR+1Pn3bhxQ4cOHZo2bYpgD5cGFxchZZYsWbTLipr/+fSh
ZMmSRsdMhxJejZ/YIygtV66c1tupVq0a/DerC0lrgTODhtUulQa3rX79+rqAWRwz
4xqeVpE59YxrA8CNrF69uvg2On8DzYgzHjp0SKuAY7u4PSNGjNAmxrG4i+DgGeMx
uYER2Ou2455EnI9LKS5NZGQkPGGT5dtGXUkmTZqEYOHgwYPaDzwRiMpcUsZpIgBy
oPBKiHuwectmeTNnXEvZNhReP//8c+k2o6KjRJrMly+fdp5QQZwZNBQslE5wWLRo
0c6dO7UfwsNTksuhe92oA40vka/VZHfu3BH7CF9Cuz0lU2X+p5f29/c3KgYwmgEB
AaZ/D8KF8RIJUoEzImfbH92ioaRgjRs3NtpEOC2wRCmtvXz37t1SpUqZrL0QRVxp
HDucEm8jvMJpkU/+YZGNOW/avEkrvCJ/GY331VdfWVVXjhw5on12ZLAdDsc9oMsZ
lwC1pvCadqHwKhvRL8j8Nbjpde64CK/GeTesooTXLVu22EiG6EKEV+N7KrNFH5Qp
Qa2OeLUqvEr4hMDDqHvGxMSIrKxTG+Fe79+/H4ENAgaZk8WUwvePCvQjUjDjdw2p
gjhN5hPImTOnbsHBrVu3ivFAN5pqPm8jvJ48eVLWkbC6zLRMmGIUXo1z2FllwIAB
SAzrYnwHCOMk07FReE0VmZ8xpUeDEOJaXCu8wg01ptcKr+Hh4XLs22g3iAfgycEl
6NmzJ/xs6dJlqgHYL6OCab/wevbsWfmcRSZq1yEv/1IVXjdu3ODr6wufftnyZTij
GH2R1Xr06KFLbEN4xYHy9YZuRhcELei9EemhEWQwo8nwBZwSXlEjYwltCK+whu3a
tcuYMSMcsNDQUJlBVSY9gFOkm8BOhFd4HanebEp4RWhq3IvSoh0mTZoEB095O1ZF
fCPwK+CijBw5Eu6EXDtvb2+tg/fFF1+YLHMH26MppCq8Wh3TbUSEV9zqxrVWUsJ+
4VU+DMINYE+2iHZEeLU6LxAyofBKiHuA8Lljx44inKW6OKEWCq9KeDVb3AD5yAAd
o26kjjgzVatWtSdnJbzaWPXebHGKRHidOXOmcS8MnIwADQoK0m63IbzKF/T+/v7a
accFOBW6qQYEOFGHDx+eNWtWhw4dZPyWybIOlQ37FRUdJQWz6vXZBm6qTOcIL073
GY0SXnXLbVnlbYRXOC3yeZNx9gDzPzO6aoVX0aC0q47b4OeffzZZRgRqFxUX8IiJ
bEXhNY1C4VVtlxcIYPz48dr0YmYQ5Ngz/g7WRZb6NU7UpQVhgHxMbbVTQ4Ane7Wf
bqE7k8HzVoVXWYACttC4EhHiHHGjrQ7zFOBqyzSs6DFtrK/14MEDycq4JphtYG9Q
eMSETZs2xeEIMLRTvB04cABhmJ39oFF4RSuZLJOdGS+QLOygFte6c+eO9IPa5bYU
MtpICa9ILKVSX4naRkJEFAMH6nbhEkggSuHVNnAj5AZr06aNB/pnhKR9XCu86qyz
oBVeYaRkvB6c4Dcrnvmfadbr16+vtYay9tFbCq8IViUEQgRiPK9YN9vCK6yJDANZ
t36ddrvMiZSS8ArDZxyoCz8ka9asiPF0M65quXXrlswNqptdVwmvxvADSMxjVXiV
OXl0CzTBcZJgRie8IgiRW8X2iB6zRng1zsCrIyIiYtCgQXJ9bac0cuHCBZksTytf
SsvnzZtXtxyKVUT9NDp+uKzyWH3yySf22D5ZXcSUwjhTG6dOVXhFBChKQUBAgD3Z
4nGQiNHql7Njxoyh8EqI2wC7L5+3W10qIyUovGqFV7NlQWl5X9W/f3/tvA2iyfj6
+tpjTWCF5c2odiZWI/DZihUrhmQwAca9t2/flr06jyIlU2X+Z6IbODxGXwiGWGaq
sTE8KyYmBjE4qu/n52fjK1u4JVWqVDFZPiS1UTsjcNtglDt16iSrlcIh1M5sAAMn
A1FxRVK9G43CK1yUjBkzwuQZL5BMxaMmZ4iK/r+V0q224caNG0yaxbVQWfEMrc5Z
ZEQWJIf/ZnzzjerLKD0Kr2kUDxRegVXhFTdr586d5Q2JNt5D92GyfHBnVRZEj6nN
RC2ulTt3bquTjygkHitVqpSx3xHFCqGLdhQ9HkuZ7sSq8CqLe6CQixYt0u2SpbRM
mknltm/fjofWmMl7771Xp04dG3P3oJOSniVbtmxW3f2UerGBAwciZ/T+ly9fFk1Z
K0zHxcVJJIneP9WZX+bOnSshkzoX4mEEbOiAdP0gAkIZn6umCkXV5OpUr17dOC71
q6++kmBDAkL8lsRwMlKaR0b775kzZ+Tdo3HlMcQzouHafi3pZryB8Nq3b195doz6
BSEkLfAOhFdYAePiWiK8jhgxwphedskkNjDH8rY/R44c4ofpsCfwE3FNVsVVyBoU
iB6NwQbsr53Cq/mfAZIITnRDXVByWV2hYsWKNsoWFhYmM/No59mE9yJjV1MSXhHx
Gt8IysLE2nALToLxU/179+4hhw4dOmg3KuEVhk+XHn4LqpCS8CqdvHa1MYCTyvy5
OuFVFvEwWWbstT0zAFpPPnDRDSXesWOHcXAxAj/cYA0bNrSRIVi2fJl2PSvh+PHj
aHztTKnyzaDJ2vSpOpKSkmSiYauRmMzuB2dGFwALuvsWBZOTWl24w2yYA9f8z9yC
qQqvaMmgoCCTZWAvjHiqJcGJ5MtZtL9ujWlcMrkt69ata7WQRii8EpLGkReE6B+M
6yGnBIVXnfBq/mexMkTu2s/7RI8zuh8KreCgQnIE71bXuVLIyCoEs8Yv0//++290
/mXKlNG+f7Vtqk6fPi0roBilPcTd8sm8+r7+4MGDVod8Fi1atHTp0jbMOmqK4F3u
NKsfnqL6VvUKlMrf3z8yMhJeisyb1K5dO20CeZdsdaFUHSK84gqqsb0XL16ET4IW
02kgt2/flskNtDM2yEtZq/Pmia4NJ0otriUCFBpW902w1creuHEje/bsVl3ia9eu
icxiz1A2N4DCa/pAgrrvvvtOtx1efokSJeQNiQquoqOj5RMwPPzoPrRD6+HTDxs2
TDfYHh2ECHABAQHaSZ3j4uIQlanZ5RC1yidvQ4cO1R6Ox69JkyZwvnUTnqIY8lRb
nacZnZeMMfH19dX2UDJAQwbhrli5QjaOGjWqY8eOuhzQLyDssTqeSMvhw4dl9WF0
04g2lQ1AI4SEhFj9kGHBggXo+9TcbcHBwWJXtOMjlixZIhsDAwO1sStqjYbSdjey
/AiiVnVqdEAye+yYMWNUyrNnzyIgEduAvk8drr5kR6+nRgfHxsYuXLiwYMGC2O7n
56ciFlxfuZQ4nTYAQ0c5bdo0lF9bMHSLItTipNqlmS9fvoz+VGaW0C247N68rvCK
W8sDW4mQ9MXbC69qFpeU5JW7d+/KnDDayWdEXW3evLn8GxERod5Zyrpbqqs5dOiQ
zKMKO47IUFkKxBWwUMYXY0ZEG23YsKF697l79275agFW26hgbtu2zWRZycG4S4TX
vn37qi1Kp+vatata0xLuweLFi2WNi3Llytn4/g6mTUbKLFu+TLY8ePAAkYZ8umj8
1Gbv3r3Srw4YMEA7PRwiCngUOu0bjTx27FhdDjD0uBw6L1GEV20x1FQ/sNryhaDV
L0vkYlWsWFHNWIrrBZ8HphauhXH4BhwkaS60pLZ5URftUmZoMZnPR32WKOUZOXKk
bs0Qs8UvQlNbdVe0IFozfve3evUqeFloE7VFfVwJR2v27Nnad7oosPaDXPhpMhrI
6vuDS5cuiWuKe2zjpo0qIoXTiJOOHj1amxheiix+YrK8WtZe2fPnz+M6Gl8PiKw/
fPhw3XYlvKrFu+Ctya1YqFCh7du3qwmscJfiNpgyZYpOPVH+W79+/VT14ROiNUQ3
r1GjhrG+VqHwSkgaB123vGupUqWK1aUXjXiy8Orv72+ytu4lItDKlStjV/78+VXf
q0b8yJtL7arXcIcGDRqk+6r16NGjEuDDpIaGhqqYFPkglFYODAyEfE0IM6p7J9ex
Y0d0/rplaWybKpxFPsBFtKsN5K9du4ZoVz6AUK4FrEDTpk11OcAZg4mBM2C76eAP
yPAp3DnwspQlQr3Wrl0zadIk4+SKMJ04RBlo+CfSmFrHDyZSdIzixYvDQVINgtxg
N7WD4ZAbkpUoUULpPPB8ZKBYUFCQOjua+vvvvxclVFtZZC7eWqtWrZTkjbaFQRc9
B5deWcy//vpLNOuyZcviWqu7BeWZN2/eggULdJUVVRf5L126VFUB5e/Vq5dIH0Zb
75ZQeE0HwKeUibpq166t9VaFLVu2SK8BT1GtGnHx4kVZwFe2//jjj7ih0Y3imbEq
g06dOlUeNjxFHTp0gOsPzxinw/OgtVL79u2TEf7ffPPN4cOHET5hS4sWLbDRuPIG
ejRxYRHCWTVd6KGkY8Wp0ZOiu4Tz3aVLF/RWMtwdG6UXnjx5MuLSMWPG4DbFSREY
4HSwo4jZ4Fin2oDoMqR/MVlW2Ro2bBhaA300zmIcBovoDo2gldLi4+MlrIUZVpOC
odeQ2RJMltVL0CAoP/o1mKXBgwcrW4I/ZBkxWBr1Bgm9mCz7a7KM0seBPXr0gOna
s2ePvLJDIbVFkslYTZblrZE5ztu6devpFmS7VvJGACCDVfEbcQsyxyGVKlXCscZF
RS5fvizz2MKMITGuO6qAGwA3lXwFifLY+KjTzXgt4VXNcFe3bl3da2FCSNrh7YVX
tVh8165drY53gF2QBNrv8eXrNlg3HAUTjK5YzDesoQSBMsZBEq9Z85sYKXTF6P+R
eOjQoTBSCE7s+TR70aJFUgD4czj2u+++g7lcsmQJckMBjDnIhJuZMmUyrpYpYyvQ
8yvPGAWWlRhNlk/YEErBBrVr1w6ONQIJk+WDEhsjiWCjpav09fWFfUFTwLJv3rJZ
xvkqYVqxe/duuDTyBrFMmTIwf2LyAgICjENBUdqCBQsiZEIciAAPoQJaEtG19qWm
gF5anF2kR9uin1dvdnFjSLDUr18/44AUiWRMlhUz0La4mj/99NO69esk5DB6PghL
ZLonk2VKU8SNOAq+ykcffaRdHEP5Bjly5Ojfvz/+Fq8DiXPlyoXyHzt2DDcMHJ7f
f/8ddUfIl+oaa02aNClduvT8+fPPnTuHcOv27duIcHALGRflgOlXq5VWrVoV/h7O
C9OPK6Wd+RS+lnzkiBpZNXO4f9TKZmifIUOG4GLBeUDgZxzygyLJZzomyzsG+Hs4
KS7Ehx9+iALoVh1BM4p/CO9LV3G14BsujdqIe0NNhgtvSkqCdsOJtFNgCTiXDGSW
6uOexC3Rtm1bxOQyGyCyMo4dtgqFV0LSPjCCEkfb+Tmzxwqv169fF2sIW298GQbr
IO+Yy5YtqwLPW7duyTgqk0VORWeOvrd9+/bo2HWv34TFixeL9URcjBAYiRGl1q9f
v1OnTtq3gMhf3pUiDfpwmMIjR4507tw5b968RgkoVVOFesl3LQDuBE4Ks4tCwrsT
fwxWQ77pgeMEDwRFglcDj0LmW4d1Q/FksKdttm/fLm8BxR8TSwQXFObMuIb5zp07
0Z7qY3+zRZWTJXDQRCib2r5x4wYZFipeE6J1mC2UCo2jfVcqI4WBmlIJjpyMwxW/
DgngSzRq1AjlFCUU105bpPHjx4v3BSP+ww8/oPBt2rSRtdklE+2oW1wIscU4pEWL
FqgI6vvJJ5+gssYRzXfu3FFLlkkV0MjIfP2G9fKSFQfaXr7MPaDwmqaB5wo/FVEE
7mzYjJw5c+LpbdWqlU5BwyOBBBkzZkS3opZuvHfvHoIi3Mfycgk96ffff69b114L
ehY87TIVjskyjhLPp7HbxZZRo0bBly1VqlS9evXkSdMt4Iu+CY8TiooOBcVG7IGn
Hd2lUcK7efMm+g4Rc02WN2zYgpsS7jIOROeFQAIRGoqNWBRmoFKlStiFjd988w2i
PnvWehbQgyOmUisFozdHYKMb7IOIGjEeDC26AN0btkuXLqFB0JL4PXXqVLUd3SI6
btUbVq5cGUZdTT6wdu0axAzIEHXBBUJzob+TbgXxNgIt6Z1x4ZCJ9JK4uNJi+EN9
7IDCIKumTZvKOCDEjTI/AzZmtYAAHhdXvVeEaUQ4qloV9w9KBeNhtWXu3r2LCyrv
skyWr0uuXbuG7Whw5IzwAx20ClDdm9cSXmUJjuzZs1tdoIMQkkZ4Y+H15cuXs2fP
hoMIeyE9ra+vLxwmeKtqiIF8HwBvUhLAVYUfLH1CTEwM7KAaQIeU2Dhz5kxYQ2yU
3hV+MyyRhHbHjx8PCgpCPKMCmHHjxtkzUbvZMvABOYuBy5YtG6IdmLOLFy/CWOBE
1atX/+mnnyQa2bNnD4wLzoLtiC5gUr/77jvtbKqIW8T4whYoHVlsEOouNghGTab/
hicm1g2lRTukNP0ZYh70qxJroSkOHz5stny3iGPz588PK6mdLmDT5k0oP8qJOEdC
ZRQGfoJxcK7Zsmg1SlW+fHkUoG7durhYuDopzQ5/8uRJVAp2PEOGDDh7XFwcXAjY
SsRdMOI4V9GiRVEYuAraN9xo25CQEPn6EsYaJUE1YU+LFCmSJUsWGH04pTrf5vnz
58uWL8O5pPyISRo0aDBnzhxdMtQIrS0vShEKigVHJAbji1sOOaNgiAbh7cDi27Mm
FZwi2Gu0Bo7FPY98UDurX9+bLRMTT548GfeGRFm4bdq2bYvGF+cHjYOrgGJLyyCE
hgeCO8c4txK8IziBMkjKZJmNCjdbSvNWoQXmz5+vWga/4fxoP7iRU+OhwKPx/vvv
IwF+oxG0E/CdOXMGG9H4FSpUQJGUm3r27NlBgwbJa3vRdlEw8WeM4NIvXboUFRQP
GUH76tWrzJYnFCeFZUcb9ujRwzhASQeFV0LSBfJOBR2d1Wm+dXig8HrgwAF0p7AI
ErmjD6xZsya26F7cogOHUZBwWI3KhPGaPn06jI54CPBwYIi1n1noCA0NRQgsX22C
kiVLwrAaxwbB/0H0CmuIeBaZw74jSNfOWWR+HVMFk4doV75ukTeFYqdg9HEgyoxM
lq9YHhYW1q5dO9gROBW1a9eGSYVvg9rZOVbabJm+ANVRrzZhE4cOHarzP+FeojCo
V8OGDXVKMaLyatWqoSXRLFrlGg4MDBy8FMkWf8BXUZ8p79ixAxYfG8UXDQgI6Nat
m6xkJb6ovCKF84NmFFW0Z8+e0mI4UK3pbbYoG9giDhuc3qlTp6K0cMmQGGYXDkaX
Ll2U7HPixIm+ffvKQgUmy/gw1Mu4gpYAxwkXVI0LrF+/vnxbDC8UmeMK1qtXb+7c
uTYmkHQDKLymafC0wKfEHRwVHYWfyMjI27dvY4vxfU50dDQSIKV2nL/ZIibKLntG
hpotbjES4xDb05MhN3RhCBuME4+aLUEauksUNSrqVbEfPnx448YNhHYprYKF7gzJ
1PxxeOSkGHhEcZRsx52KkyIcQrY4r/09oK7YUjurii3OiwbEKaxGOHIs6qVbGRNH
4TJJ+XU+Ojai4kgvlw/9FEquteJyoHbmB0R00mK4yroPNHCgXEo1MATXSHJGsXU5
mzWtmmrkoBJrr6aUBGXAJfCEd1Dm1xFeL168KJNFGL8JJYSkKd5mxCs6QPThMHbS
00p/KG8HJQFsMf5F9ysJ4OvrvvySTl51zjBqyBBmWuWGQ7Rephga/NjTb+uQY9XZ
YXDl7CgeLJeUGbYVJcRJle2AYdIaRDlEKq57XYdawKBYtUHIX9ssVhH7pZoCmYiV
x4m0iqTyPdAscjrb3guqiUuMAqAi+G37+wOcXeds4Cidr4LmMja+lFYZa9RUynbX
glXfRjUXfqfUMiiANKB2o3g7uEYoGDK303lTJ0VjSmsgh1TvIjSXXBedaI4y4HBk
IveqOGO4c1LKEPlIRWy7jqqQ0jJWlXo5NU6nfUy07hDKINcL1USRdO6cXKlUnViV
lVRf3Tb/V5GoV1cW7Z9qBEjhlZB0ATpGGWLSunXrVN9jeaDwit4Y3ekrZ8bSuwIR
HIzhtvTe6H51HgK6YtllZ4QuYaa2+7UK9oo1tBqKvq6pUjqA6ttVtItM5BTYBTsC
f0AEhzf77lMskQ2bCMcSJbd6g4kZkgS6XSk1muhFERERshclR3W0jSC6ilZwkMBf
nD2dsgGXRncpcXGVs4fMdWbXtrqSUsuox1BKgiuIMhtXXHczKLwSQsgr7BReYcnk
swj4cDpbRQhJa7z9VAOEEGIVCq+EpBe2bNkiQ+1S1RA8UHglhLwDKLwSQsgr7BRe
V69eJa6b7gNJQkgahMIrIcRJUHglJL3w8uXLDh06mCyzhxvHEmqh8EoIcQYUXgkh
5BX2CK+PHj2SGYK6dOni3tPQEOIexMfH161bl8IrIcThiPCqnYKWEJJmuXTpklpK
MaXp78wUXgkhzoHCKyGEvCJV4RVeWs+ePWVtmZQWDyGEpCni4uI44pUQ4gxEeFVL
oRJC0jhz5szBM+vt7b1v376U0lB4JYQ4AwqvhBDyilSF1127dqkFoCtUqFDegCxF
XalSJfxh3Ot+oJoVK1YMDAz8+OOPXV0W8ubgOvr7++PWdcv7tly5crJwPIVXQohj
GTt2LPqWvHnzurqfI4TYRdmyZWW6MPg8aqFIHRReCSHOgMIrIYS8IlXhddasWSZi
IHPmzK4uAiGpQ+GVEOJYRHglhKRHhg4davW5pvBKCHEGFF4JIeQVqQqv0dHRn3zy
CdLkypUrODh49epViw0sW75s6dKlxu3uypIlS9atX+fqUpC3ZakFV5fC8eB5nDt3
bqlSpUwUXgkhjmbMmDHoWzp27Lhi5QpYQ1d3eISQFMETunbtmjp16ojq+sUXX/z+
++9WZ3ql8EoIcQYUXgkh5BX2LK518ODBzJkze3l5DR8+/J0VjBDyNjRo0IDCKyHE
4cgcr0uWLHF1QQghqXPjxo2iRYvimfXz87t37x62WF0ml8IrIcQZUHglhJBX2CO8
gl9//RXJvLy8Nm7a+G4KRgh5Y7i4FiHESYjwOmfOHFcXhBCSCjExMTVr1sQDmz17
9uPHj9tISeGVEOIMKLwSQsgr7BRe0Wm2a9cOKQsVKnTz5s13UzZCyJvx7NkzCq+E
EGdA4ZWQ9ELPnj1lkoHx48fbTknhlRDiDCi8EkLIK+wUXs2Wj5WKFSsmU0Q9e/bs
HZSNEPJmUHglhDgJCq+EpAt27Njh7e2Np7Vhw4bx8fG2E1N4JYQ4AwqvhBDyCvuF
V7Bt2zbx4X755RdnF4wQ8sZQeCWEOAkKr4SkfW7cuFGgQAE8qr6+vufOnUs1PYVX
QogzoPBKCCGveC3h1fzPV0tZsmQ5cuSIUwtGCHljKLymRxITE6Ojo11din9x/fr1
EydOnDp16s6dOzaS3bp1C8lOnz79+PFj496YmJibKfDw4UNJE2vBKXUgjobCKyFp
nJcvX7Zt21YmGVi0aJE9h1B4JYQ4AwqvxLk8ffrU9hTm7waENCtWrrDxs3zF8rCw
sJQO//vvvxFNGbcjODx8+PCqVSuRw4EDB5KSkrR7ETuh7lZXzCRpkNcVXiMjI6tW
rYpD8BvhtFPLRgh5Myi8pjvgNrRv3z4kJMTVBfk/zp4926dPn86dO3fo0OHzzz+v
UqVKt27drl+/rksGN2P8+PFff/01kjVs2LBy5cqjRo3Sya+yNqNVAgMDJQ2ciiZN
mty4ceMdVY+8BRReCUnjzJ07V/rY3r1723kIhdf0SEJCQmhoaHJysmuLER0dnarg
gHKq9LjH9u3bN3PmzGnTpq3+bfWjR4/sOcuFCxfOnTunFIb4+Pjjx48nJiY6pUrE
cVB4JU4kLi6ubdu2ffv2dXVBzLt27Uop2lFMnjzZeCCq0KtXrxw5cixYsEC36+jR
o3Xq1PHy8pLDvb29GzVqdObMGZUA0WODBg2GDBni3LoRB/G6wqvZosj7+vriqKCg
IOcVjBDyxlB4TXd07ty5cuXKDx48cHVBXgFDX6xYsX79+kVERMiWPXv2ICYvU6aM
Vht9/PhxlSpVPv/8c1lxEVHQxIkTcdfBSdBqr1OmTEnJA2nSpImkef78eYcOHSpU
qGBnAEZcCIVXQtIyhw4dypQpEx5SPz8/BGV2HkXhNd3x4sWL77//Hs6Dyy/ZqVOn
UhUcfvjhB0l8+vTp5s2bt27desKECfAZGjdu/PHHH69evcr2KebNm4eb87vvvlPC
K9yGli1bdu/enYO90jgUXokT6dWrF4KTu3fvurogryIl3Da5c+cubQDG2NvbG5GV
1TBvxowZ0kuu37Beuz0sLOyDDz7A9g8//BCZ5MmTR5Khvrdv31bJDh48aFW0JWmQ
NxBewezZs+XSr1nzm5MKRgh5Yyi8pi+mTp2aPXt2RCOuLsgr4uPjYdP9/f3hK2u3
yxCqgQMHqi2I93LmzHnv3j1tso4dOyLZ2LFj1RZEVg0bNrxiDe2x0dHRJUuWbNWq
le68JK1B4ZWQNAusf0BAgIyMQRho/4EUXtMdI0eOLFiw4KVLl1xdEPOZM2dwy+H+
sSo4vPfee76+vteuXUPK48eP58iRA1GnejsbGxvbunVr2zYFR2XIkAFpBgwYoDtv
7ty5J0yY4NTakbeEwitxFiEhITB1u3fvdnVBXrFt27by5ctLT6fj0aNHRYsWDQ4O
Nu4KDw8vUaIEgkAvL6+jR49qd/Xu3btw4cIbN22UudiuX7+OuEsEuDFjxmhTTp48
Gf3siRMnHFoh4njeTHgFMnsUDJ7VG4wQ4kIovKYjjh07BnM5bNgwVxfk/9i/fz/u
nPbt2+u2nz17FtsbNWok/54/fx6BULNmzXTJ1q1fh2TwItRcNAiKWrZsac+p4V3g
2IULF75VBYiTofBKSJolKChI4rLXtSkUXtMXm7dshglOdaDou+Ho0aOlSpWy+vI4
Li7uo48++vHHH+Vvf3//nDlz6kanPX782MfHJ0eOHJcvXzbm8Pz588DAwFy5cuGu
njp1qm7vkiVL0o7wQqxC4ZU4hUuXLmXNmtUYrriKVatWtmvXzuou3FEVK1ZEX2bc
1bFjR+ytX7++ekIERPJVqlTZt2+fNjE21qhRAym/+uor7fanT5+WLFmyatWqSOCI
qhBn8cbC6/Xr1/Pnz49jW7RooZvnlxDiWii8phfQedarVy937ty2V696lyxevBh3
TtOmTXXb4Q9ge7du3eTfyZMnG9+5AgROH3zwAQIhtQDjxIkTe/XqZc+pk5OT4Wbk
y5cvLXwzRFKCwishaZOtW7fKXHAwK6+7DMP/Y+9coG0q9/6/XDOQ4RwM4YxQGkUd
owgZcklk4HhViuFWURwqvaek1yW5djvdUyhdDildXFKiXoncinJtRzoRoUju5dLB
/n+s32v+Z8+ca+1l77Wtvdf+fkajsc211pzPfObz/C7f+VwkvOYjtm7deu655/KU
88gEkY8//vi//uu/Qj96/PHHa9SoYYsI2RKIoS9ibTTPc889F/zo2Wef7dixo71R
CI4YI2xo2LAhlwjd21PkBSS8iuRDq+rRowePafXq1akuy/8xZ86ccePGBY9//fXX
FStWdJYRMKa8OeWaa64hA2zRooUjvJJNEW0HF1IxU4jFdI7bbHSF5nmcbAuvMH36
NIvwxowZk/SCCSGyjYTX/MLcuXN5TPfdd59znFyCRCUjI+Pw4cP886efflq8ePGi
RYvWrl2b29tozJz5LkUqXLjw62+87j+Or/fLqTfddNPJuDQw3ObAgQOXXHKJP2R9
4oknbCbgzz//TFDBjRCExHpdN3XqO/z2ySefTPJdieQh4VWIPAi5W61atWw5uGzM
RZPwmo8YPHgwD/q0lpLIVZYuXfrYY48Fj2/durVq1aqes3jooYco9s033xz85gMP
PGBigiMl0ywbNGjw5ZdfPvLII6HCK8x4dwYf4ZiScCciF5DwKpIP6VDx4sWbN2/u
HN+xY8f69evfeutNkg3+uWXLlmefffb+++8fNWrUggULznw5af3t27dv2bLlkSNH
nI9Iilq0aPHhhx/yd5MmTRzhNRZ33nln6NzAnTt3li1btmbNmomv7C7OPDkRXmHQ
oEH8nJa/YsWK5BZMCJFtJLzmF66//noe0wcffOAdWb16dd++fa+77rr69euff/75
mzZtIqm44IILbPZooUKFOnXq9MUXX+RekXbt2lWjRg1bInDAgAE2FJfA4Nxzz336
6aftO94ygsE3uCdOnGjWrFnEt3UnMc+wYcNeeuklE2ShRIkSN95449y5c4NX37hx
I59Wr15d02XyLBJehchr2EZD5iOmTZuajTNIeM0vbNmyhSdVu3ZtR6Mki9+wYcP0
6dPMt+7YsWPcuHH333//8OHDP/roo5SMje3Vq1fdunU9HcD04h49egS/SSH5qF69
er/99pt3kHDijjvuGDp0KH9zI7GE14MHD1544YXUiQa95k0kvIrkE3wVQ9owaNCg
Jk2a4Mb4CMMxb968OnXqFC1a1HIPsppu3bphKM9kOWfPnl2qVKn//d//DX40evTo
nj17WskbN26ciPCKp7/88subNm0aumpBmzZtOMmsWbOSUnKRG+RQeMWbXn311UR7
eWQzbiFEpoTXfMK2bdvKlClTrly5zZs3ewd/+OGHqVPf6d27N4+vdOnSWFcC1hdf
fJH44bXXXrv44os5ft5558V5sqTNvyRAnCVi3p/1fvny5S1QqVGjRufOnevXr28v
ZQ1+TjDDp8uXLw/+vFWrVv7hJwMHDixWrFihQoUKFy5csmRJIh87c/HixafPmO78
lliiZcuWfLpw4cIEq1GcYSS8CpHXOHr06OTJk/Emt9xyS/aW/5Lwml94+eWXscAP
PPCAd4Qnjlm+6qqrqlWrhqvt06fPZ5991qhRI5ys98q2ffv233///Zks57Jly4hw
3pjyhndk6NChFIaCBV+s3n777Xx0xRVX+IXXjz/+uGnTpqaTDBkyJJbwCjbn+F//
+lcu3IfIKRJeRZI5cuQIpsFJFWhnO3bsyMjI8DIlmt3rb7y+e/fuPXv3kEGVKlWK
49iaWKfFjy5YsOC999+L/9/69esTLKet03rdddcFP1q7dm29evX4f2ZUTbPbiS+8
7tu3b9CgQW3bto21ON3jjz/OSQYMGJBg8cSZJ4fCa2Z0rfTg6GkhRAqR8Jov+OCD
D3hGOOVgnrxixQoTKDt06LBz507vOA/UJNGXXnop1mltMdYsib8ZxTfffGOreBuF
Cxcmzfvhhx/sU8KYyy+/nOMWMzjYGvEPP/yw/bN79+4k82RfRD779+9fvnw5aaGd
9sILL+Sg8/N+/fpptYG8jIRXIfImW7duxThn77cSXvMLNlHG/9ryxIkTP//8M+GB
jZqqWrVq69atJ0yYsGvXLlL16dOnnXPOORy/8cYbY417PXbs2JIlS7IUHEI9fihH
jx5t27Yt5fEffH/W++b6nSFZhBYVK1bkeP369T1Nlj+IJbgL+6etRRBLeH311Vf5
lGAjjyx6K/xIeBVJZtu2beRIJUqU8I9b8ejSpYslGHg1/3Hbm4LjmMXQ02IxzRLF
5x//+O8Ey/n888/z/eCscEx2p06dbDB/ZnS2gk0JDBVeN23adM8999x+++22rVaP
Hj1WrVoVernZs2fzBTqbhLk8S86FVyFEXkPCa77giSee4Bm1adMm+BFuunDhwkWL
Fl23bp3zUa9evfjVvffeG+u0P/7446MJ4KmoQQ4fPjxkyJBWrVo999xzBBilS5f2
dNJPPvkk0ye8hu5ibMKrt+/W0qVLt2zZ4nzHlqkJjWxHjRrF8byzT6lwkPAqRPoh
4TVfsG/fvnLlyhEehKbe+GuMc+XKlR2FdPLkyRznh7E2rvztt9+8tYDiENzQJRZ4
dr7vzK/1JtSec8453gpLCxcuJNiwN81/+9vfjh49aseffvppjnsCAolqHOH1s88+
i0QHzMZSVEQKkfAqksySJUt4QBdccMFPP/0U/LRz5858OmLECOc4mVXx4sXLlCnz
1VdfhZ4W57d+/fqVWUGWlUght27dWqpUqdBk5v1Z79evX987z6ZNm7DOsYTXOXPm
9O/ff+Z7MxcsWPDYY49VqFCB095666179+51vrls2TJOcv7554dWi8gLSHgVIv2Q
8JovsEXN7rnnnuBHX375ZaFChUiDccfOR8QS/Kp37965VCrSnp49e5IXee9o161b
d8stt1jedfHFF+/atYskzYTX0NVmba2AWAmSsWXLlkqVKvG1Rx55xPlo0qRJHG/R
okWy7kgkFwmvQqQfEl7zBRkZGRYbfPvtt8FP77rrrkjYVFqbK1O4cGHbbybI8ePH
OWGWgkOc97V+9u7dW6VKlVatWgXbEuFEgwYNLJyoUKFCrVq16tev/9JLL9n72sGD
B9vXtm7dWqdOnY8//tj+eeLEibZt28aJK7755psiRYr86U9/2rBhQyIlFGcSCa8i
ySxYsIAHhNUI3Q7C1jsfPXq0c3zt2rWlS5cuWbJkrBGjyYVUqkSJEkFLbS+gxo4d
6x0hI7LJjKE5lbOl8meffYYp9w9v8dixYwfHSa4woEm6CZFkJLwKkX5IeM0X2Hpn
/pXaPEx4LVu2rDNRJvPUFhN9+vSJddpdu3a9mgCxXojaGkGvvfaa/yBpDwmPJUuz
Zs06evRovXr1+Hv69GnBM7Ro0SLyx4mQQQ4dOmSJ1siRI52Ppk59h+M04Dg/FylE
wqsQ6YeE13zBqlWrML9169YN3UjKFuoJToTdvHlz1apVCSrOzLbeAwcOLFy48LJl
y0I/3bt37yuvvNKtW7drr7122LBh33zzzZEjR2wxhJkz37Xv3H333c7o2nbt2vGF
MWPGhJ6TiKJ06dLFixf/+uuvk3svIudIeBVJZu7cuTZh0L8mtIcJr8HsYvXq1aWi
8EfoaQ8cONC/f//rs8K/cHUsPv74Y8qAIQt+RPTctGnT/fv3Hz+Ft4rc0qVL7Uj8
k2M6I9GVWZwR/qR/9l4uOM1Q5BEkvAqRfkh4zReYhDpkyJDgRzkRXm0KTpbYxscO
hw8fvvTSS7lucL9EIoFGjRrxw2effZbM/KqrruLvYPhB/nPZZZdReOKHOPd+4sQJ
ixyCu2G8/fZbHG/evHmcn4sUIuFViPRDwmu+YPny5ZjfevXqhS7ma8Ir/3eOb9q0
iSeLX/70009DT3v06NFhw4ZlKTgkYvZXrlxZuHDhLl26JH5TM2e+S7Fr1qy5a9cu
/rlmzZratWsTBREnmApx7NgxG/H69NNP2xE+cspfpkyZIkWKJL4KrThjSHgVSeaT
Tz6xPOHAgQPBT7MtvO7Zu4dzls+KRx99NH7x9u/f36BBg6JFiwaT8D179thbJopR
/BTFihWzxIyf8E+M9ddff71z505nrKtH3759+XKdOnWc1Qa2bdvG8YoVK2rEa55F
wqsQ6YeE13yBLWYamp/kRHg9fPjwdwlw6NCh4G/37dtXo0aNSpUqhSZ1N954ozcm
pWfPnvw9fPhw5zskTlWi2FZasZZC4msXXnjhWWedFfyCLX/funXrWDcoUouEVyHS
Dwmv+YIVK1ZgfmvXru3fddMj28IrYUOHDh2yFBwGDRoUv3i2p1YkbDuZWBw7dqx5
8+b8ZOLEiZlRka5r1678s2TJksV9UPhIdJ9P++eUN6f4T3LgwIFSpUoVK1YsIyMj
weuKM4aEV5FkFi1axAM677zzQufuZVt4TRbPPfdcrOGuO3bsGDJkSN++fXv6uOGG
G7xVrvknP9yyZcutt97KbYae35IxDL3zAsrWuj733HNjLeYtUo6EVyHSDwmv+YJx
48bFUhhJWrItvOYEsq+LLrqI9Ds0qWvcuDERixVp/PjxFKNdu3bOd7744gviB/Mp
xDZdunQJ3ezC9t70tvT0Y3o0IUcS7kfkAhJehUg/JLzmC9auXVu4cGFig9DFTLMt
vCaLKW9OoQDdu3dP/CemURAq2D5av//++9ixY++44w5iAL80YaPE6tWrZ/90ptSs
W7eOwKN06dLr169P8i2JHCPhVSSZzZs3R6Kb9G3bti34qW2ulSrhFdOMgcZMJz78
fu/evWbg/GZ9wIABvXr1Cn4ZV12iRIkyZcosX77c+Wj+/PmcpEmTJvv37892+UWu
IuFViPRDwmu+wObK1K1bNzj41F5bkgZ///33zkcmvJKW5FKp+vTpw/nfe/895/iq
VauKFSvmRTI7duyoUKFC8eLFnfRv6NChZHdkQZnRDKpr166DBw92FiyiWdaoUaNl
y5ahk4Ruv/12CkAylsy7EslDwqsQ6YeE13zBnj17zopiTtbBNtdKlfC6ffv26tWr
U4DEV5Kd+d7MwoULt2vXjvuK/80OHTpw5pdffjn009WrV3N3NWvWDK6SJFKOhFeR
ZMhya9WqxTMKSqg4MFsQOrh1rwmvZ599du4tBc3Vb7rpJhs84gxHjcPWrVvLlSvn
zBQgDSPFGj16tH89b7551VVXFSlSZNq0qcHzYB8l6uVxJLwKkX5IeM0X/Pzzz5Uq
VcLbbt682fnIho2UKFEiOHzjgQce4CNn34kkQoZ20UUXVa5cecmSJd5BgoFmzZoR
SNiYFGPGuzNImdq2beulOnPnzj3nnHOeeuop7ztEDpT22muvnThxIikfHmfkyJHk
Zq1atQpdg+jQoUMtW7Y8rYmK4gwj4VWI9EPCa77g+PHjjRs3xgLPmzcv+KktAXTv
vfc6x014xV9/9tlnuVSwEydO9O/f3ybL+uOEWPzyyy+DBw8uVKjQddddF7q0kYNp
Kc8//3zop0QjfNq+fftYiyKKFCLhVSQZzA1mLvQZYezOO+88PurcubPjzFatWlW8
ePFIdI/gXCrYpEmTOD92jWwn8V/NmTPH1ngdN26cd3Djxo2lSpXi4KWXXtqvX79B
gwb17t27atWqNWvWnD17duh5bNyKLdoi8iYSXoVIPyS85hd69OjBY/rggw+8I6tX
rybkq127tnnhpk2bjhw50r9B5W233cbxIkWK9O3bN/SVZ84hbrnllluuvPJKrkVh
hg0bduedd7766qvBlGb6jOkNGjRo1qzZfffdN3To0K5duzoDUg4cOMAZbPEiIObh
jsaMGUMTDb00kUbJkiUJM5Q+5VkkvAqRfkh4zS88+uijWOCxY8c6x3fu3Fm3bl0+
atGihTONBsdqM1lzLyUnjLFlWOPv+H3ixImvvvrq6aefxsufd95548eP//3337M8
+fbt26tUqcLJCZkOHjwY/MLw4cP59LHHHsv+DYhcQ8KrSD4mYPln/5FXDBo0CPNX
sWLFsmXLVq5c+dprryV18b6wePHiqlWrnn322fXq1SPJ+eGHH5JbpH379l133XWl
S5du27ZtIm+fsGs3RMFwlylThjLXrFnz+uuv79mz59atW7GMn3zySZ8+ffiIOz3r
rLNI7J9//vlYo/qPHj16wQUXcBLtrJWXkfAqRPoh4TW/sHDhQh7TPffc4x3BY06f
Pu3DDz9cGIVkZtasWf7xIF9//TXHcccz3p2Rq8NC169f//6s9ykM14ozDXDv3r2U
x8ocusw9ZGRkfBqFc8aSXA1ytjijWkReQMKrEOmHhNf8wsqVK7HAHTt29I6QoWOW
W7duXblyZfLuChUqtGvXbsyYMd5U17Vr19aqVYv8vXbt2p07d076QqiHDh3q2bNn
qVKlGjVq5Oyz7TB//vwWLVq0adMGLx9r700//fv3v+GGG5o3b142Cu2zbdu2HHHW
TGjSpEnhwoVDl18QKUfCq0g+Bw4cuPzyyzFqXn5CO9u1a9eOHTv2799/8ODBffv2
YWL8u0xgKA9G4WukK4m88zktKACl4vxHjx5N5Pv42u1RKI8VjGSPMjtl++233/iI
/zurtjksWLCARnvbbbfl9DZEbiLhVYj0Q8JrfgHfam9nE8lA0h6yxIYNG1aqVCl0
uXyRR5DwKkT6IeE1v3DkyJE2bdoULlzYmwqD6yRhJ1vft28fGfr+/fuJKPbs/f+v
S3mmltf/8ssvfJSgLJA4FMAEh8OHD8f/5m+//UZRE1c8fv755+3bt+/YscPOv3fv
Xm6TI5zH+86aNWuKFSv2t7/9Lfs3IHITCa8iV5g4cWLo4P+CSY8ePYoUKZKRkZHq
goh4SHgVIv2Q8JqPWLp0Kb7y/vvvT3VBUs/06dNotOPHj091QUQ8JLwKkX5IeM1H
zJo1CyM8fPjwVBckTzBo0CBqY9GiRakuiAhHwqvIFY4dO9aiRYsqVapoTz3MHy12
9OjRqS6IyAIJr0KkHxJe8xfDhg0rUqTI8uXLU12QVLJr165q1aq1b98+6bN/RHKR
8CpE+iHhNR9x4sSJrl27lixZkqeW6rKkmIyMDMKnu+66K9UFETGR8Cpyiw0bNpQv
X75Xr16pLkgqIeevW7du8+bNDxw4kOqyiCyQ8CpE+iHhNX9x9OjRDh06XHrppTt3
7kx1WVLDoUOHunfvXrNmze3bt6e6LCILJLwKkX5IeM1fbN269fzzz2/fvn1B3ojy
999/v+aaa4idfv7551SXRcREwqvIRRYuXFi5cuXc2zcwj0PvuvPOOy+66KKk7xUm
cgMJr0KkHxJe8x0HDhzo2LHjhAkTUl2Q1LB48WJa7Pfff5/qgoiskfAqRPoh4TXf
sWbNmurVqz/55JPeJloFCu56xIgRtNivvvoq1WUR8ZDwKnKXOXPmFNiFV3bv3n33
3XevXbs21QURCSHhVYj0Q8JrfuTQoUM40FSXIjXs378//lbIIu8g4VWI9EPCa35k
6dKlAwcOTPpmWfmCgwcP/s///M/ixYtTXRCRBRJehRDiJBJehUg/JLwKIXIJCa9C
pB8SXoUQuYGEVyGEOImEVyHSDwmvQohcQsKrEOmHhFchRG4g4VUIIU4i4VWI9EPC
qxAil5DwKkT6IeFVCJEbSHgVQoiTSHgVIv2Q8CqEyCUkvAqRfkh4FULkBhJehRDi
JBJehUg/JLwKIXIJCa9CpB8SXoUQuYGEVyGEOImEVyHSDwmvQohcQsKrEOmHhFch
RG4g4VUIIU4i4VWI9EPCqxAil5DwKkT6IeFVCJEbSHgVQoiTSHgVIv2Q8CqEyCUk
vAqRfkh4FULkBhJehRDiJBJehUg/JLwKIXIJCa9CpB8SXoUQuYGEVyGEOImEVyHS
DwmvQohcQsKrEOmHhFchRG4g4VUIIU4i4VWI9EPCqxAil5DwKkT6IeFVCJEbSHgV
QoiTSHgVIv2Q8CqEyCUkvAqRfkh4FULkBhJehRDiJBJehUg/JLwKIXIJCa9CpB8S
XoUQuUF+FV7nzJmT6oIIIdIKjKCEVyHSDE943b17d6rLIoRIK5566ikJr0KkGf/+
97//9Kc/VatWLdUFEUKkGzfeeGN+El4HDBhAca+//voRQgiRPLp164Zt6d27d6qN
nBAiafz666/Nmzena/fr1y/VNiZPM3LkyNFRUl0QkdcZPny4WovRpEkTbMsLL7yQ
ajsnhEga3377bbly5YoVKzZs2LBU2xghRPpA+HTuuefmJ+F18ODBESGEyB1uv/32
VBs5IUTS+PXXX9u0aZNquyKESFskvAqRTnz33XfVqlVLtV0RQqQnJUqUWLp0aWa+
EF5Xrlz54osvThBCiGQzfvz4JUuWpNrICSGSxn/+85+PPvqIrp1q65KneeWVV3r0
6EE4WLly5XHjxr388supLpHIu/zrX/+67777aC1FihQZM2ZMAW8tpCQZGRmptnNC
iKRx4MCB6dOnvfDCC6m2LkKIdIOYgSBq69atmflCeBVCCCGEEEnk7bffikQi9erV
S3VBRD7giy++oLWcffbZx48fT3VZhBBCCCHyGRJehRBCCCEKFpMmTYpEInXr1j1y
5EiqyyLyOgsXLqS1lC5d+sCBA6kuixBCCCFEPkPCqxBCCCFEwULCq0gcCa9CCCGE
ENlGwqsQQgghRMFCwqtIHAmvQgghhBDZRsKrEEIIIUTBQsKrSBwJr0IIIYQQ2UbC
qxBCCCFEwULCq0gcCa9CCCGEENlGwqsQQgghRMFCwqtIHAmvQgghhBDZRsKrEEII
IUTBQsKrSBwJr0IIIYQQ2UbCqxBCCCFEwULCq0gcCa9CCCGEENlGwqsQQgghRMFC
wqtIHAmvQgghhBDZRsKrEEIIIUTBQsKrSBwJr0IIIYQQ2UbCqxBCCCFEwULCq0gc
Ca9CCCGEENlGwqsQQgghRMFCwqtIHAmvQgghhBDZRsKrEEIIIUTBQsKrSBwJr0II
IYQQ2UbCqxBCCCFEwULCq0gcCa9CCCGEENlGwqsQQgghRMFCwqtIHAmvQgghhBDZ
RsKrEEIIIUTBQsKrSBwJr0IIIYQQ2UbCqxBCCCFEwULCq0gcCa9CCCGEENlGwqsQ
QgghRMFCwqtIHAmvQgghhBDZRsKrEEIIIUS6cezYsSVLlhw/fjz00yyF1++++27L
li25WUCRt1ixYkWsxpCl8Lpx48b169fnZumEEEIIIfIrEl6FEEIIIdKK48ePP/ro
oyVLlhw2bFjoF+ILr2vWrDn//POvvPLKn376KXcLKvIGU96cUrp06d69ex87diz4
aXzhddOmTXXq1PnLX/7y1Vdf5X5JhRBCCCHyGRJehRBCCCHSiqNHj/7jH/8diTJy
5MjgF+IIrxkZGTVr1uTTP/3pTxrGWEAYM2aMtZa///3vNB7n0zjC6+bNm+vXr8+n
xYsXnzdv3pkqrxBCCCFEvkHCqxBCCCFEurF///7evXubmjZ69Gjn01jC69q1a887
7zw++stf/vL555+fwfKKFPP4449ba7n99tudca+xhNfvvvuOJsRH5cqV++CDD85s
eYUQQggh8gcSXoUQQggh0pAjR4542uuoUaP8H4UKr2vXrr3ooos4XqlSpSVLlpzx
8ooU89hjj1lrueOOO/7zn/94x0OF1++//75BgwYcL1u27KxZs1JRXiGEEEKIfICE
VyGEEEKI9OTXX3/t1atXUHsNCq/r1q3zVNfPPvssReUVKeaJJ56w1tK3b19vzYGg
8Lp58+Z69erZehQa6yqEEEIIEQcJr0IIIYQQacuvv/4aXHNg4sSJJryauLZmzZoa
NWpohQGR6Rv3evvtt584cYIjn376qV949VYY+POf/yzVVQghhBAiPhJehRBCCCHS
mcOHD//973/3a69vvfWmCa/8/c0339huWuecc45WGBCZvvVe+/bte/z48eXLl5vw
euLEiR9//FErDAghhBBCJI6EVyGEEEKINMe/5sBTTz319ttv8Ufjxo1XrVpVq1Yt
/q5SpYrGugoPT3sdPHjwokWL+KNChQoZGRkNGzbUWFchhBBCiMSR8CqEEEIIkf4c
OnTIW3Ogfv36Jp9VrVrVVFet6yocvDUH6tSpw/+LFi1qGj3NRmNdhRBCCCESRMKr
EEIIIUSBwK+9elSsWFErDIhQvL22PMqUKSPVVQghhBAicSS8CiGEEEIUFA4ePHjb
bbd5OlqVKlWWLVuW6kKJvIs37hXKlSsn1VUIIYQQ4rSQ8CqEEEIIUYA4fPiwjXst
Xbq0xrqKLPG015nvzUx1WYQQQggh8hkSXoUQQgghCha//fZbt27datWqdezYsVSX
ReQDHnzwweLFix88eDDVBRFCCCGEyGdIeBVCCCGEKHDs27dv3Lhxv/76a6oLIvIH
EydOPHDgQKpLIYQQQgiRz5DwKoQQQghRQDlx4kSqiyCEEEIIIUTaIuFVCCGEEEII
IYQQQgghkoyEVyGEEEIIIYQQQgghhEgyEl6FEEIIIYQQQgghhBAiyUh4FUIIIYQQ
QgghhBBCiCQj4VUIIYQQQgghhBBCCCGSTD4QXrXfrhAiLcG4bd++fePGjZuEEELk
DtjYPXv3ZM9KHzt2bOvWrbLSQgiRe3z//fe//vprUkPs0+D48eNSG4QQuU0+EF4n
T5584403Xn/99e3bt79WCCGSAfbkuuuuw7a8+uqrqTJupPS33XZb9erVzzvvvOpC
CCGSjVnXRx55JHtWevfu3a1bt64uKy2EEMmmWrVq1aPW9YILLpg5893kxtiJs23b
tr59+3bs2DHVqYkQIt3o0KHDrbfeunnz5sx8IbzeddddESGEyB1uvvnmVBm3Y8eO
tWzZMtUVIIQQac7f//737FnpnTt3/uUvf0l18YUQIs158cUXkxtjJ86GDRtKly6d
6goQQqQtixcvzswXwuv//M//UNwHHnhg6dKlnwohRDJYsmTJk08+iW3p06dPqozb
sWPH/va3v1GGiy+++MEHH3z44YcfEkIIkQywqISO5cuXx8beeeed2bPSP//8c40a
NThDy5YtZaKFECKJPPLII//4x38XKlQIG/vKK68kN8ZOnH//+994ilKlSn3yySeL
Fi1KdYIihEgHMCaYlHr16mHfPv/888x8JLzOfG9mqgsihEgrsImRHIyEyjme8Nql
S5dUlUEIIdKVEydONGzYMIfC6/nnn88ZnnnmmeSWTQghxJYtW4oXL55y4fXPf/5z
1apVU1UAIUS6ct111+U/4fXtd95OdUGEEGnF//7v/+YR4fWGG244fvx4qoohhBBp
yb59+2ysQc6F10cffTS5ZRNCCPH1118XK1YsLwivf/nLX/7zn/+kqgxCiPSD7P6/
/uu/JLwKIQo6El6FECKNkfAqhBB5GQmvQoh0RcKrEEKcRMKrEEKkMRJehRAiLyPh
VQiRrkh4FUKIk0h4FUKINEbCqxBC5GUkvAoh0hUJr0IIcRIJr0IIkcZIeBVCiLyM
hFchRLoi4VUIIU4i4VUIIdIYCa9CCJGXkfAqhEhXJLwKIcRJJLwKIUQaI+FVCCHy
MhJehRDpioRXIYQ4iYRXIYRIYyS8CiFEXkbCqxAiXZHwKoQQJ5HwKoQQaYyEVyGE
yMtIeBVCpCsSXoUQ4iQSXoUQIo2R8CqEEHkZCa9CiHRFwqsQQpxEwqsQQqQxEl6F
ECIvI+FVCJGuSHgVQoiTSHgVQog0RsKrEELkZSS8CiHSFQmvQghxEgmvQgiRxkh4
FUKIvIyEVyFEuiLhVQghTiLhVQgh0hgJr0IIkZeR8CqESFckvAohxEkkvAohRBoj
4VUIIfIyEl6FEOmKhFchhDiJhFchhEhjJLwKIUReRsKrECJdkfAqhBAnkfAqhBBp
jIRXIYTIy0h4FUKkKxJehRDiJBJehRAijZHwKoQQeRkJr0KIdEXCqxBCnETCqxBC
pDESXoUQIi8j4VUIka5IeBVCiJNIeBVCiDRGwqsQQuRlJLwKIdIVCa9CCHESCa9C
CJHGSHgVQoi8jIRXIUS6IuH1jEJ1//77785BjkhkOZPgR0+cOJHqUqSAo0eP5tKZ
cy804UkdO3Ysl07uIOE1j0BDdXootaHw90xyLEqqSyGyA53ldJ8dQUgB6V8SXoUQ
Ii8j4TWJhMZyBTYLTgnZCMnSg1xN3HKvSjlzribgEl7/j6+++mr27NkLFiz4Isqi
RYtm+5g7dy5HVqxYsXfv3tM9MynNvHnznn/++ZEjRzZq1Ig/OLh9+/Y3przx1FNP
Ef1feeWV33//fXJvRzisXr36pZdeeuihh9q3bz9w4MDckyDzGuvWrXv11Vcff/zx
rl273nDDDUk0ghs3bvzXv/719NNP9+zZs2nTpocOHUrWmSnk4sWLn3vuuUceeaRF
ixYUPllnjo+E1/js2bMHY0gt4S0wksuWLfvoo488I8nf8+fP5+CWLVuycfL169db
Q+3Wrdv111+P2aSTci0M5ogRIxo2bPjiiy8m/Y6Enx9//HHq1HeefPLJPn360A4x
HakukUgUzMWHH344fvz40aNHX3HFFRZmJMKevXv69u1bsmTJ2rVrZyO8yXdIeM02
+OUffvjh66+/9h/89ddfOfLTTz+lqlQFCrr5jh07NmzYQLWnuizitPntt9/oLDt3
7kz8JwRdy5cv51cFSiYrCMLr4cOHP4yydOlSkx3mzp3rhdMcnzdvHpH2t99+m41c
YPfu3cRyY8aMufvuuxs0aPDll19ycO3ataRsuC2yYLK2gpMFpwSiqVmzZj377LMD
Bgxo3rw5TzPVJTpDYKkWLlw4YcKEkSNHNm3aNLlhEt2ETPCf//wnGcrAgQOTeOYD
Bw68/c7bRM5DhgwhGOYWknhyBwmv/8eUN6f069fvkksuiUSpUqVKv1Pcfvvt7dq1
q1ix4llnnWX267TA19L+OnbsaGd++eWXM6OthzNfdtllHMGyK2xNnDVr1jz22GN4
psQDEb752muvUeHFixfPScaVH5k+Yzr3W7lyZW68TZs2STzzxx9/TJVedNFFnLlS
pUpJ9OKHDh164oknunbtWqhQIU4+evToZJ05PhJe47Nx40aeOEFb5BSdO3f27GSX
Ll3q1KnDQcxdNk4+490ZNFQML2e45pprMqMp/bBhwzp06GDXmjRpUrJvKG3Zs3cP
0cm4ceN++eWXxH+1cuVKwvTLL7+c2sbfbd++PfdKKJILySGdhf5oNvPJJ59M5Fek
Z4SwWDx6WcmSJQvCE09X4XX9+vVDhw4dPnw4pSJA4v8PPPDA0FPQNkaMGMFBkvxs
nBzjbI3kvPPOM+NMVomdv+mmm1q3bl2iRAny+WTfkPgDpAwY5xtvvPHSSy8lLdy8
eXOqSyQShRyQznjLLbe0bdu2WLFiib8VwyPzrDE1ZcqUSeLIhrxPQRBe8UT9+/fv
1q1bkSJFLMSleXjh9M0333zllVdysHv37tkoAIW/6667rrrqKjvzpk2bOPjGlDfu
uOMOQju7Vi7cU9pCbohXXb16deI/wUQPGTKkVatW9giWLVuWe8XLU5C6Pv7445g7
a9gPPfRQEk/+8ssv9+nTh5CDM996661JPPOPP/5IvyO8secl4fUP5OpSA9QCHo7z
Dx482H/82LFj02dMr1mz5saNG7N3ZkwnARNn9keos2fP5gix7I4dOxI/T3CxgtyD
G0/ha7HDhw878hO+qkWLFqaMZ0OtxpnxW+LX5JUxf/Dggw9y49ddd13Sz/zMM8+Y
UpZ0ofDIkSPWZaa8OSW5Z46FhNdEoJCmvVauXNn5CDvWoEEDmkS2T/7oo49yZnyS
dwQjgOHlIFFj4ueh8WS7DNmAy6VqQMrvUZyD48ePt+ghG33HegEGlkAkSWUUZwg6
S40aNXh806ZNzfLLBw8evPPOO19/43X756pVq/h5Lhcw9aSr8Lp169bXXnvt3nvv
9d6KPf3006+d4uGHH77++us5+Oyzz2bj5EuXLiVwNTtMEJUZfStGEP7AAw/YtebM
mZPk+0lf6GgdOnTo3r37aU10+/bbb+mqFh7UqlWLZpxrBRRJhvDg7bffGjVqlHUW
/k7kV8uWLRs2bBge/KmnnmrWrNmBAwdyu5x5h4IgvHrcc8891jCcF5/0cRKBnIwT
wmjYmf2mZuDAgaebDJ7h+Da1Cx8Fb/a7774zpQ+7fbr1sGnTprPOOqtQoUJffPFF
UouZD2jSpAmV9thjjyX9zCZnjxgxIulnzsjI4GEVL148Vyf8SXj9Axs3bqxatSrn
Hz58uPMRnuCSSy5JXCF1IKVp2LChI7zOmzcvceGVSJffEnglklPlHAzfzPdmEqyn
ZIYvHogwpXXr1s6L/WPHjpFFXH311TygbGSJ//jHf1Ph/D95Jc0fELrlkvA6ZswY
U8qS7pj37NlzxRVXJCgiJAUJrwnSt29fClmtWrXgR23atBk7dmy2z+w1J+8Idq9u
3boJCq80QuKbXr160cfPTKSIX7j77rtvu+02musZuJwfWgspHCHI5MmTg6Xq2LEj
/T0b0cP8+fNNVZfwmu/Yu3evTUHAd2f55f79+59zzjk2FqbgkK7Cqwe9nrJddtll
zvHffvvtyiuvzMnQVIIuznzTTTd5RzDO1atX5+AHH3yQ4Em2bduW7eEL2YCH9e9/
/ztV6+thfimAc9BeLsKsWbNO94Tvvf8eP6xZs+aevWfa3YgcgnGuVKkSj++TTz7J
8str165t2bLlZ599Zv+ko2mpgTPMGRNen3zySe60UKFCwYjrrijZPvP3338fFF5H
jBiReDJIJQwYMKBbt25nxuDgnUkfiGk//vjjM3A5h5UrV/bp04cKdxZyOXz4ML7v
6quvPq3BHwbOrly5cgVTeMWC5ZLwSpqZ9LG0xpo1awoXLnz22Wdv2LAh6Sf3kPD6
B9avX4+d5fwPPPCA8xF2JycCEFFvgwYNHOHVhJ4EhdeMjIySJUvy/enTp2W7GInD
/VIwGzdxBi7n8Pobr3PpsmXLEqYn8bR33HFHwRReH3/88Vwd8fq3v/0t6XHh7t27
69evz8mnTn0nuWeOhYTXROBB33bbbRSyatWqwUKSgeckr8baOMLrgQMHbEmWRIIe
ytOlSxe+3LVr12yX4bQwf9S4ceODBw+emSt6cMWiRYsmPTkh5JXwmk/Zs2fPhRde
eFJ4nflu/G/u2rWrVKlSFSpUKGjry6e38Pr777936tSJsl166aXBT0lX3p/1frZP
PmzYMEd4/eWXX6wqEhFe//Of/7zwwguXXHJJr169sl2G04KInWdN2JMS40wgUb58
+eBbsZ07dxI1jR8/PhtaxvQZ0yW85lPwp+ecc04iwiu9uGHDhuRfQdW+gFCghNdH
HnnEhNetW7c6Hy1evDgngt13330XFF5tmkKCyaC9bMOKnplFpZcsWWIFnj9//hm4
nIPlNe3bt0/iNF9a0Z/+9KeCKbxeffXVuSS8tm7dmjM/+OCDST/zqlWrChcuXLp0
6W+++SbpJ/eQ8PoH4givOSTnwuu6detwA2Ta9qhym71799qKt4R6Z+ByDm+//RaX
JqZP7lAFCa9JP3PuCa+0QAmveZD4wmsOybnw2rNnz9ApC7nE0KFDuVyXLl3O/IAU
QmFbGCe5y/ZLeM2/7Nu374ILLkhEeCWjI76sUqWKRryeLnlZeD1y5MiNN94YS3gl
D89J/mwZu1943bVrl72eT0R4PXz4sK0TRQyf7TKcFuYLOnbseOYnrhLSm4KQ3EUY
pk+fJuE1n7J9+/YEhdeMjAx7ygV28w8Jr0kh58LrQw89ZPHtmTGhn3/+edGiRcuV
K7d+/fozcDkH0wf69euXxHNKeM1fwquNeJXw6pJ3hFeCTmpt2bJljkkitCWZId7y
b2ySc+H1hx9+KF++/FlnnUVPDv0Cxfj0009ffPFFfNWCBQuChnL37t2TJ09+/Y3X
p059JzgxltLy6Xvvv2daJz83vYNTZVk2Dww9Z3jrrTdnzZoVZyjNoUOHuJ0lS5ZQ
h/xzy5Yt06ZNnTt3rlfm92e9H4kuZRX8LYnT6tWrg9VufPvtt9NnTKcAFIPCOJ/G
El5PnDhBYai3l19+mYcSPzlZvnw5D3HChAlcZcWKFdRqnC870N8WLlzIVbjWvHnz
aBXB73DaiRMn0sKD5afeiLwnTZq0f/9+5yOywdmzZ/NbajJYOUHh9cCBA+vWrZs/
f77TEn7//XdaI2X76quvQm+BH3788cdciBZO9P/SSy/FEl6PHj1KiGkNkrtOREOn
bXODnHzlypU0yMaNG0t4zWuclvB68OBBHBjNzNnlifa5c+dOjjvL1edQeM08tQxC
nM2FKA+Gjv5LTwnuJsQd0fjp4HRAfHDw5/Qy2rwnStrqyVRIImUzsGDcOI2cS8SP
xvgm3RCDY//ERtEX/PafxICrB5f8P3z48ObNm+l0ZmAd6LY09ZMFePstTu6s2RJH
eMUi8SuqjmLEH9fMJbDh9H1sHTWGWU581V0a2JdffsklKB4VFbR1QTCkmBq7I5xg
rAFunHnp0qV8h/+ogdDKyYwurvfqq69Sckzc3r1741yXmn/ttdeoEP5PmWNtZcYj
o2xmCRcvXkzFxjKGWGOrN1rgqlWr4t70/0HQYjaTwlDtthlLlsIrz51kgC4cS8HB
11ClL0ehSEFnZNB4fvrpJ1omDj0z6obwvx999NGZH2OYIAVZeM0hORReCS1sndnn
nnsu6WUL5a677krVi3ZMgW0tEiuOyh4SXvMv2I0EhVd6E1+75JJLNOJVwqsfUiqC
B+K6oFXBr5GNEvz4R2vmXHi1RerizFGgzIRqhECvv/E6YV7wC1SjJctEBcGwhxsh
2yV+8P7Jc69UqVKs2CwI9+sFdYsWLYoTZ5JKUEKuZd8hXqLk/uC5f//+kcAGP5nR
vAx7TshEsww9M2E8N8h/RJVO2BxHeCVwmvHuDII9Upu1a9fGuUeiLMJyvknqQWhH
LZ3WC1ScBUE4P580aZKXTfghWeDTKW9O4WvBCtywYQM/9J6RH6tDbhyTtWXLFufT
oPC6e/duUnsasDOmmBskoaD2YklhZGpEoVzI9ryyXUZChVfuhZZAk+N2Epx8aY/P
kpp169bhuCW8uqREeKU10CJNJiN5IxXp0KED4XuJEiUIQ729TWh53bt3p7XZBhcY
Qe8MORFeuSK9d8iQIYULF6YDX3PNNd2ijBkzxnMJ9MauXbuSS/z973+nAMWLF+dr
TlfBi5MqcJJIdD84x5106tSJX9GxuZ1t27YRHNt60o0bN7bLYY9ChUKDjnH33Xdb
FG5QCePGjXO+tmnTpjvuuKNly5bEjmXKlMFQYjStzvknlhEbxxGbLkd5up0Cq00a
TLVfeeWVuENK5Zge+glxdrVq1bwCkFU6+4eGCq9YNKqOeuPnrVq14qKcPHSmA4+p
T58+OCHquWfPnnXq1Dn77LPJJRIMgrmFzp07c4Z+/fq1aNHirLPOatq0aXDvPB6B
tR8ajON+eCgcxz345YD9+/c//fTTtg6mUbRoUS7h/45feP3ss89opVy6cuXKVJHf
Ng0bNqxt27a2Nz11FbwF7K+Jocbll19u62e3a9fOEV6xYl26dLEG2axZM2q1devW
oUbfwFzee++93uOj7dGAK1SoIOE1rxFLeOVvupIn0Hz55Ze33HILj57eTSDlX2z0
oYceosHQeLBmPXr08J88J8IrDR6/YCP+Lr74YrMbt99+uxd0YnxokJg+egddvnz5
8lghbJQ/HOQuZs2aZb2JYjve15bYo/v88MMPhw4dokfbyt1VqlTxLFUcvYyqI5Fo
1KiRGWEzcdRScGDLtGlTMSx0rooVK2ItiUtsaG3k1GBefM0zzzxj58Hg26VHjx5N
kNS7d29+cuGFFxLCOoNhMeDcr5XZsxVUhT/BCxVeMe/33Xcf38T43HzzzdQMT5+I
KlRAnD5jOgacSsbW8SirV69OG3j11VfjPz4Dn0VQVbZsWa+EWKrQmM+gAJMnT6aZ
0Za8n3CG4Gs/HhbHqXDva/Xr16eV+r+DbcSh07zxZZS8ZMmSfCd0vVRs/j333ENV
4E1owwQDPKkrrrjCeQ9H8UirsIR8GcfBA6ViyaiDcTbumMZPDeOG+OZf//pXnAu2
KE4yZs6Utme3U6pUKayHDYKOI7zSCGk8dAR7+tymNR7/qmqY3ObNm+MvKABdlTNz
lYEDB+7cudP7DqkIjQGPSfekpVneZbNk+GdoDpYXkPCaeeq9F42fp0Zs4O/pBw8e
JAxesGDByJEjnXUJcii80vBMeCVw9R/0/saA0/CwGwRXdKtgaERoOnbsWLobHSSY
AhAI8Uwx+PYOIPOU8OpfJDHLeQmLFy8m0sbCY0WJ80NX7iZpJGoiW8Omvfbaa1YP
dHM6Cz+372AfTHj193SsAdXOEfwIxjOYqQJZg+11jp964YUXnE0OYgmvBMN8NGDA
APNu8YfZYk5xInyTer7//vtJ/hOXOfDvTz75JG0At0X7T2RgGlEfpoM74nI0tlgD
R7AY+C++hlEdMWKEY5kNjOH48eP79u1LG6A1xlEr6KSkWlQFt8lzoSYpRvDpU2+4
WiJPq42nnnqKyD/W7hHUGxEy3+TqEydOzFL7wNQQzHNaqot2QmnPPffcRITXDz/8
0GIYLzF0Sr5y5UoqnyZKSciIiVicbI4wht7EFQkAeF4ZGRkc5Lp4ZKKv+G8T8wIS
XjOjWxryoO1v2hIGmRyqdu3aeG0aqve1uXPnEm6Rl+H6icr8sVxOhFdiRUIm0m2L
b4lMrG96HRMTRFBK28bA0g7J3fgaHcTZBY7Iny5jxZgwYYL/I4p60UUX1apVi9iD
FksrpcPyNSwnUYeFJfEXJcdDWSpt56cOqaKgKr1o0SKqiCiRQpIgEG9zWgsFO3bs
mBm1A5yKoCsSnWhrl+am1qxZQ9JNYYgZiAaJ4pwzU3LOQKjmRZWcxO+5QoVXqoj+
yw8x9fgyisR3OHlox8TsWCpN5+UnVBeZy6hRoxLJEGm6L774IukkAS1mk1DNRBXP
RXqFNG0kEth+k4ZHLIHhopn5j3M7uIBy5cp5N07G4QQMJrw+8cQT/I2/phgNGjQg
tidM9WwsbR6XTbJvMVUwcLWWb4GlQchqkpEjvBKRDho0iFLRIPk/ZaY78J04hpqA
n1KVLl3azkwDpmw8LB6HhNc/cGaEV0yh/zjeC9vhDb3hkdAZTEj1q3h0J3q4qWM8
PP+AqZwIr4TF9Dfz2YCVKR2FTsvzIxjF2JEaEc5aCQm+6WzWjIKbq7wx5Y2gESQs
ICG0/JaT0Ettjw6TBuxy9I1YHmjbtm3cXaNGjbDUWE+icBsKDm+99ab/m5x82bJl
toUO5pUeRS56zjnnUF14FAJTbBYuhHZvPy99CopNF6WE1l75zqFDh+ycBCXPP/88
D46EmQLgs/k/xoWvYar8V3eEV35IrovRJOCzCJvKtOVl8biOSsjD5dKYP8+x8RPi
SOxFcFdxBx4T3yxRogTW1mwrsTuhGxfChgaVGlqOvRsnZPRCLnwwXybu9H+TBAlD
37Rp0ylvTrHBcTSGwoULE7T5Q3O/8EroT3pAjG4+xq8UrFixgjZp+8s9/PDD/gtR
q3g4In5ugQIT0pE5VKxY0R6TX3jl1jB/NEgaoY17wshiza2pB8NuHjphMW2V6sXs
ciHKgDv3XKmE1zyFJ7zyNP3H6QWEZd4AeXI5eit5XSSqYPq1xdWrV5MD2GKUziuu
nAivJBiECJbu2ktLoHdY7krBMBF0AS/mwFLZG47gCCxMLvFNJDqU2x8i0P69AmPZ
MHoW89FKPUtFJ4pVQn5LF37mmWfo4HRVMnyTC4OTYTdt2kTttW3blk+Jffkh9t+i
nJdffpmqxh+ZxOw30cRnmBd8OVbCPvKHgIRK9evXb9iwIckM/Rd7Qh+n/BUqVPAv
pR0UXrkj7Alhq6em8Ye9ngkubz979myCJFyAWUWa9JYtW7ioY09CIYHEGuN98BHY
gXHjxpnX405Dl7rHmLRq1YrL8QRpVBhA7Ay3Q4X4xyZgqIluiblxN5wZnzhp0iQr
v39/Gw5Sh4S/JkNQcu6lSBRnqwc8LE29e/fu3ohp/BrPhXL6x1DTU0aMGEH06RUe
n0X8SqvzBBqDkJEuT/vEBFm9EW7ivCghbSA4epSy0YqoHH41872Z3OycOXNIjTyb
GUd45Wy0E9vmJRJ9xWWNx/Rlyow35JZ5sl490FToWXyZ2va0V/oFlUmlWY8jMKNz
4RH4Jw9RI15TQizhleP0Ji8apD3jsrHANBVakd84Uy30dAvA7r33Xv9Jsi280qjI
cHr37m1NpWjRomWiXH755Z6wiDklFCRyePXVVwlX6J70YlIyfxqPT6Sp2w1iuJxO
NHjwYCIfuiFtjzsdOHCgvYTgoF2OmwqV8wwbNkHci+nzXs/UrVs3OO9h7NixBMMW
JrVv355b8F57E4jSf4lYzHQD6bpdHYtB4EQfwZ3ZEAonwuSfdEwsLZ3IkxJ4Fv5x
9KHCK+nuVVdd1a9fP8J4zALGlnom86SpOyWnGdx33324GxoDXmD48OGEjlzrpZde
ivP4DEwcNpxLV69e3RMaMLb45VhyNokShhf7jLWxDSoi0W3fnIFIND+eO1/DAHo5
MI7S/3yJKgk4ubVRo0ZNnjx56NChPCZK/s9//jMYKWGXSEBoD1gnnkjPnj2pUqyu
k4Hz4GhLNHhCcYJVKpAewZMKqsk0p+uvv56cAsfKNzt37lysWLErrrgilq/HNpJH
YGdwOmXLlrX3o9QVD52/4wivPCA6ggU8lv5Y43nv/ffsCzx3/AJ1xXOkqRNfUWbO
yf36ZWiCHEqLu7fRM/zcy/t4dtneI/qMUTCFV8dpEorQMu1v2j+Nbca7M8ym+dNq
gjd6Ch0tElX9vLw4M2fC69vvvB2Mb+lHtuEbXZtPMeCeeSTywSryZeK3YJe0d2C0
Pfqmd5CWTB+xiILaxmYGw5I4GyjRNjDpRNHEfjT+J554wl7Y4zuc999YGKrIJsOZ
GEeoZim2DTCiK3Ev1uRspjkQb3Ob9H1yBxsShE/xzklP5E4xhvRE3ApfIwe3MQ30
fe9rQeGVPILeSrddunSpWU4sfIcOHfhhjx49nMbGfeFcMDue7eJeOnXqhHnP8iUi
FpsTYnbo/jbCFI9gD6Jly5bB4WK2hjtP3D/sjHvE5vvbj201hvnlo08//ZSuOn3G
dMIJfut/H5B5SnjFm2dGNxkjoyGAjESH/XmFp82TsGCo7bk7Yyxo8FydwIAvkK/x
qZXf8AuvfIrZbNSokRf5YwPxbnwN5xL6yq1///5VqlShVWCQ7fHhbT2/JuH1D5wZ
4ZU45p+n4OnyPPDQzuhozGIkbEEQ0r9IVLnzhxc5EV55SLR1Tss5iQidcM2WQw1u
JmObzNC2gicknOUjbKi5aloq7c8bkUQbxf1jC+wlQyL7I2N8iRf9Ii/N2mwQBiWo
S5K32yRZjJ3ltGPGjKF3YSmwO1ydPmD5dvBaEyZMiETFCM/BmKjnJAlAnThLPTrC
KzmwZbbOD01XIgr3j+eic3LQXh17mMadVfWcNB/8tk2bNs5xc5bY0OBPTDqPnNpL
jfSDW3YaG54YT1O7dm3HhmKmMXn+ag8uNWD3TtsLDnawQay4Iu8IESrPAl/ovYD1
jgdHvNLCI2GTr220C5Gic9xeVPCwnHaC9ypVqlREI17zGJ7wytN59NFHzUjyh725
dazTokWL+CYhTnBSv/lgZ0x6ToRX7DP90db1Iz3zf0QjP/fccwkpnEFG+BELxYKb
+NEYTCawmTI8GvJV2rk3E4fmyhVNWSbJiV+2zKgZpwuMHDnSf9A6Jkmp07MMi8gp
BskhoeTPP/9MZ7cXyHgEoigLNIOrwRDLmoH1hFdcG0aeO3VG11q04Y9THeEVm2wa
pTOGkeAsEtV8nZfnVBFRnVMeipHIElfcGvbEHyQRaVnG7rQTu0c8FHmIM/+LCJsG
45UKN0FzIph23sYT/l566aVe1ZFOEHaTtzj9zrYAxpz6fQFxNg/FS4YNPBe22m+K
eV4EcKNHj3ZKTkmcAbk2/tR5qcaTMlULF++cwfZBpqk7ASVG2zSj+CNeaTw8PpIB
moRTEjI6sz/Or2g/Jsbhg/y5AS2HyNictYUKnIHTJrJAREooIMIr2Zr/OLHotdde
673i5QkSkdKnIlEVzz/Qhv5COGqvnZwZS9kWXulTeHmMpL2ppd91jkJGhHmnQZqh
I23z2vOePXssayKEcxo5PyE+j0S3fPG624cffoiXwWjbPzHshFVWNnJjuxwF8A/Z
9mOeF7tBFVFaLkEztgk311xzjTPTi0rmCCe0MnBa6tyUVro2meSAAQPoQRa/4ebs
6vRursIP58yZY1bdexzc4DPPPEN8RWi6YcMG/snXOBXJOUXyd6Wg8Mpp6ciDBw/2
DBeF51lHwiYtPfTQQ4Tc/jFxFAmvZON244NxxkJSKvOAmHRLUzELocsp4FnOPvts
4jqyA8pGkyOEJgnCEfuDASIETAdmnxzezox17dSpE9fyNBqqFFvn2HDSDZNOnGSQ
k+MXzEt64NRat27ttHOO+Ec2ZEYTE0y9czv4oEqVKrVo0cIfKluLpTKDY6IpAJE2
1TJ27FjzocTJWGxTq4sWLRpHeMWc8tSs5dMeeI7WeCy34lrNmzcnjDHxy/uJhda0
Fk8ypsJpQjwjcwckg/hlei6WmQw31tXzDgVQeI1EJ7l74TSZe7Vq1Zy2TcBpbcMv
7RkvvPCC5cX+gzkRXi2+taW0yIX9cRH9lHYYCWyBRc+lefPgglMbf/nlF9uxA9Nt
GiI2B3fgxb2mcixdupQzYHgT2VP+vvvuo2D+I4Q99pIjNP6ZNm1qJCoid+jQAYfI
XVAJln0fjWLCSOjSNPYW3BNe+a3NyiW193+N/n7FFVf4zZQjvNKWKHMksPY3iYk1
eGeeB1ck2HCm/2dkZDjjT0Ox2NUZVkIlm1ucNGmS8318irWuk2Yt6l+4OyyG39rw
mGzMlrOYG8+UJ+uMaA4uNWBNnTp3wmxvSXS/aDZr1iy8JIVxBgITtNsYFE94xZib
3ORsgEQuQM1jSJ23p1SCDe3C7fqP0+ZpVObUJLz+gTMjvBItjTvFs88+26ZNG7Ju
p/XbqPig8IrRMeHVvyxaztd4xRKZ8Op/aU+DM6UmaGiIPCKBUWkGgZcNYOGmuDQu
OahaEr3ZwHsnvQyFXrd27VrHP1lyyEmCr1a2bdtm2ZrX7vnt6tWrvRqeOvWdWMIr
uSUfNWrUyIRXTmUDBILLefDgCP78Rxzh1VIU/8Q3w8aLEcf4RQqsQCQ6Dv90FTE6
s73OCk62Nc0RwxpMUwmIe/Towad4XyI5bGj79u2dN/Y2xCmYlhOwEqf6yxkUXu12
gsIrtUrd8pF/EAThaahmCnSQiG+NV0po1vajjz5yvjl69OhIdOEq/0ECgpIlS+Jy
gkOzOZV1GQmveQpPeCWRILUwI8kfd999N+m6E3KZihcUXukUttGKExbkfI1Xm9bk
qF2E7xwkgXG+jIm2zCR0fyp7A0z7JNCh81KMYN5u33Hiv1CoN3y5cwbCMnu7ELqH
oRUb++YNesLKeSEp0YMJr8E5uVhFm4FuH3FpjF5QScmMjqMfNGiQX1nwhFezfniW
oI6TGQ2VbHSSM6eB7k9q7bygShAS1OAUdTMCxEPO8YcffjgStlHPvn37MOzeHZlU
cc011wQvRzrqVaa9Rg0uGmWLS9AG/PqyvU4gJo6fkhFME/PhXuNPSuWZEufRDoNT
jy04c1ZYoxXxZfITZxpyZjTMsKkqWa7xyi2Y8Oq/KG7I4lcnnTDo4Nbr/c+IK9pP
/CujEaknvqTvGaaACK9Yle6nIE4g6cXXO0P5rG3TYJwIjRjAqshJ73O41EBmdD0r
J7TIjJogmiL5lTOywV5X4zuCq22sWLHCRn7RJjOj6S538c9//tP5miVRQdMRhHrD
qTmxrsWBXCh0sW/b75vM0IvriK8mT55sf+Pg6KF8IdhJsfmYhcKFC3vCK8afb/Lg
nG9SA5zTbz0c4ZUHanvROFX36aefRqJvxfw5CNEFLoxH4Fxl06ZNiWziRAzpH/Bl
VzcXEBwwu3TpUmqGSNIJY7jlk3L5KbGSyilfvrznazxw+v6xxtQwV7n55pudq4wa
NSoSnf3mfytGU6Q5Yd/83+QLuCS/UcLyUz/ELc45uSlHnzX75gyv9oyANybRwB6a
DBpUDOfOnWvjT7NcagCvHYm+n3CsqLXnoNnBF5u79y98lxl9uWjds2nTptaJOHPz
5s3P/F5zp0vBFF4feughL5wmsCQDdYQOWqYt9RYUXm0WaRKFV3/Z/DY/M6p8WSrn
tE8iUgs/HD3LWLJkiZkLLAlRR+3atYNBL+mDCa+xFiTxw0051pXeZ8PFQjd0smJj
HLyB6vRi/4gHe/9tPsXB1B7PANowrCZNmjhrbVEhpB5+pdIRXr/66iv+JohyFmQA
G9/gZC533HEHZsp7oZg4uGYbYh8cv29yBP4uOA6UmrGXoyNGjOAZEXt7Hs0wZ12p
UqXgeixU0ezZs/1HgsKriQBB4ZVHaQ3Vc1j4CMv7/JPSPCxN9sJ1W5uFIMe5I4I9
m5jiH0aWeSq0+Otf/xoMU6kuG98t4fUPnBnh1ZkXuWzZsgEDBjjqWNKFV2Kpz/8I
HdhLctatW0cHdk6LN7UBQX379iVqnOWjY8eOJuqF3imRmTm2li1b0g2C7Q8TbyYs
zvp6oXAXFJVbM3Um+L4iM6oL2ETjWO9tbNwNIULwI9vNyRNebcBv6MhNTJsTj/qF
119++cXEXyLRWX+ECC8S3drLH/ETMtq84KuuugpT8vHHH/NonPOHwkksRKOeZ743
038hWw+BC4XuyuLVEjfbunVrxxURqlruEVyO1kbD+Y/kRHjdvXu3TfgNleBtuLEn
vNI4rV3ddddd789633+zth62I7zaFIPgir12XQmveZBYSw3Yu1AnP0m68EoQTOzi
2Enss+UblMFeV7zwwgv+09orCmwRAau/TRIgmr8PNUTeWwRyRewkyWTwO7b06umK
OJSWUIO6ev7550uVKoVhccZjGjZ4nKwpNPSneBbIBic8YnPIZiOnhFcssE2VsuHz
frD8zgQ3T3g1r2RDemvUqEH26686atjsoSOIm4MuW7Zsr169bC3/7E1sJCYmVJ0z
Z44tB+G89aFCLB92RjZlRjuRfxSStVUnczC8r+HZzehde+2106ZN9d/mvffeG4nO
e/WbX8J9S6GvuOIKQsl58+YROQQjUSrWXl5i4amWDz74gKYbfMdmsgvhNRm1/9LY
W0tjHOHVJkNQ4GDcjPM1l5Gl8EoAYMLrpk2bvIOrV68uHCV0RrYpGk4rIrChEpzA
Ji9TQITXCy64YM0pCF3ovM2aNXOG8lnDCwqvtFtMJR85AyFzKLzaCKNIYPT6kCFD
ImHjjOhTZpz9s1M9xo4dG4muJkzSRVznrBVuWIieyOZadCXu2jGzFMBey4XmveY7
qCjvCLGTZ0tpJDZhIijaktGReHvCqw29DI2vMOyvvPKKPxLwhFcLqm1wg99dGt74
Kf8bFO6Orko2zsFY2wDGAXcTNHFmoJz5JWCRbXCaAlErltxTK2zP9ODWPTyOQYMG
WRBLs7EBvM5wqszooFozzn7d1pLwnj17btiwIc7rHz7FmhF5rl27NiiCeOBAzU4G
sxgb9OfINDacuXr16sFLE9DaTOoEN9e6+OKL/feF0zElxRnVZQwcODASnSbsfytG
mTlJ5I/yJZ09y0nKKacACq88Wacd0jucUTW5IbzyHSecJuX3SmI91Jk4awfpFASB
/oiFUllEShgfeqc2GoxeQN8JvicDro7ZJOQ73aCRiJdQkwKYPwotgL3PIBkJbhtr
mD4QtGaZpzRZT3i1KDcoIPJPXIBfjfWEV4upbIFBMndMt7/qSHJN8XSmxNkEX+qk
U6dOBH7eLqZZQlBqjYrH7egbFpTeeuutoTmmDZ2mzLQ0pzCZpzwOGVnwhxgWp6fk
RHjlTiPRUf+hrqpNmzYRn/BqIQQ5zksvveS/U2rbPLj/1SDWz0aShUaAFgNLeHVJ
yeZaGRkZHHHC0yQKrzb3x1qDg/fuaN26dXRXiudXyujV9rX27dsTX/r/I2N86qmn
4qyyb5YanNcUhuezE9wlg5iMh2LLbHNpLLV5iC5dugSXGvAkxeC4SMOE19AJvI7w
auEvaUYiG4D6hVcSTnsZ0qJFC6fqKDwegmrxB5p0V2J9/2LSpUqV6tChAxYzfhxD
B7ZJmoTXwQvxjAizYrl2rKd5MmfNhMyogbDQJHQfMIecCK+kBybuh4pTVv+e8EpP
scqhZpybHTBgAO7QyWEsXmzbtq1/ZSKDONUmp0h4zVPE2lyLbv7www/7dxTMTKrw
aqPX7VWzg7fwiCe8Om3GrkW+6rRJsiacNzY51hRUOq8lSyRyoV8w4dXxF3H44osv
+EnXrl25ND0CE4ebxz74N1f1sJE+zZo1C00gyYTpmFih4LQsR3glfzPJbNq0qVmW
0BNerU5sYaxzzz03WHVEqEQ2zng0cn7Lkz1q1ap1zz33JLINi/2cNnDzzTfjSrgE
FzKT66zognGw2dBB4dUP7cEKEyq8euA7bMHcJk2aOLdJyQkcp8+Y7rwZwkNZDRuY
YhotDclxdtS/hbkGT4GnSZn9sYQ9ZQJEQmHn6oMHD37++ecdGdTGPWEzQ4TXPTkS
Xm1ICPcS2hpXrFhhWpL/WXiBTYKbp6WcAiK81qlTx3+cSGbQoEFOQ0q68ErNEA+M
+iPjx4+38MZT0Jzx1DZjnQ5IOHS/Dy5EEy1fvnzoHkqc02YLVqhQAXfpLOpnWIju
bNiQJZhTwuZnn32W/JACYGBDNwU1V8UdhZ6EqrCBM/7+ZeBTOO4Jr5s3b7axsYkM
a/KEV1NGzBHTi7GW/qqziflk8s5MDhJpM0Q0jz59+vCwFi1alMjoAT94k6VLl2IE
hg0bZtGpM5HCG2cU3yYQ7ZjiHNyyxg+Rg3W3hg0bEi76bxO3TiUTr/qDfzyIWWaS
dmwykfMbU94I7rVII7cMhTM0b96c3vHKK68EJ2qYvm97YPovTUlsMXFnjI71keBS
LXYjtjZC9oRXcqVIVLLx55UeNno98scBYvTr/5sAkcB6cXmKgim8OqEUltOZTpR0
4RXr5C0n7eEP101jdYZh2ttozAs+1IlYsAlYhljjVb2J9jTj0FH2n3/+OYaLgD/L
neuMb7/9Fi9MFI2pJy7CHnLmWOMYbB4A1jLWhqWmDwRfF2UGhFdzskEBMYgjvJpw
afumOlXHc6HqnKmf2FJbAMGDBtm7d2//oNpQbBU1Aja8pHMhbB33GGftL5s1yIMI
VpTpb6HCa5CcCK82JKts2bKhO7qb4/CEV5POMPs0A+dmR4wYMWHCBH/7p2nZMndD
hgwJnhmnLOE1hJQIrzhpLJRjf5MovFqKu2zZso/+yPz5871mZ8IrVsMfZHjCa5a+
PIiZIYsSgq+yPeE1kcVWiIyx+BQPs0tMZu8obKJWp06d4givH374YegJTXjt0qVL
8KNQ4bVatWqx3mL5cYRXe9bBtU7iQG3g82iEV1xxhbePtjO8zoEObENTg8PNsoRE
2oJO0hLnTdfKlSvtZU6obu6QE+F18eLFFgOFJgbOiFdPeM3SMRjmVEKFV+5dI17z
ILGEV/4mh3QGhiR9xCumg6zYsZNe1/CEV8dB2LWcrfYSxDQI7HnoThomvPL/LM9D
fkvAShDWrl07EiGbJEXJMQ6kiMEd9jJPSXJNmzaNI7xCMESIJbwmslyDI7za4lah
U/Xj3Cn5PI8SA242NhKd1xO6i7efyZMnY8lr1apFAIpPsbu2fXUdG7t7925zT3H2
Xsj0Ca/BVSb84FJtXG1w2Zk44N/xU0SxzZo1M0UyEpgrkxmt/Bnvzhg5ciTP3dth
pmfPnl44YU+5UqVKoVuoBzGbSegZOuI1waUGQoVXCwmIO53XJ4atbMsX/LPPvMAm
hRnyaVFAhFdncy1sBf3R0dOTLrzSHbygyAN/am7CE16dQMKuhc3n5xgo7z/8/pIl
S0LHkhvEmWZeSERDv2AhenDvxFhne+qpp8gV6afDhw+nV44aNco2HwuKp5lhrsqP
Ca/0r+Dq4Y7w+u2331pFZUN4tY0cGjdu7FQd7g/LT9U5Wev+/fu5Nf/oAXo0BjbO
+AyPk2tYz5jevn375s2b33fffdTqxIkTbRlcR0nHqdnM9/jCK4/VNPfQub0eOEpv
G5wpb07x3yblIWnauHGjM+EXS9WyZUt/U6Q8NAbHwJKNd+3a1TPdkWieT8Lil428
MXovv/yy/9KUhOfFE/QPyKKd33LLLZEYQ0ZyKLzaoyd+CFW1vGzOP0bScwehCxnl
ZSS8ZkYbjDMgIOnCKy2ETNAJp/3anwmvziBQE16JS7Nxs9hYK1Ko9zThFeeVyOac
5P6EqTYdHivKYyLytH0OQ2dnWh/hJ/GF11B/ESq88n/H8gQJFV5JnU6rUX3xxReE
xLfeeqvJJpGoch36OtDDhNfgHgyJYDPtIn9cP8ow/e2SSy5JZNR8ToRXW8OQ2wyV
4J0Rrya8tmrVKpG78zoRoXvwU414DSclwmso1kuDQcOaNWsi0fkvydpcywgd8col
rL2Givdx+PHHH4mf+vbta+Pbg0Yw8RGvv//+u0UbTqWZhQ0VXrm6TfOPL7wGdwzL
DAivNjAe+5KI/ugXXr0VALInxxA10lrsxkPfb3tgSizeImE+rUtYxd588822IC+1
4bdWGHQLTRJpq0Hh1d6Q16hRwxkqgj+wBba9oNnbViVUtXGEV296YHBLmVBs/e9a
tWoFZ3IRJVuGLOE1TxFLeA3F9nAjbwm+3zbf6QyWyeEar7FGvNrOJyfXm05M2/LA
rpKH288x4MF9ohMf8fr+rPetqftPkpGRgVUvWbJkqPBq85LiC6+JjHj9+eefbVxD
IrbOEV5tF1EykOBaLlli29TgrG2tktBhCB4EiDhNvuYs6WB+0xFeOa2thHP99dfH
CWFpqxYi165dO87sWmygnS2WjBIfng7W2JZApY3F+hr2fNu2bYSheCuyfW8232uv
vRaJyp2JLKeeeWpZYRxo8MZzuNQAoYvtTREqQJM5FIriXxYNP2hrPkh4zQvEEl5t
RzUnS0y68IpFwsByNv9/no/whFcn6rNUGTtzuje7efPm6tWr0yDpUKGRpAmvhChZ
nmr79u3cMr2SqJVo3ELWtWvXcoTgLVTqSkR4xfEFk/xYwmsicU6o8BrcHjY+dAG6
/xNPPEGYYTs+Uc7QcZQeVIhNfeDpE+N5ybBZG2ciBZbcvI+zybUDDdJCzVtvvTXO
12yKfTBUiM/Ro0dxixRswIAB1sAiYRvw2tviWbNmDR8+vEmTJqbV+icTeFtlBHeq
CEL/sjUWQjMCQqCcLDUw872ZlumEjmmwvS7BNis2JLzmhJQLr0F4oDYsxhkJm3kq
EW7cuLH/YM7XeA0d8Tpo0CCLCUPnIsSBVkoJsSTcLBFpcGeFxEe8EqtgnDmJXyYm
xrNkITSUsqX5sxReExnxalmGtx5XHBzh1ZtnHLqaU3wwSlQLlWYhcXzranszRE5/
vNeSJUuwhGQKlJkadhYRsuCTnCV0Q0WHoPBqUy4w+I5u++OPPzoN1ROOQ996OiNe
7elUrFgxkfnZ+B1b9jBUX1q9erXWeA0h7wivNks6OAXVdn8qWrSov2l6wqt/LXYT
egjiY0109WPCK57bP+KV8Mu2lU9wrr1BFNW5c2fTAekVkejaQM7ijJ7wGtz1yIE+
Y3m1s569WWcuFBRe6R6mRcYXXkPDF2dzLfqJxY5cKEsZyK+VUyrTU7CeiXRXoqWg
n+CxWvIf54eU0y5E0zqtt08jRozAS/EgFi5caK/l/SkEN2s+mPIHt4x3MOG1Q4cO
3hGTV2hOzm+pCgua+YkdIYS1phv6fs/29sWImCWltLY+wF//+tfQ2X8O3szxWYEl
tPFMNqQ3GyOFs4eE10Q4LeHV9vDBcDnuc8uWLeTMkcC79OD8TWepgfj8/xGvf1wb
y94zB4/HZ/LkyXXq1CH5oVPYnEpnd5HMU8JrIu+9bHsrZ8FBohx7vxoqvFptxBde
yU+CwquzuRa2zpb85kFkGU+YZeDnFlO+/sbrVnWhGyY4cCEqLShx2ku4+MKrZZuk
uP5RWty4SaLBWQX2lhvDGNxbzI+9GYoE1tf3Q2bVu3fvSHQTLb+qGAseVnB4mm0X
S6LrHSGlJ/wN2kz8BZ3CG9PhuTBn7+BYWEVxhqD39GYnZDm31Fu70N8xKZK5KuLa
4E8s88dA+R8Qz9rWUpDwmheIJbyGYiqe8yooM+rxzYk7G2vkfI1XE16dBaZatmxp
EWwi2pYHZW7VqhUxktkBnkgwCjLhNZFh7BYgORtPLV++PI7wanOt4guvhFJZjnjd
unWrOZdEdmh0hFebjlChQoVEdscKBeODe6WofsEuyGeffWarLjiv32yigCO8UjZr
FZiRYPDvgWFs165dJCr9x8mAcEO2qkybNm0Svq0/QHt+/vnnbVGC+N/ExP35z3/m
cXh22BbU5mGF7jcYZPDgwZHoiLCgWkfMY2ONsye8rlixwmx76IsEC6TLly/vn/lH
NG4DXCS8ZoM8KLwS8pm1HD9+vP84MbnltnXr1vXPD/CEV/8mVGbG4yetHia8Omt9
0k3sFUXocqix+P777wmnJ02aRH3a/k70a2eiqgmvtWvXznLEq60BQm34JTy6WJz9
SGywUZZLDYT2Lxt/4MX/XlQcazVbD094tQlzX3zxhf0wOFU6lLffeTvofWzVkfjC
K37H3Er79u3jGGEHewFpNWCLQpCm+VWLOXPm2Lv54K62QUx49ZSEzFOJGGGAI7za
qBTwFkDAS9q2w8G1gPGt9sLPm+5mO/1Eslp5zMMG3laqVCmo6prB55ElMtU720h4
/QMbN260TUgSMSj4cksU/SNb586da5vTeXVqEHSaTOZ3JOYsseyJCK+4orJlyxYv
Xtyb8WqDBN+Y8oZd7oYbbvAbFKINorRQA3TvvfeSLNkuHwRJNg8XY+d38wTB5rO9
FC5WWMxFTUX13hRxs1OnvmPLPIUmk19++WXRokUxRqGbiXs3RQG8e/EMsb0yatq0
qbedjkWfmIPHHnvMb6/xQM4AN7Oensmjt5sRadasmV97tUlVznCPAQMGOEuMZ0aD
Qu4idJlwPzwIc1REov6uzi0QYwXfXmZG9w3AhdhrMe7RNt3m6fv3OrMRK+ZE/VkH
Ro0b94cLpuCQM3tHMjIyzC77bxP3fMstt1idcL/ece81HTXsrQjGHxTS9lX3zzqx
rdgj0RdK/hZ1chXgt99yJrXRCK2/0I/821Dgj22FtWD6l3tIeE0QG/yCS87ym3Qr
G8bo3xmDmKB3797WzJxh4M8995yj+/z22282/CqRZkCl2c54XqRoQ664omkl5KhE
LX4tjFb3wgsvBF8SzJ8/nzTJs5/WBWiQjuuxRMtbFAVzGmtDD5P2iBS9VTXWrVtn
u81QRaEvkG3N+FjbEJvwyhcWLFhgR/AIFtDQkU3L83yQyamR6KIBTrTBvfuX+bOx
M94rmV9++cV2TzrrrLPov/5vEtY//PDD/t2iKBIPK/iubujQoVRmcINvP7bTKOkW
ns4r2PDhw+3tS1A2Xbt2rX102WWXOTvY8NC9SvaWEaCS6eD+R0/JPX+xaNEiGxRM
+f0zsqnPTz/9lKv7f4inC05foLQED/71CrF1oekND7RVq1beCWmfphDRuogI/Tts
cCN0HEcL3rVrF87a0nv/kBPi427dupnNzPIFg8Xu+GjnXSDtxFacdNwf9YCXpL05
E9zIpizVcb6fZ5Hw6sGzprVgEp02gNGzNuAENjbaxT/UAONgElusN+hO2WykifOS
1cZqRWIopJiUUOuHObUX896L/5tuusn5pg2E8Sd+sejUqVMw7LeCEZ+HCq828CK+
8EqIFRReyej8wit2gCqNRN/6hO7f6MdCvosvvtis7rRpU63qgnNCM6P2zR9FEBMS
1AU9HekrRQ3dwczDJp/6dxLLjI5T+fOf/xwJWzqcUNkKFn/ovU1fi8TYhdzgFuw5
Yu1Dl0RwXhsEQ/fMaLBKkkKm4x2hqkNFE/wjnsLTBbhHC2AIzIJiEM/OWczBNNNQ
e2hrr1HVWe7KMHv27EhAeOUW7O1paDxgisYDDzzgf+I4aBtFIeE1G5wx4dWeHQ0j
kbFTNqS6Xbt2XiSGXSU+sVHhF154of+1tzeD269R2CzDWItTO2ASI76lMzApXJfg
im5iXXLixIl+qXfLli1jx44NLqmMGW/YsKE3tp3na3Nte/To4dfg6JVFihThXqzA
1HxwM1LDKu2CCy7wRA8cwR133MHPqcnQ+a+WmRLzxHpNZUqCpw9gWDzJ0ky0NyCP
SrZx9OS/M9+b6W8hxGz+EI6qsAmjFjhhMWynXwrJLfgH9nLORx55xAnOMVnBzvvW
W2/iPpyhckEsfYhER/r7jSRV+swzzwRXKuA5YuUonj0RHoGN0O/QoYN3gzQ2ezdP
hOA8eu7FMcX2ksAfJplCWqZMGf9q2jx0m/sf8b3B9dZw58v+gIFLkE1YfOI9Dm8A
Ig1yyptT/CkYd0GDdKT2FStWmPpBL/CPWea4l+wkuClF9pDw+gdIsUxl79u3b5Zr
WPCQvFSNRztp0iQ6J5126tR3rFn4OwZd3dI/f2Jmi7uBl2rGYefOnRbjkrPh1An7
vIEDZKd2Hrzs/fff//obrxMyYhmxwsEVlAmmaXN+3//ll1/aHs1kiV4YgW01QbZO
nTq23FUs4YOf8MNIdOoBoQy9EfPHHxaYUtqg37Ix/3HyQ08m+Mc//puKJeL3knkL
wsg5PVGVurUeHolOteDSFJXezkH/ZnZgqtbVV1/t2VNifctUMY5EpVQdPgyvVqtW
LWcIAGXAZFPgzZs3H45CqNqmTRt8SZxNUT3srSaUK1du0KBBlBA3QOWQQgdHbM2d
O/fss8/2v9EiXLZ0ke/7V7T0Hj3xAWaI8tMUic+oN7/HsmmwuDov26fMtsI0dg1D
Rnnwx2QyBMr2nso/9Y9HbOmcNRKicJ4yXuqJJ54wL05pvZcHXMIGO0eia+9Sb5Rq
3LhxV111FaFkcHIKjcEGAvB/uwVOe9ttt9HIbXnHbGfIp4uE10Sg5dtED55XlpEi
zti0RbJKa/YPPvggjnz69Gnmv3nQ/u/b6lGc2euhuEx7GRaaWwYxs0PoRmxBQyKj
MzdML7NQLxJ9JYBlwLDQTTiISXRqG9tuO5Z4RyiPPRr6i3+WkC1FRJJAR+Cc/D9W
nXDvdvVevXrxN52OCsFQY3mIokJTbs/WhS4wTwRsgw2JObiXk3vgnnKLlNCu5R8t
bpMbrHJwo5RhwoQJBDeUx/+Cyl7m+0eSrly50mYsWhBGAsnlOAPPhQ7rVyTxGuS3
hOn4PgJQSohZoFouu+yyLMetf/vtt+aGmjZtinnBjGNhsLc23jk0M8dEmPaKI+Zh
vTHlDaw3/bdz587+SMv/6Lt374754odYe1qg/1FikM1xc04ahlk5bCmO23l/+eyz
zxKScl/kZkeirFq1im/S1P0jwubMmYNPHD16NEaPmqEJcY+cGbPmRHXE3KZJQf36
9Wm3PJ3HH3+cR4+LCS7yYA7CTLoZ2IcffpgbJyI3TTbLzmJvOKjw4JQ36tACGxwQ
voYuTAPg7nAxwYfIjZj1TnCsQcpJb+EVLK8jLczymzw7W32eJmr2lqCXJIfuY+9T
nYlf5uv9UiN93MLaRGalYA1sxKu3thr9givS+G21Cm+mv33Kk8KG07yDuTdOhA7o
pfee/kgq6/+ajWAidLF/EmbHmsFqr+sohvU17C2Wh0CI4BArF7o4tZ081sAxGom9
WbQonRN6I2jWrFljszg9I0CUbj2uZs2aH374oZfNEtmSHvuXv7cJpN62ENSMuVeg
ojyjx+UI2rGf/hSUIhHWBmc8cAZMbvy5vTYSgjJ7foo/8N1W7ODwjk2bNtlojPLl
y1OTXoTMs+Zmvfyc8luiy5kx+F4MSWGwS15L+Oqrr0xA5JyYOE8A5bnQdJ0RarSN
4FsxSstv/SkMpQpqT7b5hNPsTXuysMEfvpIgkCc6uRuelEDXbnz6jOleXEG3op7N
W8Wf+ZF5ygVj/B3Lv3r1alO6nRGIdAQ6cqNGjZy5JhkZGSb6BOeT5XEKlPBqliSS
2PRz2+Y+El0rgHZCEEKyQBcgAIhEVUV/LGe7ZTo91DRE4oRYa2f78ebvWnxL1Gpt
DDNigVkkOk6CrJOYynJkOoWzXx/dnLgL4+YXubyXLv7I4bvvvjPXw01ZkBbrXRTH
LXPHH1EP+GKSXFqLrcsXXAM389QchdKlS8ea4WrDe/kCZyOwx5KYpaIX2+AP3IS/
AN4GBnjMF198kQIPGTKkWbNm/sVAMHdWTm+RSay0pdiAraBUlhZdcMEFPXr0cNbc
wyVxQuI9rDe1isPFehAiZjnSNjNa7aZdRqIyziOPPMKFcJFUEaGv49TwFL179+bx
+Y97i7bz9L2D/kdPTkQKY+pBy5Yt/ZaNXmPpyS233OIdpE/Z86UxjBkzhjwCW33r
rbd676v8DRX/aBfCOxDecxWiVr485c0pVoE4X8/B4SNsYkQk+lqCJIXHcf/995PH
0TCC086odrs1OgJRBycno+nfvz9FMqeWqxNtJbz+H6RYhBE2xtP6Hl6ZHD7+JG6e
jbdncalSpcipCB3wGRZykV/169ePyIngoHnz5vY14kUSJB4wDcgEhUg01eS3wddE
DsQKXgJMD/fsJsHr1KnvkLlZ4mqR2b333uss24S5sX4Y3JCEzmOt8JprrvEGSS1Z
ssTmmFvMEWfmODEl0a3dNVm9OUtv9VU8hLd8FQEZ9+6dligHN+At1eFB4EW4Yy8l
qFgbE8pD5xlZPBeJ6qdUgkkSBCiYFTOOBsYFN2CRHPWD/+jSpYvl1fSrDh06YLks
KsJYYDctQDHXxVMLSuFYBGJEHhkpTatWrejz+JLHHnssVBMJZca7M3AnlurYhbAm
ThzMjZOWYJuCEwQ+/fRTs1kUwIsgMShUDoWxyo9EY9NevXp5Lpw2w43bRXnEtGqC
NotcMYJYKG8LAmyoOQzb8QCnQm17HQ1/wM1aVh+Jvuiz8SnecBXCPryyRdiUikgd
426BZiT6ZpLeFKuFr1ixgu7g7TxDZyE5oXmb8EozoHUlMpkxh+RQeKU54a0/+eST
RNYdDyWPC68YEJoEjd9rM/QI+i9hQZxf8dD97ZOf25oktsYrzZVzYh/oHRgZa+HW
UDEUxHDWGr0GmeWMP4yel4tSPL8NpFHR42yJA7MD1LMzVovgxtbsp5c5MRC3TzO2
nkuYZeE4VpF4xSqEM8d5C017xqZZAhmJyq/EUkQ5ZtDq1auHa/NC/GnTptJtbRQD
J6crce/+KRTG/PnzvS5JMSgwnfrOO++0jhOJzsDlh96QyZnvzeSWvV6J0SPU88pM
jEjjt3u02iMqsjfw3Pt9991ni89EopEQzzTohTEs/IQz4KcaN25MsTGS3GmCez/O
nj3b5oWYPbFBWLYO4Lnnnst9BcfScmZaoHmKSFRJxFY4c5kzo4+e8MuWX4hEp0fg
6bCijo2lJeMiPZWW+qdWg0MD5s2bR7PkbHgZsg6qFA+CXXUmhRAL0hR54qTQRKXU
GM/0nnvuCTWD/JaYmDj7/7F3H8BRlP//wFM0MLQRgaHI0MShMwEBYegQYEK+GEL+
waGHIlKEr5Sv0qSDhSIdaQKCIAgoTUB67zVICCb0kghJDIQ0IPm/uY/ub929XI7c
XfZy936N45C9vd3ndp999nnet7erHFw4S+Ikpb/5tUBlwDBAeSQxlo9zFj6O3Jmh
SJEiKJXZNhO7G1VC2cvoxL9s5//9DSjmQXcZw050b/ABcTLCgaP57RXOuagS2A5S
YGwNtOHYCFY+j9gorhq8ounAlketkNFgwYIF0X/D8WghNUCLJL/Tl8MNlRNtMg5Y
HGVyGKIOYJmpJnfv3pXRDvoSt2/fRrcHL6FTJA07ukz40/JPGnFaxEBIGjSMOtDC
o/OgXFyjHPjYtuiede3aFccCaqm66cDMWO/XX3/9+uuvq++Iqtz9xsN0K3BlMKY8
JAQ9ig8++AD98Mx+wao8FB4VHtsBxUP3RvlFFJpNdfqJ5WPwLF/2o83HKQafXTO0
w/xyDQ6ORDQOOLWh0cA8mFNJHDCMVN6IoYRcWSkNL96CdgxtO1ot6WFi22Jm+eWT
h+kaRpmO/SJnUmkksVWxLrSZ2HSawx/1Fl0snNfmzJlz7NgxNBcHDhxA+4a3W/4t
QobpJxSSsKNNwJZEU4YGAe2b/KwNPW0URrMFcJaXt3iYhv34RB07dkQXHRVM3U5i
6ym7HmXGPNj+2HR+fn7qdhLVQBku4SNgNiwHZxnUSc31yBhN4CyAz4VNdNlkyZIl
aOXQfVV3zOT6GLTPGGnj7IA6jymoJ2gWNC0YDhPlAl5sQLSH2MKoIWjYJ0yYoB/S
Y7NI+uNhGtnh4+A8iN4vTq9yAurXrx/2mtmDRfay/DgGh8m2bdvkAFRmwC6TMSA+
/o4dO3Bmx0GEcStqi/paOfQe5csDaZzRM8dyrAnanIRdgldsBJzi1b8RfCWODl5x
Zkf/Vt0fQ/8K53TL99RCZcBQV+mi4BCTDE4GYuiY4WSNZvbSpUuoZkrnsFatWmgh
UY3RvZHOEuZE5c/yqbCPHj3COUJqUYUKFdT9W/RdsSLpb0h1RZOIDa5JXXHkNm/e
HA2p5u5MaEXltmB4CUWVL41whOJolV8wyG9YLWx8DOqVrA2HGPonWKZ8kVOpUiV8
XuUaCLRFWJectT1Ml2fhVf3tmB48eCB3zZYTAbYhjkdsXuwjiQ7wf7R+yu0i0bag
QVYGFB6mDBo1VraAZB1y0x4PU9SIlUqfNiYmBicjJQYBNHfz58/X/FoOFRizoSTY
y2gk0VCjFUUvy+xvZM3C+Q4nMvkGUTm5TJ06VdNTxfZByTGPZniFjS/fCuAlfHAl
DcPpADVHGQ7IYjFuUnJqNMIYycrZEwcRah1GTPJe9LFlH3mY0iG0dahI6EzKFOmO
Kr9gQ8fgk0/+q2Q+2N0yXpOrdvB2FFu59zdmHjlypFIlsHa8ijYwsyqEDyvLEdiw
qDAY6UjLg22O/o/mt3T2wuD1b2hk0aacPXv2qgnOncePH8eZMstYDTUG84eHhys3
K0GXCzsPE/F2LAQznD9/HscbTu2YiB2JMwH+xOowXVaHoR12gDUXTuKIxfxmR25Y
L2owSoK1m32GDI4KrFeGZ5qX0N7hXSghZlBfsYXjE6tDi5blw/vQZKDeY+3Kt9Y4
r+C9aJuwEZQC4zNiFdgy8sHRb8B20DxsV4HDW71hsRDMjA2IN0pRz5w586+L/OPi
8CnwFuxNzVUS+AjY7CiMFAn9Tvxf6Ydhg6DdxxvxambPYMEWwAZEhwl7DTsLq7bm
BhEaaJFlRSiP2RXh42DJ+Ixmh6/Yv1KvNJE6Nj5aeVms5oI7TMcHxylENhr2Bcqv
bDRUbywKb8RsMhHbBMMqzIydgq2tqWkoM1aB+ZUfa2CbS/1HHcbeVFctLFwqJHZH
lrdvw3plZjl9ZpjaJvm8OBixv7K8/5HtbAleUX65otCa22hmxsmDV9R/VAlUfrQh
stNRFTEly1sMo8cvjQP+r3TLsEOlPZRqhn2tqag4wLHfUa+k5ZQKafbiI/3qpHhm
D6Lo6Gipwyi2fiNjCj6d5mnF6vdKq4X/K60H9pocRNbc1Bgrle0gf2Jr4NDD0nDU
45Mq5cEGwdZQ2jpsc3x2s9fSopyYB+2elAftnpy5pIHFB8Eb1Z8FB5e0q3hV82QA
nKqwUvl0snOx/dVnJeXwRxNhtn6iDPhE2A445OWkhpk1HXHL5KwByplX6gn2Pj6X
2WYEJUF5wk2weS187YFTicyG+TMrFfam7COsNLMWHmtEjxZLww6Sc4H+B8UZpq2B
k7J8F4vZsEHMPihA8/HlSMGcWSaYKKrsSux9aTMxBTVHDqvM2kyUB1VC9rKcTfCn
vmDSIEu1NHvQ4Sg7ZaI+PNUnF+fkqsErdkRwcHCLFi0wYMCws3Llyk2bNsUUy79r
xtE9fvx4X1/fYsWK4S0YL0kj1rVrVywEoyAsYcOGn5YvX44TE8bYmIjhFoYrGKVg
JIZVVDLBGBJzZvl0OLl5CAbwRYsWxRhJnWai5q9YsQInPoy6Cxcu3KxZszlz5mga
YRwRo0ePRgE+/fRTzZJRq9u3b48l16lTR8lz5Vs0zI/VYRBl4fF6mH/Tz5swssUY
D9tBfieOI7FRo0bvvPMOCqN+iC5Getga2Gj44BhOY3SHz66/Wg1HJTZj6dKly5Yt
iwViFRhfYKM1adIEb8RiZaMpF1GizcSQGBOxL4oUKYLCYLMr5xSMVzEzPp3sXOzo
nj17yo+f0BZheNmtWzdsOoxyGzRo8M033+izVJwasElRAIzD8YlatWqFrs6CBQus
fGoi2pn+/fvj42ATYd/JF0LYX1JPevXqZfYZj/PmzUMlKV68OAqGMuNP/eNo0Kpj
+2AgWrJkSex6LG3y5Mn62zugFZo1axa2NpaGHRoYGPjDmh/0jSR2xLBhwzAbtjM+
IzYa/tR/84fljxs3DvsRm8LPzw9LGzhw4MaNG8w2X2jwcRyhxahZsyZ2Dcb2WKaF
u4HjM6Ko2BEoJ7YYPg5OZ9hNbdq0weaqXbs21qv/djDDdGEsCowGCrPhQEbZ5ABU
z4PzDvYjaiaWj4+JnYKqqxnToWKgeuDtqCpYFBaI5YwdOzaz+yA5G7sEr3KZNg4K
y89/z4yjg1e0TsdMZFgKaB9wDlXfFiAz6G/IW5SRvgzEsN3QTcJy8Cf6ckqggYMC
S5YeNcZT6jmzXBcqv/RvzaYKaFSxofAqDk+ztQvVFes1e7cWHBQyHscOUh/I0k+z
5oEoOBdLQCH7SLqCSrCgnF9wPCp5i4xVMxtKYKdIhqBkiBIXyJBH/q35LDIowFvQ
9VL3Ks1mHerGFk2oMvo2u+lwysDnwmbHkrEH0YfEySLLu9/qoSSSD8h3hPoZ8BGw
cLPPV1T2ET645r1K9qXprKLY0l2XjYYyoyqqB8USK+GNSrcZ201dUTU1TemQK1ch
yKAApZIhhqZUUiEtdPLVn07pb8sUJb7D/sJHftWnMVuJwSsR0UvZDl4ldZUvFTt3
7mxhgGeZkwevRES5mqsGrzh3YMygHmmkpaVhSpZfmVuAcxCWgLEfFqW+XA6jRPwp
d8/QzJntdVkD51ms2vKZEZ/X+meJWAkLVA+MZWsoX/DgJSu3s+wjZSvJn1ae6PEu
9cxShmx3EuQT2VI31LAcWwrjICiVXKxteTYU25rZ7AhrxOYye7Do97KFwwrTMyu2
rEI5EKSm5ZbUNcNOwevhw4flKnI01/p77mUpx241QERuhcErEdFL2Q5ep0+fLqlr
aGioNdetZ4bBKxGR47hq8EpE5BrsdY/XM2fOyN0wypUrZ/nxcXoMXonIERi8EhG9
lI3gNT09fcaMGUrqauP9DRm8EhE5DoNXIiJnZseHa504cUJurP+q170yeCUiR2Dw
SkT00qsGr+o7DISGhuofvvyqGLwSETkOg1ciImdmx+A1w/TUUHnkYIUKFazPXhm8
EpEjMHglInrpVYNX9R0G7PIsbwavRESOw+CViMiZ2Td4zTBlr2XKlMECy5cvb+U9
Bxi8EpEjMHglInrJ+uA1PT3d7qlrBoNXIiJHYvBKROTM7B68wvHjx0uWLIllVqxY
8cyZM1nOz+CViByBwSsR0UvWB69K6tqjRw/b7zCgYPBKROQ4DF6JiJyZI4JXOHv2
rFz3Wq5cuSzvOcDglYgcgcErEdFLVgavSuo6aNAgu5ehffv2DF6JiByBwSsRkTNT
gtc1a9fYd8nh4eHVqlWT+71avucAg1cicgQGr0REL2UZvKrvMFCnTp39+/efO3fu
pP0cO3asQYMGDF6JiByBwSsRkTP7/ffffXx80MaOGTPm1KlTduxjX7hwYc6cOd7e
3lj4O++8Y+GeAwxeicgRGLwSEb1kOXhNTk6eNGmSxz/y5MmDrqG3vcnCQ0JCGLwS
EdkXg1ciImf2+++/582bF22sp6en3fvYBQsW9PLykp52qVKlDh48mJ6eri8Dg1ci
cgQGr0REL1kIXtFQrlq1Su7NrwSv6Jbls5/8+fPj/3I5LYNXIiK7Y/BKROTMlODV
29u7QIEC9u1mo98u3WzRpEmTyMhIfRkYvBKRIzB4JSJ6yULwmpaWFh4eHhYWtnDh
QrkutV69eufOnbt69eplO0Ff8+LFi+gF8lYDRESOwOCViMiZKbcamDRpkh372HD9
+vVvv/02X758WHiZMmU2b9mMbvyjR4/0ZWDwSkSOwOCViOglKx+utXz5cvnCHHOa
/Y2SLaQ5ZvBKNkpKSkpLS3P0WtJMbFxIcnJyDhSVKIPBKxGRc1MerrVq1Sr7Lvns
2bPlypXDksuWLXv48GELczJ4JSJHYPBKOefBgwdmv1p0BtHR0bdu3bIwQ3p6ekRE
RGJionoijp8bN24wNXANVgavsGLFCrlLVPfu3Z8+fWqvAjx//vw///kPg1fKnri4
uDVr13z99ddDhw6tWbPmgQMHHLEWjEMOHjw4c+bMiRMnNmvWDKvLxkJiYmLWrftx
6tSp/fv3x0Kk/0HkaAxeyUDoRqIPfPr06fj4eIeuCD3VK1eu3L9/P9tLQDuPXvHF
ixdxyNixYERZUoLX7777zo6LPXr0aKlSpeRa10OHDlmemcGrq4qNjX3w4IHRpfg/
CQkJR44c+fmXn7ds3YL2VnM1z507dzCDUWUjR2DwSjkELUurVq3Onz9vdEHM2Lz5
l1q1avXt29fsq3fv3l22bFmXLl2qVasWERGhfun58+djx47t169fSkpKjpSUHMj6
4BVWrlypZK9PnjyxSwEYvJItbt26NXz4cDSzcnO0s2fPKi9hmDF58uT9+/dne+F4
L5aA5aCtmzdvXu/eveW673HjxlnzdtTt9evXYQkYU+FPNKQ4lTdu3BhLKFKkSHh4
uDLn7t27MRvGSNkuKlFmGLySIa5duzZo0KDg4OD69esXLFjQwuPUbZGYmDhjxoxO
nTr5+/tjLVOnTs3GQsLCwgYPHhwYGFi7du2KFSteunTJ7uUkssARweuJEyeU1NWa
3gWDV5eEdrhNmza//vqr0QX52+Ytm0NCQj755L/ouvfo0aNWrVodO3ZEC6zMsGjR
IjTmTnvJGmUDg1fKCdevX69SpcqECROcME5CQ1y0aFFUqgEDBqinJyQkbN++vW/f
vi1btixbtixmwGw3b97UvB0frVq1aqiWOVhkcohXCl4BnUK5PX9oaGhycrLtBWDw
SrZDg+bt7f3aa6+dO3dOpsTHx5coUQL1qnLlytm7OQa6fYULF8YSfH19ZQrq53vv
vYcpK1eutGYJp06dkoNl4MCBysSTJ096eXkVK1bs6tWrMuXu3bvFixfHbC1atND8
kiBnbp5Aro3BKxkiOjp6w4af0LtAzXnzzTejoqJkempq6qRJk5o2bYoBdvaWjL7H
uHHjsIRly5alpKTs2rVr1qxZ8q2YlcuMiYn58MMP0eTu3bs3w3SNFYrauXNnLKFi
xYpok2U2tMBjxozBilavXp29ohJZw+7B65EjR6QLlOUdBhQMXl0PesJovnr16mWX
8Zrtvv/+e1QwVHKlZ3vs2LEiRYqgg6H8ADcuLq5JkyZBQUGshy6DwSs5HNq4li1b
NmvWzAmHzc+fP0eP87XXXkOl0lwdMHfu3DfeeAMd5cuXL6NHK8Gr0l1W++2337y8
vFasWJFTpSaHeNXgNePf9xzQ3IYiGxi8ku0wYMiTJ486eEW9WrhwYUBAAP6fvWVi
CWgPsYSlS5fKlL/++gtdWNTVNWvXWLOEhISEkSNHYgm7du1SJp45c8bHxwftqhK8
4hwxe/ZszLZy5UolI46Lj5sxY4afn58tV+wSZTB4JUOFhYV5enqiY4lWWqY8ePBA
HvXTuHHj7C3zzp078iQitJAyBV2R6tWrY8qWrVusWcK+ffvkW7GxY8cqEw8dOoQp
FSpUuH37tkxBmeVZ8+ifqL/AQw8fn8vRN08g92Hf4PXYsWNyrWvp0qWtTF0zGLy6
otDQUJy7neTq0Vu3bhUpUgR9Xc10dIBRV9HjVabgcChYsOCkSZNytoDkKAxeyeHQ
XmCX4eRndEHMWL9+XXBwcN++fVHCL774Qv3SuXPn0B+Vf69atUqu9sKgy+xyOnbs
WKhQocjISIeXmBwmG8Frhil7latLbM9eGbyS7a5evYpxuDp4dQQMs+VGAT+s+SHb
Czl58iTGV+rg1ayjR49KLpDlfdmILGPwSgY6e/asJnjNMF2O980336jvDPOqDh48
iCVcuHBB/oyJialRo4b1weuzZ882bdqIAb/6OQd79+7VBK8yEStS33wgIiIiICDA
+gsJibJkx+D1xIkTJUuWlDsM4ECz/o0MXl3M6tWrrb9QIAdg5IjyDB06VDNdGt5e
vXqpJ44ZM8bLy4s34HINDF7JsdAtQ0czJCTECYMkjKAaNmyIPuvUqVP1V7yqSRPZ
qlWrzJI1dHkxQ79+/RxWWHK47AWvGap7DvTs2dOWu/0yeCXbuV7wit4JTiIFChRQ
pxVE2cDglQx05swZffBqdzExMa90xatZe/bs0Qevetu3b8ds+fLlk5t3E9nOXsHr
0aNHldT1Vb+1ZfDqSh4+fFiqVKlatWqlpqYaXZa/ff3116iZHTt21EzfuHEDps+b
N089Eb2O/Pnzt27d2klukkC2YPBKjoXhDfbXtm3b1BPT09NjY2Mx6lYug923b9+K
FStWrlx58ODB58+f50zZxowZIynbqFGjrAleW7Ro8fjxY7Mz4BMFBgb6+Piw95l7
ZTt4zVDdc6BLly7Z/iULg1eyAG3m5s2/zJ07d9GiRRhRZHa3Vn3wipED6uSpU6fM
fmGO+XE+RT8Pdfj48eNmm19ZAnoJmEGmaIJXdAcPHz680gTz6MuGGe7du4fmXf0c
LX3wihWhi4nzwtmzZ5WFKL/PjYuLU9676edNCxcu/P7771etWrVs2bJZs2YpbS8O
5Pnz56Mk+ERz5szJ7GcK5IYYvJKBXC94leuzSpcu/fDhw2yvi0jNLsHrgQMH5A4D
b731VjYux2bw6krk9/voFmqmJyQkRERE7Nu3Ly7+Zd/y8uXL6NCi37h5y2ZHN2hL
ly6Vr6w0dykMCAhAl/jBgwea+YcPH4750Sw7tFSUAxi8kgPdv3+/RIkShQsXVkdR
GCe3b98eg58CBQr4+/ujV9evXz+5RxWgV4pX0RQ6umznz5+vX7++dH9HjBhhY/AK
aNMtL4ScnC3Ba8Y/172qb4v+qhi8klmoGGhegoKChg4dOnjwYDSeaDDxp9nRuxK8
yi9P0b1DpcJbChYsqLmfFJpZtL2o8JMnT+7Zs6e3tzfe2KZNm65du3YwkfPs4sWL
sYQ6derkz58fK5X3KsEreqjorWLJeFXacKy6Y8eOylHw119/jR07tnXr1tWqVcNL
6ju6KMGrfJB58+ZhRbVr186bN2/v3r3T09Pxwc+dOzdw4EA5NbRq1UoKtnDhwk2b
NuJPWSNGVtOnT0cxZLG//vpraGiovIS2ncErKRi8kiMcOnRo3Lhx3bt379Kly9y5
c2NiYszOpglenz59ilbr8OHDc+bM0T+lMC4+buPGDWPGjOlmgkbv7t27L0zQMMoj
E7CEsLAwLGHWrFnKM6+U4FUe3o0TwYQJE4KDg1G2RYsWqdtDLCo2NhadYXR+UJ/V
VwVqgteEhAQU9cCBAzNnzvz5l5+V2SR4RQt87969F/+YOHEiTiIocw+TXr16yY0U
UGw08pgiGwrTGdeSnl2CV/RbsIRSpUq90h0GFAxeXcaTJ08aNmyIynDlyhVlIlpF
tEJNmjQpU6ZMiRIljh8/jsqGdszjH+iIopPpuFKhwaxYsSJW5OXlhe4u+u3o8aIZ
r1Sp0sGDB/Xzb978C2ZGu+q4IlHOYPBKDiTXzGMkr5548+ZN9D4xUMdL5cuX9/f3
HzJkyOnTpyMjI9evX4dGUJ4SgH5eZotFX+1iViIiIiz8pgD9v5CQkC+//FL+HD16
tO3BqzyLoFatWk74DDGyho3Ba4bpKjxb7sLD4JX00GvESLVIkSLbtm2TtiUxMXHk
yJGoJw0aNNAPXJXgFcNp/BkVFXXy5Em0qJgfY29lNlRU9DJR39D/kykYvb/xxhvS
6cTqSpYsKd+uo2VGr1QepYXRsswcHx+PPiumDB48GL3GL774IsxkypQp3t7e6jYc
ZcY4CgeXLPybb75RyqAEr/JNG4Y6OBGgCVVu24IpKHPZsmWlVFhCURN5zkB0dHSV
KlUwvU+fPpqNcOPGDYyahg0bZscdQS6AwSvZl7RRQUFBy5YtW7N2DdoitL0YUZsd
PCvB6/Xr1/EnuqAtW7ZEg4bq9MEHHyizPXv27Pvvv0fzPnbsWPmVg7SBmLN48eJo
3vPnzy8/NUB7i34pmmu8itOEvF0JXnfu3Inl4N8YzCtte7Vq1WS8J3MOHDiwUaNG
knOprwhTgtf79++jZzJx4kQUtWDBgpiIHnuG6XHbKJivr68s1ucfmPPy5cv9+/eX
6XgX2nn5sUJ6evqVK1dw4GA62ucdO3bYcmsmclV2CV7R8UD9zPYVggxeXQZ6lahL
77zzjvp3+nHxcWfPnpW2KE+ePM2bN0cLjMYW+/3YsWNo0jG9QIECFlL7pKQkNHRZ
ZhFyLa1Z6BUrnVs07HVNMrvvFqajDUcLzCsJcjsGr+RA6DViZ40bN07/0pw5c6Sv
tmTJEvV0nCYxbkff1MIdedBb9cgKeqIWHnWFPmvDhg2Vx7BKH9HG4PXmzZslS5ZE
nzvbFzySsWwPXm3E4JX0JGOdPn26eiJ6kBJQYmihmd/sPV6lzUS9kj8TExPlclH1
JQAwY8YMD9PztfV3kpowYYImeG3WrBmm1KhRIywsTD3nxo0b5BcMmmu4goKCMgte
1X1N+bxokzNMA3UcFHKPV/Q40cZqSjV+/HjMXLNmTc39PRYsWIBTAJti0mDwSnZ0
6dKlChUq1K9fX/3LUPkNaZkyZfTtj+aK12fPnj19+hTNMubv3bu3Mpt0j9U/DkDT
984772BisWLFMCdq7927d2UJT548kVHcgAEDZOaYmBg0iVgRmtzhw4dLdpCamrpl
65by5ctLoy2jdzSwaWlpKKdc6rVs2TJljZorXrEinDXk6zc00RmmE82QIUPatm2L
KWjGO3fu3Mdk586dGaYrZOUMpT/Qjh49mi9fPltuDk6uzY4P18o2Bq8uQ8bvPXr0
0N8CKzw8XL736tq1K/oGynT8u3bt2pg+evTozBaLDnaWQUSWdfjixYvKV2Lg7e2N
rq/y4y21x48fv/fee5gne1dwk/Ng8EqOgtMVumIe5u6rkvHPD/PRjdPcUhDvkuex
au57ohYVFbV58y+W/9u7dy96tGbfHhcf16BBg3XrflSmtGnTRtPN1bAmeMXIX778
3717d2bzkDNj8ErOBkPoUqVKeXl5KU+sVshwXUlCFWaDV7mRvxK8oruJZaKTp2nQ
wsLCMFvVqlX1Dd2kSZM8zF3xqkmERWBgoMe/H8yKYX9ISIg1wevnn3+uBK/i1KlT
ErzeuHFDsyL0UDGGx6vyo1qBkwia9E8++a++YOTmGLySveB8LV9foeegno62rlq1
apg+e/ZszVvM3uNVnjGgBK/3799Hm69vnL/99lvMprldjBg2bJgmeJXUAKM7TTf4
6NGjhQoV0mSsmKd169aWg1chz2yQ4FWgcZaUWX/tqnzbh7OJ5mcZgwcPdqqn3JCz
YfBKdiQN7GeffaZ/CTUNexmNLVpmzUvyQ9iOHTtm9jQF9CW2b9+eZRZx586dzAp2
8+bNtm3bolONxnbKlCmobBK/lixZcu/evZqZMSSUb7k0F6tRrsPglRwF/Sq5xGnr
tq36V+fNm4eX0NvTP8ulXr16eGnRokUOKhgaOD8/P/UU6XQqdx7QsyZ4xenZ398f
s6GptWdxKacweCVngzqJgbqXlxdOfJs2bVT/V6lSJQ/Vz0sVZoNX+UWVEryeP3/e
w3TXVM3Pms6ePYvpaMf0o+iJEydqgle5x6v6GyzN6oKDg5VqjNOBJMVZBq9jxozR
BK9yxWvx4sWV3yioSZ6rhA7yKdBz1UfVRAxeyV7QwmDEXrhwYf0XQs2bNzfbl7Am
eD18+LCH6Zf4mkZYIs5GjRrpG2d98CqXL5gdKEkfQ13/nzx5ku3gdffu3R6mh2vp
fwAbFRVVoEABvLp9+3ZlYmxsbLVq1ZYvX64vGJFg8Ep2NHTo0MyuALt8+TJa47x5
88qNudSmTZuGd7Vv3z6z4NVGd+7cqVOnTr169ZRfa928eXP48OFyqy5fX1/1s2RF
nz59NF1oyo0YvJKjJCcnt2vXDjtr165d+lclePXz89PfERWNkeVvdY4dOzYqK7Nm
zTJ7axU0bRh3YQnqifI90owZMzJbozXBK1pnOZYcekNuchwGr+RscKbzMP2Qs2fP
nv/7t7Fjxy5duvT06dOat1gTvKJtfPfddzFFbpaqwGLR7TP7LOzMglezvxjd9PMm
uVhAmWJ78FquXDmzm0ieOYCFKFcWjBs3rlevXg7qLlOuxuCV7GXVqlXy49Dg4ODP
/u3NN9/Mnz//hAkTNG8xG7zKzVWU4PX48ePS5oeHh6vf+/MvP3uY7q+qb9kkWVAH
r3KP123btumL/cUXX+Clvn37KlOePHkil+5mGbzKcw71wWvVqlXN5lPdu3eXdSll
xhmtSpUqsbGx+pmJBINXsqNBgwahLi1evFj/kgSvefLkkaf/qUk72aFDh8x6ktHR
0eg/Z5lFmL0CAGM9NNdYvuY+XTBr1ixPE/WvuES/fv3wlmnTpln7yckpMXglR0lJ
SZEfnKq/7lbYErzKDbAsq1y5sv4yBDSgcmlA5X+TczzaX/lzw4afNG+0JnhFSypP
DNv08ybLW4acE4NXcjYSvBYsWNDCHas1rAleAWPyIkWK5M+fH/1LjPDRAR03bpyv
r6++9ROvFLwuWrQIL6G/q0yxPXgtW7as2YLFxcfJI7akY40mumHDhvv27bO0jchd
MXgle5HHpqP5wj80P0fYv38/WlTNjaczrAteExIS5PbZ6Ioo3QAsChNr1qxp9kSQ
WfBq9iu05cuX46WBAwcqU2wPXmvVqmV2E+3YsQOv4iwjC0EPvHPnzgwOyDIGr2RH
gwcPRl1asGCB/iVbgtdLly6hZcsyi1izdo3+vdHR0WXKlKlYsaL+aQqJiYly00J1
ayzkilezd/eiXITBKzlKWlqajLTN3jTAluAVb3mSladPn+qjK7xx0qRJbdu2bdq0
aWOVfPnyYY1vvfWW/KnvrVoTvMbGxkrJzd5agZwfg1dyNnI5p4fFe15rWBm8ZpjG
55hSoEABDIYx7EdDLQ9sMSuz4NVst7JHjx54Sf1AYcdd8Zrxz80E69evn2GKqoOC
gvR3sCHKYPBK9iNfL2Hcfv36dSvfYk3wmmG6qwD6qIUKFQoJCcHwG53h7t27d+vW
LbMVvVLwKs+8Vd9/1vbg1dfX12zBlMNt1qxZGaZArV69evpLIojUGLySHQ0fPtwj
k8dk2RK8YoyWmJiYZRZhtv7cunUL661Tpw6WoHkJ8zdq1AirPnr0qHo6iiG/IZ4z
Z84rfHhyPgxeyVHQTMi19PonDGT883Ct7AWvdidpl3QNzfr+++8xQ8uWLdGMZjYP
OrvyRAV0mh1TTHIsBq/kbDDolTvut2nTJikpyZq3SPCKcYv6rlWah2uJtT+ubdGi
hdlbwejpH64lwev69es0c6JPWahQoaCgIHXbbuHhWsWKFYuIiFAmSi6gD16xHTI7
KC5cuICus5eX16FDh3r27MnnZVNmGLySvWzY8BPaJdQE6+9YamXwmmFqMIODg9EZ
njhx4owZMyz3KjMLXvU/Vs0wdbALFCigTj8dd8UrzJw5EzPUrl0b3ZvJkycPGTLE
wgchymDwSnY1ffp01KVhw4bpX0JNK1y4cPaCV1tER0eXNdE/AzwxMbFKlSrly5fX
XOalPMuR8Vdux+CVHGj27Nke/37siUKuwGrbtq3+JQlec/Lu+/JQrK+//jqzGeTS
hubNm1vIPtCCo/kuWLCg2XvLkvNj8EpOaPz48XLR68cff6y+NV5cXBzapQMHDmjm
j4yMzJs3r7e3t7orKQvp3LmzMkUGzDVr1rSyGJIOhIaGyp/x8fHye1i04bdu3VJm
e/DgQVBQEFpUzbNcU1JS5Fba6kccoIQ+Pj5vvPGG+m6GGJljtsGDBytTjh075unp
mT9/frngC4eJpo3F0Ehua4MOa9euXdkCU2YYvJK9oK3DyFmutY+JidG8mpaWpv+B
FFo8NGVvvvlmVFSUMlHzcK0MUy3t0aMHGlgr74Wa2cO19PeN2bptq5eXl+bHqhjq
6x+utXfvXkypWLGi+mcQ+odrSa+pevXqmZXt8uXLBQoUwEpXrlzZoUMH/dPDiTQY
vJIdbdu2DXUpICBAP6o6d+4chu3oW+rvtSrBq/pBBXaETmz//v01PwsTq1atQmup
f1QMWnX0b3H6QIvqiCJRjmHwSg6EATPG/3Xq1NG3dxjAy9fg+gdVY6JHDt5AWrmj
Sr9+/TKboXPnzvKbMv2jDxVyNysHNdOUAxi8khN68uRJr169JHutXLnyhAkTli5d
+tVXX1WtWjUwMFB9OZLAgFmuw1KfJeVq0wYNGij1CkMaTMmbNy9G0ctUMB1v1MSm
IMlms2bN5M+EhAQsTUpVrFixMWPGoFRTp05t3rz50KFD9b8MePjw4VtvvaW57kCe
wQWbt2xWJkqe265dO+VCg8jIyKJFi8rEJUuWfPrpp0eOHNEsf/Xq1bKouXPnvtLm
JbfC4JXsaMGCBdLstGrVSgZRYt++fehIaB7immG6Nh+Dah8fH/XNVeSRKer+pzzG
oEmTJlYWQ04Qn3zyX/kTQ/RatWphSo0aNTCwVxrSbdu2vfvuu19++aUmS0InXHrd
aEWVifv378eU4sWLqzNi9G8xcdy4ccoU6TUVKFDg0qVLGaZHdevvJBAcHCzzoPHn
TWAoSwxeyY7QIhUxQa9V89KGDT+hmqFNxvhd85IEr02bNnXQY1rRrqIrgp4tmlCZ
kpqair63r6/vwoUL9fOfP38eB0W1atVSUlIcUR7KMQxeyYHQjqBlQS9TfUnUqlWr
evTogbG6tHctW7bEoF1pSjBil+/qy5YtGxoaunfvXseVDQMnrAI95tdeew1rLFy4
MDqImKJcRLZ129YuXbr4+fnhI0j3Gt3Zzp07f/755/oWfOrUqWYvMaDcgsErOaen
T58uXbrU399faYjee++96dOna761Qk+uZ8+e0n7K1ayhJiEhIWjcMMXT0zMwMHDG
jBlpaWloAPEPj0xUrVp19+7dslj0AlEhCxUqJC12+/btFyxYgHUNGjRo3bofP/30
U3nJw3TrGP2jFFHIiRMntm3bFu/1MD0oDI3q2LFjcaBVrlxZ3ohhv1JUueO2t7c3
iooVYdiDju+atWsk7cJHmDlzpn70/vDhQ5xT0IvlDQTJAgavZEdoiNDxQ2MlbWPj
xo2DgoLQ1hUvXnzSpEnqH0ihyUVLKHej9jA9CTDeJCIiQlpsNIbXr1+XW/6hk4xm
EAusX79+oAo6qKi36l85oMN85coVaUgxYkdPGyeLe/fuofF/8803ZV0NGjRAqQIC
Apo3b6559Cu6GejKysWt0LVrVzSkjx8/RsFGjBghE7/77jspanh4eIkSJWSBN2/e
lB/Jor0tX768h+kZCR06dOjevbv6vjFC0g3YuXOnA3cGuQoGr2RH6EB269ZNybnE
hQsX0AWVi648TD+Wwp/qn17JzwhQD9HjddDzrB48eDB8+PCWLVui34ve75AhQ0aN
GnX48GGzM+OkwF6Ha2DwSo4lX92rv8BB1/D06dNXr15FLzMyMvL8+fNhYWHKQBon
udu3b+Ml9CYxm/4HXPaCqo8ynDp1CgXAKRZrRH/x7NmzmIKRlcxz//59lAEzXLt2
DTNERUVdunTpzJkzly9f1tyaNjk5uXr16uXKlYuOjnZQgcnRGLySM8NA9+7du2iI
0ELq7wyVYRqEo71Cc3rdBP84ZYImC42btLdo4mRgjFcxTv7ggw/QAb3+D8ywectm
Sab8/Pzkp7Jo9zRLwP+TkpKUxwKgncRLaNhTU1P1pUJTiXHUuXPn8C5pZlFINKFY
Dv6vL6o0tmiTZUXK5QZoljH93r17mW2fzp07G3jwUq7A4JXs7uTJk6NHj27QoMFb
b71VrVq1Tz/9VH9LVjSzwcHBjRo1qlGjRs2aNVu0aBFs0q5duzp16tQ0wb9nzJgh
88+aNcvLy6ukSokSJSTh9fHxkUcaorc8ZcoUvOvdd9+VJWA49+2336LxnD9/Ptrt
1atXY0WlS5euUqXK5MmT9d1pTPnkk/+2adNG3o7l4KTwv//9r1OnTvXr18cUlLZl
y5ZSVHROateujYm+vr6yImmcjx07hndVqFABn07/W4QM011xihcvjgXqnyRDpMfg
lexry9YtqE5o2ZQp8fHx6GEqvWXpkaovqELbqHRE9V8m2dGDBw/QPcYp4+rVqxYq
G0aFOCOge+y4klDOYPBKjhUbG4suF7qkVj4ZJpfavn27h8W7xJLzY/BKbgJD5YIF
C2IkbDbAPXr0qKenJ2ZQf//v5HB+CQwMdNwvJMg1MHglQ6Snp2sG1c9M1BfvPzdJ
SUmZN29e5cqV8X9NNwCjbvnZfrNmzeRbMXmLZgmvWir1Wp79QzOP2aJavyIUe+bM
mdbPT+6MwSvZV3JycoMGDUqUKPHo0SOjy5IdOCLkdjQcGLoABq/kcD+s+QG7bOXK
lUYXxFHQpvv6+latWlV/v1rKRRi8kpuQ+/qjZTb7alJSUp48eTDkUD9Wxclt3Lgh
KChI80MEIg0Gr+TklixZYqF+nj9/Hq+WKFFCff8uJ3f9+nU/Pz95NCJRlhi8kt0d
PHgQNerzzz83uiDZgSFh0aJFIyMjjS4I2QGDV3I4VLJevXqh1bDwK9FcDQMwb29v
NOtGF4RswuCV3ISc9fXPExARERFyv78cLlW2paSktGjRYunSpUYXhJwdg1dyZs+e
PQsICEDtOnTokNkZHj16hFcbN26sf4Ch0xo/fny2DzdyQwxeyREmTpyIofqZM2eM
Lsir2bhxg5eXV2bXSVCuw+CVckJsbGyrVq2Cg4NzUWfRSnv37i1RooQLX8/rPhi8
kpuYNGkSqtnUqVPNvjpgwAAfH5+TJ0/mcKmybcmSJfXq1dM/8JBIg8ErObO0tLSW
LVuidmX2iJVt27blrrp348aNatWqHT161OiCUK7B4JUcISUlpWfPnvXr189Fz2LB
sfDWW2+NHDnS6IKQ3TB4pRxy//79Pn365Lrvmix7/vz55MmT586da3RByA4YvJKb
iIqKqlixoqen56afNylPr8owXU41depUjDec/wz75MmTKVOmnD17dseOHQULFuRX
X2QNBq/k5KZPn47ahZGO/qW4+DhfX99333334cOHOV8w6+GckpKSIv/u3bt3586d
jS0P5S4MXslBEhMTcerfvn270QWx1qJFi4YPH250KcieGLxSzkFtc7178Cn9S8rt
GLyS+7hw4YK/v3/58uU//PDDhQsXLlu2bPbs2QMHDuzatav0BpzclStXPEwKFy48
YsQIHi9kDQav5OQePHjQokULVLBJkyYpj4JJTk4+cOBAQEBAkyZNoqKijC1hlm7f
vo2iSmRQqFChixcvGl0iyk0YvJJDpaamGl0EazFhcD0MXomIXmLwSm4lPT391KlT
CxcunDJlyldfffX9999jwGN0oawVHR29cuXK2bNnZ3YzRCI9Bq/k/B4+fDhu3Lj6
9ev7+/ujQzJo0KChQ4cOGTJkwYIFueJuXUePHpVvxWrWrJnZncSJMsPglYhcFYNX
IqKXGLwSEbkwBq+UW8TFxZ05c2b//v0HDx68dOlSYmKi0SWy1uPHj69evRoWFhYX
H2d0WSj3YfBKRK6KwSsR0UsMXomIXBiDVyIiZ8bglYhcFYNXIqKXGLwSEbkwBq9E
RM6MwSsRuSoGr0RELzF4JSJyYQxeiYicGYNXInJVDF6JiF5i8EpE5MIYvBIROTMG
r0Tkqhi8EhG9xOCViMiFMXglInJmDF6JyFUxeCUieonBK7mGR48e3bx50+hSZOrG
jRu//vrr3bt39dMPHjy4d+/eY8eOxcbGal79888/MUMOFZFcFINXMlZ0dPSdO3eM
LoUZUVFR9+/fz3K2P/74Qz/bgwcPbt++7Zhykdth8EpErorBKxHRSwxeyQXcu3ev
bdu2y5cvN7ogZly5cmXQoEHNmzcfMGAABlfK9Li4uBEjRpQqVcrjHw0bNpwzZ05a
Wpoyz9mzZ+vWrXvkyBEjCk4ugsErGej69et+fn6bNm00uiD/JzExcfOWzQMHDixX
rty3335rYbYtW7eg9X7rrbcWL16sefXgwYP16tW7cOGCgwtLboHBKxG5KgavREQv
MXil3A6DhICAANSihIQEo8vyLyjYlClTMLbv1KnTyZMn1S+hqKjwqPZeXl4Y6hQp
UkSJX4cMGaIMe3B0jB8/vnjx4leuXDHiE5ArYPBKRnny5Enjxo27dOny9OlTo8vy
sjlFOzx69Gg/P7+GDRtKe7ts2TL9bKdPn8awq2XLli1atJDZVq5cqZktLS0NbXX5
8uVv3bqVU5+AXBaDVyJyVQxeiYheYvBKud2IESPeeOMNZxv9xsfHd+zY0cfHZ+nS
pfpXjx075u3t/ckn/w0PD09OTn769OmqVavKlSsng/xt27Ypc2II1Lx580aNGiUm
JuZg8cl1MHglQ6Snp/ft27dkyZKoP0aX5aWoqCi0sU2bNt26bevVq1dLly6NKq2/
lBVtcpUqVdDkYrb79+/ny5cvszgMbbKvr29AQEBKSkqOfAJyWQxeichVMXglInqJ
wSvlart370blmTt3rtEF+Ze4+LjAwEAUbNPPm8zOsHLlysaNG2smHjlyRIZeOOOr
p6OngokTJ050VHHJpTF4JUNs2rQRdeaHNT8YXZC/oVnes2dPcnIy/n3//n25zYv6
Wy7x6NGjAwcOSJb6+PHjvHnzYrZdu3aZXSamO+EJiHIdBq9E5Kpya/C6ddtWowtC
RC7lyJEjDF4pl8IQulq1auXKlXOSK6oEqvGHH35oeTS+ePFis1fC+vv7443t2rVL
T09XTw8ODs6TJ094eLj9i0uujsEr5TzUutKlS9eqVevx48dGl8WM27dvlyxZElX6
+PHjFmaLi49Dw4vZzpw5Y3YGdGD8/PyKFCnCB22RLZwkeC1cuHDZsmWNKgARuaoO
HTrkvuB1woQJhw4dOkBEZA8HDx7EQJrBK+VSa39ci5ozcuRIzfT4+PjIyMjt27fL
o7QxnMBgZuHChT+s+SEH7kggV5HXrVvXws0BNLmqYujQoXhvt27dzC5TcyUskTUY
vFLOW7BgASrM9OnTNdPj4uIiIiK2bdsm35ZduXJl6dKlaJzXrfvx/v37OVY8JXi1
/OhCJXjV3KRbbf1P63lokI2cJHgtWrRokSJF9u7da/TohIhcx/79+997773cFLzK
YAw8PT09iIjsqlevXkY1bgxeKXuePXsmP+fft2+fMvHGjRuhoaGNGzcuX768t7f3
lq1bNm7c8M477yhV/e23354/f77jSoX63Lp1a6xIeVh2qomVdTskJMTD3G0H7969
W7x48UKFCj169MjOJSZXx+CVclhycnLDhg0xYDl9+rQyMTw8vHPnzphetmxZHx8f
DMa+//57NNRK41y1atUcS53sGLxGREQUKFCgTJkyzvAAMcqlnCF4vXbt2ptvvpmD
Iw8ici9Hjx7NyBXB64oVK/xMWhIR2U+rVq1atGixcOFCoxo3Bq+UPZGRkYULF86X
L9/Dhw+ViRj6hoWFrV69Wr6kbNCgQceOHTdu3HDr1q3Lly8PHDhQzv0bNvyU2WKf
PXt27ty5U1mJjo42+/ZLly75+PhgrI5xFJbToUMH/Jk3b14ca6tWrUpLS7PwiTDI
xwC+WLFi+l+t4o1BQUEevOMQvToGr5TDLly4gHavVKlS6vsMPHnyBM3jt99+i4rk
5eXVqFGjLl26oEFD44z5e/ToIdN/++23zBabmpp6+vTpLBtna76dsmPwmpSU1KxZ
M8xz8ODBLNdLZJYzBK/o1Xz00UdGD0qIyAX5+fkFBwdjIJaRK4JXIiKXxOCVsmf7
9u2oNg0bNtS/FBsbW6FCBbzq7+8fExOjTE9PT5fK1qdPn8wWi/da87Xt5MmTzb59
/vz5eLVcuXKjR49+//33MYz5+OOPa9euLe8aPny4hcdWyH0/Zs2aZfbVESNGWFgv
UWYYvFIOW716NWpL27Zt9S/duXOnWLFieLVjx47x8fHK9NTUVDTmHhZvqHLz5k1r
GudFixZlWUI7Bq8gN/WeM2dOluslMssZglciohzA4JWIyBgMXil7Zs+ejWrzwQcf
6F/6888/5Res27dv17y0ePFiTG/RosWTJ0/MLjYtLW3Pnj07snLjxg2zb//kk/9i
+d7e3h999FFUVJRMjIuLGzBggIQCO3fuNPtGjLswwg8MDJSnaetNnz4db+/QoYPZ
V4kyw+CVctiECRNQW/r27at/6datW/JzZvnJodq0adMwPTg4OLM2MCkpadeuXVk2
zvfu3cuyhPYNXkeNGoV5evfuneV6icxi8EpEboLBKxGRMRi8UvbIKH3MmDH6l2Ji
YsqWLWs25Vy37ke5ThYjakeUKjQ0FMv39fXVLD8uLq5GjRp4aejQofp3JSQk1K9f
v0mTJurbJmjII1yaNWtm/0KTS2PwSjls9OjRqC1oovUv3bx5s3Dhwp6ensePH9e8
JN+KBQQE5MDNUu0bvC5ZskQiY3sXk9wFg1cichMMXomIjMHglbLniy++QLWZMGGC
/iUleP311181L8lvYBs3bqz+lasaxvwjRowYnBX1E73U5E6F7du31780aNAgvNSt
WzfN9CdPngQFBTVo0CCz+8aKn3/5GW9v0qSJhXmI9Bi8Ug777LPPMrtrihK86q94
XbBgAd7Vrl27pKQks4uNi48bOnRolo3zqVOnsiyhfYPXFStWZNbsE1mDwSsRuQkG
r0RExmDwStkjd0S1fMVrNoJXjLQlF7Asszuxys3+AgMD9S+NHTsWL3Xv3l0zfeDA
gRUqVFDuS5AZueK1adOmlmcj0mDwSjls5MiRWV7xmo3g9c6dO6+//nqWjTMa+SxL
6IgrXnkfGMo2Bq9E5CYYvBIRGYPBK2XPjBkzUG26dOmif8mW4DU9PT3FCqi3FkrV
pk0b/Uvjxo3DS59++qkyBRV+2LBhlStXDgsLy/Lzzpw5M7MlE1nA4JVy2Oeff47a
0r9/f/1LtgSvNjbOavYNXuXzdurUKcv1EpnF4JWI3ASDVyIiYzB4pexZ++PazH7d
+eeff5YrVy57wauNzp8/7+3tjbXr79aKGo5V79q1S5kyevTounXr3r5925olT506
FW/v16+fPYtLboDBK+UwiVB79Oihf0kerpW94NWO7ty5U6pUKbPP+FLDaUKCV8u3
Lxg2bBjmGTlypL2LSe6CwSsRuQkGr0RExmDwStlz8uRJVJty5crpr2+6fft2iRIl
8OqePXs0L0nw2rx588ePHzuiVKjDnTp1wipWrFihnn7r1i0fH5+ePXs+e/ZMpnzz
zTdvvPHG+vXrbty4cUXn7t27miV/9NFHWOyiRYscUWxyYQxeKYf99ttvqC21atXS
vxQeHp4/f35PT8/Tp09rXpLgNSgoKDU11dElvHPnTr58+bC6Y8eOWZgtOjoa7bbl
4DU9PT0kJATzrP1xrQNKSm6BwSsRuQkGr0RExmDwStkTFx/n6+vr5eV1/fp1zUsH
DhzAdFSqpUuXal6S4PXtt9+OiYlxUMFQnipVqhQpUmTL1i0yJSwszM/Pz9/f/6+/
/sowDdRXrFjh7e3tkTnNlbyJiYnNmjXD9MuXLzuo2OSqGLxSDouOji5btmyBAgX0
DwxEqyhN3KZNGzUvSfD67rvvOuhbMUVKSsrGjRukGFOmTMns1gSpqalr1q6R2b7+
+uu0tDSzs8XFvTwToT2/deuWI0tNrozBKxG5CQavRETGYPBK2fbpp5+i5qxfv06Z
cuPGjb59+zZo0ADDYC8vr7fffjs0NFT9Y9K5c+diOl5t3br15MmTk5OTHVEwjMAH
DhxYp06d4ODgXr16oUhfffXV06dP5dWIiIgiRYp4enqiJJk9H0Zzu0C85bXXXmvU
qBGPEXpVDF4p56HdQ4XZsWOHMiU8PLxnz55oFb1Mqlat2qdPn3PnzikzoEHGdB8f
H3QJZsyYYc2tWl9VTExM9+7dsXzUZylG8eLF27dvj9Kqr2m9e/duv3792rVrV758
eZmtZMmS77//Pt579uxZzTIxBS02XrV7acl9MHglIjfB4JWIyBgMXinbzp8/j5oT
EhKiTElKSsIAJiIiAiPne/fuRUVFhYWFxcXHKTPEx8djOl69cuUKXnVolYuOjr5s
8ueff6qnP3369ObNm/csiouLU79Fnpq9cuVKx5WWXBWDV8p5hw4dQoUZMGCAMuXJ
kydoja9duyZNXGRkJNrGhIQEZQY01Jh+584dtOE3btxIT0+3e6lSU1NRBiwfjb8U
AyvCnyiJ/BxBJCcn4wShnu369ev489KlS+oCi2nTpuGTKr9vIMoGBq9E5CYYvBIR
GYPBK9miU6dOPj4+rv0D/JSUlCpVqlSqVCk2NtboslDuw+CVch7O7P7+/oULF3bt
H+Dj4CpdunS9evUcfXsEcm0MXonITTB4JSIyBoNXskVUVJQ8tMrogjjQ4sWLcYBs
3LjB6IJQrsTglQxx8eJFT0/P4cOHG10QB/ryyy9xXPz2229GF4RyNwavROQmGLwS
ERmDwSvZaMWKFRjeb/p5k9EFcYioqKhChQp99NFHRheEcisGr2SUWbNmoXHes2eP
0QVxiAsXLrz++usjRowwuiCU6zF4JSI3weCViMgYDF7JduPHj3/77bfDw8ONLoid
/fXXX61atfLz89PfWJDISgxeySg4pw8ZMqRGjRo3btwwuix2hoOiQYMGwcHBDnpC
I7kVBq9E5CYYvBIRGYPBK9kONWf8+PGLFy82uiB2dvz48e7du8fHxxtdEMrFGLyS
gdLS0j777LN16340uiB2tnv37j59+iQlJRldEHIFDF6JyE0weCUiMgaDV7KX1NRU
o4tgZ8+ePTO6CJTrMXglw6WlpRldBDtzvU9EBmLwSkRugsErEZExGLwSETkOg1ci
ImfG4JWI3ASDVyIiYzB4JSJyHAavRETOjMErEbkJBq9ERMZg8EpE5DgMXomInBmD
VyJyEwxeiYiMweCViMhxGLwSETkzBq9E5CYYvBIRGYPBKxGR4zB4JSJyZgxeichN
MHglIjIGg1ciIsdh8EpE5MwYvBKRm2DwSkRkDAavRESOw+CViMiZMXglIjfB4JWI
yBgMXomIHIfBKxGRM2PwSkRugsErEZExGLwSETkOg1ciImfG4JWI3ASDVyIiYzB4
JSJyHAavRETOjMErEbkJBq9ERMZg8EpE5DgMXomInBmDVyJyEwxeiYiMoQSvISEh
RpeFiMjVPH782F7B67Rp0+xbNiIiCg8PZ/BKRO6AwSsRkTHUV7waXRYiIleTkpLS
oEEDuwSv06dPt2/ZiIgoMjLSx8eHwSsRuTwGr0RExlCC19KlS//vf/8bOXLkZ0RE
ZA+jRo0aOnRoqVKlbAxeK1asiCU0aNBg9OjRI0aMMPpjERG5iDFjxvTp08fLy4vB
KxG5PAavRETGeP78efPmzT2IiMiRPvzww+y10jExMSVKlDC6+ERELm7RokX27WMT
ETkVBq9ERMZ48eLFiBEj6tatW4/I6b333nuoq4UKFcIAqVixYvjT6BIRWQX1dsaM
GdlrpePi47p27cpWmnKF+vXr16pVy9vbG610uXLl8KfRJSKyCnoUW7ZusW8fm4jI
qTB4JSIiIqv07NkTQ/qJEycaXRCiV5Cenm50EYhyQmxsbI0aNdBKr/9pvdFlIXoF
L168MLoIREQOxOCViIiIrMLglYjIacXGxtasWROt9IYNPxldFiIiIvobg1ciIiLK
2osXL0JDQzGknzBhgtFlISIirYcPH/59xev6dUaXhYiIiP7G4JWIiIiyxuCViMiZ
MXglIiJyQgxeiYiIKGsMXomInBmDVyIiIifE4JWIiIiyxuCViMiZMXglIiJyQgxe
iYiIKGsMXomInBmDVyIiIifE4JWIiIiyxuCViMiZMXglIiJyQgxeiYiIKGsMXomI
nBmDVyIiIifE4JWIiIiyxuCViMiZMXglIiJyQgxeiYiIKGsMXomInBmDVyIiIifE
4JWIiIiyxuCViMiZMXglIiJyQgxeiYiIKGsMXomInBmDVyIiIifE4JWIiIiyxuCV
iMiZMXglIiJyQgxeiYiIKGsMXomInBmDVyIiIifE4JWIiIiyxuCViMiZMXglIiJy
QgxeiYiIKGsMXomInBmDVyIiIifE4JWIiIiyxuCViMiZMXglIiJyQgxeiYiIKGsM
XomInBmDVyIiIifE4JWIiIj+9vz584SEBLMvWRO83r9/32FFIyKil+lqfHx8Zi9Z
Dl7RjMfFxTmydERERKTF4JWIiIheSk1NHTVqVN26dSMiIvSvZhm8bt22tXLlytOn
T3/27JmDS0pE5I5u3brV2uThw4f6V7MMXufPn48Z9u/fn56e7uCSEhER0d8YvBIR
EdFLN2/eLF++PAbttWvXvn79uuZVy8Hrzp07S5YsiVfr1q1rNhEgIiIb/fbbbx4m
AQEB+uteLQevS5cu9fLywqv9+/fn12NEREQ5hsErERER/e3UqVNly5bFyByj98jI
SPVLFoLXnTt3Fi9eHC9Vr179999/z8HyEhG5l++++87T0xPtbevWrf/880/1SxaC
V7zL29sbL73//vv37t3LwfISERG5OwavRERE9H+U7NXX1/ePP/5QpmcWvO7YsUNS
V8x/7dq1HC8vEZF7WbZsmVz36u/vHxsbq0zPLHjF/HKta2BgYFw87/FKRESUoxi8
EhER0b+cOHGiVKlScs+BGzduyESzwatyh4GqVateuXLFmOISEbmZFStWSJbatm1b
5XlZZoNX5Q4DgYGBvA8MERFRzmPwSkRERFpnzpyR616rV68u17Gmp6drgtedO3cW
LVoUU2rWrKm+NpaIiBxt+fLlmnsO6IPXZcuWKXcYYOpKRERkCAavREREZMbJkyfL
lCmDEXutWrXkulcJXidPnpxhSl1LlCghqWtERITBZSUicj/K/V4DAgISExOfPn0q
weumTRszTKmrvNq+fXvlqlgiIiLKYQxeiYiIyLyTJ0/KPQfq1KkTFRU1cOBA/Hva
tGn79u2T6bzDABGRgZYvXy53Emjfvv21a9fq1auHf2/ZumXtj2uVa101z+AiIiKi
nMTglYiIiDJ1+vRp5Z4DjRo1wj+aNGkiV8LyDgNERIZTrmytW7du+fLl5eYDPj4+
+Ee7du0ePXpkdAGJiIjcGoNXIiIisuTEiROlS5f2+LcaNWqEh4cbXTQiIvq/ew6o
tW/fPjY21uiiERERuTsGr0RERJSF06dPq7PXqlWrMnUlInIeyj0HRLt27XiHASIi
ImfA4JWIiIiydurUKbnnQI0aNa5du2Z0cYiI6F+WLVsmqWtAQACfpkVEROQkGLwS
ERGRVY4fP/7mm2/+73//M7ogRERkxtKlS728vFatWmV0QYiIiOhvDF6JiIjIWkeO
HFm37scXL14YXRAiIjJjxYoVm7dsNroURERE9DcGr0RERPQKnj9/np6ebnQpiIjI
vKSkJKOLQERERH9j8EpERERERERERERkZwxeiYiIiIiIiIiIiOyMwSsRERERERER
ERGRnTF4JSIiIiIiIiIiIrIzBq9EREREREREREREdsbglYhcU1JSUhzE8z/+x//4
H/9z4//i4p48eZK988iLFy/i4+N5KuF//I//8T+3/g//i49/9uyZfYcqROQ+GLwS
kWv67rvvGjVq1Lhx4yZEROSucCL44osvsnce+fPPPwMDA7EEoz8EEREZBmcBf3//
ixcv2neoQkTug8ErEbmmzz77zIOIiNxely5dsnceuX379muvvWZ08YmIyHj79u2z
71CFiNwHg1cick2ff/45Okmenp7+/v5BQUHtiYjIbaDZb9u27euvv44TQa9evbJ3
Hrlz506hQoWwhIoVK/I8QkTkhipXroyzgI+Pz8GDB+07VCEi98HglYhckwSvBQsW
fPr0qdFlISKinJaamlq9enUbg1ecRLCEUaNG2bdsRESUK6z9cS2DVyKyEYNXInJN
ErwWKFDg4cOHRpeFiIhyWlx8XNWqVe0SvA4fPty+ZSMiolxhxYoVDF6JyEYMXonI
NSnB659//ml0WYiIKKfFxTF4JSIimyxfvpzBKxHZiMErEbkmBq9ERO6MwSsREdmI
wSsR2Y7BKxG5JgavRETujMErERHZiMErEdmOwSsRuSYGr0RE7ozBKxER2YjBKxHZ
jsErEbkmBq9ERO6MwSsREdmIwSsR2Y7BKxG5JgavRETujMErERHZiMErEdmOwSsR
uSYGr0RE7ozBKxER2YjBKxHZjsErEbkmBq9ERO6MwSsREdmIwSsR2Y7BKxG5Jgav
RETujMErERHZiMErEdmOwSsRuSYGr0RE7ozBKxER2YjBKxHZjsErEbkmBq9ERO6M
wSsREdmIwSsR2Y7BKxG5JgavRETujMErERHZiMErEdmOwSsRuSYGr0RE7ozBKxER
2YjBKxHZjsErEbkmBq9ERO6MwSsREdmIwSsR2Y7BKxG5JgavRETujMErERHZiMEr
EdmOwSsRuSYGr0RE7ozBKxER2YjBKxHZjsErEbkmBq9ERO6MwSsREdmIwSsR2Y7B
KxG5JgavRETujMErERHZiMErEdmOwSsRuSYGr0RE7ozBKxER2YjBKxHZjsErEbkm
Bq9ERO6MwSsREdmIwSsR2Y7BKxG5JgavRETujMErERHZiMErEdmOwSsRuSbbg1e8
8cqVK2FhYdeuXYuLj7Nv8awRERGxefMv3333XY8ePYYNG5bzBTBKenr6H3/8senn
TYsWLerVq9eUKVPsteTnz5///vvvGzb8tGTJkm7dus2bN89eS4akpKTjx4+v/XHt
7NmzQ0JCdu7caceF5yLYyOfPn8dGXrBgQfv27RcuXGh0ici8tLS0ixcvosZiH4WG
huIfRpfIzpwheE1JSbl16xbOI5cvX759+3ZiYmL2lpNtaJeOHTv2w5ofZs2aFRgY
uGvXrhwugIEePXq0Z8+e1atXjxw5Mjg4GNvfXkuOj4/fu3cvtuoXX3wRFBR06dIl
ey0ZIiMjcepfvnx57969Bw4caMcl5y44fvfv379ixYpx48Z16dIF/TGjS0TmoZ3c
um0rauyQIUM+++yz5ORko0tkZwxeich2DF6JyDXZEryeP3/+448/LmdSvXr10qVL
Y/SOofv6n9Y/fvzYEaU1C+PkDz74QIb9GDCrX7p58+aqVatOnTqVY4VRpKenYyiL
AWd0dLSDVvHs2bN58+Z17NjR29sbn33EiBH2WnJSUtL06dMxTvby8sKSR40aZa8l
w71794YNG9asWTMPk40bN1ie/9atW9iJR44cwSa1YzEMh408cuTIgIAAT09PbAd1
uh0TE4OPjLH08+fPc6w8qE47d+5c++PaR48e5dhKc4WEhITRo0e3b99eDrQvvvjC
wMKcPHkSdePatWt2XKaxwSsqHmpd69aty5QpU7ly5UqVKpUqVap+/frjx48/ffp0
jh31aJcGDhzYpEkTaZd+/uVn9as4GLHZ79+/nzOFUcMZZPXq1bt378aGctAq0Lr2
6NFD6oCPj48dT9+XLl3q3bt3vXr1ZKueO3fOXkuGBQsWdOrUqXDhwlhyixYtLM+M
inTo0CHsxLt379qxDM4APZzQ0FAcO9gOOIhu3LihfgkfOSoqKifLgy2MlR44cODF
ixc5uV7nt2HDT927dy9fvjz2VO3atXP+6yUFOvzYR3v37rVvq8LglYhsx+CViFxT
toNXDJUx4Hn77bcXLVp0/vx59OyPHj369ddfY1Genp5nzpxxUIEzExwcjA8ycuRI
Zcrz588bN26MiW+++WZOBsECow4Zak6YMMHR6woKCsKKxo8fb9/FYqSKsQGWvHTp
UvsuOcN0nbK3t7eXl9fp06ctzJaUlPT++++jDEWLFn3w4IHdi2G45ORkX19fzUbG
2EwqT04OmLdv3y4rnTlzZo6tNBdJSEiQZGr69OlGleHq1auFChVCGTp37mzHRNLA
4DU+Pj40NBRv7NSp06+//hphsmXrlm7dumFi+/btHZc2mnXx4kW0S3ny5FG3Szi1
yaFh36+grJGamjpw4ECs+rXXXgsLC3PourDZ5XSJVte+Sz506BCWnC9fPkd8qSNV
ZfDgwZZnQ59EvuIaNGiQ3cvgDDZv/gWfrmLFisoFy5GRkXJUdunSJce+wMAZrUeP
HlgpVo0C5MxKnZl+y48ZMwbbp2HDhkYFry9evOjfvz/KgLbOvq0Kg1cish2DVyJy
TdkLXi9dupQ3b94SJUpgkKx5af/+/WXLlsXwVT3x+fPnhw8f7tq1K7pltpfZLCwc
H2TixInKFPR3v/nmm6pVqw4YMCAtLc1B683MnTt3OnToUKNGja3btjp6XdKHtnvw
ijG/XP+1atUq+y45wxS8YmDm5eWlqSoaqDkLFy7ETuzbt++TJ0/sXgzDoWY2bdoU
G3nJkiXKxB/W/FCtWrWQkJC4uL/v3YGR0qlTpwYPHowqbcvqsJzjx4/jiFi8eLHm
JQySAwICatWqtWfPHltWkds9evRo/vz5Xbp0uXfvnnr6/fv3DQ9e4+Pj+/Xrh2Is
WLDAjos1MHidMmUK3oUKqY8nPvroow8++EAz/fbt23jL0KFDlUPDvnBqK2Cibpew
6zt27IhNtOnnTY5YqQU4YNf/tL569eooQExMjEPXdfDgQQlenz59at8lo82RboYj
kqYPP/zQmh98REdH46DGTly37ke7l8EZoOuF7fD2228rwWtCQgL6BvjIixYtUmbD
dpg1a1aPHj1sDMEfP368cuVKnKTCw8PV03HKxnSsFKtw0EGaK+DMvm/fPlTO77//
XvMS6qqxwSsaVbQq6GOggbVvq8LglYhsx+CViFxT9oJXuQbH7FAnKioKo0SMw9UT
4+Lj5HdwjsssOnfu7Ijw0fmhDy0jT7t/9uTk5EaNGmHJ+pGD7TBaQ63z8vK6cOGC
3Reei2Ajy3XZ6uBVD6NcyWdtvKHE06dP69Spo/mKgtRWrVol8ZMmeP3rr78wVDY2
eHUQo4LXu3fvYjt7e3ub/QX6qFGjPvroI83EsWPHYi3vvfdefHx89opqGZqj/CZu
2C7t3bvXQcHrkSNHpJvhiJ+e9O7dGwv/9NNP7b7k3GX37t2a4NWs+fPnyx0JYmNj
bVndvn37sBycwS9fvmzLclwVTh/vvPMONtHcuXM1L02bNg3T69evb+CtBhyEwSsR
2Y7BKxG5pmwEry9evPD398e70IPXv4qR1YkTJzS/D42Lj6tUqRLesv6n9XYotDkM
Xu3+2dPS0hwXvEZERDB4zXiV4FXuimt5tiw9ffpU7rfoiH3qGlavXo3tg/ZK04jh
QJO7XjB41cte8Hr06FG0AKVKlbp586b+1fDw8D/++EMzcdy4cVhLSEiIg24feenS
JQavdg9e5V4NDF4dysrgdcGCBZitTp06Nh5BEry+8cYbf/31ly3LcVX37t2TTq/+
N09yisGJmMErEZEeg1cick3ZCF6fP3/epk0bvGv06NFWviUtLa1atWp4CzrrmpdS
U1Pv3r2LUa7+h+Tx8fGYntnzTNDdP3XqFLp3V65cSU9Pl9GXJnzEeu/cuYMZ9DcK
vHXr1o4dO9AnPnbsmOXfsMfFxR04cGDzls3bt2+/ePEi/rRyxJKQkHD16lX1w7WS
kpJQGLlxJ8qMpaH8hw8fRmEsLwqdeMyGmU+fPq35aZjZ4BVbFWvB8vEPzcyxsbFh
YWGZ7W68ikEyVnTt2jVstBYtWmQW0sXFv9wsW7ZuwT7VXBuYGXxM+bwPHjy4ceMG
xmzWBK8oxs2bN9V3IkMNxEbAlpSAADXkyJEjWPK5c+dSUlKsKcm/PkhcHN6+Z8+e
EydOyK8vsUYUVf0b58ePH5uNgWRObGf9elF7z549i1IdP37cwt1pzQavWCyqzeXL
l5WbLaIwctBpnvmjwAwoIVZ36NAh/Q1A1GR1qMz6l1BmLOThw4cZplsibtu27ZAJ
hvSbNm1U0jHsCxQD+12OC83l7RmmVB3Lx9tRXV91j2Dn4l1YLI5NbDo0Dur7hMgN
QLFelAoF2Lz5F2xkeQl7B+/CRLyE9yq3F8SWQVuBjSk7F0clFosNdfLkSbORAT4a
tk/NmjX1BfvPf/6jBK84srCJsBwcLxYaT+XjoLVBa2D5s+PT/frrr3JM4QAxm39h
4u+//65+fo5A5ccb8cFRHmw0zYFvmVHBK/aUt7d3vnz5rE85v/zyS6wFrb3+JbRI
WI6+NuIQw+bCRsvshjN4FSVBu4RWBfsI7ZK+SGgB8JL+QE5MTMQGx/7FMaLfKRpo
KKRiS5tv5T5Ca4AGFs2d8gx0nIDwYXEY4v8Zpt0njTZqmuUoB+0J6ok0wvpWQgle
lYVgRTgjoNj6D456iLbCQlODM4gcHWhVsFILwavSXOCAsuY57ziE8UmxcBzUOLoH
DRpkZfCKz4WdqM4lsTq0G8qttLFA2TjZu7k2NhSqwf79+5XGB+tCaZUZUAPRiqJq
6e+ii12JtZvt7aBeyQkOb7SwfZTgVd2dwG7CB1RPWblyJWZr0qRJZsvBqQedIqlO
6sJroPeF5RQrVkz/EmosDkNUD7R+aP/Rov72229yKsGO3rVrl3wK7A5Ml7MM/oHp
miNCul5o1lAzrexjaD4I3ihtLw5/1EPlnI5SYck7d+6UUuEfOMFJM446jz2IcmI6
3o6OgXI4oHj4XKhCshzs5YMmODb1a8fJpXr16thEON1oXpJdUK9ePfm8OFKwrsyW
o8B5GYXB1kDx5BydGdQurBQfHNsWuwnNmv4pndhHqGzYR5qqiBqLHYG14P949VWj
YQavRGQ7Bq9E5JqyEbyi0ykP/ylVqpTZ+EYDI4rVq1djFfKwlBEm33777b59+/r3
7x8QEIAxf82aNZVRK4YK06ZN69SpU+PGjTEs1z9DHF3GJUuWvPfee/LAE3TyMHOt
WrXU4eOvv/4aGhrarl27ypUrN2rUSB2tous8atSoDz/8sEePHm3bti1YsGDz5s0z
uxPrhg0/de3atW/fvh988EHDhg3LlCmD7jI6vhY+L0aqU6ZMCQkJadasGQaxcjPN
uXPnYjlt2rTBqP7jjz/GNunVq5c86wPKlSuHkpvt42KzYB9VqFDB4x/4pBgkKDNo
glfskT59+vznP/9566236tatq/SqscYJEyYEBQXVr18/b968+lt8Yog1c+ZMedCT
PBkDBZbH72qCV4yaFi5c2K1bt379+uFjohpgsDdjxgwLOQLGscOHD8ecsvBKlSph
4dhx2L8WMheMl7CV3n//fXx87Ed8UgxNBwwYEBgYWLt2bSwEf27e/EvFihWVjYOZ
MWi0sHfUHj9+PG/evFatWpUuXVoeWI9t+9VXX/2///f/UFoMwOSTona1aNGicOHC
Y8eOVd575swZ1AopW8mSJa9fv668hG2OxSoP8gYMwFDhzT7eRAle5eFaGC9h92Gx
2BH4yDJgRjmxx7FDMZu/v78cQdhZErsAxmM4svLkySOrQx376KOP1Im/wC7GGBhD
ZcyDGiLLmTVrFvbOpEmT8KkxGi9SpMgPa37AzOt/Wt+6dWtZIFb92WefKY8bQh3D
XsDuw0sdO3ZU70EMSgcPHiwHFzYajnoc4BhVWrlHzp07h/diw3bu3BkHy9sm2JjK
psOhh0+qHPg9e/bcuHGDvIS14F358uXDSziujx49+uDBA3zADh06NG3aFNsExcZH
kNsFCByh6rt2Yo9j6IvtL/V/xD9kDKkEr9iVGJFiFepDEhP138dgPI8S4hN16dIF
daBQoUJYuNmrO+Pj47Gi3r17Y7sFBwdXqVKlePHieK86Gp4+fTqWg52CrYo2RL3N
scWwx/EqSojGBHVy6tSp1j9Ox6jgNSIiQh5JjyNafQSZhc2Lg05+bPHOO+/Irhk5
ciSOd9Re5Xzx3XffKW9BbcEmRUXCNsEBpb+pJQrwySf/lSMCsBGwDV9//XXUFqnV
2C9oENDK4RyBxnzOnDnKe7F516xdg1MhmkGsHdscu2zMmDFm0/zIyEgcMthNmBNH
BNoutDlokC3ffBx1WFoDFKxatWo4ou/evTtkyBA04zip4VA9fPgwqv27776rVEW0
Zmg29YtC7V237kf5Ik2gNmIDKm1Ihip4Ralw7OC8I+cLrGjzls3KbDjicG5FPcS+
w1Ggz3RwlGEGOeN7mH5SLXdgRw3RBK+outj+qOeoeChb/vz5sUALzQXqwIoVK5RD
GLsb52VpaS0ErzixokeBnYiNg083efLkDFP4hVMYqlOJEiWwX1A3Bg0a5OXlJUvG
RFQt629ngc4MagK6MfgI0gLjqMeKUPfkFqioilgLOiSoJzhhKZVEyoZDHjsUbZem
t4P3YjmoV1IqdBhQGZSvmjSU4PX+/fvYKWiR0B7iI+OzyA1qsPUuXbqEGu5helil
0r4pySDeiD/lOk2BnYJGTL8unDLkRqWvvfbasGHDZDm7du06ceIEjjgUEgtBtcQG
RNcL3S2UQRaIaoPPK9UAzQ7aNPkZAT7jl19+qXRX0JdYtGgRdhCaNew4nGGx0b7+
+mvrv8ZDFxFvR2FwxKEjhOVjCyunKmz2b775Rm4FAGgc0HDJF6vYdLNnz5bfl6CC
4SBFOf8/e28C9WO1/v9/lGLxOxZhFVo0sBrESiiWjoxZDSoKyxA6JFNOSHJqVZIh
HWWoUOqrUWTIkClimeehMlM4KEuGSEXx/F/n8z7t/27fn+fzPHzUw+N6r1bLc3/u
e997X/va197X+772tZEtKop1pV00Ye/evcy/sl2AmZcX+WQ9j7z11lsaAkyskg+L
LjVQxCv1QQ2ef/55WU7Awoxyop/hERdtxxRQB6Y/+o4ZhwVDwoMHGT5MIsiN3q9Z
s2aJEiXKlCnjW0W3xuA66yhneBn1dAdqTB2oMz/xIpp8SiekGfFqMBhShxGvBoMh
e+L0cryyttOakoUpXhC+E6t8lt0s0YLoUZaGLH/FGflgPae4OR1JjO/kzmFgzY0b
g5eIA8xPQ4cODV6Ng826k+U7zgwOoTsCPuYRr6Lk5KXj+LkFPZ4qK3gWnQrV4V1U
G2cJjysaSzhmzGiW7DNnzhSl+MMPP8yaNQvHCX87iXBY07NMRyDiVVl/c3Hu3Llj
Ph4jipAyWRnjUE2dOpXlKW6JKs/SP+BKWC5fd911LLXxdSmB9boSfXbp0sXdExCv
kiq+vVb27rajR4/ikA8ZMkS+paOrBGRFrSpXrvz666+rqvfee6+Tqk+84pDjjdMQ
RCHWAEnyILehS1Fp4MbwUu6nwFEfjaK9uB+O3sVjSUK8qhNVE8SeFvcM6fFOnTpJ
aXEPcGURNXVGYcTF42lk5qBedIz78UL5B/4t78KlL168uCqmU+BoIPr23nvv4YFw
0T/RCO8IObdt25bruIUuAoXeFwtDMykZOTv60nd+HIKIV7wgipVKX3755Th49C8+
2xVXXBGMIIaMeAEexM9/4oknZsXRuXNn3dCwYUM/ZJKKde/eXUy6D7wvKo+S423q
CmqvR1B4xexQn2jNkTPC96/QWYx0nEO5jrydkRKLEy6Muwx7ZN26dfTIwIEDRQbh
Y9Mv1atXDxJ9njhxQvwRjn2U60QsXNc3DNzayVMmv/jii2rXvXH06dNHAU2ocSzO
ZTAM9SzDlgo4/tpByuCI11q1atHwp556iv5F4NKB2B9Tr9BrvXv3zpcvH+69LBsG
lmHLbXR3YGwRFGawZcuWjpNFgD169KCzfKJh9uzZjCC0Iuad4f7NN99gE2iUC9ZG
aFQPo5GhwB2yinhFSt26dZP0aBfV7tu3L8Nt2bJljPSAVsAoYfb1gcQHvYYNZxTI
3k6ZMsU9gmliNN1///0yhv7cxNB++eWXGVbYEEwHdonRra93sTgNJLtE1yD2ESNG
6L2uixkaqCUDnwGuUbZz5059EkCGAT20e/dudAaF0WYFXs1E2ahRI9Qpylr62LZt
m28NUBuGBgYQUy/VrV+/PnMZDVHsuUzNxRdfHHCXGLfatWvTOrQRpZ0+fTpTdiz+
wc//POOIV+rP2EGSdEcsPsv7UXurV69mpIvuRHr+nIUoaCZWlDoz9JDqgAEDnFFl
OPjE66TJkxAgd+qbK89+8OEH3JYnT56FCxdGpbFkyRKsAfaqX79+tILqaZuLkIR4
pTmMUyZiKsCdGAQuLl26lFaIesNioCR0nGbkXr16aZbs2LFj8g5Ki39n7dChA7Id
Pnz42rVrUblFixZhe1UrViBSY6miSM9rrrkmqBsKpgWVv+9hwYIFzCOYLCZu+rd/
//76QoAmJPxK4YjXXbt2YRh5HEuuR1hjpMW/RjPLa1nlgBbJ4G/evLlChQpVq1Zl
oPE65i/l5c+dO3dgvVesWFGtWjVHrDtQQ81fGnEsXdyibvz4cbqHoRpUG61D2v4H
MEwZJWD93NKLuinrEVYxw+9J3DB48GDup4slfKrBOEWvUCH/TgXtgldffTUohCZz
nZGlPzGqbj3JYobq0cVjx36MtrD8EK3MGJcRZuy0bt0a3Q7kQ1eqOSJeaSCFoBLU
TfZHy4w6der4H2+2bNlCp9A1ag49i5ppA1k06Q26hzIzYWmgse7FjjGpPf300+4e
9ZFU0SWmoFjuYWJlFpaEsTY0DRORmdWUgxGvBoMhdRjxajAYsidOj3hNi4eCli1b
NlhZsoBmZc8K0gU/soajZJZ68nA+HPXhkTica4p7FotnHIuGIynMk/Wuu4I/VqBA
Aa4HQQEUouiDINWAFrhVqlQR8YqTWaJEibx58wbb1oYMGRKLHNiCe0ytHnzwwaBW
rFld6F8S4LCJUBPxKrRp04YrVEBBhQ4vvPCC3GB/pyHOAxe7d+/u+344/HjX/oI7
YaqBoUOHxuIUT1ArPP9ixYrRTb5nTlfG4tF//hnEii2Sk+aIV9b9LVq04IrjqgQW
91KA6BodP5zr3bp18zkyWqF4GRboGe4yHj36o1g8xs1dwfEQy3PPPff4e2DRCumM
XOskwEfl1fhmwT47fBv8zAsvvBCv1b8uki7qnk2aPClwpKkPVfUDxH788Ufx4AyN
aFBzwlQDSp9XvHhx6QO+PU0T544vpBHk9pyKs/PLHDhwoDxq3/n57/bkAwfwyXW4
1ttvv61ynASOHj0q4skRr0CsJa5+EKfJEKB6vhZt3LgRbbnhhhuC3amPP/44JeCp
ZrixukuXLtdff33ApTLkfSpNQLxqYLDTeevWrbly5Xrvvff8i7ig1113XSwed+wr
G+0VgevYRq5grOgILl577bVHfoeqxDBUcFbRokXRH/8VGteVK1d2XOGIESO4wsD0
b6PLFKw3YMAA//rcuXO5GJxRg6r0798/KiUls37ssX/qz969eyOH4B4GyCnlAs4q
4jUtHolPv7uYU4c8efLQUp/vox/37dvXo0ePWDzHq+sdd4MIPoZk8AoZ0kaNGrnw
UrrpiSeeiMWPqvN5HEoTI1mwYMHALtWqVSvmfXrRvOkfFp8Wn18khIBdYjxeeuml
wQS3bt06f6AlgQg1xqCzdTLjsfg3RT9/BfOXRjf21l3ctm3b1VdfTQUCto62VK1a
1f82E001wERZpEgR5osoE9q+fXtubteunbvCANdnVGyUfyfVbty4ceyPEa+oaL58
+ZiOAwv89NNPx+LfZQM7sHLlSpSEVgfxdzNnzhRdlZlUA7LD/uzA9BqLf/+jK31N
0AlUVHjz5s1JCsQySzEQnX+dohQR7z6QCOMnjBcjGZSDwLWa8nfeMInfdNNNfm4B
ZiXtM4ie15SWTo5Xxe8rKxRvwb69/PLLWnFp+HBRokaSzJ6+nUdzNJ8GraBKlKOV
G+suRqWKctZP2VowoW5FgZrpa2u0mygcGbqxSWW0xgg+hK9evfrCOJYtWxZteyDM
nDlz9uzZM7g+aNCgYBbjXQ888EAsvhMruLlXr16sx4Lzx0Z9NErzDuPLn84w4GLq
Z82apWIZ7AxwLXrp9GDRq3UpbcGM+J+Xpk+frg88KictPqY0SQXcN3fKTAX6ieiY
xIO2KJdCcJFXxOLfs6UtzKTMa/5iNS2+BsZGpZfsKyGMeDUYDKnDiFeDwZA9cdrE
a1rc6xg3bmzfvn1btWpVs2ZNt/EqFg9+9BemLDrFffiElKBQiCjxiuuiKD9HvDqK
KojWFLSZMSBedUB55cqV5b3gEPJnmzZtgmdXrFiharO4dxd/+OEH1s1ULJqOLTNg
9V+7du2AeJWzSlWDm7ds2YKPx9rd8X14vHRK/vz5owdlvPLKK37IbULiVVxDlHjF
lWJ57ROv9DtyxpeIpt8FCmV1xOuqVat4Fs88INHwKPD3og6hIkp4Y3TbOzXB3c1M
jldpiE+88gjCwbmKMuAdO3bk5oceeihJgXiDChiJ+gYbNmxQhkdfE1AexbJFiVfc
koB4RVtwaQKdGfPxGHkj0VGWkHidM2eOiFf3hYDb5OFH8+0uXbo0SD6LJ6ysDiNH
jgxuxpWqVKkSP40e/VEoloMH1N0+H7Rr1y6N66Corl27BsFuYtL9yBpBTjiFRDPk
BsBpRPi+5NMDY1PRWAMHDvSv9+nTJwhsVLvEKkYD1WUQbrvtNj8QT33KI8HNLuJV
W5V9TJkyRf0lx54KVKxYMRYPxgzu1FC98847fV5JPHImjztT/KMjXukI/mRgZubZ
9JCFxKuwdu3aN95446mnnmrQoEHZsmVdDpbChQsHlF+vXr243rRp06AE5KlY4Cjx
qjPEfeKV8cUr6K9oCsv169cz/IPDtRh94ty1/ULG+cILL4zmk9UOZe3sdmA25OaZ
M2eemlB+hyiSYsWKOeJ1z549GuDRVD/9+/ePxWPrHMsjKjnYOJIWlznS9nmf6OFa
W7duTY94lSb7xKusHBKI5k9YsmRJ7I85XkWw+slbBH3KQv6+bClQGa6Dbyp+TTIk
XjFWMuM+8aqz2qK8G0YDOfgUWEIoIjjhhgBkG4vkwddHxCjxyvyovQU+8YoxiU5w
MkFt27aNvjEh8aoJ0a8GAy0W/8wcPI52MZUEfPcjjzzCzXXr1o3mllVMKIY92t0y
aEyL/qdcfQy+9NJL/cUAU9VNN93kp0764osvYvGP0H4SDEEDfNCgQdG2+zh06BC3
NWnSJOFO/ABaXeTLl88XGtN3uXLlXLirgz5RM/UEhCzQFzV/TwxzvRa90YEv4vXG
G28MPsTqY7+/0lCfMi8H/ULhCrMNJjU0mTk0M/lwNdgd8YqmMeg6dOiQ4YPJYcSr
wWBIHUa8GgyG7IlUiFcfOFT4CR98+IEWx8D3GVhDlypVCl83mh113LixmSRedUAH
q8OEZ5ho51RAvL777rs+8apN67hwLDqXehg+fLjq7AdTsNIV1YVj0LNnT9aRO3bs
yPxxz0eOHNHjPvGKm8qVYOt0WjyCSXJza3RRxnhHvusisOj3q5GQeNW28cwQr5L/
9ddfH/VzHCfoKCEJihJGfTTKFyDVLliwYCy+2dAvQVkUEp6Es3HjRnHNGRKv8nZ8
4nX16tW5c+fGwVi3bl1ws2KHGzVqlKTATz/9VJxOtDe//PJLfDAK95ks5CDNyQzx
6kOpEqmt/PPME68u4tV5UIyv6tWrxxIdkewDbdmwYcPUqVPllUWJV5qshAzRRJA8
K042CMTT2TU1atRwVA6twC/1P6LQUhV7//33L/0jnn/++Vh8v2q0swKIM0KROnXq
NOGTCZs2bYrqpEOfPn1i8T3Czrs+duwYZiTqLdOu9E6XxrZEjY+OnK5Zs2ZwsyNe
X3nlleAn7EbOnDkvueQSnY6C8ijVI20PpEGxsXiiQ58U4HosHgDVsGFDHFcUJjhA
z4eCCh3xKu6YoYRVYSwzrKIWI0NkOfHqgCLt27ePYdi5c2fRr0jM5/e1yz5KPNE7
mSdeFTbrk4YOa9euzRuHb5d++ukndb3oS8X6MZwRvt+5ixYtkhiDCEFpFEMAQ83g
YiBEt3ckgcgXn3jFLGiAR9kNTXkITRTnoUOHFBsbDRvHFASxbFHidcuWLZknXmUk
e/XqFW0Cj/vE648//ihrxqw9d+5cX4Ya19zpB7MjMZQBgSc8nk5BnRkSr0zoqqFP
vGr906JFi+j9Uqeo3BywTjJ6CVMPabu99vg7KGQyk8SrD/qRuRsFU/xjdAmRlg7x
qm+9PvEqAjR5KhIUgOXcypUrFaqM8kfnSn0dLF26dHQrg+xqQLxSKwW2K3OL8Pbb
bzPp+Kzu66+/rrmPURMYT0X79uvXL0nN0+KjVaGmTKyM/QULFuzatSu95LCspsqU
KRNY9enTp9NH0XWmpvsqVapEk/+KZ/fXPwxSJIDeBvkN0n4nXv0UWA5aNDoVlaXC
qqAYviiYfCUNX5hAiYZYOWOHmeJpQnrHowURr/zfJZFnncMrqH+GeTaiMOLVYDCk
DiNeDQZD9sSZIl4d5s2bp11XYz4e4y7iouAP5MqVC7c2uD/zxKucFlbkLKOj79UO
3OTEq6IJrr322pYtWz70R3Tp0mXgwIGBEHAX5Q4JOXPmZFWKY5CED3JIQrwGG5DT
vAgmF18jfoGaR2MrAqRIvIqpxAeIelYITYnVHPGqcLN8+fLhMAcCpGl4REH/Kiea
I4l8bNiwAa1LhXj929/+9sUXXwQ3S24oQ5IC5XlSt2iG0DNFvKI5vXv3btOmzZNP
PomTXLVq1Vg81UAQjJl2KsSrgumiXlxaPNHnsGHD2rZti7uFtB944AF0NWEUsyNe
o4Gl6RGvixcvFgXmTi3DJa5bt64frcOIUBBxuXLlHoqgW7dujIIMT6phFLiDs4Ty
5cs/++yzCXf7Un8dzuYcPMYO9Y9Slo549ZOWCFKtm2++2R9losmiXIwjXqOZ9egU
BF6oUCERQ7Nnz84RBzoWiALL88wzzwTk4K+//sowpATXcLqe3kwYhB4Qr7TOT3Id
iyft/de//hUdGklw9hCvPpTKGan6IXUa4NHA6swTr0hb/RiQYgLmKEPiFWXm3xdd
dNH9998f9C9DHiMZ0JQ//PCDyEEHpN29e/dMxiknIV6jGqK61a5dW6Zm06ZNysWZ
hEB0SIV4xRpECSyHBQsWxDzilblewYAM8Ki5eOKJJ0aMGOETRtqhX7hw4YS5TZXp
NRXiNboHBSXRjBwk1fGB1dXnxoSph84I8Xro0CHWUSxOHn30UYY8RknsWMKoz0wS
r2I2E8Y2MkCoQI8ePTrFQRdrY4F/lJ+DJqk6depE6bmExGtaPJlMLL7DQCORBxmV
fmpsgHmMxU8na9y4caAYzKR9+vTJzJYIeq1EiRJuuDGc69WrN3LkyIQfzhV8XbNm
TUeD0vCE6qTpPuHncCUj8qcGBimLFqxEdKuHiFfmnWjqIX2Zw2TpT1odix/1RtcH
0qAHWXEFyXb40+WUj8WzIrCEQ2jRA7sC4jUtnh7HT/lCFzBb0eRTol+NeDUYDKnD
iFeDwZA9cXrEK0ux9I44YGkrCiYh8Rpl2TJPvCq2y2ejfGQm4lXEK35F5lu6a9cu
lpI4DNWqVXNHHuMSBKczR5Ei8aotkDfddJM7tSk9pEi8KtdhlSpVEhKvQcSrohdx
sJNXyUEcX0LiNfWI19MmXiUcWhHdI5k68Up/tW7dmgGFkjAEdNKxQuTOCPHqZ70U
hg8fXrJkyXLlyuHBrlix4tixYwcPHpR/noR4jZI+6RGvv/zyi/b5qh8RWrNmzYJk
cDwr4iDIXnqqQBpTpkzp2bPn3Xff7VKX0LpopNuvv/5av359n0FgFDBqomWeHvEa
3T58SsRrLP6dhu7IfNvpWaSHR60j+GLxGNhoMF1AvKb9fkLgCy+80KBBAzFB8tXT
O/08iiw8XCuJVz9t2jTRbVHiNdjBnXYqxKvLtJtwIli7di2DNzPEK6LO8KuYX73P
PvusX79+KK074R2FSfgdJUAqxOuGDRvUL/5u7vSQCvGK3RNJFw05T4tEvDLX6+bB
gwdnWKu039kcxJVws0vqEa+nR7wqQRD3RBNopp0J4nXmzJkYZLQaezh//nwpm0JQ
E8rtlIhXrgePMyOwYmH669atG/ZEyqYEMkmI19tvvz3zxCurjosuugizpm94y5Yt
Q1GDNEQiXpmkMswJnhxbt25lSu3UqZPy5wg0JOHX1osvvtgtipAeC8VoiEDa6RKv
0Q+Hp0q8oreZb7jIehTvrrvu0sYL1TngXqPEa1r8FD5WEQxtd8ygGhUVWnow4tVg
MKQOI14NBkP2xGkQr7ivrVq1Su+IA5aSN910E2XOnTvXXRTxmjt37uhyVonhAu5D
0MEOzpHWqpeFbHC8hpAZ4lWUU/Xq1aMJyzIE7cLRYg2qHV4J6+AjReJVOy55V4bs
SULiVccrVa1aNbj5P//5T/Hixf1ksnoRbnCU4aWjgxyvupnHM8zXKegwE9zaKE2/
adOmTOZ4PePEqxIm8PbgqI20+J7WAgUKBMTrTz/9VLdu3ViiPInuFBF3RRHEwUZO
93XhjEe8Ll++PBY/icj37nBldaTyGYl4BTptvFixYt9//z0P1qhRIwj6/uGHH/S5
JWG6w9MAYsHz/3DUh8odnPCoKEmVltLeXbt2Ma4TZjM4UxGvOJ9SgwyJ1zlz5ugj
TZSpzxA6mGXhwoVKKtqgQYPghijx6sCARRQTJ008VRI8q4jXRYsWde/ePT1rLGqg
YsWKPrOTJOI1vbSnSnjNBKH0Dvxfsk2oq5iUaI7XgHgdOXKkKAn/cLlM4tixY3v3
7p08ZbKyAD///PMZPpIK8YqJE/kSlVgUUeIVq8KLLrzwwuj3HjF67rMH86NOT2JF
ES05iHhF3xQeW79+/QxrlfY7kceYSjjAs4p4/eabb2Rme/fuHf1Ve88D4hWDFkuU
Pxr7I6rLvc4FBWOj3G0McB0GdcYjXhmDog4Do6Gt62cq4pVlgJYEXbt2TYuzutEk
v/q4y8rnlGL2kwCVW79+PRJAfwoWLBhNN5/2O21KY/k35p31bcLAgjMV8apEUpkh
XqXbV1xxRTTXf4agT3kKY5XQMCYkXh0OHjzIWr1t27axeDaJ9PIVRGHEq8FgSB1G
vBoMhuyJ0yBeWc9Vq1bN51V97Nixg1VX+fLl/Z3FIl65HiVeFQyIjxFUAE9ep1u4
8zS2bt3KKpYrwd60tLgjJ68v8GODw7V0hDHr7+CI2ISgTDyZaBIunVWSIfGa5HCt
zBCv1FD7u+WiJIEjXv1jfLWbHg8h8B9wgHPnzk3JzsHD2b4gjvETxgcl4znkz5/f
74IZM2aIcYieL5QQOkD50ksvjfoeOpY3oUoEEL8WHK6VJ0+e0yZenWyj7islo2MU
7hOvuLsNGzaMRTLYpv2elvTKK6+UB8X/lYMvOARGES7JidcRI0a4i9HDtRzx6vb7
C5Iw1fMvbt++XWMnCfEaDcZMeLjW/346cEBhmO+++y5DLGEaR4moUKFCGeZyTQ/T
pk2LBrOLqohS3mnxbxsKiuee4cOH4yUm9JZpl8LrTol4jXIxv/zyi3ZxZki8MpyV
ZNBPjJsEy5YtW7p0aXCRKlEC/nxwPThci3EUDQOcN2/eOUG8UvngfCcfikwPyGsN
8Giw6okTJyRzf6eFIPLizjvvdMZcw/ayyy6L6ps+BDJ8fLvEIPU/vWB2ZEASZomN
gmEYjXpTH0WJpygSHq6V3peVgHhN+/3YH+53j6cHR7w6QWFJSpQoEU1aglaLifa/
T0jOTP3RVDyaj9AQ1QqLiqbpyoYNGzKUwM6dO0UfR1WaAvW5KDjQLIokh2udHvGK
LRWNiEWN7heRwgTEq+Yy1kLBZosvv/xSFttFuItFZQrwTRNPaVGRhHjFUPvnknXo
0CEh8RpkiUXC+lYUKKrSOCQhXoMUzELCw7UEcZdXXXXVwoULUaGvvvoquEELg8yv
MaJgUCdMrIE1Zr2RcBToAypDbNOmTY0aNUovL4eMwykRr8wL0bGvT7+UkyHxyqpA
0gi2mCQEZgpbEV3Jv/nmm7FIFovgcC1WaPRI0JUMcyqJRh06dCjDtwtGvBoMhtRh
xKvBYMieOA3ide/evWXLlvW9FwfclaZNm1JawGziiYm4cW4Ma0Qt8lauXKl8iP4J
4DiWeHRacbq1LK61okgKFizoAjbT4qtD1qlyGwLvS8vWqlWratsa7o0S3t1www38
27+TxfHo0R/5H/ZXrVqF7xT1IfFYrrzyygxPsKGoYJ9+2u9uTPRkGEe8usPHXFgW
C3ecMX+r12+//Ra4eQpM8PdZy5HAl/ObiYsrty3mnclAUTfffLOYTZ/H5LpyLIK3
337bXRSxyMIacfnL9MOHDw8bNizwanijAoTxeP1UEqz15WBcdNFFGYb0ij33o0qX
LVvGg/nz59dZRj7Eyzz44INJCnTxa7i1Pr2CrJSUtkCBAsFOfB0wVatWLT+6Z9q0
aZQgZlnBswcPHhQL4PMp1LZ8+fKxdBLp4kvfdtttsT8Gdcr5vOKKK1zGUsSr20Z9
NEpXVJSy7laoUMGVvG/fvnbt2jGgGBFR54fblHDDbT12JAsdpKirKAWf9vsOUEbx
jTfeqPwJAebOnSs2inoGqRiXLFnC6zJMFceD0TPEP/jwA4qN7nT2a4U5ql69epS7
FJChYuej7rSI18qVK/tfiRQmj5T0J0ou8hT5KJY/msVSxKv/gaFnz54aO0888YT/
8QYh0LkBjfX4449HaSMsTCwSwg8aNWrk85t16tRhsAf3iLifMWNGQoFEkVXE6zvv
vMMICtIUCtiivHnz3nXXXQE3oQnLBati2B1vq4QYfigf0n7rrbfE2aEkzpgzumWX
mFD8pDHorUYZtsW3ANRB2xc0SFGJZs2axeIpFAcPHuwTx6gK1jIgE+vXr+9MqIOI
14RjLYAOAyxRooTblIC1KVSoUCxRyK2IV+yYMwgi+2LxmN9g2kIz/VHJEI79MeL1
yJEjsgn+5ILMX375ZQkQQ+rmJhHEsfhXAd/QrVu3Tl8+mHxdBWbPnn3hhRdysVq1
aoG5wA5j5QJzofUAOsaDfk2GDBmiqR8TnVyMWNo777wzYG9RV660bNkyuNkRr9Ej
6X3IVgRkLmsbXpEnT54o8YpB1uzpL5DoTeUl8Fc74i7RQxd5TbEDBw5UsQlD6TXq
sXU+8aolh29GeFZi1590H2L85ptvVAFnNJD/mDGjlbpEoaABxNwVK1bM6b8LXRdB
iUmJRkoy3PSBhHkk4RFhFKI1Rq5cuaiAv/LhWaaDDHfb0ATXOh+sxzDg0fxCafE5
QgtU5hFsS3pZDtTdt956a5SIFPFKB7kru3btUpluUecGhVYplBMN9te6yOXrYNJR
bDgdEUyOrNhZGfrn43333Xf33ntvNIkQY4ShF3DcLMW16lMJI0eOjAYE0LPMg9i6
zKd5NeLVYDCkDiNeDQZD9sRpEK+7d+9WBkn8q0WLFrFuw5ti4c5695577rnmmmt8
10jAwRPdw5Ka5ePrr78+fvw4rYAPHjwor+zKK68cOnToZ599NmjQIPxh1u7aZeyH
GeKNK5EfvjSLV16E49qxY0d8CbkuOOr+e3F75AC4uDM8OoXN0uTu3buz+pw+ffrT
Tz+Nl8Vi119frl69unjx4r179968ebOu79+//7XXXrvhhhsS5nQLwFL+0ksvjf0x
552ogcaNGwc3s2KWSP2S8VfFhugRnBBEN2LEiLp16zr2TRBF6ycCo87yGxH7+++/
j/fYp0+fhx56iOU1co79MYACf1ukyWWXXYbnQBdQfrt27ZCqQiB9n5bluztwDE+e
WnE/YsE/x2OJOlr0tfi4SpUqvffeezSBmylw8ODBivEJjuWNQnsP6Xfn4Omsldy5
c0fzXejmDHOiLV26VCFj/B9fl1ohnzvuuKNRo0b/L47Ae1EUZCweG4WeT5s2Dfk8
88wzPCuqQt7LyZMn27RpE4ufPzZ8+HDuRH+4TaPM10MHnEkFa/uhzUpnTLHOheZB
hWtVrFhxypQpjBT14KTJkxzZQSt46eOPP45spU5R1gCXUuwDPUs5b7zxhpP/119/
rc8SCff1b926FU84lihe2wGFUV8XLly4V69eDE/GF33NOHrnnXfSywrtgAoh/zVr
1ohrw2h8/vnnt9xyC12T3rMrV64UfVOrVq30inWfW3Dag5+wQrF4uL3vSCMWcWr9
+vVjPGJ/FMeKhRRlEA3F0pcAjJJj3OhWJT+JxSNqESm9M27c2Ntvvx3JB9qFeqAb
NFbRbTR2/fr1DRs2xKZFE7Doc06rVq30J73J8F+xYoWLJWQ449L36NEj84n5sop4
Rf1i8e8f6C3mjsbu27dv7dq1Q4YMQdRNmjSJft8SbYSoMSOTp0zu27ev+9hDf0ng
DCWG3sSJn2CRGIA6PKdkyZL+6NPIFdXy7rvvYsQw1J06daJ8nTDjawvV0LzD61x7
eVAlYJCxbJTAUKJz6ZHg+Edu4OYlS5bIPDIGly9fjsZ27tw5vWhfH4qPYzZxWRoX
L16so9iieRVEfGBsHcGEGiiRt0wQFl7zJgOTCvgSHj36o1j8U59PHD/yyCO6yGSK
DnMPkxEdp5QX2Ex3Jy/SIeySydixH2N/XnzxReQvaQd7TV555RVnLhhTjDXsaocO
Heh6hB8Mecag1gMXX3wxBdIE+pcmsFrQuZoJuTYfjHHNXH74p77ABZlh1BZNENEw
eR/YKHe0HWMH08GEyMjl37LqAfGKYiglC2uet99+G/kgBCTJvCyC2xG4mzZtUpLr
2rVro1pYqi5dunCzPg0m/OytYFKE7B/2pQ+Bfmi28sxiNgcMGIDAX3rpJRZvmFxZ
AKpBx9EQVkfcoH0MCW2+stzE4l+7aQhd7KZjZVVmpRE96tD9Gks/UwcWQGkW/rfy
+XgMEmAhUbZsWdYwGR5tim4wdaKijBet3DARLAzKly+f3se5tN+P2AJMVend4+bx
qFnW+tPfccXKVoteVn3IB/PiskaI7ufX9IhXf4pZsGCBVpIMltatW0/4ZIJKYzgw
WHyOmBmK7mvfvj3rZNk6upWRXqZMGaQRDCgZUpZ8+uzBiEPhsWOsZDRx7Ny5Ex3A
oGUyr5RgxKvBYEgdRrwaDIbsidMgXnE2WLTh27O6Yi2Im3TzzTfXiOPZZ59NePJV
WjztlxynWDyzm/+hntWwtkMKeKSKflUaO8pnneoCMdasWYOjoriPWDwqUHtL5X3h
dTRo0ODDUR/iUeCVacEKWBbjtCi4iWXrAw884I4duOiii3Bmxo0bG1SY9Wi9evVw
fvCU7rnnnqZNm+Ji8ZYM8/qxKO/fv78iIGLx8MnHHvsnTWDRLG8ZnwfHzI+BwqvM
ly9fLH6aFm6h25uG99WxY0f/fF5cR4pSnjKcdhw25/hROE4yC2g5GxMnTXTeSywe
msRy3O1RxYehHOehLVy4kE5xp4fhWoizk9tGycjcOfnUCkdOUYQCq/M+ffpE980J
OIRiiwQ8SdqLU6ROpJflKkQfnDp1Kt6mKA814fE4FHgYi29rRVx+wJRoAhrSqlWr
5LvzlixZUrduXXn+sThTgL+HC5o/f/4gx2tanCvBF1LihVicEqViR44cUWQxQKN6
9OiBguGlIEkVSzVwvBkv4vJi8ZwAjjTH6cJ/Fmkei7MPlEnrunbtKoJPY4H3qrvx
J92RF4w1xdhSSK9evRT+JtmuW7eOimnsICgeD9grPCJHnePmUQ7uce/evbVtVj1C
TYKcBkDMb3KHavz4cbRIeh6LE2RIIzMfKnD2OnXqVLx4cawEtWIU42Mz6JJ3Is0X
dZIwchB/G/umWEXZCsTrJ8nVrttY3CINHDhQbjAOMzVRD2Li8MO5/tJLLylBZCxO
gSEf3w4oekj90rNnTwV3owzYAaXydBVAP6MHhTFArrnmmqJFizKOqAljjYajTkHH
4WwjEw1SrFbbtm3xk1EhhEbJ1apVQ2gtWrRo3Ljx4MGDM8+6pmUd8bphwwasouLC
sAYM56pVq952220Yz9GjP0r4CH2qfQ/qCOy83wrskoj4WDwWD6OEkcTy6wrCQTIu
xBVTySzmeof+3bp1K7ZXND1Wl7bMnz9/yJAhLiCRNjKtaHrClnbv3l08msDwfPLJ
J6MzKWMQa0mB9BGGgmo0a9ZswIABCYPvfCxYsIA66MNkLL51QwaQf+gKFp46+GH7
ffv21U+owbBhw0Ts8qI33nhDgYRuYDKc3YcZJgKKdRM0ZsTNMvxf4b0CeqJwSyUW
yJUrFyqNiFQOLxo0aJA4R4HpCYGsXLlSf2J5mNHc7D927MeYHQXPqlaIOj1z8eWX
X6L/6h3AeFFGF2XaYcAqsjj6kYaJ6d///rdTGzSNAU4DO3TooFfzLDP70KFD3bP7
9u3T9ET/duvWLUkictSJoapZVVqnPS5akATEa1o8LtU/uQhbt3jx4kOHDkmR6AIq
JhvLMsbN4IhdYlHAO69DjI4fRwH87kPNpCctW7Z0MxFSEvGHdZLEJHA3H2HQ3HBg
ClDqG9oei68P6e4gu9TRo0eff/5513dYSBYeTFK8Vx931brnnnvO30+Q9numjgoV
KiSxURhJVgWunFj88xXDOTPJRtETGsIcjR4yGTEQUEIsW/Js8ow1TAcyTLitniGP
zXe9fOedd6JR7k7URhwrEzGLPbd5C4G7kxLpOAYCM0Xnzp31aScWXzb4gQW//PKL
dIMXcZuLYGD4oPluNRuLR8uirsEGGuSM0LiNl9apU4eG8xSvCBa3zOz0kasY2oLR
wN4y+yA05IxlYMgjNIZ2wt0tSWDEq8FgSB1GvBoMhuyJ0yBeBRZ5LI4XLlw4Y8YM
XAI8twx33+/YsYPVLW5GdMP1/v37uY6XyxLTRQGsWLGC+1nFTvhkQrB5kz/nx+F4
3k2bNnEzvsHkKZN5cP369RMnfsLKlYvcxkUcHlcy/qEqz08UlXBnGV4BC2tccdap
U+JYtmxZZjI24uZRZ+6ncN5OHag//02cNJHqqZL82z+uBHdi6dKl/IQwqWrQF8hN
wuEe/wgsasiVSZMnscb9X7ETP6EjnD+za9cuPYirIw8cCSBhvYgq+QfdIgRu42bE
ogrgTuDDcDOi4y1B7s7//Oc/S5Ys4f5Vq1Zl6A4dOHiATuFmZKid1+gA/6bwWbNm
Ue2EfD1vpJLcoE5EpJIklV8QB4qHuPzwE3ozoYQTgprgslIyDXHJKPLlyxclXgV0
RlrnqF66w9UNEUnB+P/q1au56Db3MTS4Dc+W2rrUCiih9ITrvp4opEUNVES2E+93
333HRRQyEPjmzZt5He2VbOlr6i/5gOhw27Nnj8oXCcX/Eemnn34qjUXg1CHY/5v2
uzpleNg0zafhEhQVyzDQVeA2Bs7OnTuRz7Rp0xAUYsnMqfEvv/xyqVKl/A3jDoxf
xIsM1S5ZEv9ENV7nug8ld0QY/1APiiTlT2QS9JSf5Znx4vqLyvuZfHUcmXQsvY9S
iJSf0HZqSMPpsoTu7ueff+5sCLVl1Mgi0QpeIaFxz6la8rSsI14FtJFhSM2VhIEh
nFxnUHIajkijh+P99ttvMmKMERctjt5q9DFCkZ5vw7FLGEzu5/9SbJSQf0tbGBF0
BNZV2sjF/3bBxE986vzbb79VCVQpPXWlwtRhzZo1Mu8UkmG6VYG3O2vAK9Au2Qf6
WirNT6iEr1cMW2dq+Ie/hwOjweDSgwxMn/ZiIqBYmuzUmD+dkUEy2BNJ1WnXli1b
nB4GJMvevXuZmLgftdRbGIkqWZHIPreFdWKyVq0oM0Nz4YywOxRINVE3BWcPuvoz
ZvlVEyXy/9+MPPET6q9n0Q0/Ghc1cDMytwUhzFHQU1pOuFqJrI8Sr2lxM66pE/nI
YmNhUA9no5xt4b3InDsDsWvSdOdEoQDR7uO/P6wNJk10ByoyBKQJQTAjCqyKuYWB
1myyPAkjH5kxtcDQnyzDXE2ksSBIlK/pKZqZOgqEKUXi/oC9TQJ0noZQW0aBVm7R
kySjoAtuueUWPxraB1rnL0WwDGiUaxdKq8WqpgbfPkiAtEJrAy1ptC6VxvoptpAM
VXVTcJCDBR1zy7mE8x3VYOpBsFSGGsoCROXGDYG2YEYOxMEbURUkhoWJpt/NDIx4
NRgMqcOIV4PBkD1x2sSrwZD9kJx4NZyF6Natm3+snOE0kLXEq8GQ/ZCEeDWchWAB
fPvtt2eGojUkgRGvBoMhdRjxajAYsieMeDUYHIx4PbegU9qCg/IMpwojXg2GMwsj
Xs8tDB48+OGHH85MzmVDEhjxajAYUocRrwaDIXvCiFeDweGrr75KmOPVcHbiueee
e/DBB7O6Fuc8jHg1GM4sHnjgASNezxXs37+/UqVKyQ9SM2QGRrwaDIbUYcSrwWDI
njDi1WBw+OKLL/72t7/lyZPHthye/di0aVPp0qX9zIyG04MRrwbDmUX9+vUZDunl
DDWcVejTp8/tt9/uzgAwnDaMeDUYDKnDiFeDwZA9YcSrweAwd+7cHDlyMBxs9/pZ
izFjRs+fP/+7776rWbNm48aNs7o62QFGvBoMZxbVqlVjODz99NNZXRFDYhw4eOCN
N9749ttvp0yZUrRo0UmTJ2V1jbIDjHg1GAypw4hXg8GQPWHEq8GQFj9bY+bMmQ8+
+GAsDv7x2WefHThwIKvrZfgDjhw5cuONN9JBBQoUqFy5sjv+25AKjHg1GM4U5s+f
P2LEiAsuuIDhcPnll4/5eIx9xjsLMX36dDooR44cBQsWfO65506ePJnVNcoOMOLV
YDCkDiNeDQZD9oQRrwZDWvxYrS5dunTq1Onxxx/v2rXro48+yj+2bNmS1fUy/AGH
Dx9+/fXXO3bsOGjQoH379mV1dbIJjHg1GM4UXnjhBQwUswlj4bHH/sm/33///ayu
lCHEV199RQd16NBh6tSpWV2X7AMjXg0GQ+ow4tVgMGRPGPFqMBgM5zOMeDUYDAZD
ijDi1WAwpA4jXg0GQ/aEEa8Gg8FwPsOIV4PBYDCkCCNeDQZD6jDi1WAwZE8Y8Wow
GAznM4x4NRgMBkOKMOLVYDCkDiNeDQZD9oQRrwaDwXA+w4hXg8FgMKQII14NBkPq
MOLVYDBkTxjxajAYDOczjHg1GAwGQ4ow4tVgMKQOI14NBkP2hBGvhnMOJ0+ezOoq
GAzZB0a8nlc4p+3nOV15gyF7w4hXg8GQOox4NRgM2RPnNPE6b968v//970WLFn3t
tdeyui5nOzZt2jTm4zFDhw5t3rz5I488ktXVOTUcOXJk/vz5I0aM6NWr1z333DNz
5sysrpHBkH1gxOuZwokTJ1599dUSJUqULl16+fLlWV2d/4HJ/dNPP33rrbe6du16
5513bt++PatrdAo4efLk2rVrPxz14ZAhQ+rVq/fMM89kdY0MBkNiGPFqMBhShxGv
BoMhe+LcJV6XLFnSqlWrZs2aFSpUqH379lldnbMdI0aMaN68eb58+ejuJk2auOs/
/vjjmI/HfPDhB4cOHTq9ko8cOTJ69EejPhp1+PDhM1TZENu3b3/ssX9WrVqVyl94
4YXz5s37k15kSA//1ZMxoz8c9eGBgweyui6p4uDBg++///7YsR/TqKyuy1kBI17P
FP7v//6PKenee+/NlSvXxEkTs7o6/4PmyrJly9JBF1100Q8//OB+wpa++eabGzZs
OO3C586dSwmbN28+EzVNgBMnTvTv379hw4Y5c+ak/k899dSf9CJDEkhPNm7cmNUV
SRUnT5787LPPaMvXX3+d1XXJhjDi1WAwpA4jXg0GQ/bEOUq84uy1bNkSb59/b926
NRW/8bxCx44d6W6ccHdl6NChsThGj/7o9MocNGiQSpjwyYQzVM3EwOvLnTs37vei
RYv+1Beljt9++y2rq5ASTpw4EVxxejJmzOgsqdIZRK9evdSWWbNmZXVdzgoY8XpG
gCV08ZgrV67cu3dv1tYnwPTp0+mgfPnyHTlyRFe++uqrPHnycLFp06ant4V/zZo1
F198cTCn/Em46667eNHzzz//Z78odZzT+RCik9e6detYIiJ8Fl3n+tTG4iFHjhy0
pXPnzlldl2wII14NBkPqMOLVYDBkT5yLxOvu3buLFSvWpUuXrK7IuYenn346cJJX
rVp1xx131KhRY+3atadX5vLly2vXrl2rVq3169efoWomxrZt24oUKXLhhReezcTr
N99889xzz+Gg+mFl5wqOHz8+c+bMevXqvf/++8FP6EmdOnVq1qy5Zs2aLKnbGcT8
+fOrV69+1113oVFZXZezAka8po7x48dhms7mLCgLFiwIiNdDhw516tSpQoUKb731
1umViea0b9+eEt57770zV9PEaNKkyVlOvCLYkSNHNmrUCFFndV1OB19++WWXOIIP
b05PaN05zSmDvXv3YuVoy7hxY7O6LtkQRrwaDIbUYcSrwWDInjgXidfhw4dT56ef
fjqrK3LuoUePHn9NdNKfgc2bN1966aVnOfHas2dPJFymTJlzcRs7Tunll19O/V9/
/fWsrovhr4MRryni2LFj99xzD80/m7OgzJ07NyBezy00bNjwLCdemZgUSj9nzpys
rsvpoFmzZlS+bt260R0PBkNmYMSrwWBIHUa8GgyG7IlzkXht06YNdabmWV2Rcw9G
vP7ZeOGFF5Bw7dq1s7oipwOMQIkSJaj/pMmTsrouhr8ORrymiG+//faqq66i+XPn
zs3quqQLI17/bCxZsiRHjhx58+b98zLe/qlo2bIlEm7Xrl1WV8RwrsKIV4PBkDqM
eDUYDNkT5yLx+vDDD1Pnvn37pnfDnj17ZsyYMWbM6EmTJ33xxRe//PJLwtt++umn
r7/+et26dYrv+Oqrr3hq69atSV7922+/7d69G/9K8Yz8f9GiRdOnT+fBhOdO4OJS
7JYtW/Tn4sWLP/vss3379gW38dKJkyaO+XjM7Nmzv//++6StzwA8Pm/ePKo0a9as
aJWixOuvv/5KfVauXOkrwIGDB1avXr1r1y41YcGCBRT4+eef79y5M/rG48eP8ywl
JKz50aNHJSIa/uWXXybMEEcF9Iq5c+cqb29CnBLxumbNmnHjxiLSTz/9dNOmTVTD
/bR3795RH43i+ow4uIf/S0loyPjx4+gLroyfMD6IXzt48CBSHT36I0qeP3/+d999
F23Oyy+/jITvu+++9CrGK2gpyjl16tQkx4sjVURBL9BB/Ll+/Xqp2TfffOPfRhdL
tuqs9HDgwAH1AgoWlOADKV199dXUPyphxghyQ4ETHq7Fg/ykGq5duzYzeQB5ZEMc
+nPFihU8y8gNbqPT6Qj6aM6cOdHsDUgJtaTL1JUTPplA73z77bf6lZ/4c9q0afQ1
97icmzxF3/HGaFv279/vTEfC3kEyY8d+TJncxj3vv/8+mu9+xSAECTdUB/oa4fCP
5OYlq2DEa4pAgMWLF6f5SRJxoBjoJ5rMaE2S4wIlZ8rQIEVRFy5cOHPmzEyeaMe4
W7Vq1fQ4+AcTnP9rQuKV13Gnm6HS4gOTQce0qD8ZzioQ653wpYcOHWIopdcinmKk
8Dj2IeH5jceOHVOduc29NCEyT7yijQx5RjGjHhPKoHYb5Hkdg3HixE+cxeA2mR2k
jXnEtnN98pTJjG5/1kiL2yjGvuYLOigQrxqbI0eO/PnzM1MkrJg69L8VmzA+iapQ
WzSKpYtMFgYNM4KIqIB/G0aMPuU6CpNcIEwTaBF3Llu2LFpth7Zt2yLhJ598MvoT
eoImpDd30HFSkqVLl2bmlE56gXUUBUrCFItIowJhrpQ1pjcTWmPeKwvPbdzDtI4u
6Sdmlg8+/IBO1BTvF07vLF++PFogwwctdWoTfR2dQlFaHtBYlAFt8WclxpG/uqOD
uB8d436p3M8//5yhcM5pGPFqMBhShxGvBoMhe+KcI14XLVpUunRp6nzTTTd1iuPp
p59227pxUJ977rnbbrutadOmjRs3vuaaa3LlynXXXXfh6/qFzJo1q3nz5nXq1Lnq
qqtq1KjB0vnNN9/MnTs3xT788MMJ38sS/x//+EfdunXLlClzwQUX7Nq1iyu33357
7HcUKlSoTZs2O3bs0P0U2KhRo5o1axYoUKBjx444GFRVd7I2dcVSTo8ePagMPs99
992HV1yhQoVohs3M4PDhw0OGDClfvryrUsGCBfv06eM7WiJeW7duzb937txJle6+
++6bb775b3/7G14BbiFubf369W+99dY8efIMHz4cj65WrVquwFKlSvEKR6t9/fXX
7du3R7wVK1ak5kF+Q0p77733qlev7h6nTO73nVIk/+KLL954443unuuuuy69fe6Z
JF7x6GgXndWqVSvacv3119M1NNnRDbh5VEMnbID777+flsoDxBnr1q0basN1aoUj
54rFhUOj6KZmzZqhM5dddhma4J80hTO5ZMmSO+64g2eLFi3a6Xc4Yo4KvPLKK2gm
b6eoYsWKlShRol+/fsGHAbxrKk+/UPMrr7wSB3LAgAGIV7VFY5WQ8cSJEz179rzk
kkt0nZtxF6PSwNNDnnSxkzAl9O/fn94J7sQCDBs2jPGi3aaqPFcQO4Pi3nvvRbUQ
WkBGowz4t34v43Sh8NGvCw5ItUmTJrVr16Y3GzZsiNyeeeYZdcdLL73kbsOJ7dKl
C6+WNLBRVatWDU6KR3TvvPPOLbfcoleXK1cOmThyk59atmypkrt27Uq/b9y4kUGK
xtIWRsfChQv97hs4cOBDDz30yCOPMHKLFy9O7/Tu3Zth5b8RId955516Hb2M8Zk6
dar7deTIkYwRX8OpA3qoOlB4QJ2cJTDiNRVgOrD2OmOqXr16Gjjvvvuuu2Ht2rUY
DSYL7DzjCHNUpEgRLIlPVqLJr7322gMPPMBQYlBjh5nLWrRoIU379NNPM6zGlClT
GLaYRz3CP6iM/wpHvMrW9e3bt0GDBtWqVaPmjz32z7S4bjMwMfiXX345Ndm7dy/z
hdol683Q8D/w9OrVixKYbbmne/fuQX0YXNg6zaoCZjPgs6gzYnF1pm6I5bvvvkvY
wEwSr4iR97Zr147/Y/cws/zfUZPMhkxh2FW9ESNPK8Q70wVDhw5lVcB1qv3ss886
DhGTQtuZRBggTNMlS5bEPnTo0MF/L7OhVlMsD+g4qQG20d3ADPLggw9SMf7P6gV5
Yp02bdrkF7J//34aSMdVqVIlf/782JPPP/9cY1MlY1plXrCEN9xwg64z9Khtwg/M
q1atQvfcNIEhwnxFrRAqMXv2bGrFPayvVPnOnTtjMF999VX1Mhb4qaeeCh5kLkar
dfSWwJ3Mg+n1zhdffIEkscDMnogR/eS99BEPsopwtzFtDR48WHMlOomlxRrTUwFr
zGSkKF2QN2/eRx99dNq0afoJ9cMWXXHFFZrOWAEyVWGuUWzmEVTuhRde8IuaPn06
DWF2wEqzBqN3aHVwauu3336LBJi29EY0gUHkZjrq9ve//50pw91P63gLpXEzKod2
nYsJiE4JRrwaDIbUYcSrwWDInji3iFdW1WJ/nBcBuCJyBOe/cuXKV1999cyZM+Vb
4sLhkGgh6J/+gR9FUXfffTc/VapUqV+/fiz9db5zeqlj8UKnTp3KsluvfuWVV/Cg
Bg0axPoer1jJ0cCtt96qwE98G16hdT9L+S5duuBVyomd8MkElbl06dJSpUrVrl1b
OxNPnDixYMEClvU0ynfYMgN5TXjRuGqKbaR6vAsfI0q8KuIV/43bXnzxRdUcBw/P
BE9m7NiP5QnjgeMgPfPMM7Rx8eLFuHy6c/jw4SrtwIEDtBFPQ9f9pfbatWvxqKkS
7hOPU70nn3wSvxEXkad0D24tHtF1111H11BnPEk5veCdd96JtjEzxCuacM899+Da
KYjp5MmT/KNbt274sUG8pDvaPhqrRS/jePuhi3Q97ujEiZ/IucUtXL16Na1DAdw9
o0d/hCpedNFFvnLS4+Kjd+7cicdLY+fPny/mmvfip3Hnv/71L//tu3fv5nWPPfZP
fsqVKxdeOj4wfiNdoyQbFIt80ED8TGSObOvXry+qJert8BP+7ZtvvilFvf/++1W9
AQMG+LfRokaNGinBq6s8aNy4sTS/f//++skX/rp161AS18u8HdHRy0WKFEkSgYvv
jdrIycd3xQTlz59fhK875IcbGJK43Iqx+vXXXxEjnULh0TQI27dvFzEd+NJpcTYZ
4+bOmsdJpi0yeohr+fLluo6SoDYMxjlz5hw7dkz9pc8qqH1wnszx48cZaPzUokWL
4HX33nsv1wMGnAF4zTXXYCLSE0iWw4jX0wa6gSVRgg5/4DzxxBO6AXVFORs0aIA9
4WaMPHZMn2fKli3rCEE0fNmyZdjAggUL8lOHDh0w4DyIlka/dgRAe9Gua6+9lppw
JyOUGe2SSy7hQaYYd5sjXsX+cOf4CeMVqKteYzgz7mSUbrjhBoxzy5YtZ8yYsWTJ
ktdff71AgQKx+Gcq9ymCAseNG3vZZZdx3afkjhw5Is6L/2O4ePy1116jetyGCXW3
9enThzKpMyaRiQ+Lp5mdtiSMysyQeEW8//73v5nyVq1apTHLFIP86Z1AgFRJhjr6
kY+fuD5kyBB3BYOMlcNoaI1ED+7YsaN169ZcdPds2rQJA6K+i6oBnYsJwsoNHTpU
0xCTrw66vOWWW/wwf9YtWFHMoESBCXr44YeZH5l/mWvEYmOR3n//fSqA8OlrVji6
GXkGlkqcJlaUnqJdL7/8skhDOj2IXcWA64uyX/9ChQqtWbMGtZwyZYp638/vhBYx
p1955ZVdu3ZVL9M6Jjhu+3DUh+n1EUsyVh2a3dAcqsQoyJs3L38iQN3DjIPusZCj
2trwQW31bQ+NiuafrVevHj9VqFAh+roHHniA61oN8iCLnFEfjaIjuJ8xonu43rdv
X6YJ5kSFltM7qFkszstHd/kwahAOsgrWIRpfN998s+rswOTLdTfXZG8Y8WowGFKH
Ea8GgyF74twiXvHHWBM/+OCD1LlHjx6/xKFlLv8Q6+FCHhw6d+4ciwfsuG1owquv
vir+Bc9kw4YNSKBOnToUm6QCOADyTKiD29Es4LrI/8H3cxcbNWqkVyPn77///osv
vihXrpx4GTyQa665huV7sLLHy+IRvI79+/dnUiwLFy6kBytWrBjs8sPZw0/2r0RT
Dezbt0+esx8UXKNGDa5cfvnluMT+4yJz8cz9PZjIQQE1bqm9efNmXDse//rrr/3H
hw0bhifj/qThJUuWxDl0V/DlRElUqVIluikvM8TrhE8mUJlg0yKOHM5SsG90+/bt
itPxY9PS4opUunRpnFt35bfffrs3juBdc+bMwSl1f1I+yvncc8/JYZZyHjt2DGeY
/zdo0IDrfmPT4vkQpE4oRlA4d8oBfuWVV5yrSU3wJGPx0KeBAwc6Nxu5yS9t06aN
73vz3quuusoPyz1+/Lg+EpQoUcKX8H83tx48QH+JQpo4aaI/uNLijLbcfid8xkKp
UqUKFy4c9DIKXLly5WhagADyvXPmzMnw3LVr17Zt22655RZ81LR41+Dz09fBEFAa
h6pVq0YLf/TRR2PxiNcg7GvMx2OKFCmye/du/yLvoi2OeEWqOjA9OOea3hHVGz2j
HOHLLXfpC9LilI2+WDRv3txnB1ASNC1JFFiWw4jXVIA2bty4UVF7M2fO1MCRAmCy
ChYsiDEMLDNzAbrK/TVr1gwMXd26dWPx/ROKtsYCX3vttYHd8MGwZURcdNFFgVXE
GpcvX97PNpMw1YBmKL/XNC2i9i+99JJvTKZMmSJjFUyj9913X8z7YInNadq0KYbL
3y6QFv/YWaZMmc8//9xvqW9mwYABA/SKhNvwMyRekWrRokWfffbZ4PrYsR/7uRT8
alNmQOQxRWL//bQ5CmcOpnsUfvToj9yf2FWMPzMCDWewr1+/Xmqgb2wjR47kXQor
9lGpUiWu+1/vBPpd47FevXp+lom33npL8qHafg379u0rHjNI1cKahJnUT/yCOunr
L3OxfycqgYpqZdW+fXtV3t8V0bhxY594pZcfeughGhtwrMwFFSpUmDFjRlpSoAbi
dtH/efPmsa7r0KEDjU2L06DoTyySZ5wpkskCtYwaUpZ8EktAbrLEQh/8L+6Cljcv
vvii/mQBoBWdfw9C01Ikqk4ISr2DeN1Fqt26detYPFba30jBCGrZsmWS1EPZDEa8
GgyG1GHEq8FgyJ44t4hX4R//+Ed0QcwyPRbPPxDdcIePpJCKYDvkuHFj1fa1a9e6
O5NkXgM7duzQEj+a8A5XpHbt2rH4wUqOruKNisVwvu5XX32ldATvvPMOP+HPBOXg
IuoVUbonIdyB2tOnTw9+mjxlMk6UfyVKvOKcKM7REa+4CnL++/fvHxS4ePFiuRY+
37Rr1y7F0biltvjZIKYyLZ4C7+GHH3bOPO4WTpcCDB3ef//9WHzbYDStYWaIV1xc
fDMXk5scqmfgFM2dOxdvzc+aRz1x1UqVKhXwdwkhHxifzb+4bNkynEwqHzj5P//8
sza9vvbaa0E5S5cu1TktAa0pH75AgQIBX0MJ4sR9/cd7xNMOtjfKTUXtoyfAHDhw
QPWJes4osAaRE363bt0SsgYU26BBg6Bbo/j3v/8di+c9cIzGpk2blCVA/Evnzp2D
R3BoNTSCPKppcXEpXGvWrFnuItLGmXfhrg68heZzvxz11atX8+9ixYoFmRmPHz+u
xB19+vQJSli3bl3OnDnpIEaEu9ilS5eqVasipXz58vmE1/PPP1+nTp1oboezB0a8
pgisqEJHA6Ot7wE9e/aMPiK6BxUK7HaHDh1i8d0Gzla4dNsJ8cYbb8TiUZDBdYYV
F30mLiHxqs8wfq9hPGVJgiGMGVQ8o/8hJy0eVOgTr+Jnq1WrFq3q/fff79tVrGLQ
rv3792sUJ8yakiHxunPnTkYf9jwIOUwIJsdYfEuBn+sTU1m6dOlg5nr55ZfppugH
3ShWrFjBnQwEv0wMtTK9RMOWZUIxDkFSbDpIa4m3337bv87KAbPDdT+9SVrcoCU0
jNzv1jYO2lbSqVOnaP1ZGKT3kxZdjnhltaDPBoGo+RO7nTBBqo9Vq1Zpj8LYsR/r
CrZX0dlUOBbfmB/Nk6shNnDgwOD60aNHlW0mMD5oMgY5urtfWxlEvPLsbbfdxp/o
Q3CbeocSonOZkuE2b97cdRwtQhrKKtC1a1d3Jyula6+99vw5rNKIV4PBkDqMeDUY
DNkT5yLxqqxe/q63tN8D6KJhiWlxJvGuu+7i1zJlyvj0x4RPJnCxfPnybvN7hnAR
rwlPmXjppZdi8USoLtOrUhMop2oAOTks+idOmjjPgwjZKIWEc7X+j1ACsm3btinO
Lho1+cMPPwQxg1HiFf9csVo+8SpxRbdhbtq0SXXzKcj//Oc/hQsXdsTr999/X7Jk
Sf70A4KEX375JT1R451SzpIlS6SQ/81IcFrE64IFC0RnPPDAA2+88cby5cuTsKWf
f/65fG8/lRvCwcP3b0P4crSuuOKKJ598EicKOaQX0fnCCy/E4skl/ItiRYsWLfru
u+/6fa1tyAlJanx4Wpo3b97gOKaZM2dyP3IIiDzxOLfeemt6x3fotC6cW2lp/vz5
owc9YQRwbnmvzycKtNcnXo8cOaJj3J3n7EAFfF4+PbzyyiuxePa9YHssEOmAEk6f
Pt0XlwuIi372oHX6WuBLnttKly4dPbFny5YttMURr+oddJih579u2rRpCgZ/7rnn
ghJ+/fVXufq0QlcYfTVq1Ni+fbsSmLityrj9dIqf1vkshBGvKWLXrl36fDV37lx3
8aeffpIlTJg4BbXURoHgLCNxtUH6kSQQixT9SMaICE47TEi8KrrQ77WhQ4dqJg0+
YR47dkxh9QEbqOwljniVqUyYWGPPnj3RwS5geVavXj15ymTtGnHZeHxkSLzSLiU0
uPnmm3v16sV89PXXX6d3lhQ6r9ziftwic/E111wTTBnjJ4wXl9S4cWO6EquSXhZa
5i/qjyXxpzkmF7HJmJF5f4T26CDVwJhjNESPutQrwr59+3T4YZBOnfpIbtEvUg6s
BDZu3MiUV6VKlVii8FugnMIJJRwsuqSlUXPBXEklMzxccc2aNXny5GHZGT0WTNaY
NQlqFohL2SFcpGr0Kcagm3qoCYJ19tmH5heV44Zh9+7dURj/dbLkf//736MqhJ6o
ku7LQdeuXfv166cv0/SR++Dx3nvvYf8z3P+RbWDEq8FgSB1GvBoMhuyJbEO8arNw
sLPeQbRs/vz5fVpKDlWFChUyv6nfEa8JTydXMq/SpUu71T/+c0L/xJGbuHkP/xFt
2rTBBxg2bJi/t1HxvAHwzdJ+pxoTEq9RnBLx6ue5E/BSRGv6gVQB8co9SnUXJV4T
Yvbs2XRl69atqVu7du2qVq0qb+f0Ug3gbj3zzDMu0aq8o7Zt2waeqnD48OHKlSvH
vJBGPNhbbrnFZ08E/EPcJ1/4t912W+/evaOsrlLHBoeQKP9AgQIFUN2guzt37jxw
4MAoObh8+XLc9bx58wabZGfNmiWWMKBF5PAklBsa8uyzzyKEJ554okOHDnI78VGj
7jFGAHHly5cvOFQkLUK8btu2Tb0cJV4zCeUNwLmNVkMkYNmyZaNDgwE1fPjwhIe8
K0cHtXISe/7554OIbyEgXnv27BmLc/0tWrQI3tipU6f+/fsnjIJHZ3jqzjvvVP2p
mAKd1BE33XSTUltgZGhIQIGdbTDiNUUkJF537Ngh4j5hyktMqIg/bIJ/Xam0k2e8
8aEwwCjxGsUpEa8MzIBvwrAo/evIkSP96z7xytyhhJvBxu30gJ3BDjzyyCPdunXT
kYOyrtEvK2mZO1xrxowZoiYFJgIa8sYbb/hNdpCtZsZxtvShhx6Knh/FNKHgR4cr
r7wSyxCdhkS8lihRwr+I+RUret999wXmhfmOSWT69OkBH/3jjz+KTx8xYoR/fd++
fTr4MYiSZhpKj3jF8rzzzju8CL3q0qULDSxatCh30stRgSjVQML9IsGiS7ywv5A4
JaxevTpPnjyoYrSjmb41VzZv3jxqjQcMGJBwnbNz504tY5SsJi3eFzVq1EhIkfvE
68KFC/XdGksenW7QkMlTJke/FrDAU9JbxUEjfxYSrAmZC8qUKcN15ejnT94V3TCR
jWHEq8FgSB1GvBoMhuyJbEa8Blu8HViyi4Pz6SoRr+XLl888LZKceNUmTT/qVsRr
EP+YFndQdTZ6cDJyesChGj36ozFjRvv/iWCSOw38fKPp4S8gXr/66qtChQrF0onz
8oG7gi+dO3du6oN7Qzlp8ZO1UyFeheXLl7/66qsU686D5qmEUVSi/8qVK6eNjcOG
DaP7EoZlccPESRNxCxGOwlRj8VyuQVo9OfNBwJqIVz+/bYZIj3jVHs9MEq8HDhxg
sDC6GzduPHHiJwrElsIkJ16jDnxAvKL/6uX3338/843yIckjzPSI1wyPLw9w6NAh
BeHS9Wnx3Je1atUKkhQLCYnXm266KXpsSxLoEJ5cuXIxgsTXixFAjUVJK50lFuns
5yKNeE0RyYnXhCQXdqNs2bL82rZtW/+6iNcgDDYJRLz6Z6mnh7+SeG3UqFHyynAn
dS5atChlvvvuu8ws2IEff/xRwaGnTbymxTNEM/V069atWrVq7rSo9u3bR/MPrFmz
BjvAdKahumnTpkqVKkW/gQnz5s3DZLVo0UJGJhbPh+PvSklLh3jFBIkVjUZ3pock
xGupUqUyT7wyYaFjVPill17C1inuUicxBjleBRGvCX9KSLw2b948ky0KIOIVixFl
UUW83nzzzaeam0U5OphQ9GDnzp2ZixPeGRCvKAnSy2RmJwHtVXSwxikvatOmjX7q
168f12vUqJEW354SPccse8OIV4PBkDqMeDUYDNkT2YZ41bI7OBbDQcQrnpvPqWm/
2BkkXh955JGAipJ4ExKv2mZ4/fXXp7cXMpNYunSpqhTNDBDFX0C8btmyRQV26dIl
SU14i1jpYFPqBx9+EEtny3zmiVfhxIkTBw8exLPSJvSmTZtG78FLF02mrHn16tXL
kEmkYt99990bb7yhw5ED3zthxKvyD1DzhGqTECtXrlSqgVSI1/79+yuWx79TOV6T
EK+0K8OIVxRAOzST93ISDBo0KD3iVYTU7bfffqq+t6JQK1WqlBZPFvzggw8mTDUb
EK+9e/eOxSNeV6xYkfl3YTS0r5keGTZsGEbJ2RbZoueee27NmjX0VHAY0VkII15T
RELi9fDhw8qYnHBbNyOI2SpKrmlzRuaJVynh3XffneFg+WuIV50ieOONNyZP4KM0
L9gQPy0JYyp14tXh6NGjTBk9e/bEkObMmTPhdm/RxPr8ibVMmBTIB3MK7ZozZ44S
gwZ5qBMSr26CzmTmcdVcJzulQrwySV1xxRVc/PTTT91FdwZpihGvOprM39xzSli7
di0WOCHxqgn04osvjmanTQ7MLB2NHHiQtiPA9Jhun3ily3TaWL9+/U7pddrexFzD
pFm9enV3ahxvvzAOVlYtWrTQiWHnD4x4NRgMqcOIV4PBkD1xLhKvwTkPwuQpky+I
I3pIAhCTOH7CeP+i1ogVKlQ4DeI1etoJPyHGm266yT8UQsc3JaQzRIrFEp3qcErA
vVcMTtmyZbW7OQlEvPruZZLDtTJJvAaHa7lDxi677LLgYCgfuMHa5j/m4zH+dbn9
yYnXaAZSB/yo6MkeW7duzZ8/f4MGDRI+otCVTp064TvR8ChfcOjQoWnTpkW3t8tF
DJIY6GJwjNuMGTPU1+nF4ESBMHVOyymlGqhataqT22+//VarVq1oP44ZMzo58apT
uYOfULPgcC3FZCHYJL2cBIpsSphqoHPnzuKpk3R0QtDRyjJBp7Rq1Sp6nrW7zSde
6VzRPdFjuJKAYaIPLXXq1EFtfHYDRaLAG2+8sW3bti4XwdkMI15TxO7duxV5GmQp
EYuKfY5ms9m4cWOuXLkKFCjgp5Q5ceKEyK/ME68IXDY5enZTAEe8+scNRQ/XGjZs
2CkRr8HhWopkB++++26SyijMvEmTJv5FLIkIxCTEaxITykyEpY0ON1HDCYnXsWM/
5if6jqmNhrhJ0Mf8+fOjFB6zTCxyppmIV0rzv++yutAMy6QWPfkzIZhrKlWqFCVe
KSp5qgH/gxkWiSslS5Zk/nIX6VN1YhLiNeEX3GDRxT3q5dPLXo1IMe+oYpR4VRLz
WKLM2hlCbDWqxZTXpk2b9BIK+4drYfpYs/FnxYoVTykT66pVq5hrlKCmadOmrmd/
/fVXjQh0o0yZMv68cD7AiFeDwZA6jHg1GAzZE+ci8ap1bbAuZ70rx6x27drBebjL
ly/nev369YPwNx1Af8stt0TPz00PjnjFb/GdKDyiBg0a4HGJynEQ4eu2ofnYunWr
sq1dccUVCxcu9H/atm3bW2+9lXk3QCdLgEcffTRIZsef/gZq3OPYHyNwd+7cqf2w
PmWgcJ7olkMRrxdccIGvLXjLCn50lJzSBYB69er5tEJanG+VY7x//34dGe8f+c1i
XSnSqEA0gIsXFSlSJHnE65NPPvnSSy8FFzdt2lSoUKFBgwYlfESsaK5cufDHErqj
dMfdd9/N/4Pr//rXv6688spgI+Hzzz8f89JNoHLoyY8//lizZs1YPOfgBx9+4FMD
+NiDBw8OpJT2ezh2wYIFA1pTh3Ffeumlwb54OTz49k7J+YcS5vqnVKOfOmIbXY22
lG4VR+DCeI8ePSr3de/evblz5+Ynp+E4/+rle+65J8i3QHszPFhch8slDAjSFmB9
Swg887Vr1yLAhBkb0+JkqAiCkiVL4oQnTAWbFldjuhtFEkdPB+kcFS6+9957fs0p
gSsB9+0wcuRISeC+++7zv3lQoNiNHDlyjPpoVHI5nA0w4jVFYEWV8zHYsMzgVUYO
5prgEcVZB8waRk8HWDkeM0N8+eWXCtmrWLHixo0b/Z8Yhv4kNX/+/Fgk4lWTqc/z
6tQ7VDqYLh3xGuwJ0Fc6Nx1jyhRoWaxYsUAalODIXH0CxBY5O7Zr1y6xwAGB6KBs
Qkn4OCx5wiTvd955J5YwoUVigKu22OemTZtGSVuq165du2gQKHMQxjwQBRcZ8kjY
5f4Wxy2RaoI+fPiwu58qjRkzOrrJHXMqHj/guDHCzIBcnz17tn89IfEqTpmp2bHY
9Dt6iJWLeblQfYh4Va7qtHh/OaFJT1y4MQseRXPTy0E6F7+X08PEiZ9odot+4UNj
RYyi1VFrjEDSs8Zg3LixsfjeBZYWgYh8VKtWLeYdaKm9F1qn+UtBXj0tjoSF0I9a
JsUi6eyRvL7kVa5c+fw5Vksw4tVgMKQOI14NBkP2xLlIvF533XUJ2czt27fXqFEj
Fs/0umrVKvxGxSpeddVVtWvXjh6zoLaf0nY5R7wClu/4XZ9++unAgQNx7Tp16hTQ
T0D1SbjJPS1OoolgYpnesWNH1usTJ03EB8alwSvIfKDc0aNHW7durVrhcgwZMoRa
vfPOO/ixuKm+FyS2q2zZsu7K4sWLFSToUqDyXu2+j8YW4dfpLcoWKuB3yc3Qbn3h
2Wef1Z0IH2ePn8Z8POaRRx75xz/+Ibcfr0YcWf78+V977TWlT8WvUyAkNYz6yStW
rMiTJ08safbYxx77J8/S6fv27Tt58uTx48fXrFlz3333NW/e3I/z8oEHJQoYHzJK
gKbFWZUSJUrQv3iwEibuGT7hDTfcgKcX3Kw8vzgeL7/88vjx41588UXJCg9TZ+mA
Bg0a8Di9Ty+jfnRKlElUXCrqEZAp8hIZsMHXgrffflvC9JupDBt42v379580eVLP
nj1feOEFMT6FCxeOSphnaRS/1qpVa8qUKTQBD1k/rVy5Ur6974gqvBcgnz59+qB1
VLt9HBlGkYtGYWAm1PMPR30otUQC3bp1QznRkC5dulx22WVIOEky1lmzZqmeSbaO
ijLmNuccbtq0qVy5co5FVe8g6uuvv75Ro0Y+V+Jj27Zt6SXxHDx4cCx+CE9CjTrb
YMRrivjiiy+kPNGz5lAkmVOmG6YPtH3Xrl0vvfQSpiy6ax6Tpe8imcz9Lbz11ls6
IKhAgQI9evRgzDJeunfvzrzjfxbCAmuu8T9maNvBww8/7K7wb3FG0YhXfcjBXLuL
NEfG04/9nDlzprJg8y5MAfVBCNiKevXquUTkoz4a5bhITM0rr7yC5mDE1JBo0g+G
vL5d1a9fPz05MK4Zj0zHW7ZskXFDLZlQKlSoEN0G4aAZJ2HfCQ8++CANx1ZoMwTr
CibN2267rXPnzsHXQWy1RkHLli3VZIUhIzpFx8fiSRgwDpqgWaiUKVMmGt6Lhoiv
507/+tatW1UIZta/vnv3bl33d88wWasXMObMv6xVmBxfffVV7UdxtKMPdIafihQp
MmLEiA8+/IBOcWZci66gl5Vsh15u27YtUyFvZ37Bfi5ZsiQ9aQujR3/EgwyB4EO1
sG7dOn1/VXfLGlMZ6sA6J8lncjpIkyy9k96XPxZLys7h8rD/8ssv2pmk1SD6Q+9Q
w9tvv71ixYpJUufrMzaPBLtkWHZKXAqqPa9gxKvBYEgdRrwaDIbsiXOIeMXhYU3c
vHlzESus7Vq0aMHq2d/1j5/Qs2fP66+//pJLLsGreeCBB+6++26W7IEP+dlnn+EQ
KngkFs8mifuXJETCwRGvderUQWj696233orrGNyJM/yPf/xD5BEORsOGDbt27RoN
5FmwYAGt0Fb9WHx7dd26dYPd95nBjz/+iJMmx1goXLgwJa9cuVI3vPvuuziQio1C
gPz0aBwKYgKlSpXSFSXpi8Vjo/BzJk2e5N6CG6mfqlev/vzzzy9atAg/v0qVKrqI
s9GlSxd3BDxvxMdTZ0nHEIIfV4t7fP/99+sGBIXPhrOkE89icXbSBZLs3LmTF4mS
iMUT4+JDJvTZcN3Lli1brFixypUr4wE2a9asSZMmOMDJkzAoN2i3bt0S/opb1bRp
06JFi/JenH9cQfxqriTcl7p3716lw1MX+GQ0bjPV1l5RoVq1aihnkFRhxYoVnTp1
EgEqHxIPH+WfP38+veOOdqlRowbK77Yw4yrrOq124dg45A8//LC4DOSMX40c5syZ
ozvvvffekSNHBrznhE8mlCxZUjcw1vbt2/ef//yH97roHumJ8paePHkS/1zhogKq
Tp8mlIzDqI9GPfLIIxo+OXPmrFevHmJxiuowa9asRo0auXPMcufOzZ3pxR85HDly
BAWgsTqrLcDGjRt5V4UKFVQmXjqdrqirr7/++vHHH3dtj8Vj4ekdf6NuAJpfqVKl
XLlyRd8lQ5HeF5ezDUa8njZQmyeeeEJhquDqq69mdLz++uv+sGKwtGrViinpyiuv
ZNChxowR3zKkxdkfhi0KL3vI6MBcU1TCY9mjYFww2cm8x+Jc2J133umirTGVFOV0
m9rK1GMe9c2MB+l6rrRt29aNOKo6aNAgZzkZWTI+xYsX587FixfzK9ZVJeiMRB3m
nhb/nkeBigIWmCURi7N1FNu3b199t4jFI98xj7xCxoqhx6/is06cOMGL3EzBi6hk
wm9vTD1M5ci5TJkyTKMIkwGIAUx+qtXSpUtpwrXXXpteHP2rr77Kr5dffjmDHeOP
VWRuYraN7smg02mj9n/E4sG5LuKY9lKOs6Kx+CdJbNHmzZv9ErDnTEY6eFOibteu
Hfrz7bffYu3FmcbiH7o6duxIzfUUSyBdx/Rh5B3bjgIoj3AsfoCkuDAdrsUUiRiD
t2/bts29miajNszI2MBg0eV6ecmSJUEvs5xAMtE0QQ5r165lkeBmN+Z0dCnamygD
t/lzJcuMAQMGpPf11EFkaBAp7HqHHlHobiweGNumTZvx48elxZnx1157jenYLVeu
uOIKJJ8w8tpBH/BcgLAPKs/Ulslk9NkJRrwaDIbUYcSrwWDInjiHiFfWzbhzLHZZ
7uMSsKjl37NmzYpu5qIt+CSfffYZ9ySMvMPBwO+dP38+5XAnhfBnZlJVOuJ148aN
FLJs2bKVK1cmdNi4TvWosKo6Y8YM/ty3b1/0zpMnT27fvn3FihWU5kJ1Tg8HDx7E
+VStAjKI61SAmlAfBMi/p8bx+eefcz8XWSjrClVFJlxZuHAh/rwfcYknvDyO2bNn
z507l1cgZFcCVyjWZwqQzLp16/RrwrN98UvxitVw/xVUYObMmS4U6NChQ3qR3k5V
qZjbzunj2LFjCHnTpk3z5s2jBP6/c+fODOWGWHBxo9yfQAfh79FYHGBUhWLprCS7
KfHicC9pVELub8+ePZTDrzQ8IR3MDfQCwqSl3IaoaSzKv2PHDq7TIl2fFYcrAT3X
darH/50WnThxQl2ATHQFYbo7V69eHY0epdrcwE/aa8z9vJdqOOHzpx/cTR3UifzK
IEoSjirQrbQI7eJ+BgjVCAp0oBV44KptZkoWGJiO/Q+AlHjXnDlz1Bb+gbb7oxKl
0ghCaJnZJUr10jsGnXKimaDPThjxeto4cPAAChyMDvQnml8SA8jgxY6hGFHODlXn
KbRRsxujQyY6PTYwCkYrY3xZHPzDTxSAVlMUdXMmxZl6N0PpdW5gygLzq6sqJgjD
xU+0gjvpcX51FaYEng0ORNIUCdavX5+wIQxqfuUpvQUhIBxKw9QzO8vGIklZCf9F
CSNYqSHGislUsz/mMTnlKvCWKlWq9OnTJ4lgmdQ2bNhAragGFUsexo5NkAGJ/sQE
LVOJJBPus8GWSklkTiVqXnf48GEZfKmZrjvzQg2ZvDQFU0M/xQrPamnhLiJz7qQV
iDG6OsLoaXqSVUy46ArSv7hepskZqiuSpAQ3uyFSGpKeuWZSoKM1V6a37SDA/v37
KTnh7Mz0oR50QwwJ+N2E8qCo6p3M7FTgLdQ8mr45LW5RqXPCox2zN4x4NRgMqcOI
V4PBkD1xDhGvZwMc8Yp3l9V1MZwxjPpoVJMmTZLE6RgM2RhGvBrOW+zateuOO+5I
eJyXwWA4JRjxajAYUocRrwaDIXvCiNdTgiNet27dmtV1MZwZ/Pzzz40bN05+BrfB
kI1hxKvhvMWgQYNat26dyWh6g8GQBEa8GgyG1GHEq8FgyJ4w4vWUsH37diNesxkm
TZ5UuXLlDA+DMhiyK4x4NZyfQPNvvvnmTz/9NKsrYjBkBxjxajAYUocRrwaDIXvC
iNdTgjtWODMJYQ1nP44dO1a9evV///vfWV0RgyHLYMSr4fxEz54969Spk0pedYPB
4GDEq8FgSB1GvBoMhuwJI15PCQsXLhTxumPHjqyui+H0gVcwduzHhw4devTRR6+7
7rrMHKNkMGRXGPFqOH/w3Xffvf3222js+PHjUNqZM2dmdY0MhmwCI14NBkPqMOLV
YDBkTxjxmkngrY2fML5hw4YiXps3bz5x0kTbn36Ook2bNnIPSpQoYY634TyHEa+G
8weTJk/SJF64cOHevXtndXUMhuwDI14NBkPqMOLVYDBkTxjxmkmsX7/+8ccf7969
+zNxPPHEE926ddu2bVtW18twyjh58uTUqVN79OjRt29fy9VrMBjxajh/sG7duqee
eurJJ5+cO3duVtfFYMhWMOLVYDCkDiNeDQZD9oQRrwaDwXA+w4hXg8FgMKQII14N
BkPqMOLVYDBkTxjxajAYDOczjHg1GAwGQ4ow4tVgMKQOI14NBkP2hBGvBoPBcD7D
iFeDwWAwpAgjXg0GQ+ow4tVgMGRPGPFqMBgM5zOMeDUYDAZDijDi1WAwpA4jXg0G
Q/aEEa8Gg8FwPsOIV4PBYDCkCCNeDQZD6jDi1WAwZE8Y8WowGAznM4x4NRgMBkOK
MOLVYDCkDiNeDQZD9oQRr4azGXv27Pnpp5+yuhb/w2+//fbNN9+sXbv2iy++2LVr
V2Ye4baff/45uLh7926K+hMqaDCcDox4NZyH2Ldv36FDh7K6Fv8/GIbr169nftm8
efPx48eDX5k1fv311yypmMGQSRjxajAYUocRrwaDIXvCiFfDWYuJkybefvvtZ4lm
rlmzpkmTJoyUWBzFixfv0KHDunXrEt68f//+sWM/bt269a233rpx48bg1x49enTr
1s24V8NZAiNeDecbVq9eXadOnRUrVmR1Rf6L48ePDxkypGLFippcLr744kaNGlFD
/54nn3yyU6dOxr0azmYY8WowGFKHEa8GgyF7wohXw9mJpUuXXnrppcOHD8/qivwX
8+fPz58/v7ziCy64IEeOHPp3sWLFli1b5m77+eef8Te6dOlyxx138BM3XH755du2
bQtK27hx41VXXdWzZ8+/thEGQ2IY8Wo4r7Bnz57SpUt369bt2LFjWV2X/26k6Nq1
a3RyKVKkyMqVK91tzBrFixf/17/+lYVVNRiSw4hXg8GQOox4NRgM2RNGvBrOQnz/
/ffXXXfdQw89lNUV+R/at2+PL/HGG29s27Zt7969K1asaN68udzjOnXqHD16VLe9
9dZbhQoVatq06fLly1999VURr1u2bIkWOHHiJ/jYY8d+/Ne2w2BIACNeDecPfvnl
l7vvvrtcuXL8I6vr8l/MmzePueDhhx9eunQpk8vGjRsfe+yfol/r1avnb4yYPGUy
18ePH5eFtTUYksCIV4PBkDqMeDUYDNkTRrwazkK0aNEib968O3bsyOqK/Bf45/fe
e+9rr70WXG/WrBljB094/fr1urJ8+fKpU6fq3yNHjuTXG264Ib2R1aBBg8KFC2cy
V6zB8OfBiFfD+YPBgwejqPPnz8/qivwPTz31VKdOnfwrJ0+ebN26NZW8+uqr9+/f
7//UuHHjokWL7t69+6+to8GQKRjxajAYUocRrwaDIXvCiFfD2YbZs2ejk0888URW
V+R/+Pbbb7t27RrNGIDrrqDXKVOmRJ8aMWIEP/39739PL65q0aJF3NCuXbszX2OD
4VRgxKvhPMH27dsvvvji++67L6sr8j/8+uuvDLporvDJUyYrk/j333/vX2fWyJEj
R4cOHf7COhoMmYURrwaDIXUY8WowGLInjHg1nFU4fvx4vXr10MnoDv0jR458+eWX
LqfqihUrJk78hP9WrVr1p1bpt99+S0ie7tmzR8TrnDlzor+KeK1SpcpPP/2UXslV
q1bNmzdveid0GQx/DYx4NZwn6N69O1o6afKk4PrRo0e/+eabxYsXK+vrxo0bNbks
XLjwT80De/LkyR9//DF6ffr06dSzevXq3BD8VKtWrQsvvHDDhg1/Xq0MhtODEa8G
gyF1GPFqMBiyJ4x4NZxVWL16NV5llSpV/OObR300qmHDhnihBQsWrFy58uHDh7t0
6cLi3p0B3bRpU9zmv7iq69at4+0FChTYs2dP9NfMEK/a9NqvX78/s5oGQwYw4tVw
PgA9ZwYpUqTIzp073cUFCxY0a9asZs2apUqVKlmy5Pbt219//fXLLrss9jvuvvvu
xYsX/8VV7d+/P6/+/PPP0/vpmWee+YurZDBkCCNeDQZD6jDi1WAwZE8Y8Wo4qyAu
8umnn/YvbtiwARcUB5ifihYtip/cqlWrzz77bPXq1W+99Ra+NNdr1arlDrmK4uDB
g19nBLxxn+3NEG+++Sbvfeyxf544cSL6a2aI14ULF3LPbbfdljDoyWD4a2DEq+F8
wMRJE1HRmjVr+hZ7165ds2fPbt++PT9dcskldevWbdKkCXcyuUz4ZEK5cuW4ftVV
VyX5sHfo0KEzO7ksXry4fPnyQ4cOTfjrvHnzlMTmyJEjp9J6g+FPhxGvBoMhdRjx
ajAYsieMeDWcVWjYsCEKOeqjUdGfcET5KWfOnK+88op/fcqUKRdccEGOHDmSxCX1
7t07lhHy5cvnR0Ilx9GjR2+44YY8efJs3Lgx4Q2ZIV737NmTN2/eCy+80A5LMWQh
jHg1nA/o0aMHKtq1a9foT2IzQfv27X2LvXXrVuYFrn846sP0ih0wYECGkwujI8M9
GWPGjB44cGDnzp1z5cp12223pZeChqUaN+TPn3/z5s3/X3t3HhJVuwdw/LoE/eP8
UUpZ0UJIRAu0YARlC0VEZbQYKBWJFRXEW39UkEJGQntpVpTZRrz13vem79v73swW
WiizMrRFiWgTy7zdMlusyZmce3/dc/F65zjO2DPjmc75fv5rnjMzz8CZeTrfGc/x
6WUD7YXwCkAd4RWAORFeETwcDkefPn1kh7xw4YJ+NCcnR4aGDBnidnt9fX1sbKwM
HTp0yNMjl5eXH/YmL++k77881UrusWPHPG3gS3itra3VglfwXGIbFkR4hem5XK5Z
s2bJLrp9+3b9qBZebTbbixcv3Ibmz5/f+p/2P3jwwJfFpfUfqFZVVU2fPj01NTU7
OzstLa1Xr16RkZHyftR/J9fY2BgdHe3pRASAgQivANQRXgGYE+EVwcPhcERERISF
hd25c0c/un//ftlXR4wY4Xa70+mcOHGiDO3evbtdpvntN7ZyaLFt27ZWtvElvNrt
9vj4eNnsz7//GYBpAj4hvML0Ghsbp0yZIrtofn6efvTKlSsy1Lt3b/0Ju2WXbocd
W5aJ5mW2oqJCJiPPO3/+fFkWm2/pcrkmTZokQ7IMBXRKQFsRXgGoI7wCMCfCK4KH
HHlGRETI/9rLy8v1o1p4jY2Ndbu9oaFh/PjxMrR3715Pj1xSUrLNm9zc3A8fPnid
5O3bt/v27ZuRkdH6Zr6EVzmiTkhIkM1O/XHK6/MCAUJ4hek5nc5WeqUWXnv06KH/
xeuKFT/J0OrVqz09cllZmdfF5cCBA+/fv2/ThLWLaMlqeO/ePbehGTNmyNBvv//W
pgcEAo3wCkAd4RWAORFeETzq6+sjIiI6dOigP9T8l1p43bx5s9fT8EVFRT1//rz1
GcoGAwYMWLx4scvlan1LX8KrzHzmzJmEVxiL8ArTczqdkydP9vRhqxJes7KyvC4u
kZGRlZWV+vva7XZPS0l+fp5236KiIrehadOmfXshp3738pqB9kV4BaCO8ArAnAiv
CB4OhyMqKkp2yEuXLulHVcLrp0+f/ulNbW1t86td69XU1MTFxSUnJ8szen0tvoTX
t3Vvhw0bJpudPn3a6wMCAUJ4hem5XC7tvC7Z2dn6UZXwKp/wviwuX79+1d93x44d
nk4U/vPxn1ucktPpjImJkaGCggLvLxtoR4RXAOoIrwDMifCK4CGHptplss6dO6cf
1S6u9X3hVV11dfXEiRN9+a2r5uDBg1p4tdvtnraRo/F+/frJZqWlpf6bKdA2hFdY
wYIFC2QX3bJli35Iu7jW94VXFb/++tcpU6a0+OXcvHnz5HlTU1Pdvg6UVbJz584t
/hIWMBbhFYA6wisAcyK8IqgsW7ZMdsjc3Fz9kPYXnSNHjnS7vSm85uTkBGhW9fX1
cng8YcKEZ8+evX79+h//79WrV1++fHG7y969e2VKo0ePdrs0SnOVlZVhYWGdOnXi
3QcDEV5hBVu3bpVddOHChfqhc+fO/eU/F9eSz3O3IS28rl27NhBTqqqq6tatmzyF
LDHNbz969Kg8aXx8vP6047IGhYeH9+jRQ+4biCkB343wCkAd4RWAORFeEVRO/HLC
U75Zvny5DPXv398tZco/tfC6adOmQEyprq5O+6lUSEhIhw4dQnVsNtvFixeb38Vu
t6ekpMhdunfv3uKFwjRyL9kmMTHRl3MXAAFCeIUVXL9+XXbRUaNGOZ1Ot6E9e/bI
kOzDjx8/dhtauXKlp1zrF4MHD5bHHzFiRFZWVn5+3uHDh+fOnRsWFjZv3rza2lr9
9ufPn5ftZ8yY0cpXeoAhCK8A1BFeAZgT4RVBpaqqymazybFo8xZ54pcTixYt6tKl
i3axkalTp27YsKFpg7d1b+WoVW6Pjo5eunTptWvX/DuljIyM1i+cEhIS0nRuhMLC
wpSUlMmTJ3fs2FEbHTp0qEx+06ZN7969c3vkjRs3ygZHjhzx74SBNiG8wgocDofs
5507d25eV2W9kFVDO2uqGDNmTGpqanV1tTba2NiYlJQkt8vneXJycn5+nt9nJWvH
7Nmzw8PDtQnI+yghIeHkyb952j49PT2gf94BfDfCKwB1hFcA5kR4RVCRA90lS5bI
Pnn79u2mGx8+fHjp0iW55f79+3fv3r169erNmzebrlXS0NDw6NEjGZINLl682HTM
7C9Pnz69d+/efc8qKio+fvyobVxZWSlTlRmWlpbKkNyxuLhYbikpKXE7HYHT6Rw4
cGB0dLT+rIJAeyK8wiJ27drl9l3Xy5cvZdW4deuW9mFeVFR0/fr1ps9zl8sln/9y
u3yeX758Wf97WL+QJezJkyfyLOXl5bIctHIacbvdPnz4cJvNpj8lAmA4wisAdYRX
AOZEeEWwKSkpCQkJCdyfdgaJwsJCeeulpaUZPRFYHeEVFvHq1avIyMi4uLim7+1+
LGfPnpV3WXp6utETAVpAeAWgjvAKwJwIrwhCK1b8FBoaWlZWZvREAsVut8vBf8+e
Pevq6oyeC6yO8Arr0K5blZd30uiJtFlDQ8PYsWNjYmLkDWv0XIAWEF4BqCO8AjAn
wiuC0OvXrwcOHDhu3Dj9VVDMITMzMzQ09MyZM0ZPBCC8wkJkTZkzZ050dHRNTY3R
c2mb7OzskJCQgoICoycCtIzwCkAd4RWAORFeEZzKy8u7du26bt06oyfif0VFRVFR
Ufv27TN6IsA3hFdYivxvZ+TIkYmJifX19UbPxVfFxcXyFsvMzDR6IoBHhFcA6giv
AMyJ8IqgdePGjfj4+B/ud0lerV69eseOHUbPAvgvwiusRvbYhISE4uJioyfiK1k1
Nm7caPQsgNYQXgGoI7wCMCfCK4LZx48fHQ6H0bPws/fv3xs9BeB/CK+wILvd/vnz
Z6Nn4StWDQQ/wisAdYRXAOZEeAUAKyO8AgAUEV4BqCO8AjAnwisAWBnhFQCgiPAK
QB3hFYA5EV4BwMoIrwAARYRXAOoIrwDMifAKAFZGeAUAKCK8AlBHeAVgToRXALAy
wisAQBHhFYA6wisAcyK8AoCVEV4BAIoIrwDUEV4BmBPhFQCsjPAKAFBEeAWgjvAK
wJwIrwBgZYRXAIAiwisAdYRXAOZEeAUAKyO8AgAUEV4BqCO8AjAnwisAWBnhFQCg
iPAKQB3hFYA5EV4BwMoIrwAARYRXAOoIrwDMqSm8vnnzxui5AADa29s6v4XXVatW
+XduAIAfwpEjRwivABQRXgGYkxZe5Zj5w4cPRs8FANDePn/+PGjQIL+E1zVr1vh3
bgCAH8LxE8cJrwAUEV4BmJMWXsPDw9evX5+ZmbkNAGAZO3fuzMjI6Nq1q1/Ca2xs
rKwj27dvN/plAQDaT3Z2dlJSEuEVgCLCKwBz0sIrAMDiVMKrzWYzevoAAIMRXgGo
ILwCAAAAAAAAgJ/9G+xP+LamZMTAAAAAAElFTkSuQmCC">
<p style="top:410.1pt;left:97.8pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Figure 1.</span></b><span style="font-family:URWPalladioL,serif;font-size:8.9pt"> Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) &#xfb02;ow diagram</span></p>
<p style="top:422.9pt;left:97.8pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">of the literature search and selection process. n, number.</span></p>
<p style="top:443.2pt;left:76.5pt;line-height:10.0pt"><i><span style="font-family:URWPalladioL,serif;font-size:10.0pt">3.1. Bias Assessment</span></i></p>
<p style="top:462.6pt;left:97.8pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">For the pre-clinical studies, the bias assessment revealed that none of the studies reported any</span></p>
<p style="top:476.2pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">blinding of personnel or allocation concealment, and only 8 out of the 21 studies reported blinding of</span></p>
<p style="top:489.7pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">the outcome assessors (Table</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt;color:#0774b7"> 2</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">).</span></p>
<p style="top:503.2pt;left:97.8pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">Regarding the randomization of the animals, all studies reported random outcome assessment,</span></p>
<p style="top:516.7pt;left:76.0pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">15 studies reported random housing, and 12 studies published the method of randomization.</span></p>
<p style="top:530.2pt;left:76.2pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">The insu</span><span style="font-family:Rpxr,serif;font-size:10.1pt">&#xfb03;</span><span style="font-family:URWPalladioL,serif;font-size:10.1pt">cient documentation as to how both blinding and randomization were performed is</span></p>
<p style="top:543.8pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">of concern, since these factors are central to accruing valid data.</span></p>
<p style="top:557.2pt;left:97.8pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">The bias assessment of the human case studies (Table</span><span style="font-family:URWPalladioL,serif;font-size:10.1pt;color:#0774b7"> 3</span><span style="font-family:URWPalladioL,serif;font-size:10.1pt">) highlighted the problematic nature of</span></p>
<p style="top:570.7pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">reporting on only a limited number of patients (one and two, respectively), resulting in a high risk</span></p>
<p style="top:584.2pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">of bias. The bias assessment of the case&#x2013;control study Table</span><span style="font-family:URWPalladioL,serif;font-size:10.1pt;color:#0774b7"> 3</span><span style="font-family:URWPalladioL,serif;font-size:10.1pt">) demonstrated a low risk of bias in</span></p>
<p style="top:597.8pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">the study.</span></p>
<p style="top:611.4pt;left:97.8pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">In future randomized controlled clinical trials investigating the treatment of human burn victims</span></p>
<p style="top:624.8pt;left:76.1pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">with stem cells, a detailed description of blinding and randomization as well as the other bias types</span></p>
<p style="top:638.3pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">should be included. In order to increase the validity and reproducibility of the results, it would be</span></p>
<p style="top:651.8pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">bene&#xfb01;cial if the bias assessment tools were already implemented in the design phase of the clinical</span></p>
<p style="top:665.4pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">trials. This would, in turn, increase the level of evidence in the produced results.</span></p>


<p style="top:56.6pt;left:76.3pt;line-height:8.0pt"><i><span style="font-family:URWPalladioL,serif;font-size:8.0pt">Cells</span></i><b><span style="font-family:URWPalladioL,serif;font-size:8.0pt"> 2020</span></b><span style="font-family:URWPalladioL,serif;font-size:8.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:8.0pt"> 9</span></i><span style="font-family:URWPalladioL,serif;font-size:8.0pt">, 2545</span></p>
<p style="top:56.6pt;left:495.8pt;line-height:8.0pt"><span style="font-family:URWPalladioL,serif;font-size:8.0pt">5 of 21</span></p>
<p style="top:89.7pt;left:162.6pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Table 2.</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> A visual representation of the risk of bias in animal studies.</span></p>
<p style="top:212.6pt;left:245.6pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Sequence Generation</span></b></p>
<p style="top:218.0pt;left:272.7pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Allocation Concealment</span></b></p>
<p style="top:213.7pt;left:297.3pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Blinding of Personnel</span></b></p>
<p style="top:236.7pt;left:323.1pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Blinding of Personnel Assessors</span></b></p>
<p style="top:222.4pt;left:348.9pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Incomplete Outcome Data</span></b></p>
<p style="top:208.8pt;left:374.7pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Selective Reporting</span></b></p>
<p style="top:190.4pt;left:401.7pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Other Bias</span></b></p>
<p style="top:204.9pt;left:426.3pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Random Housing</span></b></p>
<p style="top:217.3pt;left:453.3pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Baseline Characteristics</span></b></p>
<p style="top:231.1pt;left:479.1pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Random Outcome Assessment</span></b></p>
<p style="top:254.4pt;left:136.4pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Oryan et al. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">27</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:272.1pt;left:135.8pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Atalay et al. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">28</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:289.8pt;left:129.7pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Eyuboglu et al. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">29</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:307.5pt;left:138.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Chen et al. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">30</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:325.2pt;left:137.2pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Loder et al. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">31</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:342.9pt;left:126.3pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Shokrgazor et al. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">32</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:360.6pt;left:138.6pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Kaita et al. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">33</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:378.3pt;left:137.8pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Bliley et al. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">34</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:396.0pt;left:105.2pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Gholipourmalekabadi et al. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">35</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:413.7pt;left:129.8pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Motamed et al. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">36</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:431.4pt;left:136.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Abbas et al. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">37</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:449.1pt;left:118.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Caliari-Oliveira et al. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">38</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:466.8pt;left:134.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Ahmed et al. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">39</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:484.5pt;left:136.4pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Singer et al. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">40</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:502.1pt;left:135.2pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Revilla et al. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">41</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:519.8pt;left:142.9pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Oh et al. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">42</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:537.5pt;left:140.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Guo et al. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">43</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:555.2pt;left:141.2pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Xue et al. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">44</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:572.9pt;left:136.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Zhang et al. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">45</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:590.6pt;left:131.6pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Pourfath et al. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">46</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:608.3pt;left:112.7pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Gholipour-Kanani et al. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">47</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:626.9pt;left:216.6pt;line-height:8.0pt"><span style="font-family:URWPalladioL,serif;font-size:8.0pt">Red: high risk of bias; green: low risk of bias.</span></p>


<p style="top:56.6pt;left:76.3pt;line-height:8.0pt"><i><span style="font-family:URWPalladioL,serif;font-size:8.0pt">Cells</span></i><b><span style="font-family:URWPalladioL,serif;font-size:8.0pt"> 2020</span></b><span style="font-family:URWPalladioL,serif;font-size:8.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:8.0pt"> 9</span></i><span style="font-family:URWPalladioL,serif;font-size:8.0pt">, 2545</span></p>
<p style="top:56.6pt;left:495.8pt;line-height:8.0pt"><span style="font-family:URWPalladioL,serif;font-size:8.0pt">6 of 21</span></p>
<p style="top:89.7pt;left:106.9pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Table 3.</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> A visual representation of the risk of bias in human case series and case-control studies.</span></p>
<p style="top:112.9pt;left:150.3pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">(</span><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">A</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">) A visual representation of the risk of bias in human case series studies.</span></p>
<p style="top:232.4pt;left:217.4pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Study Question</span></b><span style="font-family:Rpxb,serif;font-size:9.0pt">/</span><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Objective</span></b></p>
<p style="top:214.9pt;left:257.7pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Study Population</span></b></p>
<p style="top:216.9pt;left:285.5pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Consecutive Cases</span></b></p>
<p style="top:222.6pt;left:311.3pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Comparable Subjects</span></b></p>
<p style="top:235.2pt;left:338.1pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Description of Intervention</span></b></p>
<p style="top:218.4pt;left:366.0pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Outcome Measures</span></b></p>
<p style="top:216.4pt;left:391.7pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Follow-Up Length</span></b></p>
<p style="top:218.1pt;left:418.6pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Statistical Analysis</span></b></p>
<p style="top:226.6pt;left:446.5pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Well Described Results</span></b></p>
<p style="top:252.9pt;left:100.7pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Xu et al., 2012 [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">48</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:270.6pt;left:89.0pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Arkilous et al., 2018 [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">49</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:288.3pt;left:146.9pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">(</span><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">B</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">) A visual representation of the risk of bias in human case&#x2013;control studies.</span></p>
<p style="top:389.6pt;left:204.0pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Objective</span></b></p>
<p style="top:405.6pt;left:230.9pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Study Population</span></b></p>
<p style="top:420.7pt;left:257.7pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Sample Size Justi&#xfb01;cation</span></b></p>
<p style="top:387.3pt;left:285.6pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Controls</span></b></p>
<p style="top:441.3pt;left:311.6pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Use of Inclusion</span></b><span style="font-family:Rpxb,serif;font-size:9.0pt">/</span><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Exclusion Criteria</span></b></p>
<p style="top:401.6pt;left:339.3pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Case De&#xfb01;nition</span></b></p>
<p style="top:407.1pt;left:366.1pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Random Selection</span></b></p>
<p style="top:411.6pt;left:392.9pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Concurrent Controls</span></b></p>
<p style="top:388.6pt;left:418.3pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Exposure</span></b></p>
<p style="top:417.8pt;left:445.2pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Exposure Measurement</span></b></p>
<p style="top:387.8pt;left:472.2pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Blinding</span></b></p>
<p style="top:408.9pt;left:499.0pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Statistical Analysis</span></b></p>
<p style="top:459.0pt;left:82.5pt;line-height:8.9pt"><span style="font-family:URWPalladioL,serif;font-size:8.9pt">Abo-Elkheir et al., 2017 [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">50</span><span style="font-family:URWPalladioL,serif;font-size:8.9pt">]</span></p>
<p style="top:459.0pt;left:364.0pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">NA</span></p>
<p style="top:459.0pt;left:417.7pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">NA</span></p>
<p style="top:459.0pt;left:471.3pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">NA</span></p>
<p style="top:477.6pt;left:180.9pt;line-height:8.0pt"><span style="font-family:URWPalladioL,serif;font-size:8.0pt">Red: high risk of bias; green: low risk of bias. NA, not applicable.</span></p>
<p style="top:507.0pt;left:76.5pt;line-height:10.0pt"><i><span style="font-family:URWPalladioL,serif;font-size:10.0pt">3.2. Study Characteristics</span></i></p>
<p style="top:526.4pt;left:97.8pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">The 21 pre-clinical studies were published between 2013 and 2019 and the three clinical studies</span></p>
<p style="top:540.0pt;left:76.1pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">were published between 2012 and 2018. For both of the systematic reviews, the studies were analyzed</span></p>
<p style="top:553.6pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">in terms of population, intervention, comparison, global outcome (Tables</span><span style="font-family:URWPalladioL,serif;font-size:9.9pt;color:#0774b7"> 4</span><span style="font-family:URWPalladioL,serif;font-size:9.9pt"> and</span><span style="font-family:URWPalladioL,serif;font-size:9.9pt;color:#0774b7"> 5</span><span style="font-family:URWPalladioL,serif;font-size:9.9pt">, respectively), and the</span></p>
<p style="top:567.0pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">e</span><span style="font-family:Rpxr,serif;font-size:10.0pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">ect of stem cells on the di</span><span style="font-family:Rpxr,serif;font-size:10.0pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">erent phases of wound healing (Tables</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt;color:#0774b7"> 6</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt"> and</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt;color:#0774b7"> 7</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">, respectively).</span></p>


<p style="top:56.6pt;left:76.3pt;line-height:8.0pt"><i><span style="font-family:URWPalladioL,serif;font-size:8.0pt">Cells</span></i><b><span style="font-family:URWPalladioL,serif;font-size:8.0pt"> 2020</span></b><span style="font-family:URWPalladioL,serif;font-size:8.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:8.0pt"> 9</span></i><span style="font-family:URWPalladioL,serif;font-size:8.0pt">, 2545</span></p>
<p style="top:56.6pt;left:742.4pt;line-height:8.0pt"><span style="font-family:URWPalladioL,serif;font-size:8.0pt">7 of 21</span></p>
<p style="top:89.7pt;left:208.2pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Table 4.</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> Summary of populations, interventions, comparisons, and global outcomes for pre-clinical studies.</span></p>
<p style="top:121.4pt;left:146.0pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Study</span></b></p>
<p style="top:110.8pt;left:264.5pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Population</span></b></p>
<p style="top:110.8pt;left:404.8pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Intervention</span></b></p>
<p style="top:121.2pt;left:557.0pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Comparison</span></b></p>
<p style="top:116.7pt;left:683.2pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Outcome</span></b></p>
<p style="top:127.6pt;left:685.0pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">(Global)</span></b></p>
<p style="top:126.8pt;left:247.9pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Sample</span></b></p>
<p style="top:137.7pt;left:254.6pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Size</span></b></p>
<p style="top:132.2pt;left:295.6pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Species</span></b></p>
<p style="top:132.2pt;left:348.7pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Type</span></b></p>
<p style="top:132.2pt;left:392.9pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Origin</span></b></p>
<p style="top:132.2pt;left:436.4pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Delivery</span></b></p>
<p style="top:132.2pt;left:491.6pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Dose</span></b></p>
<p style="top:169.9pt;left:115.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Oryan et al., 2019 [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">27</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:169.9pt;left:258.9pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">12</span></p>
<p style="top:169.9pt;left:308.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">R</span></p>
<p style="top:169.9pt;left:349.8pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">ASC</span></p>
<p style="top:169.9pt;left:391.8pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Murine</span></p>
<p style="top:169.9pt;left:437.2pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Injection</span></p>
<p style="top:170.2pt;left:488.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">1</span><span style="font-family:Pxsy,serif;font-size:9.0pt"> &#xd7;</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 10</span><sup><span style="font-family:URWPalladioL,serif;font-size:7.0pt">6</span></sup></p>
<p style="top:153.5pt;left:548.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">ASC</span><span style="font-family:Rpxr,serif;font-size:9.0pt"> +</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> Aloe Vera</span></p>
<p style="top:164.4pt;left:562.6pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Aloe Vera</span></p>
<p style="top:175.4pt;left:546.9pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Aloe Vera</span><span style="font-family:Rpxr,serif;font-size:9.0pt"> +</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> DBM</span></p>
<p style="top:186.4pt;left:571.7pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">DBM</span></p>
<p style="top:164.4pt;left:646.9pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Positive, signi&#xfb01;cantly better</span></p>
<p style="top:175.4pt;left:666.4pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">than other groups</span></p>
<p style="top:207.6pt;left:114.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Atalay et al., 2014 [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">28</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:207.6pt;left:258.9pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">20</span></p>
<p style="top:207.6pt;left:308.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">R</span></p>
<p style="top:207.6pt;left:346.9pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">ASC *</span></p>
<p style="top:207.6pt;left:391.8pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Murine</span></p>
<p style="top:207.6pt;left:437.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Injection</span></p>
<p style="top:207.9pt;left:488.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">4</span><span style="font-family:Pxsy,serif;font-size:9.0pt"> &#xd7;</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 10</span><sup><span style="font-family:URWPalladioL,serif;font-size:7.0pt">6</span></sup></p>
<p style="top:202.1pt;left:573.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">ASC</span></p>
<p style="top:213.1pt;left:567.0pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Control</span></p>
<p style="top:207.6pt;left:686.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Positive</span></p>
<p style="top:234.3pt;left:108.3pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Eyuboglu et al., 2018 [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">29</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:234.3pt;left:258.9pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">20</span></p>
<p style="top:234.3pt;left:308.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">R</span></p>
<p style="top:234.3pt;left:346.9pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">ASC *</span></p>
<p style="top:234.3pt;left:391.8pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Murine</span></p>
<p style="top:234.3pt;left:437.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Injection</span></p>
<p style="top:234.6pt;left:488.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">4</span><span style="font-family:Pxsy,serif;font-size:9.0pt"> &#xd7;</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 10</span><sup><span style="font-family:URWPalladioL,serif;font-size:7.0pt">6</span></sup></p>
<p style="top:228.8pt;left:573.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">ASC</span></p>
<p style="top:239.8pt;left:567.0pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Control</span></p>
<p style="top:234.3pt;left:686.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Positive</span></p>
<p style="top:261.0pt;left:117.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Chen et al., 2017 [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">30</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:261.0pt;left:261.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">6</span></p>
<p style="top:261.0pt;left:308.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">R</span></p>
<p style="top:261.0pt;left:349.8pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">ASC</span></p>
<p style="top:261.0pt;left:391.8pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Murine</span></p>
<p style="top:261.0pt;left:437.2pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Injection</span></p>
<p style="top:261.3pt;left:488.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">1</span><span style="font-family:Pxsy,serif;font-size:9.0pt"> &#xd7;</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 10</span><sup><span style="font-family:URWPalladioL,serif;font-size:7.0pt">6</span></sup></p>
<p style="top:255.6pt;left:573.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">ASC</span></p>
<p style="top:266.5pt;left:567.0pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Control</span></p>
<p style="top:261.0pt;left:686.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Positive</span></p>
<p style="top:298.7pt;left:115.8pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Loder et al., 2015 [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">31</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:298.7pt;left:258.9pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">20</span></p>
<p style="top:298.7pt;left:306.8pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">M</span></p>
<p style="top:298.7pt;left:349.8pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">ASC</span></p>
<p style="top:298.7pt;left:391.8pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Murine</span></p>
<p style="top:298.7pt;left:437.2pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Injection</span></p>
<p style="top:299.0pt;left:488.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">1</span><span style="font-family:Pxsy,serif;font-size:9.0pt"> &#xd7;</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 10</span><sup><span style="font-family:URWPalladioL,serif;font-size:7.0pt">6</span></sup></p>
<p style="top:282.3pt;left:573.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">ASC</span></p>
<p style="top:293.2pt;left:576.2pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">AT</span></p>
<p style="top:304.2pt;left:561.8pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">AT</span><span style="font-family:Rpxr,serif;font-size:9.0pt"> +</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> ASC</span></p>
<p style="top:315.2pt;left:571.0pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Sham</span></p>
<p style="top:293.2pt;left:646.9pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Positive, signi&#xfb01;cantly better</span></p>
<p style="top:304.2pt;left:650.3pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">than non-stem cell groups</span></p>
<p style="top:336.4pt;left:104.9pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Shokrgazor et al., 2012 [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">32</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:336.4pt;left:258.9pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">10</span></p>
<p style="top:336.4pt;left:308.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">R</span></p>
<p style="top:336.4pt;left:349.8pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">ASC</span></p>
<p style="top:336.4pt;left:391.8pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Murine</span></p>
<p style="top:336.4pt;left:443.9pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Graft</span></p>
<p style="top:336.7pt;left:488.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">5</span><span style="font-family:Pxsy,serif;font-size:9.0pt"> &#xd7;</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 10</span><sup><span style="font-family:URWPalladioL,serif;font-size:7.0pt">5</span></sup></p>
<p style="top:330.9pt;left:573.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">ASC</span></p>
<p style="top:341.9pt;left:567.0pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Control</span></p>
<p style="top:336.4pt;left:686.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Positive</span></p>
<p style="top:368.6pt;left:117.2pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Kaita et al., 2019 [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">33</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:368.6pt;left:258.9pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">18</span></p>
<p style="top:368.6pt;left:306.8pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">M</span></p>
<p style="top:368.6pt;left:349.8pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">ASC</span></p>
<p style="top:368.6pt;left:391.3pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Human</span></p>
<p style="top:368.6pt;left:443.9pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Graft</span></p>
<p style="top:368.9pt;left:488.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">5</span><span style="font-family:Pxsy,serif;font-size:9.0pt"> &#xd7;</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 10</span><sup><span style="font-family:URWPalladioL,serif;font-size:7.0pt">4</span></sup></p>
<p style="top:357.6pt;left:571.3pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Fresh</span></p>
<p style="top:368.6pt;left:568.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Frozen</span></p>
<p style="top:379.6pt;left:567.0pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Control</span></p>
<p style="top:368.6pt;left:686.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Positive</span></p>
<p style="top:400.8pt;left:116.4pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Bliley et al., 2016 [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">34</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:400.8pt;left:258.9pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">24</span></p>
<p style="top:400.8pt;left:306.8pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">M</span></p>
<p style="top:400.8pt;left:349.8pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">ASC</span></p>
<p style="top:400.8pt;left:391.3pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Human</span></p>
<p style="top:400.8pt;left:437.2pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Injection</span></p>
<p style="top:401.1pt;left:484.7pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">6.8</span><span style="font-family:Pxsy,serif;font-size:9.0pt"> &#xd7;</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 10</span><sup><span style="font-family:URWPalladioL,serif;font-size:7.0pt">6</span></sup></p>
<p style="top:395.3pt;left:573.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">ASC</span></p>
<p style="top:406.3pt;left:567.0pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Control</span></p>
<p style="top:400.8pt;left:661.9pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Positive, but limited</span></p>
<p style="top:433.0pt;left:83.8pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Gholipourmalekabadi et al., 2018 [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">35</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:433.0pt;left:258.9pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">45</span></p>
<p style="top:433.0pt;left:306.8pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">M</span></p>
<p style="top:433.0pt;left:349.8pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">ASC</span></p>
<p style="top:433.0pt;left:391.3pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Human</span></p>
<p style="top:433.0pt;left:443.9pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Graft</span></p>
<p style="top:433.3pt;left:488.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">1</span><span style="font-family:Pxsy,serif;font-size:9.0pt"> &#xd7;</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 10</span><sup><span style="font-family:URWPalladioL,serif;font-size:7.0pt">4</span></sup></p>
<p style="top:422.0pt;left:570.7pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">HAM</span></p>
<p style="top:433.0pt;left:556.4pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">HAM</span><span style="font-family:Rpxr,serif;font-size:9.0pt"> +</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> ASC</span></p>
<p style="top:444.0pt;left:567.0pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Control</span></p>
<p style="top:427.5pt;left:646.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Positive. More signi&#xfb01;cant in</span></p>
<p style="top:438.5pt;left:676.2pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">HAM</span><span style="font-family:Rpxr,serif;font-size:9.0pt"> +</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> ASC</span></p>
<p style="top:470.7pt;left:108.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Motamed et al., 2017 [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">36</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:470.7pt;left:258.9pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">24</span></p>
<p style="top:470.7pt;left:308.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">R</span></p>
<p style="top:470.7pt;left:349.8pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">ASC</span></p>
<p style="top:470.7pt;left:391.3pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Human</span></p>
<p style="top:470.7pt;left:443.9pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Graft</span></p>
<p style="top:470.9pt;left:488.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">5</span><span style="font-family:Pxsy,serif;font-size:9.0pt"> &#xd7;</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 10</span><sup><span style="font-family:URWPalladioL,serif;font-size:7.0pt">5</span></sup></p>
<p style="top:459.7pt;left:570.7pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">HAM</span></p>
<p style="top:470.7pt;left:556.4pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">HAM</span><span style="font-family:Rpxr,serif;font-size:9.0pt"> +</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> ASC</span></p>
<p style="top:481.6pt;left:567.0pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Control</span></p>
<p style="top:465.2pt;left:646.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Positive. More signi&#xfb01;cant in</span></p>
<p style="top:476.2pt;left:676.2pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">HAM</span><span style="font-family:Rpxr,serif;font-size:9.0pt"> +</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> ASC</span></p>


<p style="top:56.6pt;left:76.3pt;line-height:8.0pt"><i><span style="font-family:URWPalladioL,serif;font-size:8.0pt">Cells</span></i><b><span style="font-family:URWPalladioL,serif;font-size:8.0pt"> 2020</span></b><span style="font-family:URWPalladioL,serif;font-size:8.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:8.0pt"> 9</span></i><span style="font-family:URWPalladioL,serif;font-size:8.0pt">, 2545</span></p>
<p style="top:56.6pt;left:742.4pt;line-height:8.0pt"><span style="font-family:URWPalladioL,serif;font-size:8.0pt">8 of 21</span></p>
<p style="top:89.7pt;left:393.4pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Table 4.</span></b><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> Cont</span></i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">.</span></p>
<p style="top:121.4pt;left:146.0pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Study</span></b></p>
<p style="top:110.8pt;left:264.5pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Population</span></b></p>
<p style="top:110.8pt;left:404.8pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Intervention</span></b></p>
<p style="top:121.2pt;left:557.0pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Comparison</span></b></p>
<p style="top:116.7pt;left:683.2pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Outcome</span></b></p>
<p style="top:127.6pt;left:685.0pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">(Global)</span></b></p>
<p style="top:126.8pt;left:247.9pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Sample</span></b></p>
<p style="top:137.7pt;left:254.6pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Size</span></b></p>
<p style="top:132.2pt;left:295.6pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Species</span></b></p>
<p style="top:132.2pt;left:348.7pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Type</span></b></p>
<p style="top:132.2pt;left:392.9pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Origin</span></b></p>
<p style="top:132.2pt;left:436.4pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Delivery</span></b></p>
<p style="top:132.2pt;left:491.6pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Dose</span></b></p>
<p style="top:169.9pt;left:115.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Abbas et al., 2018 [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">37</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:169.9pt;left:258.9pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">40</span></p>
<p style="top:169.9pt;left:308.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">R</span></p>
<p style="top:159.0pt;left:349.2pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">ASC,</span></p>
<p style="top:170.0pt;left:340.9pt;line-height:8.9pt"><span style="font-family:URWPalladioL,serif;font-size:8.9pt">BM-MSC,</span></p>
<p style="top:180.9pt;left:347.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">DPSC</span></p>
<p style="top:169.9pt;left:391.3pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Human</span></p>
<p style="top:169.9pt;left:437.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Injection</span></p>
<p style="top:170.2pt;left:488.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">1</span><span style="font-family:Pxsy,serif;font-size:9.0pt"> &#xd7;</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 10</span><sup><span style="font-family:URWPalladioL,serif;font-size:7.0pt">6</span></sup></p>
<p style="top:153.5pt;left:563.9pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">BM-MSC</span></p>
<p style="top:164.4pt;left:573.0pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">ASC</span></p>
<p style="top:175.4pt;left:570.4pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">DPSC</span></p>
<p style="top:186.4pt;left:567.0pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Control</span></p>
<p style="top:164.4pt;left:658.2pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Positive, no di</span><span style="font-family:Rpxr,serif;font-size:9.0pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">erence</span></p>
<p style="top:175.4pt;left:646.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">between choice of stem cells</span></p>
<p style="top:207.6pt;left:96.7pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Caliari-Oliveira et al., 2016 [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">38</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:207.6pt;left:258.9pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">54</span></p>
<p style="top:207.6pt;left:308.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">R</span></p>
<p style="top:207.7pt;left:340.9pt;line-height:8.9pt"><span style="font-family:URWPalladioL,serif;font-size:8.9pt">BM-MSC</span></p>
<p style="top:207.6pt;left:391.8pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Murine</span></p>
<p style="top:207.6pt;left:437.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Injection</span></p>
<p style="top:207.9pt;left:488.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">5</span><span style="font-family:Pxsy,serif;font-size:9.0pt"> &#xd7;</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 10</span><sup><span style="font-family:URWPalladioL,serif;font-size:7.0pt">6</span></sup></p>
<p style="top:202.1pt;left:572.4pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">MSC</span></p>
<p style="top:213.1pt;left:567.0pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Control</span></p>
<p style="top:207.6pt;left:686.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Positive</span></p>
<p style="top:239.8pt;left:112.7pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Ahmed et al., 2017 [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">39</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:239.8pt;left:258.9pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">36</span></p>
<p style="top:239.8pt;left:308.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">R</span></p>
<p style="top:239.9pt;left:340.9pt;line-height:8.9pt"><span style="font-family:URWPalladioL,serif;font-size:8.9pt">BM-MSC</span></p>
<p style="top:239.8pt;left:391.8pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Murine</span></p>
<p style="top:239.8pt;left:437.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Injection</span></p>
<p style="top:240.1pt;left:488.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">1</span><span style="font-family:Pxsy,serif;font-size:9.0pt"> &#xd7;</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 10</span><sup><span style="font-family:URWPalladioL,serif;font-size:7.0pt">6</span></sup></p>
<p style="top:228.8pt;left:572.4pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">MSC</span></p>
<p style="top:239.8pt;left:567.0pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Control</span></p>
<p style="top:250.8pt;left:571.0pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Sham</span></p>
<p style="top:239.8pt;left:686.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Positive</span></p>
<p style="top:272.0pt;left:115.0pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Singer et al., 2013 [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">40</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:272.0pt;left:258.9pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">20</span></p>
<p style="top:272.0pt;left:308.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">R</span></p>
<p style="top:272.1pt;left:340.9pt;line-height:8.9pt"><span style="font-family:URWPalladioL,serif;font-size:8.9pt">BM-MSC</span></p>
<p style="top:272.0pt;left:391.8pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Murine</span></p>
<p style="top:272.0pt;left:437.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Injection</span></p>
<p style="top:272.3pt;left:488.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">1</span><span style="font-family:Pxsy,serif;font-size:9.0pt"> &#xd7;</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 10</span><sup><span style="font-family:URWPalladioL,serif;font-size:7.0pt">6</span></sup></p>
<p style="top:266.5pt;left:572.4pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">MSC</span></p>
<p style="top:277.5pt;left:567.0pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Control</span></p>
<p style="top:272.0pt;left:686.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Positive</span></p>
<p style="top:298.7pt;left:113.9pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Revilla et al., 2016 [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">41</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:298.7pt;left:258.9pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">12</span></p>
<p style="top:298.7pt;left:308.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">R</span></p>
<p style="top:298.8pt;left:340.9pt;line-height:8.9pt"><span style="font-family:URWPalladioL,serif;font-size:8.9pt">BM-MSC</span></p>
<p style="top:298.7pt;left:391.8pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Murine</span></p>
<p style="top:298.7pt;left:437.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Injection</span></p>
<p style="top:299.0pt;left:488.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">2</span><span style="font-family:Pxsy,serif;font-size:9.0pt"> &#xd7;</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 10</span><sup><span style="font-family:URWPalladioL,serif;font-size:7.0pt">6</span></sup></p>
<p style="top:293.2pt;left:572.4pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">MSC</span></p>
<p style="top:304.2pt;left:567.0pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Control</span></p>
<p style="top:298.7pt;left:686.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Positive</span></p>
<p style="top:330.9pt;left:121.6pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Oh et al., 2018 [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">42</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:330.9pt;left:258.9pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">30</span></p>
<p style="top:330.9pt;left:306.8pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">M</span></p>
<p style="top:331.0pt;left:340.9pt;line-height:8.9pt"><span style="font-family:URWPalladioL,serif;font-size:8.9pt">BM-MSC</span></p>
<p style="top:330.9pt;left:391.8pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Murine</span></p>
<p style="top:330.9pt;left:437.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Injection</span></p>
<p style="top:331.2pt;left:488.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">5</span><span style="font-family:Pxsy,serif;font-size:9.0pt"> &#xd7;</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 10</span><sup><span style="font-family:URWPalladioL,serif;font-size:7.0pt">5</span></sup></p>
<p style="top:320.0pt;left:572.4pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">MSC</span></p>
<p style="top:330.9pt;left:567.0pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Control</span></p>
<p style="top:341.9pt;left:571.0pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Sham</span></p>
<p style="top:330.9pt;left:686.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Positive</span></p>
<p style="top:368.6pt;left:119.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Guo et al., 2016 [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">43</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:368.6pt;left:258.9pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">48</span></p>
<p style="top:368.6pt;left:308.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">R</span></p>
<p style="top:368.7pt;left:340.9pt;line-height:8.9pt"><span style="font-family:URWPalladioL,serif;font-size:8.9pt">BM-MSC</span></p>
<p style="top:368.6pt;left:391.8pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Murine</span></p>
<p style="top:368.6pt;left:443.9pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Graft</span></p>
<p style="top:368.9pt;left:488.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">5</span><span style="font-family:Pxsy,serif;font-size:9.0pt"> &#xd7;</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 10</span><sup><span style="font-family:URWPalladioL,serif;font-size:7.0pt">5</span></sup></p>
<p style="top:357.6pt;left:575.9pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">SIS</span></p>
<p style="top:368.6pt;left:560.9pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">SIS</span><span style="font-family:Rpxr,serif;font-size:9.0pt"> +</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> MSC</span></p>
<p style="top:379.6pt;left:567.0pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Control</span></p>
<p style="top:363.1pt;left:646.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Positive. More signi&#xfb01;cant in</span></p>
<p style="top:374.1pt;left:680.7pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">SIS</span><span style="font-family:Rpxr,serif;font-size:9.0pt"> +</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> MSC</span></p>
<p style="top:400.8pt;left:119.8pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Xue et al., 2013 [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">44</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:400.8pt;left:258.9pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">60</span></p>
<p style="top:400.8pt;left:306.8pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">M</span></p>
<p style="top:400.9pt;left:340.9pt;line-height:8.9pt"><span style="font-family:URWPalladioL,serif;font-size:8.9pt">BM-MSC</span></p>
<p style="top:400.8pt;left:391.3pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Human</span></p>
<p style="top:400.8pt;left:437.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Injection</span></p>
<p style="top:401.1pt;left:488.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">1</span><span style="font-family:Pxsy,serif;font-size:9.0pt"> &#xd7;</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 10</span><sup><span style="font-family:URWPalladioL,serif;font-size:7.0pt">6</span></sup></p>
<p style="top:395.3pt;left:572.4pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">MSC</span></p>
<p style="top:406.3pt;left:567.0pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Control</span></p>
<p style="top:400.8pt;left:686.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Positive</span></p>
<p style="top:427.5pt;left:114.7pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Zhang et al., 2015 [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">45</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:427.5pt;left:258.9pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">84</span></p>
<p style="top:427.5pt;left:308.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">R</span></p>
<p style="top:427.5pt;left:340.9pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">UC-MSC</span></p>
<p style="top:427.5pt;left:391.3pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Human</span></p>
<p style="top:427.5pt;left:437.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Injection</span></p>
<p style="top:427.8pt;left:488.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">2</span><span style="font-family:Pxsy,serif;font-size:9.0pt"> &#xd7;</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 10</span><sup><span style="font-family:URWPalladioL,serif;font-size:7.0pt">6</span></sup></p>
<p style="top:422.0pt;left:572.4pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">MSC</span></p>
<p style="top:433.0pt;left:567.0pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Control</span></p>
<p style="top:427.5pt;left:686.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Positive</span></p>
<p style="top:454.2pt;left:110.3pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Pourfath et al., 2018 [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">46</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:454.2pt;left:258.9pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">24</span></p>
<p style="top:454.2pt;left:308.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">R</span></p>
<p style="top:454.2pt;left:340.9pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">UC-MSC</span></p>
<p style="top:454.2pt;left:391.3pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Human</span></p>
<p style="top:454.2pt;left:442.7pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Spray</span></p>
<p style="top:454.5pt;left:488.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">5</span><span style="font-family:Pxsy,serif;font-size:9.0pt"> &#xd7;</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 10</span><sup><span style="font-family:URWPalladioL,serif;font-size:7.0pt">5</span></sup></p>
<p style="top:448.8pt;left:572.4pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">MSC</span></p>
<p style="top:459.7pt;left:567.0pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Control</span></p>
<p style="top:454.2pt;left:686.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Positive</span></p>
<p style="top:481.0pt;left:91.3pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Gholipour-Kanani et al., 2014 [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">47</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:481.0pt;left:258.9pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">12</span></p>
<p style="top:481.0pt;left:308.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">R</span></p>
<p style="top:481.0pt;left:340.9pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">UC-MSC</span></p>
<p style="top:481.0pt;left:391.3pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Human</span></p>
<p style="top:481.0pt;left:443.9pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Graft</span></p>
<p style="top:481.2pt;left:488.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">4</span><span style="font-family:Pxsy,serif;font-size:9.0pt"> &#xd7;</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 10</span><sup><span style="font-family:URWPalladioL,serif;font-size:7.0pt">4</span></sup></p>
<p style="top:475.5pt;left:572.4pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">MSC</span></p>
<p style="top:486.4pt;left:567.0pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Control</span></p>
<p style="top:481.0pt;left:686.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Positive</span></p>
<p style="top:501.7pt;left:97.8pt;line-height:8.0pt"><span style="font-family:URWPalladioL,serif;font-size:8.0pt">ASC: adipose-derived stem cells, AT: adipose tissue, BM-MSC: bone-marrow-derived mesenchymal stem cells, DBM: demineralized bone matrix, DPSC: dental pulp stem cells, HAM:</span></p>
<p style="top:511.1pt;left:97.8pt;line-height:8.0pt"><span style="font-family:URWPalladioL,serif;font-size:8.0pt">human amniotic membrane, M: mouse, MSC: mesenchymal stem cells, R: rat, SIS: small intestine submucosa, UC-MSC: umbilical cord mesenchymal stem cells. * ASCs delivered as</span></p>
<p style="top:520.6pt;left:97.8pt;line-height:8.0pt"><span style="font-family:URWPalladioL,serif;font-size:8.0pt">stromal vascular fraction.</span></p>


<p style="top:56.6pt;left:76.3pt;line-height:8.0pt"><i><span style="font-family:URWPalladioL,serif;font-size:8.0pt">Cells</span></i><b><span style="font-family:URWPalladioL,serif;font-size:8.0pt"> 2020</span></b><span style="font-family:URWPalladioL,serif;font-size:8.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:8.0pt"> 9</span></i><span style="font-family:URWPalladioL,serif;font-size:8.0pt">, 2545</span></p>
<p style="top:56.6pt;left:742.4pt;line-height:8.0pt"><span style="font-family:URWPalladioL,serif;font-size:8.0pt">9 of 21</span></p>
<p style="top:89.7pt;left:216.2pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Table 5.</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> Summary of populations, interventions, comparisons, and global outcomes for clinical studies.</span></p>
<p style="top:114.3pt;left:117.5pt;line-height:7.2pt"><b><span style="font-family:URWPalladioL,serif;font-size:7.2pt">Study</span></b></p>
<p style="top:114.3pt;left:192.9pt;line-height:7.2pt"><b><span style="font-family:URWPalladioL,serif;font-size:7.2pt">Population</span></b></p>
<p style="top:114.3pt;left:337.9pt;line-height:7.2pt"><b><span style="font-family:URWPalladioL,serif;font-size:7.2pt">Intervention</span></b></p>
<p style="top:114.3pt;left:574.1pt;line-height:7.2pt"><b><span style="font-family:URWPalladioL,serif;font-size:7.2pt">Comparison</span></b></p>
<p style="top:110.0pt;left:725.6pt;line-height:7.2pt"><b><span style="font-family:URWPalladioL,serif;font-size:7.2pt">Outcome</span></b></p>
<p style="top:118.7pt;left:726.7pt;line-height:7.2pt"><b><span style="font-family:URWPalladioL,serif;font-size:7.2pt">(Global)</span></b></p>
<p style="top:131.3pt;left:180.1pt;line-height:7.2pt"><b><span style="font-family:URWPalladioL,serif;font-size:7.2pt">Sample</span></b></p>
<p style="top:140.1pt;left:184.8pt;line-height:7.2pt"><b><span style="font-family:URWPalladioL,serif;font-size:7.2pt">Size</span></b></p>
<p style="top:135.7pt;left:215.1pt;line-height:7.2pt"><b><span style="font-family:URWPalladioL,serif;font-size:7.2pt">Species</span></b></p>
<p style="top:135.7pt;left:260.9pt;line-height:7.2pt"><b><span style="font-family:URWPalladioL,serif;font-size:7.2pt">Type</span></b></p>
<p style="top:135.7pt;left:305.2pt;line-height:7.2pt"><b><span style="font-family:URWPalladioL,serif;font-size:7.2pt">Origin</span></b></p>
<p style="top:135.7pt;left:351.9pt;line-height:7.2pt"><b><span style="font-family:URWPalladioL,serif;font-size:7.2pt">Delivery</span></b></p>
<p style="top:135.7pt;left:422.4pt;line-height:7.2pt"><b><span style="font-family:URWPalladioL,serif;font-size:7.2pt">Dose</span></b></p>
<p style="top:161.5pt;left:98.5pt;line-height:7.2pt"><span style="font-family:URWPalladioL,serif;font-size:7.2pt">Xu et al., 2012 [</span><span style="font-family:URWPalladioL,serif;font-size:7.2pt;color:#0774b7">48</span><span style="font-family:URWPalladioL,serif;font-size:7.2pt">]</span></p>
<p style="top:161.5pt;left:190.0pt;line-height:7.2pt"><span style="font-family:URWPalladioL,serif;font-size:7.2pt">1</span></p>
<p style="top:161.5pt;left:224.5pt;line-height:7.2pt"><span style="font-family:URWPalladioL,serif;font-size:7.2pt">H</span></p>
<p style="top:161.5pt;left:254.3pt;line-height:7.2pt"><span style="font-family:URWPalladioL,serif;font-size:7.2pt">BM-MSC</span></p>
<p style="top:161.5pt;left:297.4pt;line-height:7.2pt"><span style="font-family:URWPalladioL,serif;font-size:7.2pt">Autologous</span></p>
<p style="top:161.5pt;left:352.5pt;line-height:7.2pt"><span style="font-family:URWPalladioL,serif;font-size:7.2pt">Injection</span></p>
<p style="top:161.7pt;left:410.5pt;line-height:7.2pt"><span style="font-family:URWPalladioL,serif;font-size:7.2pt">2.1</span><span style="font-family:Pxsy,serif;font-size:7.2pt"> &#xd7;</span><span style="font-family:URWPalladioL,serif;font-size:7.2pt"> 10</span><sup><span style="font-family:URWPalladioL,serif;font-size:5.6pt">6</span></sup><span style="font-family:Rpxr,serif;font-size:7.2pt">/</span><span style="font-family:URWPalladioL,serif;font-size:7.2pt">mL</span></p>
<p style="top:152.7pt;left:482.2pt;line-height:7.2pt"><span style="font-family:URWPalladioL,serif;font-size:7.2pt">BM-MSC</span><span style="font-family:Rpxr,serif;font-size:7.2pt"> +</span><span style="font-family:URWPalladioL,serif;font-size:7.2pt"> Decellularized</span></p>
<p style="top:161.5pt;left:495.8pt;line-height:7.2pt"><span style="font-family:URWPalladioL,serif;font-size:7.2pt">allogeneic dermal</span></p>
<p style="top:170.2pt;left:493.9pt;line-height:7.2pt"><span style="font-family:URWPalladioL,serif;font-size:7.2pt">matrix</span><span style="font-family:Rpxr,serif;font-size:7.2pt"> +</span><span style="font-family:URWPalladioL,serif;font-size:7.2pt"> Skin graft</span></p>
<p style="top:157.1pt;left:596.0pt;line-height:7.2pt"><span style="font-family:URWPalladioL,serif;font-size:7.2pt">Decellularized allogeneic dermal</span></p>
<p style="top:165.9pt;left:618.0pt;line-height:7.2pt"><span style="font-family:URWPalladioL,serif;font-size:7.2pt">matrix</span><span style="font-family:Rpxr,serif;font-size:7.2pt"> +</span><span style="font-family:URWPalladioL,serif;font-size:7.2pt"> Skin graft</span></p>
<p style="top:161.5pt;left:727.9pt;line-height:7.2pt"><span style="font-family:URWPalladioL,serif;font-size:7.2pt">Positive</span></p>
<p style="top:183.1pt;left:89.1pt;line-height:7.2pt"><span style="font-family:URWPalladioL,serif;font-size:7.2pt">Arkoulis et al., 2018 [</span><span style="font-family:URWPalladioL,serif;font-size:7.2pt;color:#0774b7">49</span><span style="font-family:URWPalladioL,serif;font-size:7.2pt">]</span></p>
<p style="top:183.1pt;left:190.0pt;line-height:7.2pt"><span style="font-family:URWPalladioL,serif;font-size:7.2pt">2</span></p>
<p style="top:183.1pt;left:224.5pt;line-height:7.2pt"><span style="font-family:URWPalladioL,serif;font-size:7.2pt">H</span></p>
<p style="top:183.1pt;left:259.4pt;line-height:7.2pt"><span style="font-family:URWPalladioL,serif;font-size:7.2pt">ASC *</span></p>
<p style="top:183.1pt;left:297.4pt;line-height:7.2pt"><span style="font-family:URWPalladioL,serif;font-size:7.2pt">Autologous</span></p>
<p style="top:183.1pt;left:354.8pt;line-height:7.2pt"><span style="font-family:URWPalladioL,serif;font-size:7.2pt">Topical</span></p>
<p style="top:183.3pt;left:412.6pt;line-height:7.2pt"><span style="font-family:URWPalladioL,serif;font-size:7.2pt">46,400</span><span style="font-family:Rpxr,serif;font-size:7.2pt"> /</span><span style="font-family:URWPalladioL,serif;font-size:7.2pt">cm</span><sup><span style="font-family:URWPalladioL,serif;font-size:5.6pt">2</span></sup></p>
<p style="top:183.1pt;left:498.1pt;line-height:7.2pt"><span style="font-family:URWPalladioL,serif;font-size:7.2pt">Pre-intervention</span></p>
<p style="top:183.1pt;left:620.6pt;line-height:7.2pt"><span style="font-family:URWPalladioL,serif;font-size:7.2pt">Post-intervention</span></p>
<p style="top:183.1pt;left:727.9pt;line-height:7.2pt"><span style="font-family:URWPalladioL,serif;font-size:7.2pt">Positive</span></p>
<p style="top:200.2pt;left:83.7pt;line-height:7.2pt"><span style="font-family:URWPalladioL,serif;font-size:7.2pt">Abo-Elkheir et al., 2017 [</span><span style="font-family:URWPalladioL,serif;font-size:7.2pt;color:#0774b7">50</span><span style="font-family:URWPalladioL,serif;font-size:7.2pt">]</span></p>
<p style="top:200.8pt;left:188.2pt;line-height:7.2pt"><span style="font-family:URWPalladioL,serif;font-size:7.2pt">60</span></p>
<p style="top:200.9pt;left:224.5pt;line-height:7.2pt"><span style="font-family:URWPalladioL,serif;font-size:7.2pt">H</span></p>
<p style="top:195.9pt;left:254.3pt;line-height:7.2pt"><span style="font-family:URWPalladioL,serif;font-size:7.2pt">BM-MSC</span></p>
<p style="top:195.9pt;left:297.4pt;line-height:7.2pt"><span style="font-family:URWPalladioL,serif;font-size:7.2pt">Autologous</span></p>
<p style="top:199.9pt;left:352.5pt;line-height:7.2pt"><span style="font-family:URWPalladioL,serif;font-size:7.2pt">Injection</span></p>
<p style="top:201.0pt;left:399.6pt;line-height:7.2pt"><span style="font-family:URWPalladioL,serif;font-size:7.2pt">1</span><span style="font-family:Pxsy,serif;font-size:7.2pt"> &#xd7;</span><span style="font-family:URWPalladioL,serif;font-size:7.2pt"> 10</span><sup><span style="font-family:URWPalladioL,serif;font-size:5.6pt">5</span></sup><span style="font-family:Rpxr,serif;font-size:7.2pt">/</span><span style="font-family:URWPalladioL,serif;font-size:7.2pt">mL</span><span style="font-family:Rpxr,serif;font-size:7.2pt">/</span><span style="font-family:URWPalladioL,serif;font-size:7.2pt">cm</span><sup><span style="font-family:URWPalladioL,serif;font-size:5.6pt">2</span></sup><sup><span style="font-family:Pxsy,serif;font-size:7.2pt"> </span></sup><span style="font-family:Pxsy,serif;font-size:7.2pt">&#xd7;</span><span style="font-family:URWPalladioL,serif;font-size:7.2pt"> 2</span></p>
<p style="top:195.7pt;left:483.6pt;line-height:7.2pt"><span style="font-family:URWPalladioL,serif;font-size:7.2pt">BM-MSC</span><span style="font-family:Rpxr,serif;font-size:7.2pt"> +</span><span style="font-family:URWPalladioL,serif;font-size:7.2pt"> dressing with</span></p>
<p style="top:204.4pt;left:491.9pt;line-height:7.2pt"><span style="font-family:URWPalladioL,serif;font-size:7.2pt">gentamicinointment</span></p>
<p style="top:195.7pt;left:585.8pt;line-height:7.2pt"><span style="font-family:URWPalladioL,serif;font-size:7.2pt">UC-MSC</span><span style="font-family:Rpxr,serif;font-size:7.2pt"> +</span><span style="font-family:URWPalladioL,serif;font-size:7.2pt"> dressing with</span></p>
<p style="top:204.4pt;left:593.9pt;line-height:7.2pt"><span style="font-family:URWPalladioL,serif;font-size:7.2pt">gentamicinointment</span></p>
<p style="top:196.6pt;left:681.7pt;line-height:7.2pt"><span style="font-family:URWPalladioL,serif;font-size:7.2pt">Standard</span></p>
<p style="top:205.4pt;left:680.9pt;line-height:7.2pt"><span style="font-family:URWPalladioL,serif;font-size:7.2pt">treatment</span></p>
<p style="top:200.8pt;left:727.9pt;line-height:7.2pt"><span style="font-family:URWPalladioL,serif;font-size:7.2pt">Positive</span></p>
<p style="top:204.8pt;left:254.6pt;line-height:7.2pt"><span style="font-family:URWPalladioL,serif;font-size:7.2pt">UC-MSC</span></p>
<p style="top:204.8pt;left:299.1pt;line-height:7.2pt"><span style="font-family:URWPalladioL,serif;font-size:7.2pt">Allogeneic</span></p>
<p style="top:217.7pt;left:97.8pt;line-height:8.0pt"><span style="font-family:URWPalladioL,serif;font-size:8.0pt">ASC: adipose-derived stem cells, BM-MSC: bone-marrow-derived mesenchymal stem cells, H: human, UC-MSC: umbilical cord mesenchymal stem cells. * ASCs delivered as stromal</span></p>
<p style="top:227.2pt;left:97.6pt;line-height:8.0pt"><span style="font-family:URWPalladioL,serif;font-size:8.0pt">vascular fraction.</span></p>


<p style="top:56.6pt;left:76.3pt;line-height:8.0pt"><i><span style="font-family:URWPalladioL,serif;font-size:8.0pt">Cells</span></i><b><span style="font-family:URWPalladioL,serif;font-size:8.0pt"> 2020</span></b><span style="font-family:URWPalladioL,serif;font-size:8.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:8.0pt"> 9</span></i><span style="font-family:URWPalladioL,serif;font-size:8.0pt">, 2545</span></p>
<p style="top:56.6pt;left:491.8pt;line-height:8.0pt"><span style="font-family:URWPalladioL,serif;font-size:8.0pt">10 of 21</span></p>
<p style="top:89.7pt;left:106.1pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Table 6.</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> Analysis of the outcomes according to the phases of wound healing in pre-clinical trials.</span></p>
<p style="top:186.1pt;left:269.4pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Wound Healing</span></b></p>
<p style="top:181.1pt;left:312.1pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">In&#xfb02;ammation</span></b></p>
<p style="top:112.9pt;left:374.3pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Proliferation</span></b></p>
<p style="top:198.7pt;left:477.2pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Remodeling</span></b><span style="font-family:Rpxb,serif;font-size:9.0pt">/</span><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Scarring</span></b></p>
<p style="top:203.5pt;left:353.7pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Neovascularization</span></b></p>
<p style="top:189.1pt;left:395.2pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Granulation</span></b></p>
<p style="top:205.3pt;left:435.7pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Re-Epithelialization</span></b></p>
<p style="top:223.0pt;left:130.0pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Oryan et al., 2019 [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">27</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:240.7pt;left:129.4pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Atalay et al., 2014 [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">28</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:258.3pt;left:123.2pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Eyuboglu et al., 2018 [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">29</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:276.0pt;left:132.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Chen et al., 2017 [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">30</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:293.7pt;left:130.8pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Loder et al., 2015 [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">31</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:311.4pt;left:119.8pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Shokrgazor et al., 2012 [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">32</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:329.1pt;left:132.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Kaita et al., 2019 [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">33</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:346.8pt;left:131.3pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Bliley et al., 2016 [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">34</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:364.5pt;left:98.8pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Gholipourmalekabadi et al., 2018 [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">35</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:382.2pt;left:123.4pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Motamed et al., 2017 [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">36</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:399.9pt;left:130.0pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Abbas et al., 2018 [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">37</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:417.6pt;left:111.6pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Caliari-Oliveira et al., 2016 [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">38</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:435.3pt;left:127.7pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Ahmed et al., 2017 [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">39</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:453.0pt;left:129.9pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Singer et al., 2013 [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">40</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:470.7pt;left:128.8pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Revilla et al., 2016 [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">41</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:488.4pt;left:136.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Oh et al., 2018 [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">42</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:506.1pt;left:134.0pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Guo et al., 2016 [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">43</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:523.8pt;left:134.8pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Xue et al., 2013 [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">44</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:541.5pt;left:129.7pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Zhang et al., 2015 [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">45</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:559.2pt;left:125.2pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Pourfath et al., 2018 [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">46</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:576.9pt;left:106.2pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Gholipour-Kanani et al., 2014 [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">47</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:595.4pt;left:97.8pt;line-height:8.0pt"><span style="font-family:URWPalladioL,serif;font-size:8.0pt">Green: Positive e</span><span style="font-family:Rpxr,serif;font-size:8.0pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:8.0pt">ect; red: non-signi&#xfb01;cant di</span><span style="font-family:Rpxr,serif;font-size:8.0pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:8.0pt">erence or contradictory results; yellow: no di</span><span style="font-family:Rpxr,serif;font-size:8.0pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:8.0pt">erence; grey:</span></p>
<p style="top:604.9pt;left:97.8pt;line-height:8.0pt"><span style="font-family:URWPalladioL,serif;font-size:8.0pt">not assessed.</span></p>


<p style="top:56.6pt;left:76.3pt;line-height:8.0pt"><i><span style="font-family:URWPalladioL,serif;font-size:8.0pt">Cells</span></i><b><span style="font-family:URWPalladioL,serif;font-size:8.0pt"> 2020</span></b><span style="font-family:URWPalladioL,serif;font-size:8.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:8.0pt"> 9</span></i><span style="font-family:URWPalladioL,serif;font-size:8.0pt">, 2545</span></p>
<p style="top:56.6pt;left:491.8pt;line-height:8.0pt"><span style="font-family:URWPalladioL,serif;font-size:8.0pt">11 of 21</span></p>
<p style="top:89.7pt;left:114.1pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Table 7.</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> Analysis of the outcomes according to the phases of wound healing in clinical trials.</span></p>
<p style="top:182.6pt;left:278.5pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Wound Healing</span></b></p>
<p style="top:178.0pt;left:332.1pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">In&#xfb02;ammation</span></b></p>
<p style="top:176.3pt;left:384.5pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Proliferation</span></b></p>
<p style="top:193.8pt;left:435.8pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Remodeling</span></b><span style="font-family:Rpxb,serif;font-size:9.0pt">/</span><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Scarring</span></b></p>
<p style="top:211.5pt;left:156.7pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Xu et al., 2012 [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">48</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:229.2pt;left:145.0pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Arkoulis et al., 2018 [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">49</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:246.9pt;left:138.2pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Abo-Elkheir et al., 2017 [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">50</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:265.5pt;left:126.6pt;line-height:8.0pt"><span style="font-family:URWPalladioL,serif;font-size:8.0pt">Green: Positive e</span><span style="font-family:Rpxr,serif;font-size:8.0pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:8.0pt">ect; red: non-signi&#xfb01;cant di</span><span style="font-family:Rpxr,serif;font-size:8.0pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:8.0pt">erence or contradictory results; grey: not assessed.</span></p>
<p style="top:288.9pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">3.2.1. Population</span></p>
<p style="top:308.3pt;left:97.8pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">The pre-clinical studies were all</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt"> in vivo</span><span style="font-family:URWPalladioL,serif;font-size:10.1pt"> studies and the population size varied between 6 and</span></p>
<p style="top:322.0pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">84 animals, with an average of 29.5 animals per study. The majority (15) of the studies were based on a</span></p>
<p style="top:335.3pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">rat model, and a mouse model was employed in six instances. The clinical studies consisted of one</span></p>
<p style="top:348.9pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">case&#x2013;control study with 60 patients in total and two case reports with one or two patients.</span></p>
<p style="top:372.1pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">3.2.2. Intervention</span></p>
<p style="top:391.6pt;left:97.8pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">For the analysis of the intervention used across studies, information about the type and origin of</span></p>
<p style="top:405.1pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">stem cells, delivery method, and dose was extracted.</span></p>
<p style="top:418.5pt;left:97.8pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">Of the 21 pre-clinical studies, 10 used ASCs, which, in two cases, were in the form of stromal</span></p>
<p style="top:432.1pt;left:76.3pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">vascular fraction (SVF), seven studies used BM-MSCs, one study used ASCs, BM-MSCs, and dental</span></p>
<p style="top:445.7pt;left:76.2pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">pulp stem cells (DPSCs), and three studies used umbilical cord (UC)-MSCs. Stem cells from the same</span></p>
<p style="top:459.1pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">species were used in 12 studies, and human stem cells were used in nine. The method of delivery</span></p>
<p style="top:472.7pt;left:76.3pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">varied, with 14 studies using injection, six using graft, and one using spray. The doses used covered a</span></p>
<p style="top:486.2pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">broad range from 1</span><span style="font-family:Pxsy,serif;font-size:10.0pt"> &#xd7;</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt"> 10</span><sup><span style="font-family:URWPalladioL,serif;font-size:7.6pt">4</span></sup><sup><span style="font-family:URWPalladioL,serif;font-size:10.0pt"> </span></sup><span style="font-family:URWPalladioL,serif;font-size:10.0pt">to 6.8</span><span style="font-family:Pxsy,serif;font-size:10.0pt"> &#xd7;</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt"> 10</span><sup><span style="font-family:URWPalladioL,serif;font-size:7.6pt">6</span></sup><sup><span style="font-family:URWPalladioL,serif;font-size:10.0pt"> </span></sup><span style="font-family:URWPalladioL,serif;font-size:10.0pt">cells, with an average of 1.6</span><span style="font-family:Pxsy,serif;font-size:10.0pt"> &#xd7;</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt"> 10</span><sup><span style="font-family:URWPalladioL,serif;font-size:7.6pt">6</span></sup><sup><span style="font-family:URWPalladioL,serif;font-size:10.0pt"> </span></sup><span style="font-family:URWPalladioL,serif;font-size:10.0pt">cells.</span></p>
<p style="top:499.7pt;left:97.8pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">For the clinical studies, one used ASCs in the form of SVF. The two other studies used BM-MSCs,</span></p>
<p style="top:513.1pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">and one additionally used UC-MSCs. All BM-MSCs were autologous, and the UC-MSCs were</span></p>
<p style="top:526.6pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">allogeneic. The method of delivery was either injection or topical administration. The doses used</span></p>
<p style="top:540.2pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">in the three di</span><span style="font-family:Rpxr,serif;font-size:10.0pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">erent studies are incomparable, as they are stated in either cells</span><span style="font-family:Rpxr,serif;font-size:10.0pt">/</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">mL</span><span style="font-family:Rpxr,serif;font-size:10.0pt">/</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">cm</span><sup><span style="font-family:URWPalladioL,serif;font-size:7.6pt">2</span></sup><span style="font-family:URWPalladioL,serif;font-size:10.0pt">, cells</span><span style="font-family:Rpxr,serif;font-size:10.0pt">/</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">mL or</span></p>
<p style="top:553.8pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">cells</span><span style="font-family:Rpxr,serif;font-size:9.9pt">/</span><span style="font-family:URWPalladioL,serif;font-size:9.9pt">cm</span><sup><span style="font-family:URWPalladioL,serif;font-size:7.6pt">2</span></sup><span style="font-family:URWPalladioL,serif;font-size:9.9pt">. It is also notable that the treatment in the case&#x2013;control study by Abo-Elkheir et al., 2017 [</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt;color:#0774b7">50</span><span style="font-family:URWPalladioL,serif;font-size:9.9pt">]</span></p>
<p style="top:567.2pt;left:76.1pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">was repeated twice.</span></p>
<p style="top:590.4pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">3.2.3. Comparison</span></p>
<p style="top:609.9pt;left:97.8pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">All the pre-clinical studies included a control group, a sham group (1 study), or both (2 studies).</span></p>
<p style="top:623.4pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">In four studies, the stem cells were used in combination with either aloe vera, human amniotic</span></p>
<p style="top:636.9pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">membrane (HAM), or small intestine submucosa (SIS), whereas in the remaining 17 studies, only the</span></p>
<p style="top:650.5pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">stem cells were administered.</span></p>
<p style="top:663.9pt;left:97.8pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">The three clinical studies compared the e</span><span style="font-family:Rpxr,serif;font-size:10.1pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:10.1pt">ect of stem cell treatment either to a control group</span></p>
<p style="top:677.4pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">using the standard treatment of early excision and grafting, to a wound not receiving stem cells</span></p>
<p style="top:690.9pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">on the opposite arm of the included patient, or to the pre-intervention wound state. One study</span></p>
<p style="top:704.5pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">investigated the e</span><span style="font-family:Rpxr,serif;font-size:10.0pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">ect of stem cells together with a dressing with gentamicin ointment, one together</span></p>
<p style="top:717.9pt;left:76.1pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">with a decellularized allogeneic dermal matrix and a skin graft, and the last one together with an</span></p>
<p style="top:731.5pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">Integra template.</span></p>


<p style="top:56.6pt;left:76.3pt;line-height:8.0pt"><i><span style="font-family:URWPalladioL,serif;font-size:8.0pt">Cells</span></i><b><span style="font-family:URWPalladioL,serif;font-size:8.0pt"> 2020</span></b><span style="font-family:URWPalladioL,serif;font-size:8.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:8.0pt"> 9</span></i><span style="font-family:URWPalladioL,serif;font-size:8.0pt">, 2545</span></p>
<p style="top:56.6pt;left:491.8pt;line-height:8.0pt"><span style="font-family:URWPalladioL,serif;font-size:8.0pt">12 of 21</span></p>
<p style="top:89.9pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">3.2.4. Outcome</span></p>
<p style="top:109.4pt;left:97.8pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">Overall, in all pre-clinical studies, the application of mesenchymal stem cells to the</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt"> in vivo</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt"> burn</span></p>
<p style="top:123.0pt;left:76.1pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">wound models had a positive e</span><span style="font-family:Rpxr,serif;font-size:9.9pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:9.9pt">ect (Table</span><span style="font-family:URWPalladioL,serif;font-size:9.9pt;color:#0774b7"> 4</span><span style="font-family:URWPalladioL,serif;font-size:9.9pt">). A more detailed analysis of the e</span><span style="font-family:Rpxr,serif;font-size:9.9pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:9.9pt">ect of stem cells on the</span></p>
<p style="top:136.4pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">di</span><span style="font-family:Rpxr,serif;font-size:10.0pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">erent phases of wound healing is presented in Table</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt;color:#0774b7"> 6</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">.</span></p>
<p style="top:150.0pt;left:97.8pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">Of the 17 studies that assessed wound healing by either measuring the wound area or closure rate,</span></p>
<p style="top:163.4pt;left:76.0pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">15 found a positive e</span><span style="font-family:Rpxr,serif;font-size:10.0pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">ect, one study did not show a signi&#xfb01;cant e</span><span style="font-family:Rpxr,serif;font-size:10.0pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">ect, and one study documented no</span></p>
<p style="top:177.0pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">e</span><span style="font-family:Rpxr,serif;font-size:9.9pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:9.9pt">ect. The e</span><span style="font-family:Rpxr,serif;font-size:9.9pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:9.9pt">ect of stem cells on in&#xfb02;ammation was evaluated in 12 studies. Of those, 10 demonstrated</span></p>
<p style="top:190.5pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">an anti-in&#xfb02;ammatory e</span><span style="font-family:Rpxr,serif;font-size:9.9pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:9.9pt">ect and two studies were inconclusive. Of the 13 studies that evaluated the e</span><span style="font-family:Rpxr,serif;font-size:9.9pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:9.9pt">ect</span></p>
<p style="top:203.9pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">on neovascularization, 12 showed a positive e</span><span style="font-family:Rpxr,serif;font-size:10.0pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">ect and one was inconclusive. Regarding granulation,</span></p>
<p style="top:217.4pt;left:76.0pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">13 studies demonstrated a positive e</span><span style="font-family:Rpxr,serif;font-size:10.0pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">ect and one study showed no e</span><span style="font-family:Rpxr,serif;font-size:10.0pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">ect. As for re-epithelialization,</span></p>
<p style="top:230.9pt;left:76.0pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">11 studies demonstrated a positive e</span><span style="font-family:Rpxr,serif;font-size:10.0pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">ect and one study showed no e</span><span style="font-family:Rpxr,serif;font-size:10.0pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">ect. The e</span><span style="font-family:Rpxr,serif;font-size:10.0pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">ect of stem cells on</span></p>
<p style="top:244.5pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">remodeling and scarring was investigated in eight studies; &#xfb01;ve of these demonstrated a positive e</span><span style="font-family:Rpxr,serif;font-size:9.9pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:9.9pt">ect,</span></p>
<p style="top:258.0pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">two were inconclusive, and one reported no di</span><span style="font-family:Rpxr,serif;font-size:10.0pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">erence.</span></p>
<p style="top:271.6pt;left:97.8pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">All three clinical studies found a positive e</span><span style="font-family:Rpxr,serif;font-size:9.9pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:9.9pt">ect of the application of mesenchymal stem cells to the</span></p>
<p style="top:285.1pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">burn wounds. However, in the case&#x2013;control study by Abo-Elkheir et al. (2017), infection was observed</span></p>
<p style="top:298.5pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">in 25&#x2013;70% of patients receiving stem cell treatment compared to 25% in the control group (Table</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt;color:#0774b7"> 7</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">).</span></p>
<p style="top:311.9pt;left:97.8pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">Xu et al. (2012) found no di</span><span style="font-family:Rpxr,serif;font-size:10.1pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:10.1pt">erence in the overall healing, as both wounds in the trial subject</span></p>
<p style="top:325.5pt;left:76.1pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">were healed when progress was investigated. Moreover, no di</span><span style="font-family:Rpxr,serif;font-size:9.9pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:9.9pt">erence in in&#xfb02;ammation was observed,</span></p>
<p style="top:338.9pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">as none of the wounds became infected. All three studies found a positive e</span><span style="font-family:Rpxr,serif;font-size:10.1pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:10.1pt">ect on scarring with a</span></p>
<p style="top:352.5pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">noticeable decrease in contracture.</span></p>
<p style="top:375.7pt;left:76.5pt;line-height:10.0pt"><i><span style="font-family:URWPalladioL,serif;font-size:10.0pt">3.3. Outcome Assessment Parameters</span></i></p>
<p style="top:395.2pt;left:97.8pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">For each of the studies, the phases of the wound healing were further characterized by invoking</span></p>
<p style="top:408.7pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">additional outcome assessment parameters (Tables</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt;color:#0774b7"> 8</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt"> and</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt;color:#0774b7"> 9</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">). For the animal studies, a range of both</span></p>
<p style="top:422.3pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">non-invasive and invasive methods were applied. However, in the case of clinical studies, only visual</span></p>
<p style="top:435.8pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">assessment was used for the evaluation of overall wound healing and for the evaluation of the e</span><span style="font-family:Rpxr,serif;font-size:9.9pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:9.9pt">ect of</span></p>
<p style="top:449.3pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">stem cells on the di</span><span style="font-family:Rpxr,serif;font-size:10.0pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">erent phases (Table</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt;color:#0774b7"> 9</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">).</span></p>


<p style="top:56.6pt;left:76.3pt;line-height:8.0pt"><i><span style="font-family:URWPalladioL,serif;font-size:8.0pt">Cells</span></i><b><span style="font-family:URWPalladioL,serif;font-size:8.0pt"> 2020</span></b><span style="font-family:URWPalladioL,serif;font-size:8.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:8.0pt"> 9</span></i><span style="font-family:URWPalladioL,serif;font-size:8.0pt">, 2545</span></p>
<p style="top:56.6pt;left:738.4pt;line-height:8.0pt"><span style="font-family:URWPalladioL,serif;font-size:8.0pt">13 of 21</span></p>
<p style="top:89.7pt;left:292.4pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Table 8.</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> Outcome assessment parameters from pre-clinical trials.</span></p>
<p style="top:114.7pt;left:130.3pt;line-height:6.3pt"><b><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Study</span></b></p>
<p style="top:114.7pt;left:222.5pt;line-height:6.3pt"><b><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Wound Healing</span></b></p>
<p style="top:115.3pt;left:319.9pt;line-height:6.3pt"><b><span style="font-family:URWPalladioL,serif;font-size:6.3pt">In&#xfb02;ammation</span></b></p>
<p style="top:109.5pt;left:509.3pt;line-height:6.3pt"><b><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Proliferation</span></b></p>
<p style="top:114.7pt;left:685.2pt;line-height:6.3pt"><b><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Remodeling</span></b><span style="font-family:Rpxb,serif;font-size:6.3pt">/</span><b><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Scarring</span></b></p>
<p style="top:120.7pt;left:405.8pt;line-height:6.3pt"><b><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Neovascularization</span></b></p>
<p style="top:120.7pt;left:510.0pt;line-height:6.3pt"><b><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Granulation</span></b></p>
<p style="top:120.7pt;left:592.8pt;line-height:6.3pt"><b><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Re-Epithelialization</span></b></p>
<p style="top:143.4pt;left:108.6pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Oryan et al., 2019 [</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt;color:#0774b7">27</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt">]</span></p>
<p style="top:139.6pt;left:206.5pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Wound area, Rate of wound</span></p>
<p style="top:147.3pt;left:228.9pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">closure (NI)</span></p>
<p style="top:131.9pt;left:298.1pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">In&#xfb02;ammation markers (visual</span></p>
<p style="top:139.6pt;left:298.2pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">inspection, NI). In&#xfb02;ammatory</span></p>
<p style="top:147.3pt;left:299.8pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">cell in&#xfb01;ltration (H, BI). IL-1b,</span></p>
<p style="top:155.0pt;left:304.0pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">TGF-</span><span style="font-family:EURM10,serif;font-size:6.3pt">&#x3b2;</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt">1, bFGF (qPCR, BI)</span></p>
<p style="top:143.4pt;left:399.5pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Capillary density (H, BI)</span></p>
<p style="top:131.9pt;left:487.8pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Collagen structure (SEM, BI).</span></p>
<p style="top:139.6pt;left:491.0pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Number of &#xfb01;broblasts and</span></p>
<p style="top:147.3pt;left:490.1pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">&#xfb01;brocytes (H, BI). Collagen</span></p>
<p style="top:155.0pt;left:491.1pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">level (Hydroxyproline, BI)</span></p>
<p style="top:143.4pt;left:582.5pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Epidermal formation (H, BI)</span></p>
<p style="top:139.6pt;left:691.3pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Connective tissue</span></p>
<p style="top:147.3pt;left:687.9pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">arrangement (H, BI)</span></p>
<p style="top:173.7pt;left:108.2pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Atalay et al., 2014 [</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt;color:#0774b7">28</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt">]</span></p>
<p style="top:166.0pt;left:305.6pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Polymorphonuclear and</span></p>
<p style="top:173.7pt;left:301.4pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">mononuclear in&#xfb02;ammatory</span></p>
<p style="top:181.3pt;left:309.6pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">in&#xfb01;ltrate score (H, BI)</span></p>
<p style="top:173.7pt;left:392.0pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">VEGF index (VEGF; H</span><span style="font-family:Rpxr,serif;font-size:6.3pt"> +</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt"> I, BI)</span></p>
<p style="top:169.8pt;left:495.4pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Cell proliferation index</span></p>
<p style="top:177.5pt;left:502.8pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">(PCNA; H</span><span style="font-family:Rpxr,serif;font-size:6.3pt"> +</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt"> I, BI)</span></p>
<p style="top:207.7pt;left:103.9pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Eyuboglu et al., 2018 [</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt;color:#0774b7">29</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt">]</span></p>
<p style="top:207.7pt;left:216.6pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Area of necrosis (NI)</span></p>
<p style="top:207.7pt;left:306.1pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Neutrophil score (H, BI)</span></p>
<p style="top:192.4pt;left:411.9pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Capillary count</span></p>
<p style="top:200.0pt;left:401.6pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">(Angiography</span><span style="font-family:Rpxr,serif;font-size:6.3pt"> +</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt"> H, BI).</span></p>
<p style="top:207.7pt;left:398.8pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Vascular density grading</span></p>
<p style="top:215.4pt;left:397.6pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">(H, BI). Endothelial count</span></p>
<p style="top:223.0pt;left:411.2pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">(vWF; H</span><span style="font-family:Rpxr,serif;font-size:6.3pt"> +</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt"> I, BI)</span></p>
<p style="top:207.7pt;left:584.6pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Epithelial thickness (H, BI)</span></p>
<p style="top:203.9pt;left:692.4pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Fibrosis gradient</span></p>
<p style="top:211.5pt;left:681.8pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">(Masson&#x2019;s trichrome, BI)</span></p>
<p style="top:237.9pt;left:110.1pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Chen et al., 2017 [</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt;color:#0774b7">30</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt">]</span></p>
<p style="top:234.1pt;left:206.5pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Wound area, Rate of wound</span></p>
<p style="top:241.7pt;left:228.9pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">closure (NI)</span></p>
<p style="top:234.1pt;left:301.6pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Lymphocytic in&#xfb02;ammatory</span></p>
<p style="top:241.7pt;left:314.6pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">in&#xfb01;ltration (H, BI)</span></p>
<p style="top:237.9pt;left:580.0pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Epithelial regeneration (H, BI)</span></p>
<p style="top:234.1pt;left:690.4pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Pathologic dermal</span></p>
<p style="top:241.7pt;left:695.7pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">&#xfb01;brosis (H, BI)</span></p>
<p style="top:260.5pt;left:109.2pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Loder et al., 2015 [</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt;color:#0774b7">31</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt">]</span></p>
<p style="top:252.8pt;left:211.1pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Wound area closure (NI).</span></p>
<p style="top:260.5pt;left:225.7pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Wound depth,</span></p>
<p style="top:268.1pt;left:208.3pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Rate of wound closure (BI)</span></p>
<p style="top:256.6pt;left:408.9pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Endothelial count</span></p>
<p style="top:264.3pt;left:409.1pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">(CD-31; H</span><span style="font-family:Rpxr,serif;font-size:6.3pt"> +</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt"> I, BI)</span></p>
<p style="top:260.5pt;left:487.5pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Proliferation (Ki67; H</span><span style="font-family:Rpxr,serif;font-size:6.3pt"> +</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt"> I, BI)</span></p>
<p style="top:279.2pt;left:101.5pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Shokrgazor et al., 2012 [</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt;color:#0774b7">32</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt">]</span></p>
<p style="top:279.2pt;left:222.0pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Wound area (NI)</span></p>
<p style="top:279.2pt;left:582.5pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Epidermal formation (H, BI)</span></p>
<p style="top:298.0pt;left:110.1pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Kaita et al., 2019 [</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt;color:#0774b7">33</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt">]</span></p>
<p style="top:294.2pt;left:206.5pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Wound area, Rate of wound</span></p>
<p style="top:301.9pt;left:228.9pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">closure (NI)</span></p>
<p style="top:298.0pt;left:391.9pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Neovascularization (IB4; I, BI)</span></p>
<p style="top:290.4pt;left:499.0pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Collagen production</span></p>
<p style="top:298.0pt;left:504.6pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">(Picro-Sirus Red,</span></p>
<p style="top:305.7pt;left:486.7pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Col I</span><span style="font-family:Rpxr,serif;font-size:6.3pt">/</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt">III; H</span><span style="font-family:Rpxr,serif;font-size:6.3pt"> +</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt"> WB</span><span style="font-family:Rpxr,serif;font-size:6.3pt"> +</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt"> qPCR, BI)</span></p>
<p style="top:294.2pt;left:579.9pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Skin thickness ratio (Masson&#x2019;s</span></p>
<p style="top:301.9pt;left:602.6pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">trichrome, BI)</span></p>
<p style="top:328.2pt;left:109.6pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Bliley et al., 2016 [</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt;color:#0774b7">34</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt">]</span></p>
<p style="top:316.7pt;left:217.3pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Wound area, Rate of</span></p>
<p style="top:324.4pt;left:224.2pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">wound closure,</span></p>
<p style="top:332.1pt;left:216.4pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Wound area, Time to</span></p>
<p style="top:339.7pt;left:228.5pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">healing (NI)</span></p>
<p style="top:328.2pt;left:393.9pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Vascularity (CD31; H</span><span style="font-family:Rpxr,serif;font-size:6.3pt"> +</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt"> I, BI)</span></p>
<p style="top:316.7pt;left:499.0pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Collagen production</span></p>
<p style="top:324.4pt;left:489.6pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">(Picro-Sirius Red, Masson&#x2019;s</span></p>
<p style="top:332.1pt;left:489.5pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">trichrome; H) (Col I, Col III;</span></p>
<p style="top:339.7pt;left:514.0pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">qPCR, BI)</span></p>
<p style="top:324.4pt;left:582.7pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Wound contraction (</span><span style="font-family:EURM10,serif;font-size:6.3pt">&#x3b1;</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt">-SMA;</span></p>
<p style="top:332.1pt;left:608.1pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">qPCR, BI)</span></p>
<p style="top:324.4pt;left:672.9pt;line-height:6.2pt"><span style="font-family:URWPalladioL,serif;font-size:6.2pt">Collagen production (Col I and</span></p>
<p style="top:332.1pt;left:697.5pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">III; qPCR, BI)</span></p>
<p style="top:370.0pt;left:86.8pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Gholipourmalekabadi et al., 2018 [</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt;color:#0774b7">35</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt">]</span></p>
<p style="top:362.3pt;left:206.5pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Wound area, Rate of wound</span></p>
<p style="top:370.0pt;left:210.3pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">closure, Wound area (NI).</span></p>
<p style="top:377.6pt;left:202.7pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Wound-healing scoring (H, BI)</span></p>
<p style="top:358.4pt;left:304.5pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Acute in&#xfb02;ammatory cells</span></p>
<p style="top:366.1pt;left:315.1pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">(H, BI). Localized</span></p>
<p style="top:373.8pt;left:296.6pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">In&#xfb02;ammatory Response (MIP2,</span></p>
<p style="top:381.5pt;left:296.9pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">TNF</span><span style="font-family:EURM10,serif;font-size:6.3pt">&#x3b1;</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt">1, and TGF</span><span style="font-family:EURM10,serif;font-size:6.3pt">&#x3b2;</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt">1; qPCR, BI)</span></p>
<p style="top:350.8pt;left:391.5pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Capillary density (CD31; I, BI).</span></p>
<p style="top:358.4pt;left:398.6pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Neovascularization score</span></p>
<p style="top:366.1pt;left:392.7pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">(CD31, VEGF-</span><span style="font-family:EURM10,serif;font-size:6.3pt"> &#x3b1;</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt">1, VEGFR2; I,</span></p>
<p style="top:373.8pt;left:394.8pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">BI). Neovascularization rate</span></p>
<p style="top:381.5pt;left:401.2pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">(IL-1b, bFGF, VEGF-</span><span style="font-family:EURM10,serif;font-size:6.3pt">&#x3b1;</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt">1,</span></p>
<p style="top:389.1pt;left:406.3pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">VEGFR2; qPCR, BI)</span></p>
<p style="top:354.6pt;left:485.7pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Deposition of the extracellular</span></p>
<p style="top:362.3pt;left:494.5pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">matrix (H, BI). Collagen</span></p>
<p style="top:370.0pt;left:490.2pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">deposition score (Masson&#x2019;s</span></p>
<p style="top:377.6pt;left:484.8pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">trichrome, BI). Density of Col I,</span></p>
<p style="top:385.3pt;left:504.2pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">III, and IV (I, BI).</span></p>
<p style="top:362.3pt;left:580.4pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Hair follicle formation (H, BI).</span></p>
<p style="top:370.0pt;left:584.2pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Re-epithelialization (H, BI),</span></p>
<p style="top:377.6pt;left:583.0pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Epidermal Thickness Index.</span></p>
<p style="top:350.8pt;left:685.3pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Maturation (Masson&#x2019;s</span></p>
<p style="top:358.4pt;left:674.6pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">trichrome, BI). Scar formation</span></p>
<p style="top:366.1pt;left:675.1pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">(Col I, III, and IV; I) (Col I, III,</span></p>
<p style="top:373.8pt;left:679.6pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">IV, MIP-2, TGF</span><span style="font-family:EURM10,serif;font-size:6.3pt">&#x3b2;</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt">1, TNF</span><span style="font-family:EURM10,serif;font-size:6.3pt">&#x3b1;</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt">1,</span></p>
<p style="top:381.5pt;left:678.0pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">MMP-1, MMP-2; qPCR, BI).</span></p>
<p style="top:389.1pt;left:686.5pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Scar Elevation Index.</span></p>
<p style="top:423.2pt;left:104.0pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Motamed et al., 2017 [</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt;color:#0774b7">36</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt">]</span></p>
<p style="top:419.3pt;left:206.5pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Wound area, Rate of wound</span></p>
<p style="top:427.0pt;left:228.9pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">closure (NI)</span></p>
<p style="top:400.2pt;left:304.5pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Acute in&#xfb02;ammatory cells</span></p>
<p style="top:407.8pt;left:303.3pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">(polymorphonuclear cells,</span></p>
<p style="top:415.5pt;left:302.8pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">eosinophils; H</span><span style="font-family:Rpxr,serif;font-size:6.3pt"> +</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt"> Masson&#x2019;s</span></p>
<p style="top:423.2pt;left:307.7pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">trichrome, BI), Chronic</span></p>
<p style="top:430.9pt;left:297.6pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">in&#xfb02;ammatory cells (histocytes,</span></p>
<p style="top:438.5pt;left:302.8pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">lymphocytes, plasma cells;</span></p>
<p style="top:446.2pt;left:300.3pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">H</span><span style="font-family:Rpxr,serif;font-size:6.3pt"> +</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt"> Masson&#x2019;s trichrome, BI)</span></p>
<p style="top:404.0pt;left:590.3pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Epidermal and dermal</span></p>
<p style="top:411.7pt;left:579.7pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">structures, re-epithelialization,</span></p>
<p style="top:419.3pt;left:592.5pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">epithelium thickness,</span></p>
<p style="top:427.0pt;left:595.3pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">rete-ridges, dermal</span></p>
<p style="top:434.7pt;left:583.9pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">appendages (H</span><span style="font-family:Rpxr,serif;font-size:6.3pt"> +</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt"> Masson&#x2019;s</span></p>
<p style="top:442.4pt;left:602.6pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">trichrome, BI)</span></p>
<p style="top:419.3pt;left:679.5pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Pathologic dermal &#xfb01;brosis</span></p>
<p style="top:427.0pt;left:675.5pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">(H</span><span style="font-family:Rpxr,serif;font-size:6.3pt"> +</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt"> Masson&#x2019;s trichrome, BI)</span></p>
<p style="top:461.1pt;left:108.7pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Abbas et al., 2018 [</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt;color:#0774b7">37</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt">]</span></p>
<p style="top:461.1pt;left:216.6pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Area of necrosis (NI)</span></p>
<p style="top:457.2pt;left:298.1pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">In&#xfb02;ammatory Cell In&#xfb01;ltration</span></p>
<p style="top:464.9pt;left:298.2pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">(myeloperoxidase activity, BI)</span></p>
<p style="top:457.2pt;left:402.8pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Microvascular density</span></p>
<p style="top:464.9pt;left:410.1pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">(CD31; H</span><span style="font-family:Rpxr,serif;font-size:6.3pt"> +</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt"> I, BI)</span></p>


<p style="top:56.6pt;left:76.3pt;line-height:8.0pt"><i><span style="font-family:URWPalladioL,serif;font-size:8.0pt">Cells</span></i><b><span style="font-family:URWPalladioL,serif;font-size:8.0pt"> 2020</span></b><span style="font-family:URWPalladioL,serif;font-size:8.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:8.0pt"> 9</span></i><span style="font-family:URWPalladioL,serif;font-size:8.0pt">, 2545</span></p>
<p style="top:56.6pt;left:738.4pt;line-height:8.0pt"><span style="font-family:URWPalladioL,serif;font-size:8.0pt">14 of 21</span></p>
<p style="top:89.7pt;left:393.4pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Table 8.</span></b><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> Cont</span></i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">.</span></p>
<p style="top:114.7pt;left:130.3pt;line-height:6.3pt"><b><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Study</span></b></p>
<p style="top:114.7pt;left:222.5pt;line-height:6.3pt"><b><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Wound Healing</span></b></p>
<p style="top:115.3pt;left:319.9pt;line-height:6.3pt"><b><span style="font-family:URWPalladioL,serif;font-size:6.3pt">In&#xfb02;ammation</span></b></p>
<p style="top:109.5pt;left:509.3pt;line-height:6.3pt"><b><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Proliferation</span></b></p>
<p style="top:114.7pt;left:685.2pt;line-height:6.3pt"><b><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Remodeling</span></b><span style="font-family:Rpxb,serif;font-size:6.3pt">/</span><b><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Scarring</span></b></p>
<p style="top:120.7pt;left:405.8pt;line-height:6.3pt"><b><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Neovascularization</span></b></p>
<p style="top:120.7pt;left:510.0pt;line-height:6.3pt"><b><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Granulation</span></b></p>
<p style="top:120.7pt;left:592.8pt;line-height:6.3pt"><b><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Re-Epithelialization</span></b></p>
<p style="top:162.6pt;left:95.8pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Caliari-Oliveira et al., 2016 [</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt;color:#0774b7">38</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt">]</span></p>
<p style="top:158.8pt;left:228.6pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Wound area</span></p>
<p style="top:166.5pt;left:207.6pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Rate of wound closure (NI)</span></p>
<p style="top:131.9pt;left:306.6pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Bacterial contamination</span></p>
<p style="top:139.6pt;left:323.2pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">(swabs, NI).</span></p>
<p style="top:147.3pt;left:304.0pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Total polymorphonuclear</span></p>
<p style="top:155.0pt;left:296.6pt;line-height:6.2pt"><span style="font-family:URWPalladioL,serif;font-size:6.2pt">in&#xfb02;ammatory cells score (H, BI).</span></p>
<p style="top:162.6pt;left:303.0pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Neutrophils accumulation</span></p>
<p style="top:170.3pt;left:300.7pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">(myeloperoxidase assay, BI).</span></p>
<p style="top:178.0pt;left:296.7pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">CD4</span><span style="font-family:Rpxr,serif;font-size:6.3pt">+</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt"> T-cells and CD8</span><span style="font-family:Rpxr,serif;font-size:6.3pt">+</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt"> T-cells</span></p>
<p style="top:185.6pt;left:299.0pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">(Flow, BI). IL-10, IL-6, TGF-</span><span style="font-family:EURM10,serif;font-size:6.3pt">&#x3b2;</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt">,</span></p>
<p style="top:193.3pt;left:311.7pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">CINC-1 (ELISA, BS)</span></p>
<p style="top:162.6pt;left:394.2pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Vascularization score (H, BI)</span></p>
<p style="top:158.8pt;left:488.3pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Granulation tissue thickness</span></p>
<p style="top:166.5pt;left:510.5pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">score (H, BI)</span></p>
<p style="top:162.6pt;left:678.3pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Collagen &#xfb01;ber score (H, BI)</span></p>
<p style="top:212.0pt;left:107.0pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Ahmed et al., 2017 [</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt;color:#0774b7">39</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt">]</span></p>
<p style="top:204.3pt;left:304.5pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Acute in&#xfb02;ammatory cells</span></p>
<p style="top:212.0pt;left:299.7pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">(H, BI). IL-10, TNF-</span><span style="font-family:EURM10,serif;font-size:6.3pt">&#x3b1;</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt">, TGF-</span><span style="font-family:EURM10,serif;font-size:6.3pt">&#x3b2;</span></p>
<p style="top:219.7pt;left:323.2pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">(ELISA, BS)</span></p>
<p style="top:204.3pt;left:397.8pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Capillaries (H, BI), TGF-</span><span style="font-family:EURM10,serif;font-size:6.3pt">&#x3b2;</span></p>
<p style="top:212.0pt;left:398.5pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">(ELISA, BS). PDGF (I, BI).</span></p>
<p style="top:219.7pt;left:396.3pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">ANG-1, ANG-2 (qPCR, BI)</span></p>
<p style="top:208.2pt;left:491.4pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">TGF-</span><span style="font-family:EURM10,serif;font-size:6.3pt">&#x3b2;</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt"> (ELISA, BS). PDGF</span></p>
<p style="top:215.8pt;left:490.0pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">(I, BI). Vimentin (qPCR, BI)</span></p>
<p style="top:204.3pt;left:587.8pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Epithelialization (H, BS),</span></p>
<p style="top:212.0pt;left:583.0pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">TGF-</span><span style="font-family:EURM10,serif;font-size:6.3pt">&#x3b2;</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt"> (ELISA, BS). MMP-1,</span></p>
<p style="top:219.7pt;left:595.8pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">TIMP-2 (qPCR, BI)</span></p>
<p style="top:212.0pt;left:689.6pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">TGF-</span><span style="font-family:EURM10,serif;font-size:6.3pt">&#x3b2;</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt"> (ELISA, BS)</span></p>
<p style="top:230.7pt;left:108.6pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Singer et al., 2013 [</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt;color:#0774b7">40</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt">]</span></p>
<p style="top:230.7pt;left:216.6pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Area of necrosis (NI)</span></p>
<p style="top:245.8pt;left:107.8pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Revilla et al., 2016 [</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt;color:#0774b7">41</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt">]</span></p>
<p style="top:245.8pt;left:211.9pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Wound appearance (NI)</span></p>
<p style="top:241.9pt;left:485.2pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Collagen type I &#xfb01;ber thickness,</span></p>
<p style="top:249.6pt;left:494.5pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Integrin a2b1 (H</span><span style="font-family:Rpxr,serif;font-size:6.3pt"> +</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt"> I, BI)</span></p>
<p style="top:268.3pt;left:113.2pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Oh et al., 2018 [</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt;color:#0774b7">42</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt">]</span></p>
<p style="top:264.5pt;left:299.1pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">In&#xfb02;ammatory cell in&#xfb01;ltration</span></p>
<p style="top:272.1pt;left:305.4pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">(Masson&#x2019;s trichrome, BI)</span></p>
<p style="top:260.7pt;left:484.8pt;line-height:6.2pt"><span style="font-family:URWPalladioL,serif;font-size:6.2pt">Collagen production (Masson&#x2019;s</span></p>
<p style="top:268.3pt;left:508.2pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">trichrome, BI).</span></p>
<p style="top:276.0pt;left:489.1pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">TGF-</span><span style="font-family:EURM10,serif;font-size:6.3pt">&#x3b2;</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt">1 and VEGF (WB, BI)</span></p>
<p style="top:294.7pt;left:111.5pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Guo et al., 2016 [</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt;color:#0774b7">43</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt">]</span></p>
<p style="top:287.0pt;left:228.2pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Wound area,</span></p>
<p style="top:294.7pt;left:207.0pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Rate of wound healing (NI).</span></p>
<p style="top:302.3pt;left:204.1pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Wound maturity score (H, BI)</span></p>
<p style="top:294.7pt;left:392.8pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Capillary density (vWF; I, BI)</span></p>
<p style="top:290.8pt;left:488.2pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Granulation score (Collagen;</span></p>
<p style="top:298.5pt;left:494.7pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Masson&#x2019;s trichrome, BI)</span></p>
<p style="top:287.0pt;left:580.9pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Neoepithelium length (H, BI).</span></p>
<p style="top:294.7pt;left:601.6pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Epidermal cell</span></p>
<p style="top:302.3pt;left:586.8pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">proliferation (Ki-67; I, BI)</span></p>
<p style="top:317.2pt;left:112.0pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Xue et al., 2013 [</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt;color:#0774b7">44</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt">]</span></p>
<p style="top:313.4pt;left:206.5pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Wound area, Rate of wound</span></p>
<p style="top:321.0pt;left:228.5pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">healing (NI)</span></p>
<p style="top:313.4pt;left:390.7pt;line-height:6.2pt"><span style="font-family:URWPalladioL,serif;font-size:6.2pt">Capillary density (H, BI). VEGF,</span></p>
<p style="top:321.1pt;left:390.4pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Ang-1</span><span style="font-family:Rpxr,serif;font-size:6.3pt">/</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt">2, CD31 (qPCR, WB, BI).</span></p>
<p style="top:343.6pt;left:108.4pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Zhang et al., 2015 [</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt;color:#0774b7">45</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt">]</span></p>
<p style="top:339.7pt;left:211.9pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Wound healing rate and</span></p>
<p style="top:347.4pt;left:232.6pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">time (NI)</span></p>
<p style="top:332.1pt;left:308.5pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">WBC (count, BS). CRP</span></p>
<p style="top:339.7pt;left:298.2pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">(nephelometric immunoassay</span></p>
<p style="top:347.4pt;left:301.2pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">method, BS). IFN-</span><span style="font-family:EURM10,serif;font-size:6.3pt">&#x3b3;</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt">, TNF-</span><span style="font-family:EURM10,serif;font-size:6.3pt">&#x3b1;</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt">,</span></p>
<p style="top:355.1pt;left:308.2pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">IL-6, IL-10 (ELISA, BS)</span></p>
<p style="top:343.6pt;left:399.5pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Capillary density (H, BI)</span></p>
<p style="top:335.9pt;left:490.4pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Granulation tissue amount</span></p>
<p style="top:343.6pt;left:501.4pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">(H, BI). Number of</span></p>
<p style="top:351.3pt;left:503.2pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">&#xfb01;broblasts (H, BI)</span></p>
<p style="top:366.1pt;left:105.3pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Pourfath et al., 2018 [</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt;color:#0774b7">46</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt">]</span></p>
<p style="top:366.1pt;left:500.7pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Granulation (H, BI)</span></p>
<p style="top:366.1pt;left:584.5pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Re-epithelialization (H, BI)</span></p>
<p style="top:385.0pt;left:92.0pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Gholipour-Kanani et al., 2014 [</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt;color:#0774b7">47</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt">]</span></p>
<p style="top:381.2pt;left:202.9pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Wound area (NI). Total wound</span></p>
<p style="top:388.8pt;left:217.1pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">healing score (H, BI)</span></p>
<p style="top:377.3pt;left:298.1pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">In&#xfb02;ammation markers (visual</span></p>
<p style="top:385.0pt;left:298.2pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">inspection, NI). In&#xfb02;ammatory</span></p>
<p style="top:392.7pt;left:309.1pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">cell in&#xfb01;ltration (H, BI)</span></p>
<p style="top:377.3pt;left:490.8pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Collagen regeneration and</span></p>
<p style="top:385.0pt;left:502.6pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">granulation tissue</span></p>
<p style="top:392.7pt;left:504.7pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">thickness (H, BI)</span></p>
<p style="top:381.2pt;left:589.6pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Epithelial regeneration,</span></p>
<p style="top:388.8pt;left:596.3pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">appendage (H, BI)</span></p>
<p style="top:404.0pt;left:97.8pt;line-height:8.0pt"><span style="font-family:URWPalladioL,serif;font-size:8.0pt">ANG-1</span><span style="font-family:Rpxr,serif;font-size:8.0pt">/</span><span style="font-family:URWPalladioL,serif;font-size:8.0pt">2: Angiopoietin-1</span><span style="font-family:Rpxr,serif;font-size:8.0pt">/</span><span style="font-family:URWPalladioL,serif;font-size:8.0pt">2,</span><span style="font-family:EURM10,serif;font-size:8.0pt"> &#x3b1;</span><span style="font-family:URWPalladioL,serif;font-size:8.0pt">-SMA: alpha smooth muscle actin, bFGF: basis &#xfb01;broblast growth factor, BI: biopsy, BS: blood sample, CD-31: platelet endothelial cell adhesion molecule,</span></p>
<p style="top:413.5pt;left:97.8pt;line-height:8.0pt"><span style="font-family:URWPalladioL,serif;font-size:8.0pt">CINC-1; cytokine-induced neutrophil chemoattractant, Col: collagen, CRP: C-reactive protein, ECM: extracellular matrix, ELISA: enzyme-linked immunosorbent assay, H: histology, I:</span></p>
<p style="top:423.0pt;left:97.8pt;line-height:7.9pt"><span style="font-family:URWPalladioL,serif;font-size:7.9pt">immunohistochemistry, IFN-</span><span style="font-family:EURM10,serif;font-size:8.0pt">&#x3b3;</span><span style="font-family:URWPalladioL,serif;font-size:7.9pt">: interferon gamma, IL: interleukin, IB4: isolectin B4, Flow: &#xfb02;owcytometry, MIP-2: macrophage-in&#xfb02;ammatory protein 2, MMP: matrix metalloproteinase, NI:</span></p>
<p style="top:432.4pt;left:97.8pt;line-height:8.0pt"><span style="font-family:URWPalladioL,serif;font-size:8.0pt">non-invasive, PCNA: proliferating cell nuclear antigen, PDGF: platelet-derived growth factor, qPCR: quantitative polymerase chain reaction, SEM: scanning electron microscopy, TGF-</span><span style="font-family:EURM10,serif;font-size:8.0pt">&#x3b2;</span><span style="font-family:URWPalladioL,serif;font-size:8.0pt">:</span></p>
<p style="top:441.8pt;left:97.8pt;line-height:8.0pt"><span style="font-family:URWPalladioL,serif;font-size:8.0pt">transforming growth factor beta, TIMP-2: tissue inhibitor of metalloproteinases 2, TNF</span><span style="font-family:EURM10,serif;font-size:8.0pt">&#x3b1;</span><span style="font-family:URWPalladioL,serif;font-size:8.0pt">: tumor necrosis factor alpha, VEGF: vascular endothelial growth factor, VEGFR2: vascular</span></p>
<p style="top:451.4pt;left:97.8pt;line-height:8.0pt"><span style="font-family:URWPalladioL,serif;font-size:8.0pt">endothelial growth factor receptor 2, vWF: von Willebrand factor, WB: western blot, WBC: white blood count.</span></p>


<p style="top:56.6pt;left:76.3pt;line-height:8.0pt"><i><span style="font-family:URWPalladioL,serif;font-size:8.0pt">Cells</span></i><b><span style="font-family:URWPalladioL,serif;font-size:8.0pt"> 2020</span></b><span style="font-family:URWPalladioL,serif;font-size:8.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:8.0pt"> 9</span></i><span style="font-family:URWPalladioL,serif;font-size:8.0pt">, 2545</span></p>
<p style="top:56.6pt;left:491.8pt;line-height:8.0pt"><span style="font-family:URWPalladioL,serif;font-size:8.0pt">15 of 21</span></p>
<p style="top:89.7pt;left:177.1pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Table 9.</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> Outcome assessment parameters from clinical trials.</span></p>
<p style="top:109.5pt;left:114.9pt;line-height:6.3pt"><b><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Study</span></b></p>
<p style="top:109.5pt;left:213.0pt;line-height:6.3pt"><b><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Wound Healing</span></b></p>
<p style="top:109.5pt;left:315.9pt;line-height:6.3pt"><b><span style="font-family:URWPalladioL,serif;font-size:6.3pt">In&#xfb02;ammation</span></b></p>
<p style="top:109.5pt;left:379.0pt;line-height:6.3pt"><b><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Proliferation</span></b></p>
<p style="top:109.5pt;left:441.3pt;line-height:6.3pt"><b><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Remodeling</span></b><span style="font-family:Rpxb,serif;font-size:6.3pt">/</span><b><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Scarring</span></b></p>
<p style="top:120.7pt;left:98.2pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Xu et al., 2012 [</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt;color:#0774b7">48</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt">]</span></p>
<p style="top:120.7pt;left:203.0pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Overall healing (visual)</span></p>
<p style="top:120.7pt;left:311.9pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Infection (visual)</span></p>
<p style="top:120.7pt;left:444.0pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Contracture (visual)</span></p>
<p style="top:131.9pt;left:90.0pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Arkoulis et al., 2018 [</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt;color:#0774b7">49</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt">]</span></p>
<p style="top:131.9pt;left:444.0pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Contracture (visual)</span></p>
<p style="top:154.6pt;left:85.2pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Abo-Elkheir et al., 2017 [</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt;color:#0774b7">50</span><span style="font-family:URWPalladioL,serif;font-size:6.3pt">]</span></p>
<p style="top:143.1pt;left:217.9pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Type of burn</span></p>
<p style="top:150.8pt;left:183.0pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Onset, cause, mechanism, site, wound</span></p>
<p style="top:158.5pt;left:180.2pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">percentage (Lund and Browder), area of</span></p>
<p style="top:166.2pt;left:180.1pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">wound, depth of wound, rate of healing</span></p>
<p style="top:154.6pt;left:311.9pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Infection (visual)</span></p>
<p style="top:147.0pt;left:444.9pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">Hypertrophic scars,</span></p>
<p style="top:154.6pt;left:445.4pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">keloid, contracture,</span></p>
<p style="top:162.3pt;left:435.8pt;line-height:6.3pt"><span style="font-family:URWPalladioL,serif;font-size:6.3pt">and pigmentation (visual)</span></p>
<p style="top:190.5pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">3.3.1. Wound Healing</span></p>
<p style="top:209.9pt;left:97.8pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">Non-invasive assessment of overall wound healing was used in 17 of 21 studies in the form of</span></p>
<p style="top:223.6pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">either end-point measurements or rate of wound closure. Some studies determined the necrotic area as</span></p>
<p style="top:237.1pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">a measure of tissue damage. In addition to the non-invasive assessment, four studies applied a wound</span></p>
<p style="top:250.5pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">healing or maturation scoring system based on histological data.</span></p>
<p style="top:273.7pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">3.3.2. In&#xfb02;ammation</span></p>
<p style="top:293.3pt;left:97.8pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">Non-invasive assessment of in&#xfb02;ammation or infection was used in three studies. The assessments</span></p>
<p style="top:306.7pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">included signs of in&#xfb02;ammation, such as redness, heat, and swelling, and the bacterial contamination</span></p>
<p style="top:320.1pt;left:76.1pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">was determined by swabbing. Biopsies were used for histological assessment of the in&#xfb01;ltration by</span></p>
<p style="top:333.7pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">in&#xfb02;ammatory cells (11 studies), and quantitation of expression of interleukin-1b (</span><i><span style="font-family:URWPalladioL,serif;font-size:9.9pt">IL-1b</span></i><span style="font-family:URWPalladioL,serif;font-size:9.9pt">), transforming</span></p>
<p style="top:347.3pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">growth factor beta 1 (</span><i><span style="font-family:URWPalladioL,serif;font-size:9.9pt">TGF-</span></i><span style="font-family:Rpxmi,serif;font-size:10.0pt">&#x3b2;</span><i><span style="font-family:URWPalladioL,serif;font-size:9.9pt">1</span></i><span style="font-family:URWPalladioL,serif;font-size:9.9pt">), basic &#xfb01;broblast growth factor (</span><i><span style="font-family:URWPalladioL,serif;font-size:9.9pt">bFGF</span></i><span style="font-family:URWPalladioL,serif;font-size:9.9pt">), macrophage-in&#xfb02;ammatory protein</span></p>
<p style="top:360.8pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">2 (</span><i><span style="font-family:URWPalladioL,serif;font-size:9.9pt">MIP2</span></i><span style="font-family:URWPalladioL,serif;font-size:9.9pt">), or tumor necrosis factor-alpha 1 (</span><i><span style="font-family:URWPalladioL,serif;font-size:9.9pt">TNF</span></i><span style="font-family:Rpxmi,serif;font-size:10.0pt">&#x3b1;</span><i><span style="font-family:URWPalladioL,serif;font-size:9.9pt">1</span></i><span style="font-family:URWPalladioL,serif;font-size:9.9pt">) was assessed using quantitative polymerase chain</span></p>
<p style="top:374.2pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">reaction (qPCR) (two studies), myeloperoxidase activity (two studies), and &#xfb02;ow cytometry of the</span></p>
<p style="top:387.7pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">CD4</span><span style="font-family:Rpxr,serif;font-size:10.1pt">+</span><span style="font-family:URWPalladioL,serif;font-size:10.1pt"> and CD8</span><span style="font-family:Rpxr,serif;font-size:10.1pt">+</span><span style="font-family:URWPalladioL,serif;font-size:10.1pt"> T cells (one study). Three studies used blood samples to determine white blood</span></p>
<p style="top:401.3pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">cell count or c-reactive protein (CRP) levels, or used enzyme-linked immunosorbent assay (ELISA) to</span></p>
<p style="top:414.8pt;left:76.3pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">quantitate levels of IL-6, IL-10, TGF-</span><span style="font-family:EURM10,serif;font-size:10.0pt">&#x3b2;</span><span style="font-family:URWPalladioL,serif;font-size:9.9pt">, cytokine-induced neutrophil chemoattractant (CINC-1), TNF-</span><span style="font-family:EURM10,serif;font-size:10.0pt">&#x3b1;</span><span style="font-family:URWPalladioL,serif;font-size:9.9pt">,</span></p>
<p style="top:428.3pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">and interferon gamma (IFN-</span><span style="font-family:EURM10,serif;font-size:10.0pt">&#x3b3;</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">).</span></p>
<p style="top:451.5pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">3.3.3. Proliferation</span></p>
<p style="top:471.1pt;left:97.8pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">Our data analysis of the methods used to analyze the proliferative phase of wound healing divides</span></p>
<p style="top:484.5pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">them further into three processes&#x2014;neovascularization, granulation, and re-epithelialization.</span></p>
<p style="top:507.7pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">Neovascularization</span></p>
<p style="top:527.1pt;left:97.8pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">Most of the studies investigated neovascularization based on biopsies. The methods included</span></p>
<p style="top:540.7pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">histomorphometry to determine capillary density (six studies), immunohistochemistry to investigate</span></p>
<p style="top:554.1pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">the presence of platelet-derived growth factor (PDGF), VEGF, vascular endothelial growth factor</span></p>
<p style="top:567.7pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">receptor 2 (VEGFR2), or isolectin B4 (IB4) as a measure of neovascularization, as well as the presence</span></p>
<p style="top:581.2pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">of von Willebrand factor (vWF) or platelet endothelial cell adhesion molecule (CD31) to estimate the</span></p>
<p style="top:594.7pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">number of endothelial cells (nine studies). Furthermore, qPCR was used to study the expression of</span></p>
<p style="top:608.2pt;left:76.5pt;line-height:10.1pt"><i><span style="font-family:URWPalladioL,serif;font-size:10.1pt">IL-1b</span></i><span style="font-family:URWPalladioL,serif;font-size:10.1pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:10.1pt"> bFGF</span></i><span style="font-family:URWPalladioL,serif;font-size:10.1pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:10.1pt"> VEGF-</span></i><span style="font-family:Rpxmi,serif;font-size:10.0pt">&#x3b1;</span><i><span style="font-family:URWPalladioL,serif;font-size:10.1pt">1</span></i><span style="font-family:URWPalladioL,serif;font-size:10.1pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:10.1pt"> VEGFR2</span></i><span style="font-family:URWPalladioL,serif;font-size:10.1pt">, angiopoietin 1 and 2 (</span><i><span style="font-family:URWPalladioL,serif;font-size:10.1pt">Ang-1</span></i><span style="font-family:Rpxi,serif;font-size:10.1pt">/</span><i><span style="font-family:URWPalladioL,serif;font-size:10.1pt">2</span></i><span style="font-family:URWPalladioL,serif;font-size:10.1pt">), or</span><i><span style="font-family:URWPalladioL,serif;font-size:10.1pt"> CD31</span></i><span style="font-family:URWPalladioL,serif;font-size:10.1pt"> (three studies), one study</span></p>
<p style="top:621.7pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">used western blotting (WB) to determine the levels of VEGF, Ang-1</span><span style="font-family:Rpxr,serif;font-size:10.0pt">/</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">2, and CD31, and, &#xfb01;nally, in one</span></p>
<p style="top:635.3pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">study, blood samples were tested for TGF-</span><span style="font-family:EURM10,serif;font-size:10.0pt"> &#x3b2;</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt"> using ELISA.</span></p>
<p style="top:658.5pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">Granulation</span></p>
<p style="top:677.9pt;left:97.8pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">The process of granulation was, in most studies, evaluated in biopsy samples. Histological</span></p>
<p style="top:691.4pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">analysis was used to determine the degree of cell proliferation (three studies) and the presence of</span></p>
<p style="top:705.0pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">&#xfb01;broblasts and</span><span style="font-family:Rpxr,serif;font-size:10.0pt">/</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">or &#xfb01;brocytes (two studies), as well as to characterize the ECM in terms of the amount</span></p>
<p style="top:718.4pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">and composition of collagens (seven studies) and integrins (one study). In one study, the ECM was</span></p>
<p style="top:731.9pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">analyzed by scanning electron microscopy. The transcriptional activation of collagen I, collagen III,</span></p>
<p style="top:745.4pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">or vimentin genes was determined by qPCR in three studies. WB was used to assess the amount of</span></p>


<p style="top:56.6pt;left:76.3pt;line-height:8.0pt"><i><span style="font-family:URWPalladioL,serif;font-size:8.0pt">Cells</span></i><b><span style="font-family:URWPalladioL,serif;font-size:8.0pt"> 2020</span></b><span style="font-family:URWPalladioL,serif;font-size:8.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:8.0pt"> 9</span></i><span style="font-family:URWPalladioL,serif;font-size:8.0pt">, 2545</span></p>
<p style="top:56.6pt;left:491.8pt;line-height:8.0pt"><span style="font-family:URWPalladioL,serif;font-size:8.0pt">16 of 21</span></p>
<p style="top:89.9pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">collagen I, collagen III, TGF-</span><span style="font-family:EURM10,serif;font-size:10.0pt">&#x3b2;</span><span style="font-family:URWPalladioL,serif;font-size:9.9pt">, or VEGF in two studies, and, lastly, a serum-based ELISA was used in</span></p>
<p style="top:103.4pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">one study to measure the level of TGF-</span><span style="font-family:EURM10,serif;font-size:10.0pt">&#x3b2;</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">.</span></p>
<p style="top:126.6pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">Re-Epithelialization</span></p>
<p style="top:146.0pt;left:97.8pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">In all 12 studies that speci&#xfb01;cally dealt with the process of re-epithelialization, the evaluation</span></p>
<p style="top:159.5pt;left:76.1pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">was done using biopsies. Eleven studies used histological analysis to determine the epidermal</span></p>
<p style="top:173.0pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">formation, epidermal cell proliferation, epidermal thickness, hair follicle formation, rete-ridges,</span></p>
<p style="top:186.5pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">and dermal appendages. qPCR was used in two studies to either investigate wound contraction by</span></p>
<p style="top:200.1pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">alpha smooth muscle actin (</span><span style="font-family:Rpxmi,serif;font-size:10.0pt">&#x3b1;</span><i><span style="font-family:URWPalladioL,serif;font-size:10.0pt">-SMA</span></i><span style="font-family:URWPalladioL,serif;font-size:10.0pt">) or to investigate metalloproteinases and their inhibitors: matrix</span></p>
<p style="top:213.7pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">metalloproteinase-1 (</span><i><span style="font-family:URWPalladioL,serif;font-size:9.9pt">MMP-1</span></i><span style="font-family:URWPalladioL,serif;font-size:9.9pt">) and tissue inhibitor of metalloproteinases 2 (</span><i><span style="font-family:URWPalladioL,serif;font-size:9.9pt">TIMP-2</span></i><span style="font-family:URWPalladioL,serif;font-size:9.9pt">). One study used a</span></p>
<p style="top:227.1pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">serum-based ELISA to measure the level of TGF-</span><span style="font-family:EURM10,serif;font-size:10.0pt">&#x3b2;</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">.</span></p>
<p style="top:250.4pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">3.3.4. Remodeling</span><span style="font-family:Rpxr,serif;font-size:10.0pt">/</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">Scarring</span></p>
<p style="top:269.8pt;left:97.8pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">Of the 21 studies, only seven investigated the processes of remodeling and scarring. Of these,</span></p>
<p style="top:283.3pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">six were based on biopsies and included histological assessment of connective tissue arrangement or</span></p>
<p style="top:296.8pt;left:76.2pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">pathologic dermal &#xfb01;brosis. Immunohistochemistry was used in one study to quantitatively evaluate</span></p>
<p style="top:310.3pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">scar formation by means of visualization of collagens I, III, and IV. Additionally, qPCR was used in</span></p>
<p style="top:323.8pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">two studies to determine the transcriptional levels of collagens I, II, and IV,</span><i><span style="font-family:URWPalladioL,serif;font-size:10.0pt"> MIP-2</span></i><span style="font-family:URWPalladioL,serif;font-size:10.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:10.0pt"> TGF-</span></i><span style="font-family:Rpxmi,serif;font-size:10.0pt">&#x3b2;</span><i><span style="font-family:URWPalladioL,serif;font-size:10.0pt">1</span></i><span style="font-family:URWPalladioL,serif;font-size:10.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:10.0pt"> TNF-</span></i><span style="font-family:Rpxmi,serif;font-size:10.0pt">&#x3b1;</span><i><span style="font-family:URWPalladioL,serif;font-size:10.0pt">1</span></i><span style="font-family:URWPalladioL,serif;font-size:10.0pt">,</span></p>
<p style="top:337.4pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">and</span><i><span style="font-family:URWPalladioL,serif;font-size:10.0pt"> MMP-1</span></i><span style="font-family:URWPalladioL,serif;font-size:10.0pt"> and</span><i><span style="font-family:URWPalladioL,serif;font-size:10.0pt"> -2</span></i><span style="font-family:URWPalladioL,serif;font-size:10.0pt">. Furthermore, in one study, ELISA was used to assay the serum level of TGF-</span><span style="font-family:EURM10,serif;font-size:10.0pt">&#x3b2;</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">.</span></p>
<p style="top:360.6pt;left:76.5pt;line-height:10.0pt"><i><span style="font-family:URWPalladioL,serif;font-size:10.0pt">3.4. Pre-Clinical to Clinical Continuity of Evidence</span></i></p>
<p style="top:380.2pt;left:97.8pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">When performing a cross-citation analysis to assess the evidence used to justify clinical translation,</span></p>
<p style="top:393.5pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">none of the pre-clinical studies were identi&#xfb01;ed in the bibliographies of any of the clinical studies.</span></p>
<p style="top:407.1pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">Moreover, none of the clinical studies cited the other clinical studies.</span></p>
<p style="top:430.3pt;left:76.5pt;line-height:10.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:10.0pt">4. Discussion</span></b></p>
<p style="top:449.8pt;left:97.8pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">In the current systematic review, we have evaluated the research of therapeutic use of stem cells</span></p>
<p style="top:463.2pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">towards healing of burn wounds. A total of 21 pre-clinical and three clinical studies were included.</span></p>
<p style="top:476.7pt;left:76.2pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">The pre-clinical studies investigated wound healing by looking at di</span><span style="font-family:Rpxr,serif;font-size:10.1pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:10.1pt">erent micro-processes of the</span></p>
<p style="top:490.4pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">di</span><span style="font-family:Rpxr,serif;font-size:9.9pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:9.9pt">erent wound healing phases, such as in&#xfb02;ammation, proliferation, neovascularization, granulation,</span></p>
<p style="top:503.9pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">re-epithelialization, and remodeling</span><span style="font-family:Rpxr,serif;font-size:9.9pt">/</span><span style="font-family:URWPalladioL,serif;font-size:9.9pt">scarring. Noticeably, the studies varied widely due to di</span><span style="font-family:Rpxr,serif;font-size:9.9pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:9.9pt">erences</span></p>
<p style="top:517.3pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">in scienti&#xfb01;c focus, research strategy, and methods used; therefore, it was not possible to directly</span></p>
<p style="top:530.8pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">compare their &#xfb01;ndings. Nevertheless, there was apparent positive e</span><span style="font-family:Rpxr,serif;font-size:10.1pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:10.1pt">ect of MSCs on the overall</span></p>
<p style="top:544.3pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">healing, and the majority of studies agreed on the positive e</span><span style="font-family:Rpxr,serif;font-size:10.1pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:10.1pt">ect on all of the individual phases as</span></p>
<p style="top:557.9pt;left:76.1pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">well (Table</span><span style="font-family:URWPalladioL,serif;font-size:9.9pt;color:#0774b7"> 5</span><span style="font-family:URWPalladioL,serif;font-size:9.9pt">). From the temporal viewpoint, most of the studies investigated the progressive e</span><span style="font-family:Rpxr,serif;font-size:9.9pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:9.9pt">ect of</span></p>
<p style="top:571.3pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">MSCs, typically 7, 14, and 21</span><span style="font-family:Rpxr,serif;font-size:10.0pt">/</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">28 days after burn in&#xfb02;iction; however, some studies also looked at the</span></p>
<p style="top:584.9pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">e</span><span style="font-family:Rpxr,serif;font-size:9.9pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:9.9pt">ect after 40&#x2013;60 days. The e</span><span style="font-family:Rpxr,serif;font-size:9.9pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:9.9pt">ect was most evident between 7 and 21 days, at which point 90% of the</span></p>
<p style="top:598.4pt;left:76.1pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">wounds were healed. It should be noted that a rapid wound closure is of importance to decrease the</span></p>
<p style="top:611.9pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">risk of hypermetabolism, infection, and hypovolemic shock [</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt;color:#0774b7">1</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">].</span></p>
<p style="top:625.4pt;left:97.8pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">In order to identify the wound healing processes where the MSCs exerted their regenerative</span></p>
<p style="top:638.9pt;left:76.2pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">properties, the e</span><span style="font-family:Rpxr,serif;font-size:10.0pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">ect on each phase and the related speci&#xfb01;c micro-processes were examined. For the</span></p>
<p style="top:652.5pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">in&#xfb02;ammation phase, 10 out of 12 studies reported immunomodulatory e</span><span style="font-family:Rpxr,serif;font-size:9.9pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:9.9pt">ects. For neovascularization,</span></p>
<p style="top:666.0pt;left:76.0pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">12 out of 14 studies found a positive e</span><span style="font-family:Rpxr,serif;font-size:9.9pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:9.9pt">ect. E</span><span style="font-family:Rpxr,serif;font-size:9.9pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:9.9pt">ects were also found in 13 out of 14 studies in regard to</span></p>
<p style="top:679.4pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">the granulation phase, as well as 11 out of 12 studies for the re-epithelialization phase. Only eight</span></p>
<p style="top:693.1pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">studies examined the e</span><span style="font-family:Rpxr,serif;font-size:9.9pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:9.9pt">ect of treatment on the remodeling</span><span style="font-family:Rpxr,serif;font-size:9.9pt">/</span><span style="font-family:URWPalladioL,serif;font-size:9.9pt">scarring phase. Out of these, &#xfb01;ve reported a</span></p>
<p style="top:706.6pt;left:76.2pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">positive e</span><span style="font-family:Rpxr,serif;font-size:9.9pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:9.9pt">ect, which was, incidentally, associated with the use of ASCs. That ASCs may be speci&#xfb01;cally</span></p>
<p style="top:720.0pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">useful in this stage, where extensive ECM remodeling takes place, also gains support from an</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt"> in vitro</span></p>
<p style="top:733.5pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">line of evidence [</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt;color:#0774b7">15</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">]. In burn wounds, the importance of this phase cannot be overstated, as scarring,</span></p>
<p style="top:747.0pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">soft tissue deformities, and &#xfb01;brosis represent serious long-term consequences [</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt;color:#0774b7">2</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">].</span></p>


<p style="top:56.6pt;left:76.3pt;line-height:8.0pt"><i><span style="font-family:URWPalladioL,serif;font-size:8.0pt">Cells</span></i><b><span style="font-family:URWPalladioL,serif;font-size:8.0pt"> 2020</span></b><span style="font-family:URWPalladioL,serif;font-size:8.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:8.0pt"> 9</span></i><span style="font-family:URWPalladioL,serif;font-size:8.0pt">, 2545</span></p>
<p style="top:56.6pt;left:491.8pt;line-height:8.0pt"><span style="font-family:URWPalladioL,serif;font-size:8.0pt">17 of 21</span></p>
<p style="top:89.8pt;left:97.8pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">To evaluate the mechanism of action of MSCs in the healing of burn wounds, a frequently</span></p>
<p style="top:103.4pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">used approach was the histological assessment. However, due to the non-quantitative nature of this</span></p>
<p style="top:117.0pt;left:76.2pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">procedure, it was di</span><span style="font-family:Rpxr,serif;font-size:9.9pt">&#xfb03;</span><span style="font-family:URWPalladioL,serif;font-size:9.9pt">cult to arrive at evidence-based conclusions. Some of the studies converted their</span></p>
<p style="top:130.4pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">&#xfb01;ndings into semi-quantitative scoring systems to enable a sort of comparison. In the face of obvious</span></p>
<p style="top:143.8pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">de&#xfb01;ciency of such attempts, it would be of great value if a uni&#xfb01;ed scoring system was developed</span></p>
<p style="top:157.4pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">and adopted across the wound healing research community. It is important that future studies strive</span></p>
<p style="top:170.9pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">to incorporate quantitative assays in their experimental design as much as possible, and that these</span></p>
<p style="top:184.4pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">approaches are applied in a way re&#xfb02;ecting wound pathogenesis. As an example, we have identi&#xfb01;ed</span></p>
<p style="top:198.0pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">several studies that attempted to determine the role of bFGF or TGF-</span><span style="font-family:EURM10,serif;font-size:10.0pt">&#x3b2;</span><span style="font-family:URWPalladioL,serif;font-size:9.9pt">. Despite providing information</span></p>
<p style="top:211.5pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">about overall production, they were not able to highlight an association of these factors with a particular</span></p>
<p style="top:225.1pt;left:76.2pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">phase of healing. This could have been useful, since such information would facilitate a more in-depth</span></p>
<p style="top:238.4pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">understanding of the MSCs&#x2019; interaction with the wound microenvironment. Future animal studies</span></p>
<p style="top:251.9pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">should also apply tools like SYRCLE in the design stage. This, including the minimization of risk of</span></p>
<p style="top:265.6pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">bias, should clearly be spelled out in the published works. Moreover, new studies should be designed</span></p>
<p style="top:278.9pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">to be con&#xfb01;rmatory studies, as these are increasingly considered to be the necessary prerequisite for</span></p>
<p style="top:292.5pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">clinical trials [</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt;color:#0774b7">51</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">,</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt;color:#0774b7">52</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">].</span></p>
<p style="top:305.9pt;left:97.8pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">Although a substantial number of studies involving MSC application have been conducted in</span></p>
<p style="top:319.5pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">animal models, very few studies have been investigating the e</span><span style="font-family:Rpxr,serif;font-size:10.1pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:10.1pt">ect in humans. These studies have</span></p>
<p style="top:333.0pt;left:76.3pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">yielded a very low level of evidence due to the study type and very limited outcome measures.</span></p>
<p style="top:346.5pt;left:76.2pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">To take MSCs into consideration as a standard treatment option, the amount of evidence needs to be</span></p>
<p style="top:360.1pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">considerably increased. To this end, randomized controlled trials need to be designed with emphasis</span></p>
<p style="top:373.5pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">on risk of bias, sample size, and choice of primary and secondary outcome measures. Additionally,</span></p>
<p style="top:387.2pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">it is important that the knowledge gap is addressed, and the available clinical and pre-clinical evidence</span></p>
<p style="top:400.5pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">is used in the rationalization step. When undertaking these studies, it is encouraged to thoroughly</span></p>
<p style="top:414.0pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">consider the risk areas, such as the randomization process, deviations from intended interventions,</span></p>
<p style="top:427.5pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">missing outcome data, measurement of the outcome, or selection of the reported results, which</span></p>
<p style="top:441.0pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">can all lead to high risk of bias in randomized controlled trials. These areas can be found through</span></p>
<p style="top:454.6pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">risk assessment tools, such as the Cochrane risk of bias tool (RoB2) [</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt;color:#0774b7">53</span><span style="font-family:URWPalladioL,serif;font-size:10.1pt">]. Another important factor,</span></p>
<p style="top:468.1pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">that should be given thorough consideration, is the sample size, since this variable is critical for the</span></p>
<p style="top:481.7pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">outcome of statistical analysis in terms of signi&#xfb01;cance and power. However, as a large study population</span></p>
<p style="top:495.2pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">can be di</span><span style="font-family:Rpxr,serif;font-size:9.9pt">&#xfb03;</span><span style="font-family:URWPalladioL,serif;font-size:9.9pt">cult to muster, due to the incidence of burn wounds, it should be remembered that sample</span></p>
<p style="top:508.7pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">size and covariates must be balanced, especially in smaller clinical trials [</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt;color:#0774b7">54</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">,</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt;color:#0774b7">55</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">].</span></p>
<p style="top:522.1pt;left:97.8pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">It appears that the most meaningful progress in understanding the clinical utility of MSCs</span></p>
<p style="top:535.6pt;left:76.1pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">would occur if the primary and secondary outcome measures included quantitative analysis of the</span></p>
<p style="top:549.2pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">biopsy samples for investigating speci&#xfb01;c markers for each of the wound healing phases. Histological</span></p>
<p style="top:562.6pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">analysis of the biopsies could include quantitation of in&#xfb01;ltrating in&#xfb02;ammatory cells, proliferating</span></p>
<p style="top:576.3pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">endothelial cells or &#xfb01;broblasts, or collagen composition to assess progression through the in&#xfb02;ammation,</span></p>
<p style="top:589.8pt;left:76.2pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">proliferation, or remodeling phases, respectively. However, ethical concerns regarding in&#xfb02;icting further</span></p>
<p style="top:603.2pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">trauma make it di</span><span style="font-family:Rpxr,serif;font-size:10.1pt">&#xfb03;</span><span style="font-family:URWPalladioL,serif;font-size:10.1pt">cult to collect biopsies from these complex wounds. In case the justi&#xfb01;cation is</span></p>
<p style="top:616.7pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">serious enough to warrant the sampling, it must be guaranteed that the utilization of the material is</span></p>
<p style="top:630.2pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">maximized. Therefore, a well-designed panel of quantitative assays should be conducted to clarify</span></p>
<p style="top:643.7pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">MOA. In cases where more than one biopsy during the healing period is needed, the timing of these</span></p>
<p style="top:657.2pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">should be designed to speci&#xfb01;cally target the di</span><span style="font-family:Rpxr,serif;font-size:10.1pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:10.1pt">erent wound healing phases. Based on the animal</span></p>
<p style="top:670.7pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">studies reviewed in this paper, we suggest days 7, 14, and 21, and perhaps a biopsy after a year to</span></p>
<p style="top:684.3pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">monitor the long-term wound maturation.</span></p>
<p style="top:697.8pt;left:97.8pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">The presented evidence indicates that the stem cell treatment is generally bene&#xfb01;cial, although it</span></p>
<p style="top:711.2pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">seems that the animal model is not entirely identical to the human scenario. Notably, we observed</span></p>
<p style="top:724.8pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">that whereas the MSCs appeared e</span><span style="font-family:Rpxr,serif;font-size:10.0pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">ective throughout all phases of wound healing in the pre-clinical</span></p>
<p style="top:738.4pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">trials, their e</span><span style="font-family:Rpxr,serif;font-size:9.9pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:9.9pt">ect was mostly reduced to modulation of scarring and contracture in patients. Moreover,</span></p>
<p style="top:751.8pt;left:76.1pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">we noted an obvious lack of coherence in knowledge translation from bench to bedside, and the</span></p>


<p style="top:56.6pt;left:76.3pt;line-height:8.0pt"><i><span style="font-family:URWPalladioL,serif;font-size:8.0pt">Cells</span></i><b><span style="font-family:URWPalladioL,serif;font-size:8.0pt"> 2020</span></b><span style="font-family:URWPalladioL,serif;font-size:8.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:8.0pt"> 9</span></i><span style="font-family:URWPalladioL,serif;font-size:8.0pt">, 2545</span></p>
<p style="top:56.6pt;left:491.8pt;line-height:8.0pt"><span style="font-family:URWPalladioL,serif;font-size:8.0pt">18 of 21</span></p>
<p style="top:89.8pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">number of clinical studies was disappointingly low and had a very low evidence level with a high</span></p>
<p style="top:103.3pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">risk of bias. Thus, more clinical studies are needed, and, hopefully, identifying and recognizing the</span></p>
<p style="top:117.0pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">knowledge gaps and the discontinuity from pre-clinical to clinical research may promote better design</span></p>
<p style="top:130.4pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">of future clinical studies.</span></p>
<p style="top:144.0pt;left:97.8pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">In summation, this article, based on two systematic reviews, provides a comprehensive overview</span></p>
<p style="top:157.3pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">of the available methodologies and MOA of MSC treatment of burn wounds from both pre-clinical</span></p>
<p style="top:170.9pt;left:76.5pt;line-height:10.1pt"><span style="font-family:URWPalladioL,serif;font-size:10.1pt">and clinical studies. Although the animal trials produced some exciting results, it is evident that</span></p>
<p style="top:184.5pt;left:76.5pt;line-height:9.9pt"><span style="font-family:URWPalladioL,serif;font-size:9.9pt">high-quality randomized controlled trials are required before drawing universal conclusions about the</span></p>
<p style="top:198.0pt;left:76.5pt;line-height:10.0pt"><span style="font-family:URWPalladioL,serif;font-size:10.0pt">clinical e</span><span style="font-family:Rpxr,serif;font-size:10.0pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:10.0pt">ect of stem cell treatment in burn wounds.</span></p>
<p style="top:220.8pt;left:76.2pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Author Contributions:</span></b><span style="font-family:URWPalladioL,serif;font-size:9.1pt"> Conceptualization, J.L.H., N.B.S. and S.R.P.; methodology, J.L.H., N.B.S. and S.R.P;</span></p>
<p style="top:231.0pt;left:76.3pt;line-height:8.9pt"><span style="font-family:URWPalladioL,serif;font-size:8.9pt">validation, T.F. and S.R.P; formal analysis, J.L.H., N.B.S., T.F. and S.R.P.; investigation, J.L.H. and N.B.S.; resources,</span></p>
<p style="top:241.1pt;left:76.3pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">T.F. and S.R.P.; writing&#x2014;original draft preparation, J.L.H. and N.B.S.; writing&#x2014;review and editing, T.F., V.Z. and</span></p>
<p style="top:251.3pt;left:76.5pt;line-height:8.9pt"><span style="font-family:URWPalladioL,serif;font-size:8.9pt">S.R.P.; visualization, J.L.H., N.B.S., T.F., V.Z. and S.R.P.; supervision, S.R.P. All authors have read and agreed to the</span></p>
<p style="top:261.4pt;left:76.3pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">published version of the manuscript.</span></p>
<p style="top:277.5pt;left:76.5pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Funding:</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> This research received no external funding.</span></p>
<p style="top:293.6pt;left:76.2pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Acknowledgments:</span></b><span style="font-family:URWPalladioL,serif;font-size:8.9pt"> We thank librarian Mette Buje Grunds&#xf8;e for the technical assistance in the systematic literature</span></p>
<p style="top:303.6pt;left:76.5pt;line-height:9.1pt"><span style="font-family:URWPalladioL,serif;font-size:9.1pt">search. We thank Danishan Balachandran and Nia Kristine J&#xf8;rgensen for their help with the initial literature</span></p>
<p style="top:313.8pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">research and bias assessment.</span></p>
<p style="top:330.0pt;left:76.5pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Con&#xfb02;icts of Interest:</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> The authors declare no con&#xfb02;ict of interest.</span></p>
<p style="top:355.5pt;left:76.5pt;line-height:10.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:10.0pt">References</span></b></p>
<p style="top:375.1pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">1.</span></p>
<p style="top:375.1pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Lang, T.C.; Zhao, R.; Kim, A.; Wijewardena, A.; Vandervord, J.; Xue, M.; Jackson, C.J. A Critical Update of</span></p>
<p style="top:388.0pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">the Assessment and Acute Management of Patients with Severe Burns.</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> Adv. Wound Care</span></i><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 2019</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 8</span></i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">, 607&#x2013;633.</span></p>
<p style="top:401.0pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">[</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">CrossRef</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">] [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">PubMed</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:413.9pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">2.</span></p>
<p style="top:413.8pt;left:98.1pt;line-height:9.1pt"><span style="font-family:URWPalladioL,serif;font-size:9.1pt">Spronk, I.; Polinder, S.; Haagsma, J.A.; Nieuwenhuis, M.; Pijpe, A.; van der Vlies, C.H.; Middelkoop, E.;</span></p>
<p style="top:426.8pt;left:97.8pt;line-height:8.9pt"><span style="font-family:URWPalladioL,serif;font-size:8.9pt">van Baar, M.E. Patient-reported scar quality of adults after burn injuries: A &#xfb01;ve-year multicenter follow-up</span></p>
<p style="top:439.7pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">study.</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> Wound Repair Regen.</span></i><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 2019</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 27</span></i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">, 406&#x2013;414. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">CrossRef</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">] [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">PubMed</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:452.6pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">3.</span></p>
<p style="top:452.5pt;left:98.1pt;line-height:9.1pt"><span style="font-family:URWPalladioL,serif;font-size:9.1pt">Tiwari, V.K. Burn wound: How it di</span><span style="font-family:Rpxr,serif;font-size:9.1pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:9.1pt">ers from other wounds.</span><i><span style="font-family:URWPalladioL,serif;font-size:9.1pt"> Indian J. Plast. Surg.</span></i><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 2012</span></b><span style="font-family:URWPalladioL,serif;font-size:9.1pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:9.1pt"> 45</span></i><span style="font-family:URWPalladioL,serif;font-size:9.1pt">, 364&#x2013;373.</span></p>
<p style="top:465.5pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">[</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">CrossRef</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">] [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">PubMed</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:478.4pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">4.</span></p>
<p style="top:478.4pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Maranda, E.L.; Rodriguez-Menocal, L.; Badiavas, E. Role of Mesenchymal Stem Cells in Dermal Repair in</span></p>
<p style="top:491.4pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Burns and Diabetic Wounds.</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> Curr. Stem Cell Res. Ther.</span></i><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 2017</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 12</span></i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">, 61&#x2013;70. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">CrossRef</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:504.3pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">5.</span></p>
<p style="top:504.2pt;left:98.1pt;line-height:9.1pt"><span style="font-family:URWPalladioL,serif;font-size:9.1pt">Li, N.; Hua, J. Interactions between mesenchymal stem cells and the immune system.</span><i><span style="font-family:URWPalladioL,serif;font-size:9.1pt"> Cell. Mol. Life Sci.</span></i></p>
<p style="top:517.2pt;left:98.1pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">2017</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 74</span></i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">, 2345&#x2013;2360. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">CrossRef</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">] [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">PubMed</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:530.1pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">6.</span></p>
<p style="top:530.2pt;left:98.1pt;line-height:8.9pt"><span style="font-family:URWPalladioL,serif;font-size:8.9pt">Guerrouahen, B.S.; Sidahmed, H.; Al Sulaiti, A.; Al Khulai&#xfb01;, M.; Cugno, C. Enhancing Mesenchymal Stromal</span></p>
<p style="top:542.9pt;left:98.1pt;line-height:9.1pt"><span style="font-family:URWPalladioL,serif;font-size:9.1pt">Cell Immunomodulation for Treating Conditions In&#xfb02;uenced by the Immune System.</span><i><span style="font-family:URWPalladioL,serif;font-size:9.1pt"> Stem Cells Int.</span></i><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 2019</span></b><span style="font-family:URWPalladioL,serif;font-size:9.1pt">,</span></p>
<p style="top:555.9pt;left:97.8pt;line-height:9.0pt"><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">2019</span></i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">, 7219297. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">CrossRef</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">] [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">PubMed</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:568.8pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">7.</span></p>
<p style="top:568.8pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Rasmussen, J.G.; Riis, S.E.; Fr&#xf8;bert, O.; Yang, S.; Kastrup, J.; Zachar, V.; Simonsen, U.; Fink, T. Activation of</span></p>
<p style="top:581.8pt;left:98.1pt;line-height:8.9pt"><span style="font-family:URWPalladioL,serif;font-size:8.9pt">Protease-Activated Receptor 2 Induces VEGF Independently of HIF-1.</span><i><span style="font-family:URWPalladioL,serif;font-size:8.9pt"> PLoS ONE</span></i><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 2012</span></b><span style="font-family:URWPalladioL,serif;font-size:8.9pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:8.9pt"> 7</span></i><span style="font-family:URWPalladioL,serif;font-size:8.9pt">, e46087. [</span><span style="font-family:URWPalladioL,serif;font-size:8.9pt;color:#0774b7">CrossRef</span><span style="font-family:URWPalladioL,serif;font-size:8.9pt">]</span></p>
<p style="top:594.6pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">8.</span></p>
<p style="top:594.6pt;left:98.1pt;line-height:9.1pt"><span style="font-family:URWPalladioL,serif;font-size:9.1pt">Rehman, J.; Traktuev, D.; Li, J.; Merfeld-Clauss, S.; Temm-Grove, C.J.; Bovenkerk, J.E.; Pell, C.L.;</span></p>
<p style="top:607.5pt;left:97.9pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Johnstone, B.H.; Considine, R.V.; March, K.L. Secretion of angiogenic and antiapoptotic factors by human</span></p>
<p style="top:620.5pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">adipose stromal cells.</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> Circulation</span></i><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 2004</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 109</span></i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">, 1292&#x2013;1298. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">CrossRef</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:633.4pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">9.</span></p>
<p style="top:633.3pt;left:98.1pt;line-height:9.1pt"><span style="font-family:URWPalladioL,serif;font-size:9.1pt">Caseiro, A.R.; Pedrosa, S.S.; Ivanova, G.; Branquinho, M.V.; Almeida, A.; Faria, F.; Amorim, I.; Pereira, T.;</span></p>
<p style="top:646.4pt;left:98.1pt;line-height:8.9pt"><span style="font-family:URWPalladioL,serif;font-size:8.9pt">Maur</span><span style="font-family:VnURWPalladioL,serif;font-size:9.0pt">&#xed;</span><span style="font-family:URWPalladioL,serif;font-size:8.9pt">cio, A.C. Mesenchymal Stem</span><span style="font-family:Rpxr,serif;font-size:8.9pt">/</span><span style="font-family:URWPalladioL,serif;font-size:8.9pt">Stromal Cells metabolomic and bioactive factors pro&#xfb01;les: A comparative</span></p>
<p style="top:659.1pt;left:98.1pt;line-height:9.1pt"><span style="font-family:URWPalladioL,serif;font-size:9.1pt">analysis on the umbilical cord and dental pulp derived Stem</span><span style="font-family:Rpxr,serif;font-size:9.1pt">/</span><span style="font-family:URWPalladioL,serif;font-size:9.1pt">Stromal Cells secretome.</span><i><span style="font-family:URWPalladioL,serif;font-size:9.1pt"> PLoS ONE</span></i><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 2019</span></b><span style="font-family:URWPalladioL,serif;font-size:9.1pt">,</span></p>
<p style="top:672.1pt;left:97.6pt;line-height:9.0pt"><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">14</span></i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">, e0221378. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">CrossRef</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:685.0pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">10.</span></p>
<p style="top:685.0pt;left:98.1pt;line-height:9.1pt"><span style="font-family:URWPalladioL,serif;font-size:9.1pt">Wu, Y.; Chen, L.; Scott, P.G.; Tredget, E.E. Mesenchymal stem cells enhance wound healing through</span></p>
<p style="top:697.9pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">di</span><span style="font-family:Rpxr,serif;font-size:9.0pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">erentiation and angiogenesis.</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> Stem Cells</span></i><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 2007</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 25</span></i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">, 2648&#x2013;2659. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">CrossRef</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:710.9pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">11.</span></p>
<p style="top:710.8pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Ferreira, J.R.; Teixeira, G.Q.; Santos, S.G.; Barbosa, M.; Almeida-Porada, G.; Gon&#xe7;alves, R.M. Mesenchymal</span></p>
<p style="top:723.7pt;left:98.1pt;line-height:9.1pt"><span style="font-family:URWPalladioL,serif;font-size:9.1pt">Stromal Cell Secretome: In&#xfb02;uencing Therapeutic Potential by Cellular Pre-conditioning.</span><i><span style="font-family:URWPalladioL,serif;font-size:9.1pt"> Front. Immunol.</span></i></p>
<p style="top:736.7pt;left:98.1pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">2018</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 9</span></i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">, 2837. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">CrossRef</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">] [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">PubMed</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>


<p style="top:56.6pt;left:76.3pt;line-height:8.0pt"><i><span style="font-family:URWPalladioL,serif;font-size:8.0pt">Cells</span></i><b><span style="font-family:URWPalladioL,serif;font-size:8.0pt"> 2020</span></b><span style="font-family:URWPalladioL,serif;font-size:8.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:8.0pt"> 9</span></i><span style="font-family:URWPalladioL,serif;font-size:8.0pt">, 2545</span></p>
<p style="top:56.6pt;left:491.8pt;line-height:8.0pt"><span style="font-family:URWPalladioL,serif;font-size:8.0pt">19 of 21</span></p>
<p style="top:90.7pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">12.</span></p>
<p style="top:90.7pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Smith, A.N.; Willis, E.; Chan, V.T.; Mu</span><span style="font-family:Rpxr,serif;font-size:9.0pt">&#xfb04;</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">ey, L.A.; Isik, F.F.; Gibran, N.S.; Hocking, A.M. Mesenchymal stem</span></p>
<p style="top:103.6pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">cells induce dermal &#xfb01;broblast responses to injury.</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> Exp. Cell Res.</span></i><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 2010</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 316</span></i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">, 48&#x2013;54. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">CrossRef</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">] [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">PubMed</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:116.5pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">13.</span></p>
<p style="top:116.6pt;left:98.1pt;line-height:8.9pt"><span style="font-family:URWPalladioL,serif;font-size:8.9pt">Riis, S.; Newman, R.; Ipek, H.; Andersen, J.I.; Kuninger, D.; Boucher, S.; Vemuri, M.C.; Pennisi, C.P.; Zachar, V.;</span></p>
<p style="top:129.3pt;left:98.1pt;line-height:9.1pt"><span style="font-family:URWPalladioL,serif;font-size:9.1pt">Fink, T. Hypoxia enhances the wound-healing potential of adipose-derived stem cells in a novel human</span></p>
<p style="top:142.3pt;left:97.8pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">primarykeratinocyte-based scratch assay.</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> Int. J. Mol. Med.</span></i><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 2017</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 39</span></i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">, 587&#x2013;594. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">CrossRef</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">] [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">PubMed</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:155.2pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">14.</span></p>
<p style="top:155.3pt;left:98.1pt;line-height:8.9pt"><span style="font-family:URWPalladioL,serif;font-size:8.9pt">Nielsen, F.M.; Riis, S.E.; Andersen, J.I.; Lesage, R.; Fink, T.; Pennisi, C.P.; Zachar, V. Discrete adipose-derived</span></p>
<p style="top:168.2pt;left:98.1pt;line-height:8.9pt"><span style="font-family:URWPalladioL,serif;font-size:8.9pt">stem cell subpopulations may display di</span><span style="font-family:Rpxr,serif;font-size:8.9pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:8.9pt">erential functionality after</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> in vitro</span><span style="font-family:URWPalladioL,serif;font-size:8.9pt"> expansion despite convergence</span></p>
<p style="top:181.1pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">to a common phenotype distribution.</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> Stem Cell Res. Ther.</span></i><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 2016</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 7</span></i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">, 177. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">CrossRef</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">] [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">PubMed</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:194.0pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">15.</span></p>
<p style="top:194.0pt;left:98.1pt;line-height:8.9pt"><span style="font-family:URWPalladioL,serif;font-size:8.9pt">Riis, S.; Stensballe, A.; Emmersen, J.; Pennisi, C.P.; Birkelund, S.; Zachar, V.; Fink, T. Mass spectrometry analysis</span></p>
<p style="top:206.8pt;left:98.1pt;line-height:9.1pt"><span style="font-family:URWPalladioL,serif;font-size:9.1pt">of adipose-derived stem cells reveals a signi&#xfb01;cant e</span><span style="font-family:Rpxr,serif;font-size:9.1pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:9.1pt">ect of hypoxia on pathways regulating extracellular</span></p>
<p style="top:219.8pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">matrix.</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> Stem Cell Res. Ther.</span></i><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 2016</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 7</span></i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">, 52. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">CrossRef</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:232.7pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">16.</span></p>
<p style="top:232.6pt;left:98.1pt;line-height:9.1pt"><span style="font-family:URWPalladioL,serif;font-size:9.1pt">Hyldig, K.; Riis, S.; Pennisi, C.P.; Zachar, V.; Fink, T. Implications of extracellular matrix production by</span></p>
<p style="top:245.7pt;left:98.1pt;line-height:8.9pt"><span style="font-family:URWPalladioL,serif;font-size:8.9pt">adipose tissue-derived stem cells for development of wound healing therapies.</span><i><span style="font-family:URWPalladioL,serif;font-size:8.9pt"> Int. J. Mol. Sci.</span></i><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 2017</span></b><span style="font-family:URWPalladioL,serif;font-size:8.9pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:8.9pt"> 18</span></i><span style="font-family:URWPalladioL,serif;font-size:8.9pt">, 1167.</span></p>
<p style="top:258.5pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">[</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">CrossRef</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:271.4pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">17.</span></p>
<p style="top:271.4pt;left:98.1pt;line-height:9.1pt"><span style="font-family:URWPalladioL,serif;font-size:9.1pt">Riis, S.; Zachar, V.; Boucher, S.; Vemuri, M.C.; Pennisi, C.P.; Fink, T. Critical steps in the isolation and</span></p>
<p style="top:284.3pt;left:98.1pt;line-height:9.1pt"><span style="font-family:URWPalladioL,serif;font-size:9.1pt">expansion of adipose-derived stem cells for translational therapy.</span><i><span style="font-family:URWPalladioL,serif;font-size:9.1pt"> Expert Rev. Mol. Med.</span></i><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 2015</span></b><span style="font-family:URWPalladioL,serif;font-size:9.1pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:9.1pt"> 17</span></i><span style="font-family:URWPalladioL,serif;font-size:9.1pt">, e11.</span></p>
<p style="top:297.3pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">[</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">CrossRef</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:310.2pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">18.</span></p>
<p style="top:310.1pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Bruun Mathiasen, A.; J&#xf8;rgensen, E.; Ali Qayyum Rigshospitalet, A.; Ali Qayyum, A.; Haack-S&#xf8;rensen, M.;</span></p>
<p style="top:323.0pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Ekblond, A.; Kastrup, J.; Copenhagen, D.M.S. Rationale and design of the &#xfb01;rst randomized, double-blind,</span></p>
<p style="top:335.9pt;left:97.8pt;line-height:9.1pt"><span style="font-family:URWPalladioL,serif;font-size:9.1pt">placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal</span></p>
<p style="top:349.0pt;left:98.1pt;line-height:8.9pt"><span style="font-family:URWPalladioL,serif;font-size:8.9pt">Stromal Cells in chr Rationale and design of the &#xfb01;rst randomized, double-blind, placebo-contro.</span><i><span style="font-family:URWPalladioL,serif;font-size:8.9pt"> Am. Heart J.</span></i></p>
<p style="top:361.8pt;left:98.1pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">2012</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 164</span></i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">, 285&#x2013;291. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">CrossRef</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:374.7pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">19.</span></p>
<p style="top:374.7pt;left:98.1pt;line-height:9.1pt"><span style="font-family:URWPalladioL,serif;font-size:9.1pt">Haack-S&#xf8;rensen, M.; Juhl, M.; Follin, B.; Harary S&#xf8;ndergaard, R.; Kirchho</span><span style="font-family:Rpxr,serif;font-size:9.1pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:9.1pt">, M.; Kastrup, J.; Ekblond, A.</span></p>
<p style="top:387.6pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Development of large-scale manufacturing of adipose-derived stromal cells for clinical applications using</span></p>
<p style="top:400.6pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">bioreactors and human platelet lysate.</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> Scand. J. Clin. Lab. Investig.</span></i><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 2018</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 78</span></i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">, 293&#x2013;300. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">CrossRef</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:413.5pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">20.</span></p>
<p style="top:413.4pt;left:98.1pt;line-height:9.1pt"><span style="font-family:URWPalladioL,serif;font-size:9.1pt">Ciccocioppo, R.; Klersy, C.; Le</span><span style="font-family:Rpxr,serif;font-size:9.1pt">&#xfb04;</span><span style="font-family:URWPalladioL,serif;font-size:9.1pt">er, D.A.; Rogers, R.; Bennett, D.; Corazza, G.R. Systematic review with</span></p>
<p style="top:426.4pt;left:98.1pt;line-height:8.9pt"><span style="font-family:URWPalladioL,serif;font-size:8.9pt">meta-analysis: Safety and e</span><span style="font-family:Rpxr,serif;font-size:8.9pt">&#xfb03;</span><span style="font-family:URWPalladioL,serif;font-size:8.9pt">cacy of local injections of mesenchymal stem cells in perianal &#xfb01;stulas.</span><i><span style="font-family:URWPalladioL,serif;font-size:8.9pt"> JGH Open</span></i></p>
<p style="top:439.3pt;left:98.1pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">2019</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 3</span></i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">, 249&#x2013;260. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">CrossRef</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:452.2pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">21.</span></p>
<p style="top:452.2pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Mathiasen, A.B.; Qayyum, A.A.; J&#xf8;rgensen, E.; Helqvist, S.; Kofoed, K.F.; Haack-S&#xf8;rensen, M.; Ekblond, A.;</span></p>
<p style="top:465.2pt;left:98.1pt;line-height:8.9pt"><span style="font-family:URWPalladioL,serif;font-size:8.9pt">Kastrup, J. Bone marrow-derived mesenchymal stromal cell treatment in patients with ischaemic heart failure:</span></p>
<p style="top:478.0pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Final 4-year follow-up of the MSC-HF trial.</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> Eur. J. Heart Fail.</span></i><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 2019</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 36</span></i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">, 1744&#x2013;1753. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">CrossRef</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">] [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">PubMed</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:490.9pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">22.</span></p>
<p style="top:490.9pt;left:98.1pt;line-height:9.1pt"><span style="font-family:URWPalladioL,serif;font-size:9.1pt">Cao, Y.; Gang, X.; Sun, C.; Wang, G. Mesenchymal Stem Cells Improve Healing of Diabetic Foot Ulcer.</span></p>
<p style="top:503.8pt;left:98.1pt;line-height:9.0pt"><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">J. Diabetes Res.</span></i><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 2017</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 2017</span></i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">, 9328347. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">CrossRef</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">] [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">PubMed</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:516.8pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">23.</span></p>
<p style="top:516.8pt;left:98.1pt;line-height:8.9pt"><span style="font-family:URWPalladioL,serif;font-size:8.9pt">Kavala, A.A.; Turkyilmaz, S. Autogenously derived regenerative cell therapy for venous leg ulcers.</span><i><span style="font-family:URWPalladioL,serif;font-size:8.9pt"> Arch. Med.</span></i></p>
<p style="top:529.7pt;left:97.8pt;line-height:9.0pt"><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Sci.-Atheroscler. Dis.</span></i><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 2018</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 3</span></i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">, 156&#x2013;163. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">CrossRef</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">] [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">PubMed</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:542.6pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">24.</span></p>
<p style="top:542.7pt;left:98.1pt;line-height:8.9pt"><span style="font-family:URWPalladioL,serif;font-size:8.9pt">Moher, D.; Liberati, A.; Tetzla</span><span style="font-family:Rpxr,serif;font-size:8.9pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:8.9pt">, J.; Altman, D.G.; PRISMA Group, T.P. Preferred reporting items for systematic</span></p>
<p style="top:555.5pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">reviews and meta-analyses: The PRISMA statement.</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> PLoS Med.</span></i><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 2009</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 6</span></i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">, e1000097. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">CrossRef</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:568.4pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">25.</span></p>
<p style="top:568.3pt;left:98.1pt;line-height:9.1pt"><span style="font-family:URWPalladioL,serif;font-size:9.1pt">Hooijmans, C.R.; Rovers, M.M.; De Vries, R.B.M.; Leenaars, M.; Ritskes-Hoitinga, M.; Langendam, M.W.</span></p>
<p style="top:581.3pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">SYRCLE&#x2019;s risk of bias tool for animal studies.</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> BMC Med. Res. Methodol.</span></i><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 2014</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 14</span></i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">, 43. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">CrossRef</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:594.2pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">26.</span></p>
<p style="top:594.2pt;left:98.1pt;line-height:9.1pt"><span style="font-family:URWPalladioL,serif;font-size:9.1pt">Study Quality Assessment Tools</span><span style="font-family:Rpxr,serif;font-size:9.1pt"> |</span><span style="font-family:URWPalladioL,serif;font-size:9.1pt"> National Heart, Lung, and Blood Institute (NHLBI). Available online:</span></p>
<p style="top:607.1pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">https:</span><span style="font-family:Rpxr,serif;font-size:9.0pt;color:#0774b7">//</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">www.nhlbi.nih.gov</span><span style="font-family:Rpxr,serif;font-size:9.0pt;color:#0774b7">/</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">health-topics</span><span style="font-family:Rpxr,serif;font-size:9.0pt;color:#0774b7">/</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">study-quality-assessment-tools</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> (accessed on 24 June 2020).</span></p>
<p style="top:620.1pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">27.</span></p>
<p style="top:620.1pt;left:98.1pt;line-height:8.9pt"><span style="font-family:URWPalladioL,serif;font-size:8.9pt">Oryan, A.; Alemzadeh, E.; Mohammadi, A.A.; Moshiri, A. Healing potential of injectable Aloe vera hydrogel</span></p>
<p style="top:632.9pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">loaded by adipose-derived stem cell in skin tissue-engineering in a rat burn wound model.</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> Cell Tissue Res.</span></i></p>
<p style="top:645.9pt;left:98.1pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">2019</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 377</span></i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">, 215&#x2013;227. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">CrossRef</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:658.8pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">28.</span></p>
<p style="top:658.7pt;left:98.1pt;line-height:9.1pt"><span style="font-family:URWPalladioL,serif;font-size:9.1pt">Atalay, S.; Coruh, A.; Deniz, K. Stromal vascular fraction improves deep partial thickness burn wound</span></p>
<p style="top:671.7pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">healing.</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> Burns</span></i><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 2014</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 40</span></i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">, 1375&#x2013;1383. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">CrossRef</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:684.6pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">29.</span></p>
<p style="top:684.5pt;left:98.1pt;line-height:9.1pt"><span style="font-family:URWPalladioL,serif;font-size:9.1pt">Eyuboglu, A.A.; Uysal, C.A.; Ozgun, G.; Coskun, E.; Markal Ertas, N.; Haberal, M. The e</span><span style="font-family:Rpxr,serif;font-size:9.1pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:9.1pt">ect of adipose</span></p>
<p style="top:697.4pt;left:98.1pt;line-height:9.1pt"><span style="font-family:URWPalladioL,serif;font-size:9.1pt">derived stromal vascular fraction on stasis zone in an experimental burn model.</span><i><span style="font-family:URWPalladioL,serif;font-size:9.1pt"> Burns</span></i><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 2018</span></b><span style="font-family:URWPalladioL,serif;font-size:9.1pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:9.1pt"> 44</span></i><span style="font-family:URWPalladioL,serif;font-size:9.1pt">, 386&#x2013;396.</span></p>
<p style="top:710.4pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">[</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">CrossRef</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:723.3pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">30.</span></p>
<p style="top:723.3pt;left:98.1pt;line-height:9.1pt"><span style="font-family:URWPalladioL,serif;font-size:9.1pt">Chen, Y.-W.; Scutaru, T.T.; Ghetu, N.; Carasevici, E.; Lupascu, C.D.; Ferariu, D.; Pieptu, D.; Coman, C.-G.;</span></p>
<p style="top:736.3pt;left:98.1pt;line-height:8.9pt"><span style="font-family:URWPalladioL,serif;font-size:8.9pt">Danciu, M. The E</span><span style="font-family:Rpxr,serif;font-size:8.9pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:8.9pt">ects of Adipose-Derived Stem Cell-Di</span><span style="font-family:Rpxr,serif;font-size:8.9pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:8.9pt">erentiated Adipocytes on Skin Burn Wound Healing</span></p>
<p style="top:749.2pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">in Rats.</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> J. Burn Care Res.</span></i><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 2017</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 38</span></i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">, 1&#x2013;10. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">CrossRef</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>


<p style="top:56.6pt;left:76.3pt;line-height:8.0pt"><i><span style="font-family:URWPalladioL,serif;font-size:8.0pt">Cells</span></i><b><span style="font-family:URWPalladioL,serif;font-size:8.0pt"> 2020</span></b><span style="font-family:URWPalladioL,serif;font-size:8.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:8.0pt"> 9</span></i><span style="font-family:URWPalladioL,serif;font-size:8.0pt">, 2545</span></p>
<p style="top:56.6pt;left:491.8pt;line-height:8.0pt"><span style="font-family:URWPalladioL,serif;font-size:8.0pt">20 of 21</span></p>
<p style="top:90.7pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">31.</span></p>
<p style="top:90.6pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Loder, S.; Peterson, J.R.; Agarwal, S.; Eboda, O.; Brownley, C.; DeLaRosa, S.; Ranganathan, K.; Cederna, P.;</span></p>
<p style="top:103.5pt;left:97.6pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Wang, S.C.; Levi, B. Wound healing after thermal injury is improved by fat and adipose-derived stem cell</span></p>
<p style="top:116.5pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">isografts.</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> J. Burn Care Res.</span></i><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 2015</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 36</span></i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">, 70&#x2013;76. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">CrossRef</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:129.4pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">32.</span></p>
<p style="top:129.3pt;left:98.1pt;line-height:9.1pt"><span style="font-family:URWPalladioL,serif;font-size:9.1pt">Shokrgozar, M.A.; Fattahi, M.; Bonakdar, S.; Ragerdi Kashani, I.; Majidi, M.; Haghighipour, N.; Bayati, V.;</span></p>
<p style="top:142.3pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Sanati, H.; Saeedi, S.N. Healing potential of mesenchymal stem cells cultured on a collagen-based sca</span><span style="font-family:Rpxr,serif;font-size:9.0pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">old</span></p>
<p style="top:155.2pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">for skin regeneration.</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> Iran. Biomed. J.</span></i><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 2012</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 16</span></i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">, 68&#x2013;76. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">PubMed</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:168.1pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">33.</span></p>
<p style="top:168.1pt;left:98.1pt;line-height:9.1pt"><span style="font-family:URWPalladioL,serif;font-size:9.1pt">Kaita, Y.; Tarui, T.; Yoshino, H.; Matsuda, T.; Yamaguchi, Y.; Nakagawa, T.; Asahi, M.; Ii, M. Su</span><span style="font-family:Rpxr,serif;font-size:9.1pt">&#xfb03;</span><span style="font-family:URWPalladioL,serif;font-size:9.1pt">cient</span></p>
<p style="top:181.1pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">therapeutic e</span><span style="font-family:Rpxr,serif;font-size:9.0pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">ect of cryopreserved frozen adipose-derived regenerative cells on burn wounds.</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> Regen. Ther.</span></i></p>
<p style="top:194.0pt;left:98.1pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">2019</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 10</span></i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">, 92&#x2013;103. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">CrossRef</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">] [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">PubMed</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:206.9pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">34.</span></p>
<p style="top:206.8pt;left:98.1pt;line-height:9.1pt"><span style="font-family:URWPalladioL,serif;font-size:9.1pt">Bliley, J.M.; Argenta, A.; Satish, L.; McLaughlin, M.M.; Dees, A.; Tompkins-Rhoades, C.; Marra, K.G.;</span></p>
<p style="top:219.8pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Rubin, J.P. Administration of adipose-derived stem cells enhances vascularity, induces collagen deposition,</span></p>
<p style="top:232.7pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">and dermal adipogenesis in burn wounds.</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> Burns</span></i><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 2016</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 42</span></i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">, 1212&#x2013;1222. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">CrossRef</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">] [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">PubMed</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:245.6pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">35.</span></p>
<p style="top:245.5pt;left:98.1pt;line-height:9.1pt"><span style="font-family:URWPalladioL,serif;font-size:9.1pt">Gholipourmalekabadi, M.; Seifalian, A.M.; Urbanska, A.M.; Omrani, M.D.; Hardy, J.G.; Madjd, Z.;</span></p>
<p style="top:258.5pt;left:98.1pt;line-height:9.1pt"><span style="font-family:URWPalladioL,serif;font-size:9.1pt">Hashemi, S.M.; Ghanbarian, H.; Milan, P.B.; Mozafari, M.; et al. 3D Protein-Based Bilayer Arti &#xfb01; cial</span></p>
<p style="top:271.4pt;left:98.1pt;line-height:9.1pt"><span style="font-family:URWPalladioL,serif;font-size:9.1pt">Skin for the Guided Scarless Healing of Third-Degree Burn Wounds in Vivo.</span><i><span style="font-family:URWPalladioL,serif;font-size:9.1pt"> Biomacromolecules</span></i><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 2018</span></b><span style="font-family:URWPalladioL,serif;font-size:9.1pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:9.1pt"> 19</span></i><span style="font-family:URWPalladioL,serif;font-size:9.1pt">,</span></p>
<p style="top:284.3pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">2409&#x2013;2422. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">CrossRef</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:297.3pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">36.</span></p>
<p style="top:297.2pt;left:98.1pt;line-height:9.1pt"><span style="font-family:URWPalladioL,serif;font-size:9.1pt">Motamed, S.; Taghiabadi, E.; Molaei, H.; Sodei&#xfb01;, N.; Hassanpour, S.E.; Sha&#xfb01;eyan, S.; Azargashb, E.;</span></p>
<p style="top:310.1pt;left:98.1pt;line-height:9.1pt"><span style="font-family:URWPalladioL,serif;font-size:9.1pt">Farajzadeh-Vajari, F.; Aghdami, N.; Bajouri, A. Cell-based skin substitutes accelerate regeneration of</span></p>
<p style="top:323.1pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">extensive burn wounds in rats.</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> Am. J. Surg.</span></i><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 2017</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 214</span></i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">, 762&#x2013;769. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">CrossRef</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:336.0pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">37.</span></p>
<p style="top:336.0pt;left:98.1pt;line-height:8.9pt"><span style="font-family:URWPalladioL,serif;font-size:8.9pt">Abbas, O.L.; &#xd6;zatik, O.; G&#xf6;nen, Z.B.; &#xd6;&#x2d8;g&#xfc;t, S.; &#xd6;zatik, F.Y.; Salk&#x131;n, H.; Musmul, A. Comparative Analysis of</span></p>
<p style="top:348.9pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Mesenchymal Stem Cells from Bone Marrow, Adipose Tissue, and Dental Pulp as Sources of Cell Therapy</span></p>
<p style="top:361.8pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">for Zone of Stasis Burns.</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> J. Investig. Surg.</span></i><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 2019</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 32</span></i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">, 477&#x2013;490. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">CrossRef</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:374.7pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">38.</span></p>
<p style="top:374.7pt;left:98.1pt;line-height:9.1pt"><span style="font-family:URWPalladioL,serif;font-size:9.1pt">Caliari-Oliveira, C.; Yaochite, J.N.U.; Ramalho, L.N.Z.; Palma, P.V.B.; Carlos, D.; de Queir</span><span style="font-family:VnURWPalladioL,serif;font-size:9.0pt">&#xf3;</span><span style="font-family:URWPalladioL,serif;font-size:9.1pt">z Cunha, F.;</span></p>
<p style="top:387.7pt;left:98.1pt;line-height:8.9pt"><span style="font-family:URWPalladioL,serif;font-size:8.9pt">De Souza, D.A.; Frade, M.A.C.; Covas, D.T.; Malmegrim, K.C.R.; et al. Xenogeneic Mesenchymal Stromal Cells</span></p>
<p style="top:400.6pt;left:98.1pt;line-height:8.9pt"><span style="font-family:URWPalladioL,serif;font-size:8.9pt">Improve Wound Healing and Modulate the Immune Response in an Extensive Burn Model.</span><i><span style="font-family:URWPalladioL,serif;font-size:8.9pt"> Cell Transplant.</span></i></p>
<p style="top:413.5pt;left:98.1pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">2016</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 25</span></i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">, 201&#x2013;215. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">CrossRef</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:426.4pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">39.</span></p>
<p style="top:426.3pt;left:98.1pt;line-height:9.1pt"><span style="font-family:URWPalladioL,serif;font-size:9.1pt">Hosni Ahmed, H.; Rashed, L.A.; Mahfouz, S.; Elsayed Hussein, R.; Alka</span><span style="font-family:Rpxr,serif;font-size:9.1pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:9.1pt">as, M.; Mostafa, S.; Abusree, A.</span></p>
<p style="top:439.3pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Can mesenchymal stem cells pretreated with platelet-rich plasma modulate tissue remodeling in a rat with</span></p>
<p style="top:452.2pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">burned skin?</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> Biochem. Cell Biol.</span></i><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 2017</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 95</span></i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">, 537&#x2013;548. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">CrossRef</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:465.1pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">40.</span></p>
<p style="top:465.2pt;left:98.1pt;line-height:8.9pt"><span style="font-family:URWPalladioL,serif;font-size:8.9pt">Singer, D.D.; Singer, A.J.; Gordon, C.; Brink, P. The e</span><span style="font-family:Rpxr,serif;font-size:8.9pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:8.9pt">ects of rat mesenchymal stem cells on injury progression</span></p>
<p style="top:478.0pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">in a rat model.</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> Acad. Emerg. Med.</span></i><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 2013</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 20</span></i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">, 398&#x2013;402. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">CrossRef</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:490.9pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">41.</span></p>
<p style="top:490.9pt;left:98.1pt;line-height:9.1pt"><span style="font-family:URWPalladioL,serif;font-size:9.1pt">Revilla, G.; Darwin, E.; Yanwirasti; Rantam, F.A. E</span><span style="font-family:Rpxr,serif;font-size:9.1pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:9.1pt">ect of Allogeneic Bone Marrow-mesenchymal Stem</span></p>
<p style="top:503.9pt;left:98.1pt;line-height:8.9pt"><span style="font-family:URWPalladioL,serif;font-size:8.9pt">Cells (BM-MSCs) to Accelerate Burn Healing of Rat on the Expression of Collagen Type I and Integrin</span><span style="font-family:EURM10,serif;font-size:9.0pt"> &#x3b1;</span><span style="font-family:URWPalladioL,serif;font-size:8.9pt">2</span><span style="font-family:EURM10,serif;font-size:9.0pt">&#x3b2;</span><span style="font-family:URWPalladioL,serif;font-size:8.9pt">1.</span></p>
<p style="top:516.8pt;left:97.8pt;line-height:9.0pt"><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Pakistan J. Biol. Sci. PJBS</span></i><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 2016</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 19</span></i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">, 345&#x2013;351. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">CrossRef</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:529.7pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">42.</span></p>
<p style="top:529.6pt;left:98.1pt;line-height:9.1pt"><span style="font-family:URWPalladioL,serif;font-size:9.1pt">Oh, E.J.; Lee, H.W.; Kalimuthu, S.; Kim, T.J.; Kim, H.M.; Baek, S.H.; Zhu, L.; Oh, J.M.; Son, S.H.;</span></p>
<p style="top:542.5pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Chung, H.Y.; et al.</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> In vivo</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> migration of mesenchymal stem cells to burn injury sites and their therapeutic</span></p>
<p style="top:555.5pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">e</span><span style="font-family:Rpxr,serif;font-size:9.0pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">ects in a living mouse model.</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> J. Control. Release</span></i><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 2018</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 279</span></i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">, 79&#x2013;88. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">CrossRef</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">] [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">PubMed</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:568.4pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">43.</span></p>
<p style="top:568.4pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Guo, X.; Xia, B.; Lu, X.B.; Zhang, Z.J.; Li, Z.; Li, W.L.; Xiong, A.B.; Deng, L.; Tan, M.Y.; Huang, Y.C. Grafting</span></p>
<p style="top:581.2pt;left:98.1pt;line-height:9.1pt"><span style="font-family:URWPalladioL,serif;font-size:9.1pt">of mesenchymal stem cell-seeded small intestinal submucosa to repair the deep partial-thickness burns.</span></p>
<p style="top:594.2pt;left:97.8pt;line-height:9.0pt"><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Connect. Tissue Res.</span></i><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 2016</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 57</span></i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">, 388&#x2013;397. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">CrossRef</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:607.1pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">44.</span></p>
<p style="top:607.1pt;left:98.1pt;line-height:9.1pt"><span style="font-family:URWPalladioL,serif;font-size:9.1pt">Xue, L.; Xu, Y.B.; Xie, J.L.; Tang, J.M.; Shu, B.; Chen, L.; Qi, S.H.; Liu, X.S. E</span><span style="font-family:Rpxr,serif;font-size:9.1pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:9.1pt">ects of human bone marrow</span></p>
<p style="top:620.1pt;left:98.1pt;line-height:8.9pt"><span style="font-family:URWPalladioL,serif;font-size:8.9pt">mesenchymal stem cells on burn injury healing in a mouse model.</span><i><span style="font-family:URWPalladioL,serif;font-size:8.9pt"> Int. J. Clin. Exp. Pathol.</span></i><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 2013</span></b><span style="font-family:URWPalladioL,serif;font-size:8.9pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:8.9pt"> 6</span></i><span style="font-family:URWPalladioL,serif;font-size:8.9pt">, 1327&#x2013;1336.</span></p>
<p style="top:633.0pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">45.</span></p>
<p style="top:633.0pt;left:98.1pt;line-height:8.9pt"><span style="font-family:URWPalladioL,serif;font-size:8.9pt">Zhang, J.; La, X.; Fan, L.; Li, P.; Yu, Y.; Huang, Y.; Ding, J.; Xing, Y. Immunosuppressive e</span><span style="font-family:Rpxr,serif;font-size:8.9pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:8.9pt">ects of mesenchymal</span></p>
<p style="top:645.9pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">stem cell transplantation in rat burn models.</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> Int. J. Clin. Exp. Pathol.</span></i><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 2015</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 8</span></i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">, 5129&#x2013;5136. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">PubMed</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:658.8pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">46.</span></p>
<p style="top:658.9pt;left:98.1pt;line-height:8.9pt"><span style="font-family:URWPalladioL,serif;font-size:8.9pt">Pourfath, M.R.; Behzad-Behbahani, A.; Hashemi, S.S.; Derakhsahnfar, A.; Taheri, M.N.; Salehi, S. Monitoring</span></p>
<p style="top:671.7pt;left:97.7pt;line-height:8.9pt"><span style="font-family:URWPalladioL,serif;font-size:8.9pt">wound healing of burn in rat model using human Wharton&#x2019;s jelly mesenchymal stem cells containing cGFP</span></p>
<p style="top:684.6pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">integrated by lentiviral vectors.</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> Iran. J. Basic Med. Sci.</span></i><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 2018</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 21</span></i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">, 70&#x2013;76. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">PubMed</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:697.5pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">47.</span></p>
<p style="top:697.6pt;left:98.1pt;line-height:8.9pt"><span style="font-family:URWPalladioL,serif;font-size:8.9pt">Gholipour-Kanani, A.; Bahrami, S.H.; Joghataie, M.T.; Samadikuchaksaraei, A.; Ahmadi-Taftie, H.; Rabbani, S.;</span></p>
<p style="top:710.4pt;left:98.1pt;line-height:9.1pt"><span style="font-family:URWPalladioL,serif;font-size:9.1pt">Kororian, A.; Erfani, E. Tissue engineered poly(caprolactone)-chitosan-poly (vinyl alcohol) nano&#xfb01;brous</span></p>
<p style="top:723.3pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">sca</span><span style="font-family:Rpxr,serif;font-size:9.0pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">olds for burn and cutting wound healing.</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> IET Nanobiotechnol.</span></i><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 2014</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 8</span></i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">, 123&#x2013;131. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">CrossRef</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:736.3pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">48.</span></p>
<p style="top:736.2pt;left:98.1pt;line-height:9.1pt"><span style="font-family:URWPalladioL,serif;font-size:9.1pt">Xu, Y.; Huang, S.; Fu, X. Autologous transplantation of bone marrow-derived mesenchymal stem cells:</span></p>
<p style="top:749.1pt;left:97.7pt;line-height:9.1pt"><span style="font-family:URWPalladioL,serif;font-size:9.1pt">A promising therapeutic strategy for prevention of skin-graft contraction.</span><i><span style="font-family:URWPalladioL,serif;font-size:9.1pt"> Clin. Exp. Dermatol.</span></i><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 2012</span></b><span style="font-family:URWPalladioL,serif;font-size:9.1pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:9.1pt"> 37</span></i><span style="font-family:URWPalladioL,serif;font-size:9.1pt">,</span></p>
<p style="top:762.1pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">497&#x2013;500. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">CrossRef</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>


<p style="top:56.6pt;left:76.3pt;line-height:8.0pt"><i><span style="font-family:URWPalladioL,serif;font-size:8.0pt">Cells</span></i><b><span style="font-family:URWPalladioL,serif;font-size:8.0pt"> 2020</span></b><span style="font-family:URWPalladioL,serif;font-size:8.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:8.0pt"> 9</span></i><span style="font-family:URWPalladioL,serif;font-size:8.0pt">, 2545</span></p>
<p style="top:56.6pt;left:491.8pt;line-height:8.0pt"><span style="font-family:URWPalladioL,serif;font-size:8.0pt">21 of 21</span></p>
<p style="top:90.7pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">49.</span></p>
<p style="top:90.6pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Arkoulis, N.; Watson, S.; Weiler-Mitho</span><span style="font-family:Rpxr,serif;font-size:9.0pt">&#xfb00;</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">, E. Stem cell enriched dermal substitutes for the treatment of late</span></p>
<p style="top:103.6pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">burn contractures in patients with major burns.</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> Burns</span></i><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 2018</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 44</span></i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">, 724&#x2013;726. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">CrossRef</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:116.5pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">50.</span></p>
<p style="top:116.4pt;left:98.1pt;line-height:9.1pt"><span style="font-family:URWPalladioL,serif;font-size:9.1pt">Abo-Elkheir, W.; Hamza, F.; Elmofty, A.M.; Emam, A.; Abdl-Moktader, M.; Elsherefy, S.; Gabr, H. Role of</span></p>
<p style="top:129.5pt;left:98.1pt;line-height:8.9pt"><span style="font-family:URWPalladioL,serif;font-size:8.9pt">cord blood and bone marrow mesenchymal stem cells in recent deep burn: A case-control prospective study.</span></p>
<p style="top:142.3pt;left:97.7pt;line-height:9.0pt"><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Am. J. Stem Cells</span></i><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 2017</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 6</span></i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">, 23&#x2013;35.</span></p>
<p style="top:155.2pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">51.</span></p>
<p style="top:155.2pt;left:98.1pt;line-height:9.1pt"><span style="font-family:URWPalladioL,serif;font-size:9.1pt">Chamuleau, S.A.J.; Van Der Naald, M.; Climent, A.M.; Kraaijeveld, A.O.; Wever, K.E.; Duncker, D.J.;</span></p>
<p style="top:168.1pt;left:98.1pt;line-height:9.1pt"><span style="font-family:URWPalladioL,serif;font-size:9.1pt">Fern</span><span style="font-family:VnURWPalladioL,serif;font-size:9.0pt">&#xe1;</span><span style="font-family:URWPalladioL,serif;font-size:9.1pt">ndez-Avil</span><span style="font-family:VnURWPalladioL,serif;font-size:9.0pt">&#xe9;</span><span style="font-family:URWPalladioL,serif;font-size:9.1pt">s, F.; Bolli, R. Translational research in cardiovascular repair a call for a paradigm shift.</span></p>
<p style="top:181.1pt;left:97.8pt;line-height:9.0pt"><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Circ. Res.</span></i><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 2018</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 122</span></i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">, 310&#x2013;318. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">CrossRef</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:194.0pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">52.</span></p>
<p style="top:193.9pt;left:98.1pt;line-height:9.1pt"><span style="font-family:URWPalladioL,serif;font-size:9.1pt">Mogil, J.S.; Macleod, M.R. No publication without con&#xfb01;rmation.</span><i><span style="font-family:URWPalladioL,serif;font-size:9.1pt"> Nature</span></i><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 2017</span></b><span style="font-family:URWPalladioL,serif;font-size:9.1pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:9.1pt"> 542</span></i><span style="font-family:URWPalladioL,serif;font-size:9.1pt">, 409&#x2013;411. [</span><span style="font-family:URWPalladioL,serif;font-size:9.1pt;color:#0774b7">CrossRef</span><span style="font-family:URWPalladioL,serif;font-size:9.1pt">]</span></p>
<p style="top:206.9pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">[</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">PubMed</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:219.8pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">53.</span></p>
<p style="top:219.7pt;left:98.1pt;line-height:9.1pt"><span style="font-family:URWPalladioL,serif;font-size:9.1pt">Sterne, J.A.C.; Savovi&#xb4;c, J.; Page, M.J.; Elbers, R.G.; Blencowe, N.S.; Boutron, I.; Cates, C.J.; Cheng, H.Y.;</span></p>
<p style="top:232.8pt;left:98.1pt;line-height:8.9pt"><span style="font-family:URWPalladioL,serif;font-size:8.9pt">Corbett, M.S.; Eldridge, S.M.; et al. RoB 2: A revised tool for assessing risk of bias in randomised trials.</span><i><span style="font-family:URWPalladioL,serif;font-size:8.9pt"> BMJ</span></i></p>
<p style="top:245.6pt;left:98.1pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">2019</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 366</span></i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">CrossRef</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">] [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">PubMed</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:258.5pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">54.</span></p>
<p style="top:258.6pt;left:98.1pt;line-height:8.9pt"><span style="font-family:URWPalladioL,serif;font-size:8.9pt">Kang, M.; Ragan, B.G.; Park, J.H. Issues in outcomes research: An overview of randomization techniques for</span></p>
<p style="top:271.4pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">clinical trials.</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> J. Athl. Train.</span></i><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 2008</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 43</span></i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">, 215&#x2013;221. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">CrossRef</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">] [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">PubMed</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:284.3pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">55.</span></p>
<p style="top:284.4pt;left:98.1pt;line-height:8.9pt"><span style="font-family:URWPalladioL,serif;font-size:8.9pt">Gupta, K.K.; Attri, J.P.; Singh, A.; Kaur, H.; Kaur, G. Basic concepts for sample size calculation: Critical step</span></p>
<p style="top:297.3pt;left:98.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">for any clinical trials!</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> Saudi J. Anaesth.</span></i><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 2016</span></b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">,</span><i><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 10</span></i><span style="font-family:URWPalladioL,serif;font-size:9.0pt">, 328&#x2013;331. [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">CrossRef</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">] [</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt;color:#0774b7">PubMed</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">]</span></p>
<p style="top:319.3pt;left:76.5pt;line-height:9.0pt"><b><span style="font-family:URWPalladioL,serif;font-size:9.0pt">Publisher&#x2019;s Note:</span></b><span style="font-family:URWPalladioL,serif;font-size:9.1pt"> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional</span></p>
<p style="top:329.5pt;left:76.5pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">a</span><span style="font-family:Rpxr,serif;font-size:9.0pt">&#xfb03;</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">liations.</span></p>
<img style="position:absolute;transform:matrix(.221696,0,-0,.221696,-91.16266,398.8003)" src="data:image/png;base64,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">
<p style="top:349.0pt;left:167.8pt;line-height:9.0pt"><span style="font-family:Rpcxr,serif;font-size:9.0pt">&#xa9;</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt"> 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access</span></p>
<p style="top:361.9pt;left:169.4pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">article distributed under the terms and conditions of the Creative Commons Attribution</span></p>
<p style="top:374.9pt;left:169.1pt;line-height:9.0pt"><span style="font-family:URWPalladioL,serif;font-size:9.0pt">(CC BY) license (http:</span><span style="font-family:Rpxr,serif;font-size:9.0pt">//</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">creativecommons.org</span><span style="font-family:Rpxr,serif;font-size:9.0pt">/</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">licenses</span><span style="font-family:Rpxr,serif;font-size:9.0pt">/</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">by</span><span style="font-family:Rpxr,serif;font-size:9.0pt">/</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">4.0</span><span style="font-family:Rpxr,serif;font-size:9.0pt">/</span><span style="font-family:URWPalladioL,serif;font-size:9.0pt">).</span></p>

</div>
